PriMera Scientific Medicine and Public Health

The aim of the study - to investigate the influence of risk factors in the mother and morbidity in the neonatal period on the development of hypoxic-ischemic encephalopathy of newborns, depending on their gestational age, as well as to determine the effect of neuroprotection on the development of hypoxic brain lesions in premature infants.
Materials and Methods At the first stage, a retrospective analysis of the course of pregnancy, child birth and the condition of newborns was carried out in 150 women whose children had suffered from hypoxic-ischemic brain damage. Group I (I G) consisted of 62 women who gave birth to full-term babies, Group II (II G) - 88 women who gave birth prematurely at 26+6 - 33+6 weeks of gestation. At the second stage, the level of neurospecific markers of nerve tissue damage (NSE and S100) was prospectively investigated in 60 preterm infants at gestational terms up to 32 weeks, which were divided in to two groups. The main group (MG) consisted of 30 preterm infants whose mothers were injected with magnesium sulfate for the purpose of neuroprotection, the comparison group (CG) - 30 preterm infants whose mothers did not receive neuroprotection for various reasons.
Results and Discussion The risk factors for the birth of children with HIE include extra genital pathology in the mother (OR 1090.818, 95% CI 64.501-18447.401), urogenital infections-chlamydia (OR 21.87, 95% CI 1.264 - 378.397), prematurity, low weight bodies at birth, PROM, chorionamnionitis (OR 17.6, 95% CI 2.288 - 135.407), Apgar score <7 points, morbidity in the neonatal period. Neurospecific enolase (NSE) was significantly higher in children with gestational age up to 32 weeks and an Apgar score of <6 points. The lower concentration of protein S 100 in
newborns of the main group can be explained by the protective effect of magnesium sulfate on the central nervous system of a premature new born.
Conclusions Risk factors for neurological disorders in newborns include extragenital pathology, urogenital infections of the mother, prematurity, premature rupture of the membranes, the development of chorionamnionitis, and fetal growth retardation. Conducting neuroprotection
with magnesium sulfate before delivery is an important measure to prevent hypoxic-ischemic brain damage to the fetus and premature newborn.
Keywords: hypoxic-ischemic encephalopathy; prematurity; preterm labor; chorionamnionitis; neuroprotection

Hand hygiene is fundamental to clinical practice and has been shown to reduce the risk of major diseases. School children and for that matter, primary school pupils are at higher risk the most because of the lack of paying special attention to a simple but very important personal hygiene behavior such as frequently washing hands with soap under running water and also due to insufficient knowledge on good hand washing with soap practice. Between November 2021 and March 2022, this study was conducted in Tehsil Lalian District Chiniot Pakistan. Data on hand washing practiced among primary school children were collected by using questionnaires. Ten students from each school were selected for the questionnaires and 20 schools in urban and 20 schools in rural areas were covered. The study helped us to check the current knowledge about hygiene and the availability of hand washing facilities in the school. Data were collected from above-mentioned schools by using questionnaires. Interviews were taken from the class students to check their knowledge about hygiene which they are given to the students to guide them about their hygiene and how they teach the students to keep them healthy. In rural schools, about 39% students were selected from class 3, 32% from class 4, and 29% students were selected from class 5, while in urban schools, about 35.5% students were taken from class 3, 36.5% from class 4 and 28% students from class 5 were selected. All schools (rural and urban) have the facility of hand washing points. About 96.75% schools have water supply within hand washing point while only 3.25 schools do not have a water supply. They have tissue papers facility instead of water. About 87.75% schools have sign boards of hand washing to guide the students while only 12.25% schools do not have sign boards on hand washing guide the students. About 71.5% students from rural schools wash their hands before eating food while 28.5% students wash their hands after eating. Further, 66.5% students from urban schools wash their hands before eating food while 32.5% students wash their hands after eating. About 74.5% students from rural schools, wash their hands after playing with friends while 25.5% students sometimes wash their hands. About 63.5% students from urban schools wash their hands after playing with friends while 36% students sometimes wash their hands and 0.5% never wash their hands after playing with friends. About 77% students know the importance to wash their hands with soap when in school and 23% students do not. About 42.75% students strongly agree that hand hygiene reduces the chances of spreading infections, 28% student only agree, 13% disagree, 12% don’t know while 4.25% strongly disagree. About 81% students think proper handwashing minimizes the risk of germ attack while 19% students do not think so. About 88.75% students know that if they fail to wash their hands properly, they will be exposed to the disease while 11.25% students do not think so. About 80.25% students think that poor hand washing can cause disease while 19.75% students do not think so.
Keywords: hand washing; disease prevalence; school children; washing practice; rural areas; urban areas

Behavior and cognitive functions are results of a fine tuning of multiple neuronal synapsis and a myriad of biochemical reactions whose number, location, components, sequence, and logic are unknown.
In entirely theoretical terms deleterious effects of reactive oxygen species (ROS) production during aerobic metabolism are neutralized by the antioxidant systems and in this manner the brain effectively regulates its oxygen consumption and redox generation capacity.
The knowledge about the metabolic processes of the CNS is so elementary, so theoretical, that only in the previous paragraph we find two notable errors: aerobic metabolism and oxygen consumption.
The phrase aerobic metabolism refers to the fact that the oxygen contained in any tissue of the human organism, such as the CNS, comes from the air that surrounds us, since it is supposedly absorbed through the lungs and reaches the bloodstream to be distributed to all the cells of the organism.
However, since 1850 researchers of the stature of Christian Bohr, Carl Ludwig, and Halender, published works in which, according to their experiments, the diffusion of atmospheric oxygen through the pulmonary alveoli could not explain the enormous difference between the concentration of atmospheric oxygen, which ranges between 19 and 21%, and the % SpO2 in the blood that reaches values of 98 and 99% [1].
It was precisely the search for the mechanism that would explain such a difference between oxygen in the atmosphere and blood oxygen, which led these researchers to publish that there was no such thing, and that diffusion alone did not explain such a difference.
Unfortunately, at that time, the work of Krogh appeared [2] who, by means of a theoretical mathematical model, apparently simple, explained the unlikely passage of atmospheric oxygen to the bloodstream through the pulmonary alveoli. Krogh’s lung gas exchange model has been the foundation of respiratory physiology for the past 100 years even though the mathematical concepts it handles are so far-fetched that they cannot even be experimentally contrasted.
Krogh’s original model has been modified and something like 100 equations have been added to try to explain the supposed passage of atmospheric oxygen to the bloodstream through the pulmonary alveoli, but even so, the experimental results do not
square with the predictions of such a model. So, research and care for patients during the past 100 years has been based on eminently theoretical models.
So, returning to the phrase “aerobic metabolism of the CNS”, we have the surprise that it is wrong because the oxygen we have inside the body does not come from the air that surrounds us but from the water that contains inside each cell that conforms us.
Keywords: Oxygen; aerobic; Krogh´s model; energy; combustion; CSF

The earliest land plants date back to around 3.70 Billion years before. Estimates on the number of Earth's current species range from 10 million to 14 million. They have major impact on Mankind. The impact of the Moon and its rotation around the Earth has many effects on life on the Earth and Mankind. Earth Science taught the Mankind, how to take care of the Nature and obtain the benefits of the atmosphere through plants so as to have a smooth life and healthy longevity.

The burning of fossil fuels by humans is the largest source of emissions of carbon dioxide which is one of the greenhouse gases that allows radiative forcing and contributes to global warming. For that reason humans should use plant based foods for their overall health instead of animal based foods and plants as a medicines instead of Chemical Drugs.

During the Nutrition month of September 2020, Government of India has taken a Plantation drive for Promotion of Kitchen Garden under “POSHAN KE LIYE PAUDHE ” (in Hindi language).

Plants give us various types of seeds and dry fruits which in tern give us Vitamin E. This Vitamin E plays important role in human personality as well as in immune system as an antioxidant, preventing important molecules and structures in the cell from reacting to oxygen. When the delicate components of living protoplasm are attacked by oxygen they are often injured. If one wants to live longer, he/she has to be very friendly with vitamin E. It has now been found out that it has good role to play in many types of pains, not as a pain killer but a pain reliever. Vitamin E may help ease muscle aches after a tough workout, a new study suggests. Researchers believe that the antioxidant mops up the damaging by products created by a strenuous workout.

Thus depending upon requirements of a person, various plants can be useful to maintain an overall health of a person so as to maintain his or her Healthy Longevity.

In one study participants took a relatively high dose of vitamin E, the average person could probably get the same benefits from lower doses of between 200 to 400 IU per day.

Thus the vitamin E which is a water soluble vitamin can be a good pain reliever as also immunity enhancer, if taken in proper proportion as also in proper Natural form.

Our day-to-day eating habits provide many opportunities for us to support our immune system’s power to protect us. All these are from plant foods like….

Black resins, dates & apple, provide us with Iron (Fe), Watermelon seeds give us Zn., Cereal sprouts give us Amino Acids. Gooseberry (Amala), Cranberry, Lime juice Sweet lime provide us vitamin C, Sunflower seeds give us Selenium. All these vitamins are plant sourced and are good for enhancing immunity but doses differs from person to person since unique physiological characteristics .Also it is important to know, how the nutrients are prepared & processed & what other substances accompany them into body. This is a Pharmacology of Nutrition. Further it considers alteration in food due to food processing, adulteration & contaminations. Hence food should be healthy & ideally suited to a particular person.

How can our diet affect immune health?

Our body produces highly reactive molecules called free radicals as part of normal metabolic processes & in response to exposures like pollution & tobacco smoke. Immune cells produce them as a way to fight infections. High levels of free radicals trigger inflammation. Antioxidant nutrients consumed in excess may actually interfere with the body’s antioxidant defences. One has to be very careful while using any nutrient, including plant that high doses of one nutrient can create deficiencies of other nutrients, including those needed by the immune system.

High-fibre diets can nurture gut microbes that provide anti-inflammatory protection. These microbes protect cells within the colon & seem likely to help protect against inflammation throughout the body. Now we are looking for plant based proteins and try avoid animal based proteins, so more of plant utilisation for our health.

Make nutrient-dense foods the majority of our plate to provide the wide range of nutrients needed for immune system cells & function. This includes – but is not limited to – minerals like Zn, Se, Fe & Cu,omega-3 fats & protein.

A few more examples where plants can be of more beneficial are like…

Lemon grass-Cloudy lemonade is served hot as a remedy for chest congestion. Ginger plant Juice-Contains gingerol, is very good muscle pain reliever. It is useful in cough and cold. Watermelon-Cucumber-Mint Juice This drink if taken during summer, it will have a soothing effect on hyperthermic body of a person. Cloves’ Powder and Honey.

Cloves contain a natural compound eugenol which helps to stabilize blood sugar & has positive effect on artery clogging cholesterol. Carrot juice along with lemon juice works in case of Diabetic persons. Coriander, Basil, Pudina, Aloe vera, Moringa, Turmeric, Garlic and such other plants are good for Human health.

The European Society of Clinical Nutrition and Metabolism guidelines on nutrition emphasize that their nutritional needs should be met through a balanced diet, adjusted as needed to meet each individual’s condition. But in general, the guidelines say that use of single high-dose micronutrients should be avoided.

In short, more is not always better.

Free radicals are normal. They are important signals within cells & “turn on” body antioxidant defences but excessive levels of free radicals can damage cells & promote inflammation. Likewise, short-term inflammation is part of how the body clears an infection. If inflammation is out of control however, it can create cell & tissue damage that is difficult to reverse. Most us may be tempted to assume, “if some is good, more is better,” to fight these diseases. But that’s not what evidence shows.

An important element to consider is that people with dementia may have limited access to information on COVID-19 and experience difficulties in applying safety strategies (social isolation, self-quarantine measures, wearing masks, and personal hygiene). Therefore, people with dementia may be more dependent on family members and social caregivers to support them [7] to live within government guidelines. This is further impounded by the provision of information through social media and the implementation of digital health technologies. Older people with dementia living in residential settings have not been able to engage with their family members due to the banning of visitors and with the cessation of group activities [8], older people, and those with dementia, are becoming further isolated [9].
The consideration of the impact of COVID-19 on older people and those with dementia is essential due to the aging global population [10]. The global population of those over 65 years of age was estimated to be over 562 million in 2012, and the population of older adults rose by 55 million in 2015, which is projected to be double by 2050 [11]. Cognitive impairment is common in the older population, although is not a natural part of ageing [12]. The cognitive function of an individual may decrease with age, but mild cognitive impairment and dementia impacts on the person’s ability to independently complete their own activities of daily living, as well as impacting on their memory, language, and orientation. Recent studies showed that the use of computer helped in cognitive stimulation and improved cognitive function with mild cognitive impairment of elderly people [45]. The combined intervention of digital inclusion and physical exercise helped to prevent cognitive and functional loss with elderly [46]. Cognitive decline is a significant issue in aging and it is associated of dementia patients and increases independence, quality of life and falls. Thus, dementia can negatively impact on a person’s quality of life and life expectancy [13]. Dementia poses a challenge to the long-term financial sustainability of health systems worldwide [14]. Likewise, the number of people living with dementia in the developing countries will reach to 71% by 2040 [15] in developed countries such as Western Europe 9.9%, in North America 9.2%, and in America 9.1% of the population by 2040 [16] furthermore, older adults with dementia require further care services such as; care delivery, medication management, education and training for family members and informal caregivers, cognitive interventions, but also leisure activities to support a person with dementia to remain independent, all of which are currently extremely limited [17].
Interventions to support people with dementia at home, have begun to use video telehealth, which has been found to be feasible to deliver cognitive rehabilitation [18] and improve cognitive performance [19, 20]. Face to face videoconference [21], pharmacological interventions [22], technology-based behavioral interventions [23] and cognitive assessments [24]. These approaches demonstrate that technology-based interventions for older people and those with dementia appears both affordable [25] and reliable [26]. COVID-19 has forced and enabled the adoption of technology in dementia support and care in the form of prevention, early detection, care, management and diagnosis [27]. The applications of these technologies could support older people and those living with dementia in rural areas, and those who have migrated and may have linguistically diverse languages. The COVID-19 crisis has provided the opportunity to embrace technology, to support older people, and those with dementia to maintain their connections with the outside world during self-isolation. Health policy makers, service providers and clinicians need to consider these innovative opportunities and support the technological transformation of dementia practice in the coming years [28].
Digital health technologies can support a reduction in the provision of care in hospital settings, and support the management of infections [29]. Considering a significant contribution of digital technologies, the American Academy of Neurology has developed guidelines to implement telemedicine services for clinicians to assess and examine their patients, although some limitations have been acknowledged, such as the follow-up appointments [30]. However, this has not been converted into clinical practice as yet. COVID-19 has forced nations to consider the use of digital health, such as telehealth and e-health, which can contribute to the management of communicable diseases during the pandemic and possibly slow the infection rate of COVID-19 through supporting social distancing [31]. Digital health technologies provide and improve patients’ health, and reduces expenses and as well as the need for care facilities [32]. Telemedicine and mobile care tele-mentoring, tele critical care were significantly useful to offer care facilities during COVID-19 [33]. Within the specialist field of dementia memory screening tools, care, management of behavioral and psychological symptoms in dementia and consultations [34], have occurred through the use of remote technology. This approach has supported the difficult balance of maintaining social distancing and continuing to support people living with dementia, and those caring for them, but has also enable a significant cost reduction to the health system and decreased the risk of infections [35]. Furthermore, these processes have enabled clinical decisions, diagnoses and outcomes to be supported in a timelier manner, supporting earlier intervention opportunities [36] to support and improve mental health.
Technology can also contribute to the reduction of the burden on healthcare institutions and professionals [37]. Technology has also been applied through satellite monitoring, health sensors and apps, Drones (drones were applied in carrying medicine), spraying disinfectants and 3D Printing which was deployed to mitigate shocks to the supply chain and export bans on personal protective equipment [38]. Digital health technologies have not only supported older people and those with dementia, through remote screening and the facilitation of care during a pandemic [39]. Telehealth played directly and indirectly in reducing the contamination by enabling physical distancing, tracking symptoms and detecting timely using interventions [40]. Further, telehealth supported to bring out put with patients’ safety, reliable and flexible regulatory [41]. Virtual care using technologies in home patients and out patients care in health institution, initial COVID-19 hospital surge, and post pandemic recovery was most effective for the care of the dementia patients [42].
Emerging technologies are changing our daily lives under lockdown. The COVID-19 crisis has shown a further way that emerging technologies like the internet and artificial intelligence are not just tools, they are essential to the functioning of our society and economy in this 21st century. Thus, such digital tools must adapt as essential developmental procedure as the time progress. It is not only for COVID-19 issues but also should be implemented to make our daily life easiest than before to fight with communicable disease. Digital technology enables to educate from remote to health workers and populations to follow better care in limited resources and accurately using the Chatbots information getting update of current health systems and patients care home location of their activities and protect from the spread of the virus. Also, saved time, money and to all the sectors and will be cost effective [43].
However, is still a gap in the research regarding how and which digital health (DH) technologies can be effective to support older people and those with dementia patients. But the reality is we are seeking more reliable proof to apply and implement the full potential of this growing area in health science [44]. Therefore, supporting older adults with dementia and maintaining their well-being during COVID-19 has become an urgent to apply digital health technology.

Evidence in clinical practice shows us various effects of improper communication on individuals; they range from minor to significant alteration of people’s health, according to the subject matter, transmission channel [oral, written format], interaction [face to face, virtual] type of communication [verbal, and nonverbal], time and exposure magnitude, dissemination area, environment characteristics, and sensitivity and vulnerability of intended recipient. Middle-aged people and the elderly are more sensitive to offensive attitudes and inappropriate words' energy transfer to them. Unskilful interactions imply the adrenergic pathway increasing activity determining changes in the blood volume flowing through the vessels, finally altering the cell’s functionality in the fragile area. Transitory and persistent unsafe communication increases blood pressure; it is another key for initiating, maintaining, and accelerating the evolution of arterial hypertension, affecting the heart and blood vessels. High blood pressure in arteries determines changes and adaptation of their structure and function in line with time action, forces, and individual susceptibility; it goes along with other risk factors for the building-up of atherosclerotic plaque. Atherosclerosis narrows blood vessels, disturbing the corresponding areas working. If nutrients and oxygen supply decrease by another medical condition interplay, the summative for possible exponential count effects increases. Atrial fibrillation, heart failure, stroke, peripheral arterial disease, chronic kidney disease, vision loss, or altered mind activity may be some effects of such disturbed blood volume flowing. Suggestive clinical signs and symptoms accompany the gradual or sudden loss of function of altered zones. Compiling all factors implying the functionality of the cardiovascular system, including communication skills, we have a general picture of its changing harmony and possible fissures; brain haemorrhage is an unwanted situation. The loss of proper control of the individual working appears under excessive nervous tension. Usually, forceful discussions between business partners, family, and community members may generate haemorrhage in fragile areas. Words’ battle forces exceeding limits lead to subsequent disorders in the easily broken zone. Other effects of inappropriate communication are initiation and advances of dyslipidaemia, altered blood sugar control, leads to depression, and generates people’s conflict ending in their separation or death by victim’s physical aggression or suicide. Concern about the wrong delivery of bad news in clinical practice is necessary since unskilful transmission of such info can lead to disaster in a person at risk. Improper communication affects an individual [intended recipient], but the effects extend to their dear ones, who will suffer for their distress. Finally, unsuitable communication alters individuals’ well-being.

By contrast, the best communication skills delight people, amend the worsening of individual health, and improve life quality and expectancy. The right, kind words and attitudes act as medicines and must be considered in the personal therapeutic plan; they may resonate with a person, harmonizing his mind-sets. Practical, suitable terms and images created with the words assist the people passing trouble time for a better emotional state and enhance their ability to deal with dilemmas. Magnificent word composition energizes and inspires humans. Stars in this zone fascinate the individual since their words are a miracle in the body's functioning. The best words’ composition, products of divine inspiration, produces a good, bright effect.

There are communications in front of indifference.

Therefore the words represent a valuable communication channel for people’s collaboration; they inform us about the difference between individuals. Words influence the nervous system’s functioning through their energy and meaning. Appropriate word energy people use in interaction leads to effective clinical outcomes in practice. Unsuitable words’ energy and power alter their health and decrease work efficiency and social and professional life. For these reasons, communication skills represent a central theme for public health. In a family, there are differences between generations. The aspirations of older adults do not align with those of a young age, leading to conflict. Excessive debates and opinion differences generate nervous tension, leading to disaster for vulnerable people, as mentioned. Respect and appreciation for the parents’ input for their children’s professional, social, and cultural life formation are required. Over time the parents usually do not have a good memory or judgment. Their child has to impart compassion, be polite, and be attentive to them. Promoting good habits in doing well for other people, especially with the parents, is mandatory. Health promotion messages, such as ‘Be polite, and you’ll be rewarded,’ can effectively increase attentiveness and interest in communication. Encouragement and emotional support are essential for the elderly health improvement. We must advocate for the refinement into a partnership between the patient’s family, community members, and business partners. Professionalism in all domains is necessary. Unhealthy behavioural manifestations may originate in mental disorders, and we must identify and treat them. Modelling people's interaction adversities is a key to preventing and treating other disorders, including recuperating altered personality traits; social, professional, and culturally safe work is essential for society’s refinement and advancement. Artificial Intelligence supply offers another perspective for analysis, modelling, and applying the best communication skills in practice. Based on an analysis of ‘what happened?’ guided by AI experts, we can predict what will happen, and they can insert an influence mechanism as a solution and services for corrective actions to mitigate the harmful effects of an individual’s improper communication. Educational programs, hybrid models, IT devices, and artificial intelligence supply offer us the opportunity for instruction, modelling, and recovery in a short time, and that chance never existed before. They ensure human safety for a better life in an unceasingly changeable environment. The people must be aware, especially of words’ power to illuminate or destroy personal values. In this digital era of innovation, technological advances and discoveries allow us to use the words’ composition to our advantage, with cost and time saving, at our e-comfort, when and where necessary, for revitalization or peaceful moments. The ability to cope with harsh conditions makes us influential people in dilemmas. Improving our knowledge, communication skills in daily practice, customer centricity, increased revenue, and best interaction with other trades define us as professionals. Guidance in this direction assists us through excellence in the way of living, in the end, appreciation, and offerings abundantly supplying.

Aim

To highlight communication dimensions between generations and new choices for moral distress restoration in the digital era.

Material and Methods

A qualitative study performed by the author in the community, 2008-2022, relating to communication value for people’s health. The effects of inappropriate communication were noticed and corrected when and where necessary and preventive actions were initiated.

Findings

One day in the spring of 2021, a patient, 89, in interaction with a physician in public, used impolite attitudes and words, determining moral distress for the physician.

Patient medical history; widow: 1972; HTA: from 1972. Heart failure, NYHA class II, 2021; NYHA class III, 2022.

Patient family health history: brothers, sisters, parents: HTA.

Actions were taken

The physician made no comment in public, but a few hours after that incident, when observed the patient alone, she went to her and compassionately scolded her. The patient commented: ‘I said it, and if I said it, what should I do now? Take a cake here from mine to pass you by! I am upset since my son-in-law passed away; he was diagnosed with COVID, and today is the funeral.’ The doctor was affected by the situation and expressed her condolences. To amend the moral distress generated by interaction with that patient, the physician listened to a selected classical music program and enjoyed chosen lectures.

Results

No other offensive communications were noticed for that person.

Conclusion

Grave life events and medical conditions make an older person less attentive in interaction with others in public. Supportive actions from the community can ameliorate their suffering. The digital era offers a new perspective on moral distress restoration.

Discussion/ Implications

Older people were more affected by the pandemic COVID ID19; the loss of their dear ones makes them more vulnerable and sometimes unwise in interaction with others. That patient, in those moments, was probably furious with all physicians, considering the loss of her son-in-law. People must resonate with their suffering, understand their judgment impairment, and support them. Compassion, kind words, friendly attitudes, and encouragement are practical actions to ameliorate their distress. Moral distress restoration benefits in this era of technological advances; IT devices offer a new perspective that never existed before. The selection of the different programs according to individual preference, using the ‘watch on demand’ function, images from nature, reading stories of interest, and channels-mid conversation with dear ones are helpful instruments for restoration of moral distress. Digital products inspire, energize, and encourage us, even in difficult times. Walking in nature is another effective, cheaper technique for health improvement. Self-esteem in intersection with the principles for people’s collaboration in public may exceed the limits; the elderly often hurt us since time slowly undermine all.

The author of the article owns a series of publications highlighting the features of the pathogenesis of a new disease: "COVID - 19 - POSTCOVID SYNDROME", as well as a method of treatment and prevention of this disease based on the scientifically proven healing properties of Hirudo medicinalis medical leeches [3-13]. At the same time, the editors of three scientific medical journals have already adopted the author's concept of the name of the disease - "COVID - 19 - POST-COVID SYNDROME" [11-13], which reflects the understanding that this is a single disease that has two phases: the first phase is an acute process, which usually lasts 2-3 weeks - ("COVID - 19") and the next phase is the development of a chronic process - ("POSTCOVID]. The team of MGNOT doctors, represented by its Chairman - Professor A.P. Vorobyov, offers the following treatment for "Post-Covid syndrome": 1. Apply direct oral anticoagulants, twice a day; 2. Plasmapheresis - at least 900 ml, for 1 procedure, at least 5 procedures, daily, with plasma replacement with saline to reduce intoxication [6]. It should be noted that the use of direct anticoagulants has a number of limitations and significant complications with damage to the central nervous system, they can cause nasal, throat and renal bleeding. Plasmapheresis is applicable only if there is special equipment and trained personnel in the clinics. Given the huge masses of the population affected by the pandemic, the proposed treatment technology has no chance of large-scale application. SYNDROME"), which can last for 18-24 months.

Such a definition of the new pandemic is important not only from a taxonomic point of view, but, above all, from a mental point of view, so it gives the doctor an understanding of the complexity of the course of the disease and requires monitoring patients during the entire specified period, for example, monitoring the dynamics: D-dimers, prothrombin time, platelet count and the level of fibrinogen in the blood of convalescents. These are the recommendations of the International Society on Thrombosis and Hemostasis (ISTH) [15]. Now these are the most informative markers of the danger of thrombosis. The term "Long COVID" does not reflect the essence of the disease process [13].

It should be clearly distinguished that the cause of the disease is the virus "COVID-19" (Beta-coronavirus SARS-CoV-2), and the disease itself, for these reasons, should be called "COVID-19 - POSTCOVID SYNDROME".

Analyzing the pathogenesis of this disease, we will dwell on the analysis of the pathogenesis and treatment offered by two scientific schools of Russia. One of them is the analysis and opinion of doctors united in the Moscow City Scientific Society of Therapists (MCSST) named after Professor S.P. Botkin. After examination and treatment of a significant number of patients (more than 2,000 people), with a confirmed diagnosis of “COVID-19”, during 2020-2021, the diagnosis of «POSTCOVID SYNDROME" was formulated. According to MCSST " POSTCOVID SYNDROME " is: “Chronically occurring thrombovasculitis with a predominant lesion of the nervous system (Central, autonomous and peripheral) and skin” [14].

The team of MCSST doctors, represented by its Chairman - Professor A.P. Vorobyov, offers the following treatment for "POSTCOVID SYNDROME":

Apply direct oral anticoagulants, twice a day;
Plasmapheresis - at least 900 ml, for 1 procedure, at least 5 procedures, daily, with plasma replacement with saline to reduce intoxication [6].

It should be noted that the use of direct anticoagulants has a number of limitations and significant complications with damage to the central nervous system; they can cause nasal, throat and renal bleeding. Plasmapheresis is applicable only if there is special equipment and trained personnel in the clinics.

Given the huge masses of the population affected by the pandemic, the proposed treatment technology has no chance of large-scale application.

Another clinical school, headed by academician Makatsaria A.D., believes that the leading pathological sign of this disease is the "Syndrome of disseminated intravascular coagulation - (DIC) syndrome [15]. The most unfavorable prognostic sign, according to the authors of this school, is coagulopathy.

If the parameters of the main markers of coagulopathy (D-dimers, prothrombin platelet time, count and fibrinogen levels) worsen, more "aggressive" resuscitation care should be carried out: Low molecular weight heparin (LMWH) should be prescribed to all patients with diagnosed “COVID-19” infection (including non-critical patients) who require hospitalization, in the absence of contraindications to LMWH in these patients. The use of LMWH drugs by this school (Enaxiparin, Nadroparin, Dalteparin) in a prophylactic dose is also justified, which does not require special control. It is recommended to take these drugs to all patients, even with a mild course of the disease, excluding active bleeding, platelet count < 25x10⁹/l, intolerance to LMWH, severe renal failure.

At the same time, it is not known how these drugs will behave with prolonged use, except for the above limitations for them.

The author of this article spoke at the 11^th European Congress for Integrative Medicine in 2018 in Ljubljana (Slovenia) [1] and at the 5^th International Meeting on Traditional and Alternative Medicine in Rome (Italy) April 2019 with a report: "The Renaissance of hirudotherapy in Russia: The end of XX and the beginning XXI century [2]. These speeches and publications were positively received by the medical community, which served as an incentive for a more complete coverage of the topic of the current state of hirudotherapy in Russia [11-13].

Without reducing the importance of the recommendations of the MCSST therapy of "POSTCOVID SYNDROME"), we offer an alternative way to solve the problem of reducing mortality from pneumonia and other complications caused by “COVID-19”. Previously, we expressed the same point of view in the treatment of elderly people with multi-organ pathology, namely, they become primarily victims of this pneumonia [4].

This is the application of the "System Method of Leeching" (SML) - (hirudotherapy). The method is based on a combination of the principles of homeopathy and acupuncture (hirudopuncture, our definition). The proposed solution is based on the almost 30-year use of SML in elderly people with multi-organ pathology and children treated at the Academy of Hirudotherapy of St. - Petersburg [16]. The preventive and therapeutic plan for anticoagulant and antiplatelet therapy for the prevention of DIC- syndrome, distress syndrome is considered step by step from the standpoint of the “System Method of Leeching” (SML) in recent publications [4, 17].

We remind readers about some unknown properties of leech.

Over the past 30 years, the Academy of Hirudotherapy in St.- Petersburg has obtained a number of new fundamental facts when applying the “System Method of Leeching (SML), which can significantly enhance the clinical effect of its use, and will reduce the mortality of patients with pneumonia caused by the “COVID-19” virus.

In addition to the already known properties of hirudotherapy - antithrombic and thrombolytic, anti-inflammatory, countercurrent, new properties of medical leeches were discovered at the department:

Discovery of the energy effect (information-entropic);
Discovery of the neurostimulating effect of the medical leech;
Discovery of the acoustic effect of leeching (hirudotherapy);
Discovery of the detoxification effect of leeching (hirudotherapy);
Discovery of the phenomenon of local hyperthermia in the body of a benign brain tumor - neurinoma;
Discovery of the negentropic effect of leeching (hirudotherapy);
The role of autohemogyrudotherapy in the formation of the immunomodulatory effect of leeching (hirudotherapy) is shown;
Discovery of the aquastructuring effect of leeching (hirudotherapy);
Discovery of the "Resonance-wave effect" of leech on the state of the human aquasystem.

Descriptions of all these discoveries are detailed in the author's publications [3-13, 17].

Therefore, as soon as the pandemic caused by the “COVID-19” virus was pumped up in Russia, our doctors, trained in the SML technology, began to actively apply this method in the treatment of the disease "COVID-19 - POST-COVID SYNDROME".

At the same time, it was shown that SML is a pathogenetic method of treating this disease, including well-known signs of damage to the central and peripheral nervous system, (restoring smell, hearing and vision loss, manifesting antidepressant syndrome) preventing the development of DIC - syndrome.

It should be noted that the use of SML has no restrictions on the timing of use, so a patient with a brain tumor - a neurinoma (schwanoma) received treatment for 23 years, demonstrating a positive result of treatment (Clinical case

described [18]).

Why do we refer to hirudotherapy as a “Method of information medicine”?

Not only because this method has about 20 types of therapeutic effect. But also because in the process of treatment with medical leeches, which is first shown in our studies, there is an impact on the information-entropy processes in the aqua system of patients, which leads to a process of harmony between the indicators of the chaos criterion (C_c) and the order criterion (C_o), with access to the harmony parameters - "Golden Proportion" or "Golden Ratio", which is characteristic of a high level of health [5, 19].

Known for many centuries, the method of hirudotherapy, as part of Ayurveda or Ayurvedic medicine, is still revered and used in India and the countries of South-East Asia.

At present, thanks to new knowledge in the field of hirudology and hirudotherapy, reflected in the "System Method of Hirudotherapy", the Ayurveda method has acquired a new image, content and capabilities.

Conclusion

The SML method has no complications and can be used as monotherapy in both the acute and chronic stages of the disease "COVID - 19 - POSTCOVID SYNDROME".

In fact, the feeding of human populations has gone from the collection of fresh vegetables in nature, to specialized production in large monoculture extensions, with high mechanization and use of agrochemicals; that is, from natural foods to those manipulated through different technological processes. The latter have become a few basic products, whose negative effects are well known, due to prolonged exposure over many generations to a low diversity of foods and their associated microbiota, which is why nutrition and immunity functions have been reduced naturally in the human microbiota (Vázquez 2022).

Paradoxically, families from periurban communities, sometimes socially marginalized, are more likely to obtain food in small spaces, which provide them with a diversity of seminatural fresh products, because they are obtained with minimal physical interventions, not chemicals and very little manipulation, whose biotic direct interactions contacts with family members influence nutrition and health, facilitating a sustainable quality of life despite living with low income. In fact, these periurban communities constitute coinnovation niches that can serve as a reference for designing the food systems of the future.

Habitat and feeding

An estimated 800 million city dwellers worldwide are involved in agriculture-related activities in cities and towns, where they produce food and generate income. A combination of data from national censuses, household surveys and research projects from various agencies indicate that up to two thirds of urban and periurban households are involved in agriculture, through local government, institutional, community and family programs (FAO 2010).

It is interesting to observe that in the members of these families there are contrasts of origin, training and ages, which converge with a permacultural, organic or agroecological perception regarding family farming, mainly when elderly people of peasant or rural origin live together, who transmit their cultural traditions; also, people who have received training that allows them to understand the differences regarding feeding with products from conventional agriculture.

Carrying out biodiversity management practices in small scale agricultural production systems, with social and environmental advantages in historical, socioeconomic, and geographical contexts in Latin America, has helped to maintain more sustainable agricultural systems than the technified ones (Mougeot 2006). These urban green spaces can provide vegetation structures and biodiversity for ecosystem functions and services, across fragmented habitats and spatial scales (Lin and Fuller 2013).

Although urban agriculture alone will not solve the complex ecological and social problems of cities, given the multiplicity of factors that intervene in it. Agrocultural development in the city constitutes an effective strategy for the management, protection, and recovery of the urban environment from various spheres of action (Moreno 2007). In fact, small scale agricultures are those that produce around 70% of the food worldwide, using only 30% of the productive resources, while industrial agriculture produces 30% of the food in 70% of the surface (ETC 2017).

Small scale food production in urban and periurban areas has become an important component in the design of feeding strategies in large cities of the developing world and is an agricultural production alternative with almost nonexistent negative environmental impacts (Morello 2000), experiences that justify the importance of integrating the habitat with the self management of food that can be considered as seminatural.

In fact, human health is closely related to the environmental factors (Mejías 2013). The different existing models on health determinants contemplate the environment as an important factor to take into account (Evans et al 1996). Considering that the city is the main environment in which life takes place for a large part of the population and that, as has already been seen, it is possible that it will increasingly accommodate a greater number of people, it seems advisable to study how to make these ecosystems healthy spaces (Mejías 2013).

Several studies indicate that contact with nature and the inclusion of green spaces in urban environments promote psychological wellbeing, stress reduction and improve the perception of health of its residents (Largo-Wight 2011).

Given this need, agroecology emerges as a discipline that provides the basic ecological principles on how to study, design, and manage agroecosystems that are both productive and conserving natural resources, and that are also culturally sensitive and socioeconomically viable (Altieri 2010).

Food and health

The modern diet is vastly different from that of our Paleolithic ancestors, who had an annual base of some 500 different plants, whereas ours has fewer than 50; they ate their food raw and often fermented, while we preserve, dry and cook our food, processes known to destroy many sensitive nutrients and antioxidants. This may be the reason why we are now seeing an increase in various atopic diseases, infections and so-called Western diseases (Bengmark 2001).

Several leading authoritative reviews have shown that dietary diversity is associated with better health outcomes, and that a monotonous diet, even biofortified, is associated with nutritional deficiencies and high rates of chronic disease (Bélanger and Johns 2008). Another potential positive effect of participation in urban gardens is an improvement in nutritional habits there are studies that indicate that the consumption of fresh fruits and vegetables is higher among horticulturists than among those who are not (Alaimo et al. 2008).

On the other hand, the postharvest rehandling of fresh agricultural products is a factor that can generate risks for healthy eating, mainly when good packaging, transportation and temporary storage practices are not guaranteed and the marketing circuits are long. This situation does not occur in family and community agriculture, where freshly harvested food is used or consumed in a short time, either by the family or community members.

Through social practice, societies have developed experiences and systematized special ways of "know and to know" about health and disease, which have gradually shaped a set of notions and knowledge formed in people's daily and spontaneous common practice, until arriving at the empirical practice that concentrates and systematizes the experience of the community in a long time. This informal knowledge, of unquestionable cultural value, is considered by some health professionals as something that must be preserved or recovered due to its secular value (Silva 1997).

Sustainable quality of life

The sustainable quality of life, although it is a highly complex socioeconomic challenge for health systems, can be considered as one of the priorities for the survival of human populations. It is a holistic approach to health conservation, which is particularly different in urban, periurban and rural systems, where factors that determine habitat quality, healthy eating and natural medication converge.

People who have a working life in different occupations in society, find a moment to take care of plants and animals, which means a change of work that they do with pleasure, because it has the double function of contributing to the wellbeing of the family and their health, for being doing physical work. This is the integral health of the family, because they coexist in harmony with plants and animals that provide them with different benefits, be they food, nutrition, medicine and pleasure.

Another problem is the social isolation suffered by a significant number of older people, which is an important risk factor for developing other disorders or pathologies (Kharicha et al 2007). It is mentioned that, for example, in Sri Lanka the shade, freshness and diversity of these orchards are considered essential for people's physical and mental wellbeing (Lok 1998).

Although the current needs of human populations are diverse and of a high magnitude, integrating orchards into urban, periurban, and rural family homes has an invaluable contribution to sustainable quality of life, because it contributes to rediscovering habitat, food, and health.

Our world revolves around its advanced axis. Everything is progressive and innovative. Newer technology is on the horizon, and it has changed the spectrum of our world and transformed the way people live. This digital rise brought pros and cons to our scheme. This technological breakthrough contributed to different spheres of existence.

The security of its citizens is the government's first priority. Since individuals are the most valuable resource the government has, improving medicine and medical procedures is essential if we want to win the public's trust. The delivery of public health is efficient if one medical practice is effective. We refer to this as the "parallel effect."

Public health and medicine are intricately intertwined. The understanding of and contribution to public health made by medicine are changing along with the world. All facets are moving toward high definition and the internet of things as we reach the fourth industry. The cosmos is increasingly facing extreme climate change, which has negative effects on human health and the ecosystem. People are more involved in unrelated work, which increases the likelihood that health hazards will arise. Because of this, innovation in medicine and public health must coexist.

By properly implementing various programs and curricula related to the effective use of medication as a therapy for any disease, public health is the process of creating a healthy environment for healthy people. The challenge here is how well public health professionals can treat everyone with inclusive medication in order to prevent any health complications. The 4^thIndustrial Revolution has profoundly changed the medical industry in many ways, so it is important to take that into account while promoting public health. Extensive learning is essential in order to practice advanced medicine.

In a general sense, the primary goal of medicine and public health is to promote and improve the health of every individual and the whole population. This must include appropriate program implementation for the right people at the right time and in the right place. A comprehensive and thorough understanding of how to carry out this attempt in order to promote healthy well-being and a disease-free environment that is resilient throughout the seasons.

Three Kenya Medical Training college campuses were selected purposively, mainly, Bungoma in Bungoma County, Webuye in Bungoma County and Kakamega in Kakamega County. Across sectional analytical Study design was employed. A sample of 222 students and 12 key informants were included in the study. Systematic random sampling was used for selection of students. Structured questionnaires were used to collect data from students, Interview schedules used to collect data from Key Informants. Collected data was entered in the SPSS Version 21.0 and data analysed by descriptive statistics using percentages and means and inferential statistics of odds ratio used to test strength of association and 0.05 set as p value used to test the hypothesis in academic dishonesty. The response rate was (90.1%) n=202. The study findings revealed that out of 202, (47%) n=95 agreed to have been involved in some form of academic dishonesty; Most students, (40.1%), n=81 confessed to have received information on academic honesty through students’ hand book. The results revealed examination cheating as the main form of academic dishonesty (71.6%) n=145. The main contributing factor to academic dishonesty was lack of lecturers adhering to policies in administration of examinations and overcrowding (OR: 2.3; 95% CI: 1.2-4.5; p=0.01), students not aware of college rules (OR: 0.6; 95% CI: 0.3-1.0; p=0.07) followed by family pressure to score high 47.8% (n=97). Students reported that punishment, remedial teaching and ant plagiarism software detection strategies were explained to them at the beginning of the training (OR: 1.4; 95% CI: 0.7-2.7; p=0.03). Consequences for academic dishonesty differed from college to college (OR: 1.9; 95% CI: 0.9-4.0; p=0.04). The most employed strategy for addressing academic dishonesty was use of punishment. In conclusion, the study revealed that academic dishonesty was prevalent in the three colleges with cheating as the commonest form. Punishment was the commonest of all strategies used to deter students’ involvement in academic dishonesty. This study therefore recommends that lecturers should adhere to college policies particularly during invigilation of examinations and provision of enough spacing during examination to reduce examination malpractices and more current strategies like software plagiarism detection to be employed by the college administration in curbing academic dishonesty.

Clinical Presentation

A 50 years old non diabetic, non-hypertensive male patient presented with acute onset fever for past 5 days and persistant hiccough and drowsiness for last 1 day. Fever was intermittent (twice daily), not associated with chill and rigor. It was associated with generalised weakness and myalgia. There was no history of cough and cold, dyspnea, abdominal pain, dysuria, headache, nausea, vomiting.

On examination, patient was drowsy, GCS 14/15. Neck rigidity was absent. Chest examination revealed mild inspiratory crepitations over left lower zone.

Investigations

Complete hemogram shows Hb 11.5, TLC 3500 (N58L40E1M1), platelet 75000. LDH 780.
Liver function test showed total bilirubin 0.8, SGOT 170, SGPT 44, ALP 92, albumin 3.1, total protein 6.
Renal function test showed urea 51, creatinine 1.5, serum sodium 125, potassium 3.6.
C reactive Protein was 75.5.
Urine examination was normal.
Chest x ray was normal.

USG whole abdomen showed liver 14 cm, spleen 14 cm.
2 D echocardiography- Normal.
Malarial parasite and Dual antigen Negative.
Dengue IgM Negative, Typhidot IgM negative.
Leptospira IgM-positive (titre-1:80).
Scrub typhus IgM-positive (titre-1:80).

Clinical Course

Patient was managed conservatively with Ceftriaxone, Doxycycline and 3% Nacl, But didn't improve. He developed dyspnea and progressive drowsiness.

CSF analysis showed protein 72mg/dl, sugar 54mg/dl.cell count 3, all lymphocytes.

Further examination revealed Triglyceride was 613mg/dl, ferritin was 14540mg/dl.

Bone marrow examination revealed Haemophagocytes.

Management

The patient was diagnosed with Macrophage Activation Syndrome secondary to Scrub typhus and Leptospirosis. He was treated with intravenous dexamethasone along with antibiotics. Patient improved dramatically from third day and he was discharged with oral antibiotic and oral steroid for total 14 days.

Learnings

We have to keep Macrophage Activation Syndrome in our mind while treating a febrile patient who was not responding to antimicrobial therapies rather who was gradually deteriorating because antimicrobials without immunosuppresion in these cases can lead to fatal consequences.

Reference

Diwan AG., et al. “Triple trouble--macrophage activation syndrome in a case of severe leptospirosis and scrub typhus co-infection”. The Journal of the Association of Physicians of India 62.1 (2014): 58-61.

Context. In the Democratic Republic of Congo (DRC), the epidemiological profile is dominated by infectious diseases including cholera. It evolves in endemic and epidemic form depending on the province. Despite multisectoral and multidisciplinary interventions organized in the field, the number of deaths remains high, as some contributing factors remain unknown while interventions need to be directed towards these factors.

Objective. Develop and analyse the conceptual model of the factors underlying cholera deaths in the community and in cholera treatment centres (CTCs).

Methodology. A retrospective cross-sectional study, from 2000 to 2013, of descriptive and exploratory type was used. It used the Directorate of Disease Control (DLM) database of 500,670 cases and 11,560 deaths. Finally, the qualitative and prospective method was carried out from 16 September to 16 December 2016, multicentric and covering five cities: Kinshasa, Lubumbashi, Kisangani, Mbandaka and Kalemie. Focus group techniques with 50 community leaders, an in-depth semi-structured interview with 50 patients, 15 health experts and 25 cholera patients. And a structured face-to-face interview with 15 health workers assigned to the CTC was organized. The percentage (%) of respondents' responses was calculated. Content analysis and triangulation of information was performed. Some qualitative survey data was collected by telephone, for obvious reasons.

Results. Four main groups of factors: (i) Organization of services (training of providers, availability of inputs, principles of separation of treatment rooms, lack of working hours, poor management of inputs, lack of systematic follow-up and evaluation of patients, poor clinical evaluation of patients), (ii) Individual factors (physiological state, pathological state and immunological status), (iii) Cholera profile (endemic area, epidemic and virulence of Vibrio cholerae). (iv) Socio-community and anthropological factors (perception and representation of cholera on the one hand, and treatment on the other). These factors can be influenced by complex interrelations without linearity.

Conclusion. Our study, to the importance of developing a conceptual model of the factors of death due to cholera. Understanding the factors that influence and interact with death is the straight line on which efforts must be focused to effectively and significantly reduce mortality from this disease. This conceptual model was designed to develop and analyze more than 96% of these factors, with the exception of those related to the biology of Vibrio cholera, including virulence genes. An ongoing prospective analytical study will determine virulence gene characteristics and antibiotic susceptibility profiles of Vibrio cholerae O1 in clinical and environmental isolates in Lubumbashi, Democratic Republic of Congo.

Conclusion. Our study showed the importance of developing a new conceptual model of cholera death factors. Understanding the factors that influence and interact on death is the straight line on which efforts must be focused to effectively and significantly reduce mortality from this disease. In our view, actors targeting these factors would ipsofacto reduce cholera deaths in the Democratic Republic of Congo.

Early diagnosis and management of COVID 19 improves prognosis. During the onset manifestation, the most common symptoms were fever (98%), cough (76%) and myalgia or fatigue (44%); less frequent symptoms were sputum production (28%), headache (8%), hemoptysis (5%) and diarrhea (3%) and more than half of the patients developed dyspnea [3]. At this stage, primary viral replication followed by cellular damage is presumed to occur in the mucous epithelium of the upper respiratory tract (nasal cavity and pharynx), with additional multiplication in the lower respiratory tract and the gastro-intestinal mucosa [4]. Activation of the immune system, which follows, is important. If this immunological response is adequate, the infection can be controlled and the patient remains asymptomatic. In contrast, it has been shown that SARS CoV 2 can block this antiviral immunity early, effectively and durably in the most serious cases [5]. Anticoronavirals should be helpful during this stage. It should be remdesivir (by antiviral activity against SARS-CoV-2), ritonavir boosted nirmatrelvir (SARS-CoV-2 main protease inhibitor and an HIV-1 protease inhibitor and CYP3A inhibitor), chloroquine and its derivative hydroxychloroquine (by a modification of an attachment protein on the head of the virus), baricitinib (by inhibiting cyclin G), among others. After this stage, major manifestations could be occurred.

Major clinical manifestations linked to COVID 19 include digestive disorders, coagulation disorders, acute respiratory distress syndrome (ARDS), macrophagic activation syndrome, etc. These imply specific therapeutic approaches over anticoronaviral therapy.

Digestive disorders

The digestive manifestations during COVID 19 are various: anorexia (83.8%), diarrhea (29.3%), vomiting (0.8%) and abdominal pain (0.4%) [6]. The interaction between SARS COV2 and intestinal microbiota on the one hand resulting a modification of microbiota, thus favoring the appearance of the cytokine storm and on the other hand interaction between SARS COV 2 and intestinal cells leads to their destruction [6]. Therefore, one of the therapeutic targets would be to add commensal bacteria to improve this modification. Another would also be to manage the cytokine storm. Some biological Disease-Modifying Antirheumatic Drugs (bDMARD) and targeted synthetic Disease-Modifying Antirheumatic Drugs (tsDMARDs) have given encouraging results in the cytokine storm management.

Coagulation disorders

It manifests as thrombosis of small pulmonary vessels, pulmonary embolism, thrombosis of small skin vessels, deep vein thrombosis, hemorrhage of small vessels, disseminated intravascular circulation (DIC), etc. Activation of the coagulation system and fibrinolytic system result from systemic inflammation, endothelial dysfunction by interaction with SARS COV 2, severe hypoxemia and the production of antiphospholipid antibodies leading to clot formation. Anticoagulants are therefore essential in the management of these coagulation disorders. Heparin and direct oral anticoagulants can be used [7].

Acute respiratory distress syndrome (ARDS)

It is characterized by acute onset of respiratory distress maked by dyspnea with hypoxia and hypocapnia; tachypnea; intercostal, sub sternal, supernal, supraclavicular pulling; crackling rales etc. The interaction between SARS COV 2 and red blood cells leads to a decrease in the capacity of hemoglobin to transport and efficiently exchange CO2 and O2 through the alveolo-capillary barrier which in the long term causes an alteration of the alveolo-capillary barrier, then can progress to pulmonary fibrosis. In addition, the interaction between SARS COV 2 and alveolar epithelial type II cells leads to the destruction of alveolar epithelial type II cells with production of hyaline membrane plus the alveolo-capillary barrier damage [2, 8]. A treatment based on hydroxychloroquine (by its action on the preservation of hemoglobin) allows to maintain the normal transport of oxygen (O2) and carbon dioxide (CO2) through the alveolo-capillary membrane. Certain bDMARDs can be used such as interleukin-6 (IL-6) blocker that seems to hold great promise for managing the massive cytokine storm associated with the development of typical lung damage and ARDS). tsDMARD can be also used (by interference with Janus kinase) in its management. Corticosteroids reduce excessive and harmful pulmonary inflammation, but they also inhibit the beneficial immune response which allows the patient to eliminate pathogens.

Macrophagic activation syndrome

It manifests clinically by high fever, hepatosplenomegaly, lymphadenopathy among others and biologically by hyperferritinemia, hypofibrinogemia, pancytopenia, hepatocellular insufficiency etc. The interaction between SARS COV2 and cells having ACE 2 receptor induces an activation of the inflammatory process: vasodilation, vascular hyperpermeability, infiltration of inflammatory cells leading to the release of pyrogenic cytokines or even a cytokine storm (interleukin-6, interleukin-8, interleukin-10, tumor necrosis factor, etc) [2]. Therapies targeting the pro-inflammatory cytokines can improve macrophagic activation syndrome. Corticosteroid therapy and certain bDMARDS such as Anakinra (interleukin 1 receptor antagonist) have been discussed in management.

So, what therapeutic strategy? The complexity of its pathophysiology, the multiple therapeutic targets and the absence of effective anticoronaviral monotherapy proven at the current state of knowledge are arguments to say that it is necessary to consider blocking several therapeutic targets in order to increase the anticoronaviral effectiveness. Hence the need to combine anticoronaviral therapeutic means taking into account the type of COVID 19 patient and in particular all the major clinical manifestations linked to COVID 19.

Anticoronaviral multitherapy proposed by some authors may be the solution, if and only if, it can suppress viral replication and prevent the immune system from dysregulation. Indeed, clinical trial is underway to assess the efficacy and tolerance of the triple-drug therapy combining baricitinib, lopinavir / ritonavir and remdesivir [9]. The genetic susceptibility of COVID 19 patients to develop the severe form is not yet well established. Could anticoronaviral multitherapy prevent progression towards severe form? However, it has been shown that a reduced viremia does not prevent the immune system from racing and its progression towards the severe form [1]. Suppressing the virus does not seem to be enough. It would be better that all the management strategies are focused on the early diagnosis and adequate treatment of the type of COVID 19 patient and in particular all the major clinical manifestations linked to COVID 19. Anecdotally, we will say that no drug proposed is effective, all the drugs proposed are effective, it is a question of early diagnosis and adequate treatment of the types of patient and all the major clinical manifestations linked to COVID 19.

This information will help to develop therapeutic strategies depending on the type of COVID 19 patient and in particular all the major clinical manifestations linked to COVID 19 instead to continuing to take account only an anticoronaviral monotherapy or anticoronaviral multitherapy, knowing well that the immune system dysregulation with its inflammatory corollary persists despite the decrease of viremia.

Competing interests

Authors declare no competing interests.

Authors contributions

Authors has read and agreed to the final manuscript.

References

Lescure F-X., et al. “Clinical and virological data of the first cases of COVID-19 in Europe: a case series”. The Lancet Infectious Diseases 20.6 (2020): 697-706.
Yuefei J., et al. “Virology, Epidemiology, Pathogenesis, and Control of COVID-19”. Viruses 12.4 (2020): 372.
Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 395.10223 (2020): 497-506.
Xiao F., et al. “Evidence for gastrointestinal infection of SARS-CoV-2”. medRxiv 158.6 (2020): 1831-1833.e3.
Meijuan Z., et al. “Functional exhaustion of antiviral lymphocytes in COVID-19 patients”. Cellular & Molecular Immunology 17.5 (2020): 533-535.
Lei P., et al. “Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study”. Am J Gastroenterol 115.5 (2020): 766-773.
McGonagle D., et al. “Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia”. Lancet Rheumatol 2.7 (2020): e437-e445.
Wenzhong L and Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism (2020).
Stebbing J., et al. “COVID-19: combining antiviral and anti-inflammatory treatments”. Lancet Infect Dis 20.4 (2020): 400-402.

The continuing spread of SARS-CoV-2 remains a Public Health Emergency of International Concern. World Health Organization (WHO) reported, globally, the number of new weekly cases (21 to 27 November 2022) was just fewer than 2.7 million new cases reported and the number of new weekly deaths with about 8400 fatalities. And, as of 27 November 2022, 637 million confirmed cases and 6.6 million deaths have been reported globally. Three types of COVID 19 patients are distinguished from the French study, (i) patients with few clinical signs but with a high nasal viral load and being highly contagious; (ii) patients with mild symptoms at the beginning but worsening towards the tenth day with the appearance of a severe acute respiratory syndrome despite a decreasing viral load; (iii) patients with a rapid worsening to an acute respiratory syndrome with persistence of a high viral load in the nose and throat and appearance of SARS-CoV-2 blood viremia causing multivisceral failure leading to death [1]. The major clinical manifestations linked to COVID 19 are numerous and diverse, among which there are digestive disorders, coagulation disorders, acute respiratory distress syndrome, macrophagic activation syndrome, myocarditis linked to SARS COV2, acute tubulopathy linked to SARS COV2, meningoencephalitis linked to SARS COV 2. These can be explained by the fact that the cellular tropism of SARS COV 2 is numerous as well as the physiopathogenic consequences. It concerns all cells with an angiotensin-converting enzyme 2 (ACE 2) receptor (example, alveolar epithelial type II cells, upper and stratified epithelial cells of the esophagus, absorbent enterocytes of the ileum and colon, pancreatic cells, glial cells, Sertoli cells) [2]. The interactions between SARS COV 2 and ACE2 cells lead to their internalization and massive viral replication with cellular damage, activation of the inflammatory process, activation of the immunological system, stimulation of the coagulation system, among others [2]. The various physiopathogenic consequences during COVID 19 largely explain its numerous therapeutic targets. What physicians need to know about physiopthothogeny with identified therapeutic targets, holistic diagnostic and therapeutic approach of Covid-19 is the subject of ongoing updates from experts at this Journal.

References

Ackoff RL. “The design of social research”. Chicago: University of Chicago Press (1953).
Alvi M. “A manual for selecting sampling techniques in research”. Munich Personal RePEc Archive (2016).
Best JW and Kahn JV. “Research in education”. Boston: Pearson Education Inc (2006).
Best J and Kahn J. Research in education (10th ed.). New Delhi: PHI Learning Pvt. Ltd (2010).
Bhardwaj P. “Types of sampling in research”. Journal of the Practice of Cardiovascular Sciences 5.3 (2019): 157-163.
Brick JM. “Explorations in non-probability sampling using the web”. Proceedings of Statistics Canada Symposium (2014).
Brown GH. “A comparison of sampling methods”. Journal of Marketing 6 (1947): 331-337.
Cochran WG. Sampling techniques (2nd ed.). New York.: John Wiley & Sons, Inc (1963).
Cohen L, Manion L and Morrison K. Research methods in education (8th ed.). New York: Routledge Palmer (2018).
Cresswell JW. Educational research: Planning, conducting, and evaluating quantitative and qualitative research (4th ed.). Noida: Pearson India Education Services Pvt. Ltd (2019).
Creswell J. Educational research: Planning, conducting, and evaluating quantitative and qualitative research (4th ed.). Boston: Pearson Publications (2012).
Davis D. “Business research for decision making”. Australia: Thomson South-Western (2005).
Dornyei Z. “Research methods in applied linguistics”. Shanghai: Oxford University Press (2007).
Fraenkel JR and Wallen NE. “How to design and evaluate research in education (7th ed.)”. New York: McGraw-Hill (1990).
Ghauri P and Gronhaug, K. “Research methods in business studies”. Harlow: Prentice Hall (2005).
Guthrie G. “Sampling in basic research methods: An entry to social science research”. Delhi: SAGE Publications India Pvt Ltd (2010).
Hansen MH, Hurwitz WN and Madow WG. “Sample survey methods and theory”. New York: Wiley 1 (1953).
Henry GT. Practical sampling. In L. Bickman, & J. D. Rog (Eds.), The SAGE handbook of applied social research methods. Delhi: SAGE Publications Ltd (2009): 29.
Kerlinger FN. “Foundations of behavioral research”. Delhi: Surjeet Publications (2011).
Kolb B. “Determining probability samples in marketing research”. Delhi: SAGE Publications (2011).
Kothari CR and Garg G. Researh methodology: Methods and technology (4th ed.). New Delhi: New Age International (P) Ltd (2019).
Kumar R. “Research methodology: A steo-by- step guide for beginners”. New Delhi: SAGE (2011).
Lohr S. “Sampling: design and analysis. Cengage Learning”. Boston: Cengage Learning (2009).
McCombes S. Sampling methods, types, techniques and examples (2022).
Nanda G and Khatoi P. “Fundamentals of educational research and statistics”. New Delhi: Kalyani Publishers. New Delhi: Kalyani Publishers (2005).
Raj D. The design of sample surveys. New York: McGraw-Hill Book Company (1972).
Ruane JM. “Essentials of research methods: A guide to social science research”. Maiden: Blackwell Publishing (2005).
Särndal C-E, Swensson B and Wretman J. “Model assisted survey sampling”. New York: Springe (1992).
Taherdoost H. “Sampling methods in research methodology: How to choose a sampling technique for research”. International Journal of Academic Research in Management 5.2 (2016): 1-10.
Taherdoost H. “Sampling methods in research methodology: How to choose a sampling technique for research”. International Journal of Academic Research in Management 5 (2020): 18-27.
Vogt WP, Gardner DC and Haeffele LM. “When to use what research design”. New York: The Guilford Press (2012).
Wilson J. “Essentials of business research: a guide to doing your research project”. SAGE Publication (2010).
Yamane T. “Elementary Sampling theory”. Englewood Cliffs: Prentice-Hall, Inc (1967).
Zikmund WG., et al. “Business research method: A south-Asian perspective”. Delhi: Cengage Learning India Pvt. Ltd (2010).

Patients’ social behaviour toward the medical team mainly supposes appreciation and respect since there is a considerable investment in a medical carrier: long education period, financial resources, and emotional involvement. In medicine, responsibility is at the highest level; nothing can replace the loss of dear ones, and our mission is to improve and save life. To achieve these goals, a professional in the healthcare industry must have specific knowledge, quickly manage info and deliver medical services when and where necessary. The art of communication with patients and community members with different backgrounds helps us to attain the best results in clinical practice. To do that, theoretically, a medical team member must not be buried, not in his daily program or society. But in their daily routine, they can experience offensive comments or attitudes from persons with reasoning or communication problems.

How much must we tolerate facing daily work adversities from the patients or other individuals?

Genetics, perception abnormalities, info-processing deficiency, reasoning nonconformity, and tolerance groups determine a patient’s social behaviour deviance. Medical conditions may affect them at various levels. Misinformation sources must be disapproved, detected, and punished when necessary. Broad-minded groups must be trained for multiple situations that are emerging offensive human actions. Identifying the origin of an individual’s wrong and cruel actions towards others and corrective actions are needed. An ethical, respectful approach to the problem must be considered.

Patients’ intentions may differ from their actions’ end. Good intentions following the worst results reveal judgment impairment or misinformation processing; modelling such gaps helps us improve behaviour and joy in redressing individual misconduct in social interaction.

Repetitive unpleasant people interactions must be stopped when necessary since improper people collaboration may lead to depression, hypertension, type 2 diabetes, or dyslipidaemia in vulnerable persons.

So, making the individual aware of the consequences of his unconventional social behaviour is mandatory.

The healthcare professionals offended by the patient may deny the further patient’s requests for healthcare services [except emergency care], The patient will be obliged to look after another healthcare provider, and that technique may initiate the patient’s reflection about his actions, consciousness’ activation and self-awareness for further interactions with professionals. Applying this possible convincing technique adds benefit to problem-solving mastery.

Suppose the patient’s social behaviour deviance maintains after initial corrective actions. In that case, interdisciplinary collaboration, a multi-level intervention approach, and a corporate strategy for individual life quality and safety are required. Prompt and proper attitudes for social behaviour improvement can solve harsh work conditions.

In this digital era, AI supply quickly detects and offers an ending to this problem with positive changes.

Usually, medical conditions alter the individual judgment and actions toward others, especially for senior adults; we may tolerate their social behaviour deviance, but not in repetition and not too much, to protect ourselves.

Time slowly undermines all, early enough for each one, and it is better not to get its work done in advance.

References

Alexis Kafando. “Evaluation of the introduction of the new A conjugate vaccine (MenAfrivac) at the national level on the epidemiology of bacterial meningitis in Burkina Faso”. University Diploma in Vaccinology, University of Bordeaux, Ecole Val de Grace (2011).
WHO: Weekly Epidemiological Record: Executive Brief: WHO Position on Meningococcal Vaccines, November (2011).
Yazi Mai Aiki Abdoul Aziz. “Clinical and paraclinical investigations of the probable sequelae of bacterial meningitis in Niger”. Medical Thesis No. 0 1935, Abdou Moumouni University of Niamey, (2011).
Adrien Deroubaix. “Impact of desert aerosols and climate on meningitis epidemics in the Sahel”. PhD thesis, Pierre and Marie Curie University. France (2013).
WHO/EMC/BAC/98.3: WHO practical guidance, Controlling meningococcal meningitis epidemics. www.who.int/emc.
WHO: Weekly Epidemiological Record: Executive Brief: WHO Position on Meningococcal Vaccines, November (2011).
Fati Sidikou., et al. Polymérase Chain Reaction Assay and Bacterial Meningitidis Surveillance in Remote Areas, Niger.
Frasch CE, Preziosi M-P and LaForce FM. “Development of a group A meningococcal conjugate vaccine, Men Afri Vac(TM)”. Hum Vaccin Immunother 8.6 (2012): 715-24.
Mamoudou Harouna Djingarey. Development and introduction of meningococcal A conjugate vaccine; Planning workshop for the introduction of the A conjugate vaccine (MenAfrivac) and operationalization of case-by-case surveillance in Burkina Faso; Bobo Dioulasso (2009).
SadouKalilou Moussa. “Evaluation of the response to the meningitis epidemic in the health district of Say, Niger, 2006”. Thesis for obtaining an interuniversity diploma, in Ouidah (2007).
WHO: Meningitis Weekly Epidemiological Bulletin 2010, week 48–52.
WHO: Meningitis Weekly Epidemiological Bulletin 2011, Week 48–52.
Sanon Adama. “Epidemiological, clinical, bacteriological and evolutionary aspects of bacterial meningitis about 179 cases at the Souro Sanou University Hospital in Bobo Dioulasso”. Thesis of Medicine, Burkina Faso (2004).
A Dembele. “Purulent meningitis in newborns from 0 to 60 days in the pediatric intensive care unit of the Gabriel Touré Hospital in Bamako”. Thesis of Medicine, University of Bamako (2001).
Towa Djeungoue Stéphanie Jackie. “Epidemiology of meningitis in Mali in 2007”. Thesis of Medicine, University of Bamako.
Abdoulkarim Sabo. Epidemiology and treatment of purulent meningitis at the infectious diseases clinic of the CHU de Fann in Dakar about 262 cases collected from 1994 to 1997, Thesis of pharmacy, Cheick AntaDiop University of Dakar (1998).
G Campagne., et al. Epidemiology of bacterial meningitis, Niamey (Niger), 1981-1996 Bulletin of World Health Organ 77.6 (1999): 499-506.
Amadou Oumarou. “Purulent meningitis in children (epidemiological, clinical, etiological, therapeutic and evolutionary aspects)”. Thèse de médecine, Niamey (Niger) (1898).
Barbach Youness. Management of meningitis in the emergency department of the Hassan II University Hospital – Fez (about 15 cases), Thesis of Medicine, Sidi Mohamed Ben Abdallah University of Fez, Morocco.
Julie Chaix. “Community-based purulent meningitis in children: a retrospective study from 1998 to 2003 of two cohorts in Dakar, Senegal and Nancy, France”. Life Sciences [q-bio]. FFHAL-01731977 (2006).
Taha MK. Meningococcal infections. EMC - Infectious Diseases 9.3 (2012): 1-17.
Syrogiannopoulos GA., et al. “Dexamethasone Therapy for Bacterial Meningitis in Children: 2- versus 4-Day Regimen”. The Journal of Infectious Diseases 169.4 (1994): 853-8.
Fabrice Bruneel and Michel Wolf. acute meningitis; Encyclopediamedico-surgical 17-160-C-10.
V des Portes. Sequelae of bacterial meningitis in children and adults; incidences, types, methods of evaluation; Medicine and infectious diseases 39.7-8 (2009): 572-580.
E Forestier. “Strategy for the management of presumed bacterial acute community-acquired meningitis in adults”. Medicine and Infectious Diseases 39.7-8 (2009): 606-614.
H Ben Hamouda., et al. “Clinical and evolutionary aspects of neonatal bacterial meningitis”. Pediatrics Archive 20 (2013): 938-944.

According to their disorder, middle-aged people and senior adults may experience difficulties in physical exercises; in that case, a remote job [virtual] or another job selection is recommended.

Regular physical activity maintains and improves the well-being of people in good health. Daily fine-organized exercise program duration, frequency, and intensity ensure a better life, but excessive limits for physical exercise make an individual vulnerable.

People at risk of various medical conditions, with specific demographic data, may carry out physical exercises well settled beyond hurt.

For a weak individual, disproportionate physical activities can lead to disaster. In addition, the warm or cold season easily facilitates brain haemorrhage or myocardial infarction for these individuals doing excessive physical work.

Generally, physical exercise, including walking in nature, is recommended to maintain and improve individual health. For young and middle age people with moral distress but a good heart activity, walking in nature is an effective remedy; fresh air, water flow sound, floral scent, and impressive or rousing trees have a positive impact on the respiratory system, blood flow and composition, and on mental functioning. It is a relatively inexpensive mode to attain expected clinical outcomes.

Some senior adults may benefit from an accurate physical exercise program. Most old persons are registered with heart failure, respiratory diseases, and mobility problems. For this category, physical exercises may generate dyspnoea, fatigue, and pain with additional discomfort on relatives and social workers excessively implied in their care. Clinical practice evidence shows that even walking a short distance can be fatal for older adults with advanced heart disease. But in the digital era, they may use IT devices to admire nature’s splendor or paintings, watch on-demand musical programs and movies, update the information of interest, lecture, and communicate with their loved ones, and this option never existed.

Physical exercise is a convenient remedy with a wide range of advice or limitation, adjusted to individual medical history and clinical and demographic data. Harm and benefit are two facets of the same method for dealing with problems for recovering and improving mental and physical health.

There is a time to use or decline the physical exercises in the best interest of the individual health.

The art of adjusting specific procedures to personal data to achieve the desired target return in the form of gratitude and admiration from the community we serve.

Better to keep physical exercise limits on the way, and in the end, be able to open the door coming the night.

Introduction

A significant global public health and economic concern was raised by the recent (COVID-19) outbreak brought on by (SARS-CoV-2). Every day, more information is learned about how the COVID-19 virus spreads. In order to open up society during the (COVID-19) crisis, many nations intend to make face masks compulsory. In order to avoid the transmission of (COVID-19) and other respiratory viral illnesses, it is recommended that people use masks as part of a comprehensive package of preventative and control measures.

Face masks are the ubiquitous symbol of a pandemic that has sickened 35 million people and killed more than 1 million. In hospitals and other health-care facilities, the use of medical-grade masks clearly cuts down transmission of the (SARS-CoV-2) virus. But for the variety of masks in use by the public, the data are messy, disparate and often hastily assembled.

Face masks are incredibly popular right now due to the corona virus outbreak. According to prior advice from the World Health Organization, healthy individuals should only use masks when caring for someone who may have (COVID-19) or when they are coughing or sneezing. However, using a mask alone is insufficient to provide an effective level of protection or source control; additional actions at the individual and community levels should be taken to prevent the spread of respiratory viruses. Whether or not masks are worn, adherence to hand cleanliness, physical segregation, and other infection prevention and control (IPC) measures is essential to preventing (COVID-19) transmission from person to person. The World Health Organization (WHO) has created particular advice on IPC strategies for healthcare settings [1], Long-Term Care Facilities (LTCF) [2] and home care [3].

Face masks can help protect against many respiratory infections that are spread through the droplet route, and that includes coronavirus and the flu. Proper donning and doffing technique are also critical measure to prevent disease transmission. The (WHO) also cautions us that masks are only effective when they are worn in conjunction with regular, effective hand washing. Furthermore, if we choose to wear a mask, we must know how to utilize it and properly dispose of it out of an abundance of caution.

WHO advises health professionals administering direct care to (COVID-19) patients to wear a medical mask in the absence of Aerosol Generating Procedures (AGPs) [4] (in addition to other PPE that are part of droplet and contact precautions). Activated carbon, spun bond, and melt blown materials are used to make facial masks (breathing masks). Combination masks with activated carbon can reduce hazardous pollution. Many diverse approaches exist for masks to protect both the wearer and others. Mechanical interception and inertial impaction are the two "intuitive methods" that masks filter bigger aerosols. A substance filters more effectively the denser its fibers are. Because of this, greater thread counts result in greater efficacy. Just more virus blockers are available. However, some masks (such those made of silk) also possess electrostatic qualities that can attract tiny particles and prevent them from passing through the mask as well. We can reduce our risk of contracting the corona virus by using one of two different types of face masks. The first of the two face masks is a surgical face and of the second type are also referred to as (N 95) masks.

The general public does not need the (N 95) respirator. The (N 95) respirator filters at least 95% of airborne particles but is not resistant to oil [5]. Filtering face piece respirators, commonly referred to as (N 95) masks, are regulated by the National Institute for Occupational Safety and Health.

N: Respirator Rating Letter Class: This. It stands for ("Non-Oil,") indicating that you can use the mask in a work setting if there are no oil-based particulates present. Other mask classifications include R (eight hours of oil resistance) and P(oil proof).

95: Masks ending in a 95, have a 95 percent efficiency. and that is the same as a High Efficiency Particulate Air(HEPA) and Aerosol Generating Procedures (AGPs).

Microns: Dust, mist, and fume pollutants are filtered out by the masks. Large droplets and particles with a minimum size of.3 microns won't be able to cross past the barrier, according to the Centres for Disease Control and Prevention (CDC.)

Material: The filtration material on the mask is an electrostatic non-woven polypropylene fiber.

Valve: halation valves are available as an option with some disposable N95 masks. According to the (CDC), "having an expiration valve reduces exhalation resistance, which makes it simpler to breathe (exhale)".

N 95 masks, which are worn by medical professionals and emergency personnel, offer superior shielding from corona virus particles than fabric or surgical masks. Protecting people who are most at risk of infection requires the use of N 95 respirators. The N 95 mask is designed for healthcare professionals, and the (WHO) states that it can be used for several patients with the same diagnosis for up to four hours. Gloves and labels should be applied to the N 95 masks before disposal. Used masks need to be destroyed or properly disposed of. Even though the majority of readily accessible N 95 pollution masks can be worn and used again, they do have a shelf life. When the mask wears out or the filter becomes clogged by pollutants, it loses its ability to effectively shield us from pollution. Masks contaminated with corona virus debris have recently emerged as a major global environmental issue. In one day, millions of masks are used and subsequently discarded globally. contrary to popular belief, the CO₂ footprint of the cotton face mask is 20% greater than that of the N 95 protective face mask. 850 tonnes of CO₂ are emitted by just 17 million of our protective N 95 masks. Imagine that a straightforward adjustment in the face masks' material may cut their impact by 20%. If 12 billion masks were used, 144.000 tonnes of CO₂ emissions would be avoided.

N 99 masks, which are one of the best options for blocking the virus because they can reduce average risk by 94-99% for 20-minute and 30-second exposures, are more effective at filtering airborne particles than N 95 masks. However, they can be difficult to find, and there are ethical considerations such as leaving those available for medical professionals.

From a purely medical perspective, the effectiveness of measures to contain the spread of the virus is independent of the geographic area where these measures are implemented. A well-fitting mask keeps the virus from reaching others. It can also protect the wearer from becoming infected.

Masks should be worn anytime you are in public or people are nearby. Masks act as a physical barrier to protect you and others from viral and bacterial particulates. Many people unknowingly infect others by going out and spreading germs by coughing or touching other. Infections spread from person to person in the community, and it is essential to identify and implement measures to reduce transmission to slow down or even stop spread. Public officials and governments strongly encourage the use of wide spread face masks in public, including the use of appropriate regulation. Research on the efficacy of face shields, including in combination with masks, is needed, along with research into the efficacy of masks with transparent windows for the mouth. It is also important for health authorities to provide clear guidelines for the production, use, and sanitization or reuse of face masks, and consider their distribution as shortages allow.

Diagnosis

Fever, exhaustion, dry cough, dyspnea, and other signs of an upper respiratory infection are also present in SARS-CoV-2 illness cases.

Conclusion

In conclusion, masks and other Personal Protective Equipment (PPE) are essential for individuals battling the pandemic and are frequently utilised by the general people. Environmentalists worry, however, that the fight against mask pollution and adverse effects on animals would result from improper disposal of masks. In the future, we must ensure that we are prepared for pandemics like this one and that we are prepared to respond to them sustainably and one does not have to come at the expense of the other.

References

Infection prevention and control during health care when COVID-19 is suspected: interim guidance. Geneva: World Health Organization (2020).
Infection prevention and control for long-term care facilities in the context of COVID-19: interim guidance. Geneva: World Health Organization (2020).
Home care for patients with COVID-19 presenting with mild symptoms and management of contacts: interim guidance. Geneva: World Health Organization (2020).
The WHO list of Aerosol Generating Procedures (AGPs) includes: tracheal intubation, non-invasive ventilation, tracheotomy, cardiopulmonary resuscitation, manual ventilation before intubation, bronchoscopy, sputum induction induced by using nebulized hypertonic saline, and autopsy procedures.
NIOSH-approved N95 Particulate Filtering Facepiece Respirators.

Cloud and Edge Computing

Many traditional healthcare and medical systems have faced a big problem of massive unstructured, diverse, and exponential-growing data collected from different sources, thus arising much more challenges to store and process data effectively and securely. To this end, the advanced techniques and high capacities of cloud computing allow analysing healthcare and medical big data. F

Immersive Technology

Immersive technology, a term that refers to the technologies for reality extension using the neuroscience of the human brain, aims to create distinct experiences by merging the physical world with a digital or simulated reality.

Besides augmented reality (AR) and virtual reality (VR) as two primary types of immersive technologies, it includes ex- tended reality (XR), mixed reality (MR), holography, telepresence, digital twins, and first-person view (FPV) drone

flight. The above-mentioned immersive technologies can be briefly featured as follows:

VR: a technology that allows the creation of a fully immersive digital environment, in which the physical or real-world environment is entirely suppressed.
AR: a technology that enables the superposition of digital elements into the real-world environment, i.e., the composite view of physical and digital elements can be observed.
MR: a technology that not only allows the superposition of digital elements being viewed in the real-world environment but also establishes their interaction.
XR: an umbrella term that encompasses any types of technology that alters reality (e.g., adding digital/virtual elements to the physical environment at any level, thus nearly erasing the line between the digital world and the physical world). Indeed, XR includes AR, VR, MR, and other technologies.
Holography: or hologram is a technology to product three-dimension image of an object with highest resolution of any imaging for device-free watching.
Telepresence: a novel form of robotic remote control, in which a human operator can observe, feel, interact, and collaborate an object from distance.
Digital twins: a virtual replication of real-world project, which is require for connecting the physical object for real-time data collection, processing, and response.
FPV drone flight: a technology uses unmanned aerial vehicle (UAV) with a camera for transferring high- quality videos to goggles, headsets, and mobile devices or another screen, thus allowing users to enjoy environing- mental experience in the first-person view.
Haptics: refers to a technology that uses tactile (touch) sensation to interact with the computer applications to uplift user experience.

Enabling Technologies of The Metaverse for Healthcare

This section presents a detailed discussion of the enabling technologies of the Metaverse for healthcare, which includes extended reality, blockchain, artificial intelligence, IoT, 5G and beyond, digital twin, big data, quantum computing, human-computer interaction, computer vision, edge computing, and 3D modelling. The illustration of the above- mentioned enabling technologies of the Metaverse for health- care is depicted in the next Fig. F

A. Extended reality

Extended reality includes technologies such as augmented reality (AR), virtual reality (VR), and mixed reality (MR), aided by artificial intelligence, computer vision, and connected devices like mobile phones, wearables, and head- mounted displays. By incorporating voice, gestures, motion tracking, vision, and haptics, this new technology is transforming the way services are delivered, improving the quality in various sectors.

B. Blockchain

The foundation of blockchain emerged in a 2008 white paper written by Satoshi Nakamoto. A blockchain is a digital database of transactions that is duplicated and dispersed over the entire blockchain network. Each block in the chain contains several transactions, and whenever a new transaction occurs on the blockchain, a record of it is added to all participant’s ledgers.

C. Artificial Intelligence

Artificial intelligence (AI), also known as machine intelligence, focuses on the development and management of technology that can autonomously learn to make decisions and carry out tasks on behalf of humans. AI is a collection of technologies that incorporates any software or hard-ware component that facilitates machine learning, computer vision, natural language understanding (NLU), and natural language processing. AI will help strengthen the Metaverse infrastructure, enhancing the 3D immersive experience, and boosting the virtual worlds’ built-in services. AI technology will also help in improving the quality of services and the Metaverse ecosystem.

The health industry has recently begun utilizing revolutionary techniques such as XR and big data combined with AI in software and hardware to increase the efficacy of medical devices, reduce the cost of health services, enhance healthcare operations, and broaden access to medical.

D. Internet of Things

The phrase "Internet of Things" (IoT) refers to the billions of devices that are currently connected to the Internet and exchanging data. Due to the introduction of low-cost computer chips and the broad availability of wireless net- works, everything from smartphones to intergalactic operations can now be connected to the IoT. Due to the incorporation of sensors and the capacity to communicate with one another, these devices can share real-time data without the need for a human supervisor.

E. 5G & Beyond

The term "5G and beyond" refers to the fifth generation and beyond of wireless technology. It outperforms 4G LTE networks in terms of both speed and latency, and it has a higher capacity. In contrast to the maximum speed of 4G technology, which is only 1 Gbps, the maximum speed of 5G technology can exceed 20 Gbps. Additionally, delivers reduced latency, which has the potential to enhance the performance of commercial applications and other digital experiences.

F. Digital Twin

A digital twin is a virtual representation that acts as the digital counterpart of a physical object or process in real-time. The first practical definition of a digital twin was proposed by NASA in 2010 to enhance the physical-model simulation of spacecraft.

G. Big Data

Big data is defined as the "Information asset characterized by such a High Volume, Velocity and Variety to require specific Technology and Analytical Methods for its transformation into Value".

H. Quantum Computing

Quantum computing is a form of computation whose activities can exploit quantum mechanical phenomena such as superposition, interference, and entanglement.

I. Human Computer Interaction

Human-computer interaction (HCI) is a multidisciplinary topic of research that focuses on the design of computer technology and, specifically, the interaction of humans and computers. Voice, gesture, visual, and brain signal interaction have replaced textual or display-based control as the dominant paradigm in HCI. HCI, VR, AR, and the future of content creation and collaboration technologies will enable the creation of the Metaverse. The visual interactions in the Metaverse will be carried out by HCI technology which is called wearable consumer head-mounted displays (HMD). These HMDs will play a crucial role in the communication between the users and surroundings in the Metaverse.

J. Computer Vision

Computer vision is the study of how computers visualize and interpret digital images and videos. Computer vision encompasses all activities done by biological vision systems, including perceiving a visual signal, interpreting what is being seen, and extracting complicated information in a form accessible by other processes.

K. Edge Computing

Edge computing is a distributed computing paradigm that moves computation and data storage closer to the data sources. Edge computing will improve response times and conserves bandwidth.

L. 3D Modeling

3D modelling is the process of producing a mathematical coordinate-based representation of any three-dimensional surface of an item using specific 3D modelling techniques. As a result of advancements in image processing, computer- aided design, and modelling techniques, it is now feasible to create extremely realistic and trustworthy 3D models. Multiple sectors, including cinema, animation, and gaming, as well as interior design and architecture, utilize 3D modelling.

Medical diagnosis is the process of determining the medical condition of a patient based on the symptoms. Adoption of the Metaverse in healthcare significantly helps in efficient diagnosis of the medical conditions of a patient with the help of various advanced technologies such as AR and VR enabled MIoT models, extended digital twin, blockchain, 5G and so on. F

A. Medical Diagnosis

Medical diagnosis is the process of determining the medical condition of a patient based on the symptoms.

B. Patient Monitoring

The convergence of telepresence, digital twinning and blockchain will reap amazing benefits of the Metaverse in healthcare, especially in terms of patient monitoring.

C. Medical Education

The Metaverse is a remarkable milestone in the field of medical education.

D. Surgeries

The Metaverse is becoming an important technology in the medical industry, especially in surgery. Surgeons are currently using tools that range from VR headsets to haptic gloves to mimic surgical procedures, boosting prepared- ness and efficiency in the operating room.

E. Medical Therapeutics & Theranostics

Medical therapeutics can be regarded as the branch of medicine that deals specifically with the treatment of diseases. Digital therapeutics (DTx) deliver evidence-based therapeutic interventions and can be considered as a class of digital medicine. Digital Therapeutics Alliance defines digital therapeutics as products that “deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease”. F

Ongoing and Upcoming Projects

Healthify.
Dehealth.
Bump galaxy.
Accuvein.
Hintvr.
Healthblocks.

Challenges & Open Issues

Data privacy concerns.
Information Security Concerns.
Interoperability Issues.
High Cost of Technology.
The Personal Touch is Lost.
Legal and Regulatory Challenges.

References

J Thomason. “Big tech, big data and the new world of digital health”. Glob. Health J., in press.
World Economic Forum. “Building the healthcare system of the future”. (2016).
J Gaubert. “Seoul to become the first city to enter the Metaverse. What will it look like?”. Euronews.next (2021).
J Burke. “Reintroducing the open Metaverse OS paper”. Outlier Ventures (2021).
Feldman J. “Flickplay’s 3d social media platform presents as an industry first”. Influencive (2020).

The rapid progress in digitalization and automation have led to an accelerated growth in healthcare, generating novel models that are creating new channels for rendering treatment with reduced cost. The Metaverse is an emerging technology in the digital space which has huge potential in healthcare, enabling realistic experiences to the patients as well as the medical practitioners. The Metaverse is a confluence of multiple enabling technologies such as artificial intelligence, virtual reality, augmented reality, internet of medical devices, robotics, quantum computing, etc. through which new directions for providing quality healthcare treatment and services can be explored. F

The amalgamation of these technologies ensures immersive, intimate, and personalized patient care. It also provides adaptive intelligent solutions that eliminates the barriers between healthcare providers and receivers. Healthcare is one of the most significant determinants of ensuring general, physical, social and mental well-being of the entire human population.

In the world. The primary objective of any healthcare system is to channelize its efforts towards activities that promotes, restores, maintains and improves healthcare services. The recent pandemic of COVID-19 have added enormous pressure to the global healthcare sector and related workforce, infrastructure and supply chain management. The COVID-19 has been the primary reason for accelerating rapid change across the healthcare ecosystem and have compelled the stake holders to pursue adaptation and innovation of all the technologies used in this sector. The need to deploy advanced digital tools and services has become a necessity to provide optimized This digital transformation has significantly impacted the healthcare ecosystem by improving their working capability, access to services, patient-clinician experience by using artificial intelligence, cloud computing, Augmented Reality (AR), Virtual Reality (VR) technologies]. The healthcare system in the Metaverse provides health-care service experience that is interactive, immersive and recreational customized to meet individual patient’s needs. The use of these technologies provides exposure towards new ways of delivering treatment in significantly lower cost thereby enhancing patient outcomes. The Metaverse technologies can help healthcare professionals in effective planning and diagnosis of diseases. The Metaverse environment enables enhanced surgical pre-operative planning by transforming CT scans into 3D reconstructions using headsets. This also helps the surgeons to specifically view, isolate and manipulate anatomical regions to perform critical surgeries. Plastic surgery is an extremely complex procedure which requires reconstruction of human body parts. In case of plastic surgeries, the use of VR in the Metaverse could play an important role wherein the virtual avatar could accurately predict the outcome of a plausible plastic surgery.

The health data can be visualized by the patients on the virtual dashboard helping them to communicate with clinicians, researchers, nutritionists, and other stake holders for achieve individual care and treatment. The Metaverse has the potential to revolutionize medical education and training. The use of AR provides the conducive environment to explain practical procedures rather than disseminating theoretical knowledge.

The Metaverse can provide 360 degrees visualization of the body ailments and can act as the most helpful surgical training tool fostering optimum level of cooperation and highest degree of immersion.

The global statistics of the Metaverse reveal that the global healthcare market in the Metaverse holds a value of 5.06 billion Dollars in 2021 and is expected to reach 71.97 billion Dollars by 2030 with a compound annual growth rate (CAGR) of 34.8 percent during considered period of forecast.

Sensors

The precision of personal healthcare analysis partly depends on the measurement of different physiological parameters using sensors. Recently, an innovative wearable temperature sensor technology which utilizes freestanding single reduction graphene oxide fibre was introduced and developed with many benefits, such as fast response, high stability and repeatability under mechanical deformation, and wearable comfort. Despite being readily available, medical equipment is costly and consumes a lot of power. With biomedical sensors, medical systems are flexible with machine-to-machine interactions, saving time of both patients and medical institutions, and offering treatment plans over tele diagnosis. Among various sensors, temperature, electrocardiogram (ECG), and pulse are the most important ones for health status evaluation besides blood pressure, accelerometers, and imaging sensors.

The following part will discuss some relevant sensors commonly used in healthcare and medical systems.

In general, big data is currently characterized by seven Vs as follows: volume (a large amount of data), variety (including structured, semi-structured, and unstructured data with different formats), velocity (high rates of data inflow and real-time processing), veracity (detailed data accumulation), value (in-depth and meaningful information), variability (offering extensionality and scalability), and valence (data interconnection).

Big data collection: Sqoop is an open-source framework for data import and export between Hadoop Distributed File System (HDFS).
Big data processing: MapReduce is a programmable model that simplifies and accelerates a massive amount of data, featured by three main functions (e.g., mapping, sorting, and reducing)
Big data storage: Hadoop performs the distributed system HDFS and the non-relational databased HBase for big data storage. HDFS, a primary component of a Hadoop cluster, provides high throughput access to application data and is suitable for high-volume data applications.

Artificial Intelligence

In the last decade, several modern technologies and tools based on distributed architectures, along with large memory and powerful computing units, have been introduced for big data processing in healthcare and medical domains:

All in healthcare is an all-encompassing term used to describe the use of ML algorithms to mimic human cognition in presenting, analysing, understanding, and learning complex healthcare and medical data. In fundamental, most of the existing AI/ML algorithms can be grouped into two categories: traditional techniques and advanced techniques, which can solve three principal problems: clustering, classification, and regression. Conventional AI/ML algorithms usually performs four data-based learning types: supervised learning (i.e., learn the relation between input and output via a mapping function using labelled data and classify/predict the outcome for an unforeseen input sample using the trained model), unsupervised learning (i.e., involve the utilization of ML algorithms for unlabelled data analysis and clustering, and can find out data groups without the need for human intervention), semi-supervised learning (i.e., trained upon the combination of clustering similar data using an unsupervised learning algorithm and using the existing labelled data to label the remaining unlabelled data), and reinforcement learning (i.e., make a sequence of decisions, in which an agent learns to attain a goal in an uncertain and complex environment). Recently, deep learning (DL) is a subset of ML with advanced architectures, e.g., recurrent neural network, long short-term memory network, and convolutional neural network, relying on multi-layered artificial neural networks, to attain ground-breaking performance in many classification and regression tasks of healthcare and medical domains.

Wireless Communication Networks

Many innovative communication technologies have been introduced in the last decade due to the explosion of IoT technologies with edge and mobile devices along with the diversity of applications and services, especially in the health- care and medical domains.

Cellular network: As so-called mobile network, a cell network is a radio network distributed over land areas called cells. Each cell is served by at least one fixed-location transceiver, a.k.a., cell site or base station. Remarkably, cellular networks can enable a huge number of portable receivers to communicate with each other and other fixed transceivers via base stations.

Wi-Fi: is a wireless networking technology that allows diverse devices, such as computers (desktops, laptop, and tablets), mobile devices (smart phones, smart watches, and wearables) and others (printers, TVs, projectors, and video cameras) to connect the Internet.

H. pylori could migrate or get forced to migrate to the colon under the influence of antibiotics where it will continue to produce ammonia for a reason or no reason leading to accumulation of profuse amounts of ammonia un-opposed or buffered by any acidity. Accumulation of profuse amounts of ammonia in the colon is toxic and could constitute a biological stress to the body causing toxic pancreatitis that could lead to potential stress diabetes in predisposed children. The spread of H. pylori-induced childhood diabetes could constitute more than 90% of the world’s burden of childhood diabetes during the latest three decades specifically since the implementation of the triple anti-H. pylori antibiotic eradication strategy in 1986 [7-10].

The concept of the biological toxic stress leading to an onset of H. pylori-induced childhood diabetes is not just hypothetical or scientific fantasy as upon the basis of this concept the newly-discovered childhood diabetic condition has been readily and adequately corrected in many children; around 89% of cases in some recent studies [10].

Colon clear with the senna leaves extract purge and vinegar-mixed food therapy have been recently demonstrated to effectively deal with the challenge of H. pylori including eradication of colonic and abnormal-behavior gastric H. pylori strains in addition to prevention of recurrence [8, 9].

Therefore; countries should follow a characteristic strategy towards H. pylori dyspepsia and H. pylori-related dysglycemia:

Any newly discovered childhood diabetes should be first considered a potential condition not an established illness and should be treated as stress diabetes. Children should be immediately investigated for existence of colonic H. pylori strains and immediate employment of colon clear with the senna leaves purge once followed by vinegar mixed salad or yogurt with principal meals once or twice daily for one week. Patients with inadequate response to colon care and colon clear by vinegar and the senna could do revision of the senna purge twice with one-month space between them. Patients who remain hyperglycemic in spite of these measures should be given one-week physical rest together with physiological rest of the pancreas by administration of fractionated regular insulin doses for one week. Children who do not recover after that could be considered established diabetics and could receive the anti-diabetic medication appropriate to their condition.
Children who recover a potential diabetic condition should practice extreme carefulness towards out-side home meals and should return to colon care and colon clear either on regular basis or at least whenever they develop colonic troubles. They should care from gastric recurrence by regular dental hygiene and cleaning of dental plaques as being possible reservoirs for H. pylori or children can just employ mouth wash with diluted dietary vinegar as tolerated once or twice weekly together with washing hands with vinegar and water after washing with soap in order to avoid fecal-oral recurrence as soap alone does kill H. pylori [8].
The antibiotic aggression towards H. pylori should be re-discussed in details and gastric sedatives including anti-urease activity should be subjected to severe revision and accurate re-determination.
The world should stop searching/re-searching after H. pylori; save these funds and direct them towards raising the life and water supply standards in poor and developing countries as the matter of H. pylori is essentially a sanitary conflict before it is a medical challenge and rich people tour in poor countries while poor people travel to work as food handlers in rich countries; that is how abnormal H. pylori strains travel from stomach to stomach via meals and navigate all over the world [8].
Patients and families should be educated as concerns misbehavior in food habits and antibiotic use.
Orientation of primary health care units as concerns natural measures towards H. pylori dyspepsia.
Dyspeptic mothers should investigate for existence of colonic H. pylori strains and deal with them via employing natural measures (colon care and colon clear) but not antibiotics in order to avoid transmitting H. pylori to their kids. Mothers preparing food for their kids particularly if dyspeptic should usually wash hands with vinegar then water after washing with soap.
Pregnant mothers should not feel lazy to cook and should not love the fast food for themselves and their kids during pregnancy.
Food handlers should strictly and frequently disinfect hands with vinegar and travelers should make vinegar a friend to their meals while touring.

References

Habib HS. “Frequency and clinical presentation of ketoacidosisat onset of childhood type 1 diabetes mellitus in Northwest Saudi Arabia”. Saudi Med J 26.12 (2005): 1936-9.
Sabin MA and Shield JP. “Childhood obesity”. Front Home Res 36 (2008): 85-96.
De Ferranti SD and Osganian SK. “Epidemiology of pediatric metabolic syndrome and type 2 diabetes mellitus”. Diab Vasc Dis Res 4.4 (2007): 285-96.
Al-Nozha MM., et al. “Diabetes mellitus in Saudi Arabia”. Saudi Med J 25.11 (2004): 1603-10.
Salardi S., et al. “Helicobacter pylori and type 1 diabetes mellitus in children”. J Pediatr Gastroenterol Nutr 28.3 (1999): 307-9.
Dore MP., et al. “Diabetes mellitus and Helicobacter pylori infection”. Nutrition 16.6 (2000): 407-10.
Farinha P and Gascoyne RD. “Helicobacter pylori and MALT Lymphoma”. Gastroenterology 128.6 (2005): 1579-605
Nasrat AM., et al. “Misconception and misbehavior towards Helicobacter pylori is leading to major spread of illness”. General Med S1 (2015): 002.
Nasrat SAM., et al. “The dramatic spread of diabetes mellitus worldwide and influence of Helicobacter pylori”. General Med 3.1 (2015): 159-62.
Nasrat AM., et al. “The challenge of childhood diabetes”. General Med 3.4 (2015): 193.

References

Aghajanyan NA, Bayevsky RM and Berseneva AP. “Problems of adaptation and the doctrine of health: studies”. manual. M (2006): 284.
Amosov NM. “Thoughts about health”. M.: AST, Donetsk: Stalker (2005): 287.
Ananyev BG. “Man as a subject of knowledge”. St. Petersburg.: Peter (2002): 288.
Ananyev VA. “Fundamentals of psychology health”. Book 1. Conceptual foundations of health psychology. St. Petersburg: Speech (2006): 384.
Ananyev VA. “Psychology of health - a new direction of medical psychology”. Psychological and psychiatric problems of clinical medicine. Collection of scientific papers dedicated to the 100th anniversary of the Department of Psychiatry and Narcology of St. Petersburg State University named after Academician I. P. Pavlov. St. Petersburg: Publishing House of St. Petersburg State University (2000): 191-194.
Belikova TA and Zhivaikina AA. “Consumer society: progress or degradation”. Bulletin of medical Internet conferences 5.12 (2015): 1787.
Bovina IB. “Social psychology of health and disease: monograph”. M.: Aspect Press (2008): 264.
Diseases in spite of: 10 celebrities who have defeated deadly diseases / Arguments of the Week [Electronic resource] (2020).
Brekhman II. “Valeology - the science of health”. M.: Physical culture and sport (1990): 206.
Vasiliev OS and Filatov FR. “Health as a subject of interdisciplinary research: approaches and problems”. Applied Psychology 5 (2001): 65-80.
Vasilyeva OS. Psychology of health. The phenomenon of health in culture, psychological science and everyday consciousness”. Rostov n/D: Mini Type (2005): 480.
Vasilyeva OS. “Psychology and health culture. Basic concepts, concepts and approaches”. Rostov n/D: Southern Federal University (2011): 176.
Vetrov II. “Fundamentals of Ayurvedic medicine”. St. Petersburg: "Svyatoslav". (2004): 353.
Giddens E and Sutton F. “Basic concepts in sociology”. M.: Publishing House of the Higher School of Economics, (2018): 336.
Goransky IV. “The life and death of Manoel dos Santos Garrinchi”. M.: Physical culture and Sport (1988): 158.
Gurvich IN. “Social psychology of health”. St. Petersburg: Publishing House of St. Petersburg State University, (1999): 1023.
Davidenko DN, Shchedrin YuN and Shchegolev VA. “Health and lifestyle of students”. St. Petersburg: SPb GUITMO (2005): 124.
Dubrovina IV. “Mental and psychological health in the context of psychological culture of personality”. Bulletin of Practical Psychology of Education. M, No 3.20 (2009): 17-21.
Dubrovsky VI. “Sports medicine: Textbook for students. higher. studies. Establishments”. 2nd ed., add. M.: Humanit. ed. center VLADOS (2002): 512.
Zhuravleva IV. “Attitude to the health of the individual and society”. Institute of Sociology of the Russian Academy of Sciences, M (2006): 238.
Healthy personality: materials of the international scientific and practical conference on June 21-22. (2012). St. Petersburg: St. Petersburg State Institute of Psychology and Social Work (2012): 167.
Healthy personality. edited by G.S. Nikiforov. St. Petersburg: Speech (2013): 400.
Islamov RE. Definition of the concept of "health" in the theoretical and legal aspect [Electronic resource] (2022).
Kalyu PI. The essential characteristic of the concept of "health" and some issues of healthcare restructuring: overview information. M (1988): 33-35.
Coronovirus COVID-19 today. Online statistics on the incidence of coronavirus in the world [Electronic resource] (2022).
Kotsan IYa, Lozhkin GV and Mushkevich MI. “Psychology of healthy people”. Lutsk: RVV Vezha (2011): 430.
Kulikov LV. “Personality psychology: basic concepts and problems: textbook”. St. Petersburg: Publishing House of St. Petersburg State University (2000): 144.
Lisitsyn YuP. “Public health and healthcare: textbook”. 2nd ed. M (2010): 512.
Lisitsyn YuP. “Human health is a social value”. Moscow: Mysl (2007): 265.
Litnitskaya EV. “The problem of personal health in psychology of the XIX-XX century”. Yaroslavl Pedagogical Bulletin 2.11 (2012): 268-274.
Medvedko LI. Russia, the West, Islam: "clash of civilizations"? Worlds in world and "other" wars at the break of epochs. Moscow: Kuchkovo Field (2003): 420-434.
Official Documents of the World Health Organization, Nº 2, p. 100, April 7, 1948 [Electronic resource] (2022).
Petlenko VP. Human valeology: health - love - beauty. St. Petersburg: PETROC, Book 1 1,2,3 (1998): 718.
Petryuk PT and Yakushchenko IA. “Psychosomatic disorders: issues of definition and classification”. Bulletin of the Association of Psychiatrists of Ukraine 3-4 (2003): 133-140.
Psychology of health. Kyiv.: Limited Liability Company "Financial Rada of Ukraine". (2017): 100.
Psychology of health: electronic textbook. E.A. Denisova et al. Togliatti: Publishing House of TSU, 1 optical disc.
Psychology of occupational health: textbook. edited by G.S. Nikiforov. SPb.: Speech (2006): 480.
Mental health. WHO [Electronic resource] (2022).
Psychological dictionary. Under the general Ed. of Yu.L. Neymer. Rostov n/D: Phoenix (2003): 640.
Reshetnikov AV. Health as a subject of study in the sociology of medicine. Grif UMO on medical education. M.: GEOTAR-Media (2008): 446.
Sekach MF. “Psychology of health: a textbook for higher education”. M.: Academic Project (2015): 192.
Spencer G and Tsigen T. Assosiativnaya psychology. Osnovaniya psychologii. Physiologicheskaya psychology v 14 lecture. The series "classic zarubejnoy psychologii". Location: AST (1998): 560.
Titshenka PD. O filosofskom smisle fenomenov zdorovya I bolezni. Location: Academy (2006): 275.
Tyumaseva ZI. Osnovi valeologii (V frame professionalnoy podgotovki Master po napravleniyu pedagogicheskogo obrazovaniya): uchebno-metodicheskoe posobie. Yuzhno - Uralsky gosudarstvenniy humanitarno-Pedagogical University. Chelyabinsk: Yuzhno-Uralsky nauchny Centre Rao (2020): 239.
Frolova YuG. Psychology zdorovya. Minsk: scale of Vissaya (2014): 256.
Khrustalev YuV. “Human health as a problem of philosophy”. Health economics 8 (2003): 5-12.
Shantyr EE. “Unification of the concept of personality as a basic term of practical psychology”. Psychology and socionics of interpersonal relations. K 4.148 (2015): 50-52.
Shantyr EE. “Integrative theory of personality: concept and practical implementation”. Scientific and methodological journal "Problems of modern science and education". 27.109 (2017): 102-111.
Shetelov A. The T. Philosopher zdorovya. Directmedia (2013): 242.
Elliatt S Decher. “Zdorove Kak tselostnost. Put K chelovecheskomu prosvetaniyu”. Location: IG" VES" (2010): 224.
Fromm E. I for himself. Translation E.M. Spira. M., (2018): 349.
Barling J and Griffiths A. “A history of occupational health psychology”. Handbook of occupational health psychology. Washington, DC: APA Books (2010): 21-34.
Belav B., Sergeeva M and Tarasova G. “Vaccination in rheumatology: Evolution of views on the problem”. Terapevticheskii arkhiv 89.5 (2017): 83-89.
Csikszentmihalyi M. “The Promise of Positive Psychology”. Psychological Topics 18.2 (2009): 203-211.

Historical Background

Before 1967, abortion was generally illegal in the United States of America except to save the patient’s life [1]. From 1967 to 1973, some states like New York, Washington, Alaska, Hawaii and California liberalized abortion laws. The landmark US Supreme Court judgement of Roe and Wade in Jan 1973 legalized abortion nationwide [1] Despite this, opposition across the US led to the camps of abortionists and the Pro–life. This had a great impact on the political dynamics of the country and also globally. The abortionist camp through advocacy, sponsorship, education and NGOs campaign against unsafe abortion and its implications led to the adoption of abortion laws or modified forms in different counties.

Despite the obvious positive effects of Abortion laws in reducing maternal mortality and morbidity, the Pro-life in the US continued its efforts to repeal the laws through legislation and the Courts. In 1992 the Supreme Court almost overturned the Roe decision, (Planned Parenthood of Southeastern Pennsylvania v Casey, 505 US 833) [1].

About fifty years after the Roe decision that legalized abortion was overturned on June 2022 by the US Supreme Court and individual states in the US were empowered to decide the legal parameters for abortion [2]. The effects of this decision will not only affect women in the US but globally, considering the global impact of US policies. The US is the leading donor globally to family planning and abortion care and has a rule that prohibits the use of its funds for a program that conflicts with its policies. The “global gag rule” will affect reproductive rights services in other countries especially the Sub –Saharan Africa which depends heavily on donor-funded program [2].

Unsafe Abortion and abortion laws in Sub-Saharan Africa

Globally there were about 6.8 million unsafe abortions annually with the majority occurring in sub-Saharan Africa. Evidence has shown that the incidence of abortions is the same worldwide whether abortion law is liberalized or restricted. Thirty-five per cent of abortions are unsafe in regions where the abortion laws are restrictive while only 1% of abortions are unsafe in counties where the abortion laws have been liberalized [3]. In Sub-Saharan Africa, 77% of abortions are unsafe due to restrictive laws on abortions [3].

According to 2019 figures, sub-Saharan Africa has the highest case fatality of 185/100,000 unsafe abortions resulting in over 15,000 avoidable deaths [3]. This was a remarkable improvement from the 2000 figure of 315 / 100,000 which was due to the availability of abortion care / post-abortion care services and the improvement of abortion law in the region [3].

Extensive work was done on unsafe abortions and abortion laws in the last two–three decades by Bankole et al of the Guttmacher Institute and published in 2020 titled “From unsafe to safe abortion in Sub-Saharan Africa: Slow but steady progress”. From the study, great progress has been made. The African Union Maputo agreement of 2003 stipulated the legal criteria of allowing abortion when the woman’s life or physical or mental health is threatened and in cases of rape, incest and grave fetal anomaly. Some countries have gone beyond the Maputo agreement and have liberalized abortion laws (Category 6) including South Africa, Cape Verde, Guinea-Bissau, and Sao Tome & Principe. Zambia also has broadly liberalized abortion law - Category 5. Twenty-seven of the 48 – sub-Saharan African countries have moderately restrictive abortion laws (abortions to save the woman’s life and to preserve her physical or mental health).

The majority of the countries in the Sub-African have either liberalized or moderately restrictive laws on abortion. Despite the above statement majority of the populace live within the highly restrictive due to the high population of countries like Nigeria in this category.

Other countries in the region have highly restrictive abortion laws which are to save the life of the mother (Category 2) except for six with total restriction on abortion – Category 1(Madagascar, Angola, DRC, Mauritania, Seria-Leone & Senegal).

Most of the progress in ensuring safe abortions in this region through legal and political means was hinged on the Roe and Wade case, the global funding for safe abortion and NGO partnership. The question of whether this overturning will have effects on reproductive rights and the safety of our women in the reproductive age is not in doubt.

The effects and the way forward

The effect of restrictive abortion laws is not limited to the termination of unwanted pregnancy but may affect adequate post-abortion care after miscarriages, and those with a significant maternal or fetal condition that requires interventions [2]. All these will hinder the achievement of the United Nations Sustainable Development goals of reducing maternal mortality to 70 per 100,000 live births by 2030.

One of the main drives to liberalize abortion law in this region was the US bio-political pressure emanating from Roe and Wade’s decision for the last half a century [2]. Reversal of this decision and the anti–abortion policy at the Federal level, may lead to counter bio-political pressure in the opposite direction.

Most of the abortion care and family planning materials were donor-driven and subsidized. This reversal may lead to reduced funding and an increase in cost even when available, coupled with the current economic downturn worldwide will harm SDG -Goal 3 3.

The decision to restrict abortion at the federal level in the US may resonate in African countries with more countries becoming more restrictive too. As it had been shown restrictive abortion law does not reduce the incidence of abortion but rather increases the incidence of unsafe abortions [1.3]. This will further increase the maternal mortality rate thereby making SDG 2030 unrealistic.

This decision will also have negative implications for medical education funding in abortion care and will influence the knowledge, skills, and quality of care provided by medical practitioners as documented by Traub and co-workers. This will be more pronounced since most funds for reproductive health education and training were from International NGOs and Partners of which the US accounts for the bulk of the donation

Conclusion

There is no doubt the Overturning Roe and Wade decision will adversely affect the African policy on Safe abortion practices and with the likelihood of increased unsafe abortion with associated mortality and morbidity.

Africans need to meet to take their destiny into their hand by ensuring local funding for reproductive health services and post–abortion care to manage complications from unsafe abortions.

References

Levine PB., et al. “Roe v Wade and American fertility”. American Journal of Public Health 89.2 (1999): 199-203.
Coen-Sanchez K., et al. “Repercussions of overturning Roe v. Wade for women across systems and beyond borders”. Reproductive Health 19.1 (2022): 1-5.
Bankole A., et al. “From unsafe to safe abortion in Sub-Saharan Africa: Slow but steady progress”. New York: Guttmacher Institute (2020).
Traub AM., et al. “The implications of overturning Roe v. Wade on medical education and future physicians”. The Lancet Regional Health–Americas (2022): 100334.

Unintentional errors necessitate moderation in spreading data, compassion, and even forgiveness.

Minor to moderate unintentional errors may benefit from the community's emotional support; frequently, they explore the problem and consider the individual's past performance and successful activities completed before the error happens. Their actions during his troubled time express their inner voice toward him.

If this doesn't happen, he must reflect on his past acts to be sure if there are some possible gaps in effecting job requirements or relational problems; these potential breaches must be detected and corrected accordingly.

Their attitude of criticism or a lack of interest in him in troubled times will determine a similar response from him when they are in need.

Intentional errors must be identified and punished; minor to significant corrective and curative actions, according to error, will be used to avoid other misconduct with more people suffering.

Consciousness and more reflection on mistakes following undesired effects on the individual and community level are necessary. Through the power of a negative example, remediation is possible only using the image of such action, without any words or aggression.

Individuals with genetic abnormalities facilitating disapproval behaviour should be re-educated for improvement since each individual has an ineffable spark.

The people responsible for spreading misinformation must be punished, paying for moral distress to the intended recipient.

In this digital era, spreading bad news about an individual alters his credibility. Honour is essential for practical, successful work, and its alteration by lousy information shared wide affects personal health.

If an untruth is applied rapidly, a disaster could follow since affected personality traits for an innocent, not guilty person exponentially amplify his distress, leading to significant mental and physical disorders.

Verification for honest info before spreading prevents possible disasters.

Sometimes, envy subtly controls the envisioned steps to attain the intended goal. Such encounters are better to be identified and exposed to the public so as not to fall again someone.

The world includes a variety of individuals, and not all are gentle, honest people. Selective relationships for life quality improvement define us, ensuring ill prediction, termination, and rehabilitation of the individual.

People's successful relationships suppose truth, respect, and consideration. To work in dignity is a requirement, and the individual good morality and integrity assure esteem in the community.

Lack of respect and admiration from our community alters mind functioning and job performance and declines perspective.

Error is usual, but not exceeding limits for survival.

References

Aju. Covid-19 (2020).
Jyothi. Consumer Behaviour: Impact of COVID-19 (2021).
Changotra R., et al. “Largest democracy in the world crippled by COVID-19: Current perspective and experience from India”. Environment, development and sustainability 23.5 (2021): 6623-6641.
Chen Q and Wang Y. “Key-performance-indicator-related state monitoring based on kernel canonical correlation analysis”. Control Engineering Practice 107 (2021): 104692.
Dani MT, Singh AG and Chaturvedi P. “COVID-19 vaccine hesitancy in India”. Cancer Research, Statistics, and Treatment 4.3 (2021): 437.
Duan, W., et al. “Evaluating model uncertainty of an in situ state parameter-based simplified method for reliability analysis of liquefaction potential”. Computers and Geotechnics 151 (2022): 104957.
Eger L., et al. “The effect of COVID-19 on consumer shopping behaviour: Generational cohort perspective”. Journal of Retailing and Consumer Services 61 (2021): 102542.
Goswami B, Mandal R and Nath HK. “Covid-19 pandemic and economic performances of the states in India”. Economic Analysis and Policy 69 (2021): 461-479.
Hupert N., et al. “Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave”. Proceedings of the National Academy of Sciences 119.3 (2022): e2025448119.
Ijsem. Inventory Management Practices in Manufacturing Industries during the COVID 19: A review (2022).
Jessica. Building Better amidst the Coronavirus Disease (COVID-19): Pandemic: An Analysis of Critical Success Factors within Resilience to Natural Hazards and COVID-19 (2022).
Madan A, Bindal S and Gupta AK. “Social distancing as risk reduction strategy during COVID-19 pandemic: A study of Delhi-NCT, India”. International Journal of Disaster Risk Reduction 63 (2021): 102468.
Mahmoudi MR and Abbasalizadeh A. “How statistics and text mining can be applied to literary studies?”. Digital Scholarship in the Humanities 34.3 (2019): 536-541.
Manish. Managing Global Management Teams in COVID and Post Lockdown Period (2022).
Asenahabi BM. “Basics of research design: A guide to selecting appropriate research design”. International Journal of Contemporary Applied Researches 6.5 (2019): 76-89.
Mazhar SA., et al. “Methods of data collection: A fundamental tool of research”. Journal of Integrated Community Health 10.1 (2021): 6-10.
Nimavat N., et al. “Online medical education in India–different challenges and probable solutions in the age of COVID-19”. Advances in Medical Education and Practice 12 (2021): 237-243.
Reiter PL, Pennell ML and Katz ML. “Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?”. Vaccine 38.42 (2020): 6500-6507.
Sharmin A., et al. “Addressing critical success factors for improving concurrent emergency management: lessons learned from the COVID-19 pandemic”. Annals of Operations Research (2021): 1-35.
Vu TTN. “Understanding validity and reliability from qualitative and quantitative research traditions”. VNU Journal of Foreign Studies 37.3 (2021).
Yang L., et al. “COVID-19: immunopathogenesis and Immunotherapeutics”. Signal transduction and targeted therapy 5.1 (2020): 128.

References

Aihie ON. “Perceived parenting styles as correlates of self-esteem among adolescents in secondary schools”. International Journal of Educational Benchmark 4.1 (2016): 96-106.
Alliance CTS. “Youth sports national report card”. Strategies 19.3 (2005): 26-28.
Ampofo?Boateng K., et al. “The motives young malaysians assign for participating in tennis”. Annals of Leisure Research 10.2 (2007): 196-214.
Anderson JC., et al. “Parental support and pressure and children's extracurricular activities: Relationships with amount of involvement and affective experience of participation”. Journal of Applied Developmental Psychology 24.2 (2003): 241-257.
Bremer KL. “Parental involvement, pressure, and support in youth sport: A narrative literature review”. Journal of Family Theory & Review 4.3 (2012): 235-248.
Brustad RJ. “Affective outcomes in competitive youth sport: The influence of intrapersonal and socialization factors”. Journal of Sport and Exercise Psychology 10.3 (1988): 307-321.
Donnelly P. “Problems associated with youth involvement in high-performance sport”. In B. R. Cahill & A. J. Pearl (Eds.), Intensive participation in children’s sports, Champaign, IL: Human Kinetics (1993): 95-126.
Ede S., et al. “Youth Hockey Athletes’ Perceptions of Parental Involvement: Thy Want More”. Journal of Sport Behavior 35.1 (2012): 3-18.
Edwardson CL and Gorely T. “Activity-related parenting practices and children’s objectively measured physical activity”. Pediatric Exercise Science 22.1 (2010): 105-113.
Feeley BT, Agel J and Laprade RF. “When is it too early for single sport specialization?”. The American Journal of Sports Medicine 44.1 (2016): 234-241.
Fredricks J and Eccles JS. “Family socialization, gender, and sport motivation and involvement”. Journal of Sport and Exercise Psychology 27.1 (2005): 3-31.
Gardner LA, Magee CA and Vella SA. “Social climate profiles in adolescent sports: Associations with enjoyment and intention to continue”. Journal of Adolescence 52 (2016): 112-123.
Gecas V and Schwalbe ML. “Parental behavior and adolescent self-esteem”. Journal of Marriage and the Family 48.1 (1986): 37-46.
Gould D. “The professionalization of youth sports: It's time to act!”. Clinical Journal of Sport Medicine 19.2 (2009): 81-82.
Gould D., et al. “Understanding the role parents play in tennis success: A national survey of junior tennis coaches”. British Journal of Sports Medicine 40.7 (2006): 632-636.
Gould D., et al. “The role of parents in tennis success: Focus group interviews with junior coaches”. The Sport Psychologist 22.1 (2008): 18-37.
Harwood C and Swain A. “The development and activation of achievement goals within tennis: Ii. A player, parent, and coach intervention”. The Sport Psychologist 16.2 (2002): 111-137.
Hollins DK. “When enough is enough: The impact of parental involvement in children's participation in organized sports”. Portland State University (2016).
Hoyle RH and Leff SS. “The role of parental involvement in youth sport participation and performance”. Adolescence 32.125 (1997): 233-243.
Jowett S and Lavallee D. “Social psychology in sport”. United States: Human Kinetics 10 (2007).
Knight CJ, Boden CM and Holt NL. “Junior tennis players’ preferences for parental behaviors”. Journal of Applied Sport Psychology 22.4 (2010): 377-391.
Knight CJ., et al. “Influences on parental involvement in youth sport”. Sport, Exercise, and Performance Psychology 5.2 (2016): 161.
Koehn R. “The association of parental involvement and youth athletes’ self-esteem”. (Master of Education), Goucher College (2017).
Krejcie RV and Morgan DW. “Determining sample size for research activities”. Educational and Psychological Measurement 30.3 (1970): 607-610.
Kushwah GS. “An investigation of Junior Tennis Players on Self Esteem and Competitive Advantage”. Proceedings of National Seminar on Fitness and Wellness, Gwalior, Madhya Pradesh (2014).
Lawn Tennis Association of Malaysia. News & ranks (2019).
Lee M and Maclean S. “Sources of parental pressure among age group swimmers”. European Journal of Physical Education 2.2 (1997): 167-177.
Lee YC. “A study of relationship between parenting styles and self-esteem: Self-esteem's indicator-parenting styles”. (Bachelor of Social Science (Hons) Psychology), UTAR (2011).
Leff SS and Hoyle RH. “Young athletes' perceptions of parental support and pressure”. Journal of Youth and Adolescence 24.2 (1995): 187-203.
McElroy M. “Consequences of perceived parental pressure on the self-esteem of youth sport participants”. American Corrective Therapy Journal 36.6 (1982): 164-167.
Qurban H., et al. “The mediating role of parental support: The relation between sports participation, self-esteem, and motivation for sports among chinese students”. Current Psychology 38.2 (2019): 308-319.
Ridley MJ. “Parental perceptions of their sport involvement with late adolescent student athletes”. (Masters of Arts), Ball State University (2013).
Rosenberg M. “Conceiving the self (reprint edition)”. Melbourne, FL: Krieger (1979).
Sánchez-Miguel PA., et al. “The importance of parents’ behavior in their children’s enjoyment and amotivation in sports”. Journal of Human Kinetics 36.1 (2013): 169-177.
Scanlan TK and Lewthwaite R. “Social psychological aspects of competition for male youth sport participants: Iv. Predictors of enjoyment”. Journal of Sport Psychology 8.1 (1986): 25-35.
Schwebel FJ, Smith RE and Smoll FL. “Measurement of perceived parental success standards in sport and relations with athletes’ self-esteem, performance anxiety, and achievement goal orientation: Comparing parental and coach influences”. Child Development Research (2016): 1-13.
Strandbu Å., et al. “Young people’s experiences of parental involvement in youth sport”. Sport, Education and Society 24.1 (2019): 66-77.
Stroebel LCE. “Parental involvement in sport: Perceptions of competitive adolescent swimmers”. (Master of Arts), University of the Free State (2006):.
Udry E., et al. “People helping people? Examining the social ties of athletes coping with burnout and injury stress”. Journal of Sport & Exercise Psychology 19.4 (1997): 368-395.
Wilson KS, Spink KS and Whittaker C. “Parental response to lapses in child's physical activity: To control or not to control”. Journal of Sport & Exercise Psychology 29 (2007).
Wuerth S, Lee M and Alfermann D. “Parental involvement and athletes’ career in youth sport”. Psychology of Sports and Exercise 5.1 (2004): 21-33.
Wylleman P., et al. “Talented athletes' perceptions of the athlete-coach-parents relationships”. Kinesiologia Slovenica 8.2 (2003): 59-69.

References

Akimova LN. “Psychology of sexuality”. Odessa: SMIL (2005): 198.
Alexandrov AA. “Integrative psychotherapy”. SPb: Piter (2009): 352.
Abnormal sexual behavior. Ed. A. A. Tkachenko and G. E. Vvedensky. SPb: Publishing house "Legal Center Press". (2003): 657.
Bantskhaf Kh, Teler B and Til N. Man and Woman. Secrets of reciprocity in astrology and psychology. Astrology of intimacy, sexuality and relationships. Insights, leading to integrity. M. IG "Ves" (2018): 510.
Badoo glorifies the heroes of masturbation in a new advertisement. Stav. ua electronic resource (2022).
Bendas TV. Gender Psychology: A Textbook. SPb. Piter (2005): 431.
Bern E. Sex in human love. Per. with M. P. Papusha. M. Izd-vo EKSMO-Press (2000): 384.
Giddens E. Transformation of intimacy. Sexuality, love and eroticism in modern societies. Per. with English by V. Anurina. SPb. Piter (2004): 208.
Giddens E. Foucault on sexuality. Sociology of sexuality. SPb: Institut sotsiologii RAN (1997): 20-29.
D?denko SL. The psychology of hollowness and hollowness. Kyiv: Aristey (2003): 312.
Deryagin GB. Criminal sexology: a course of lectures. M. Shchit-M (2008): 552.
Davidson Richard. The Flames of Yahweh. Sexuality in the Bible. Per. with G. Yastrebova. M. Izdatelstvo: "Eksmo" (2015): 1270.
Giddens E and Sutton F. Basic concepts in sociology. M. Izd. House of the Higher School of Economics (2018): 336.
Ivanova NY. Psychological aspects of "sexuality". Bulletin of Tomsk State Pedagogical University (Tomsk State Pedagogical University Bulletin) 11.139 (2013): 81-86.
Ilyin EP. Differential psychophysiology of men and women. SPb. Piter (2003): 544.
The Story of Sexuality-III: Self-Care. Per. with fr. T. N. Titovoy and O. I. Khomy pod obshch. red. A. B. Mokrousova. M. Refl-buk (1998): 288.
Zberovsky AV. Men's sexual fears, tricks and tricks. Psychology of love behavior. Moscow: Mir (2018): 416.
Zdravomyslov VI, Anisimova ZE and Libih SS. Functional female sexopathology. Perm', M. Mir (1998): 692.
What is the attitude towards LGBT people in the world and in Russia?. news. myseldon.com [Electronic resource] (2022).
Caprio F. Manifold of sexual behavior. M. Artania (1995): 352.
Klein LS. Other Love: Human Nature and Homosexuality. SPb. Folio-Press (2000): 864.
Kon IS. Adolescent sexuality on the threshold of the 21st century. M: Phoenix (2001): 147.
Kocharyan AS. Personality and sexual role. Khar'kov: «Osnova» (1996): 127.
Crooks R and Baur K. Sexuality. SPb: Prime-Evreznak, (2005): 480.
Obukhovskii K. Psychology of human inclusion. M Progress (2012): 248.
Will Europe remain itself? Opinions of the clergy [Electronic resource] (2022).
Psychology of sexuality. Textbook for the course "Psychological counseling in sexology". Ed. Kashchenko E. A. M. Ridero (2019): 554.
Sexology. Ed. by D. N. Isaev. SPb. Piter (2001): 512.
List of sexual deviations. Wikipedia. Free Encyclopedia. wikipedia.org [Electronic resource] (2022).
List of countries in the world in relation to the legality of homosexual contacts. Wikipedia. Free Encyclopedia. wikipedia.org ;Electronic resource] (2022).
Starovich Z. Forensic sexology. Per. with Polish. M. Yurid. lit (1991): 336.
Tkachenko AA. Boundaries of the sexual norm and modern classifications of violations of psychosexual orientations. Abnormal sexual behavior. M. RIO GNTS SiSP im. V. P. Serbskogo (1997): 6-31.
Tkachenko AA. Sexual perversions – paraphilias. M. Triada-Kh (1999): 461.
Top-10 countries of the world by the number of homosexuals. top10a. ru [Electronic resource] (2022).
Tennehill R. Sex in History. M. Kron-Press (1995): 400.
Freud Z. Essays on the psychology of sexuality. M. Eksmo (2017): 533.
Freud Z. "Psychology of Sexuality". Khar'kov: Folio (2007): 288.
Foucault M. Will to Truth: Beyond Knowledge, Power and Sexuality. Works of different years. Per. from French M. Castal (1996): 448.
Shantyr EE. “Socio-psychological concept of the foundations of lawmaking in the field of family and marriage relations”. Psychologist (2017): 68-89.
Erickson E. Identity: youth, crisis. Per. from English. M: Progress (1996): 342.
Andersen M. Thinking about women. Sociological Perspectives on Sex and Gender. Boston: Allyn and Bacon (1997): 78-79.
Baker Robin R. Human sperm competition: Ejaculate adjustment by males and the function of masturbation”. Animal Behavior 46.5 (1993): 861.
Brian Y Park., et zl. “Is Internet Pornography Causing Sexual Dysfunctions? A Review with Clinical Reports”. Behav Sci (Basel).6.3 (2016): 17.
Foucault M. History of sexuality, t. II: The use of pleasures, t. III: The concern for oneself, Paris, Gallimard (1984): 285.
Fromm E. Man for himself. Translation from English E. Spirova (2018): 349.
Giles GG., et al. “Sexual factors and prostate cancer”. BJU International 92.3 (2003): 211-216.
S Seidman, N Fischer and C Meeks. Introducing the New Sexuality Studies. 2nd edn. L. N. Y. Rout-ledge (2011): 571.

References

Aleksandrov AA. “Integrative psychotherapy”. St. Petersburg: Peter (2009): 352.
Ananiev BG. “Man as a subject of knowledge”. St. Petersburg: Piter (2001): 228. (in Russian).
Vekker LM. “Psyche and reality: a unified theory of psychic Processes”. Moscow: Smysl (1998): 670. (in Russian).
Types of psychological problems. Psikhologos. Encyclopedia of Practical Psychology.
Voynivska OO. “Actual psychological problems of religious appeal of personality in modern society”. Science and education 4-5 (2004): 14-17.
Eliseev OP. “Practicum on the psychology of personality”. St. Petersburg: Peter (2001): 560.
Zhdan AN. History of psychology. From Antiquity to the present day: Textbook for universities. 5th ed., rev. and add. M.: Akademicheskii Project (2004): 576. (in Russian).
Caprara J and Servon D. “Psychology of personality”. SPb.: Piter (2003): 640. (in Russian).
Cloninger S. “Theories of personality: cognition of a person”. SPb.: Piter (2003): 718.
Kozlov NI. “Personality”. Psikhologos. Encyclopedia of Practical Psychology.
Kozlov NI. “Personality in psychology”. Psikhologos. Encyclopedia of Practical Psychology.
Kulikov LV. “Psychology of personality in the works of domestic psychologists”. Anthology, 2nd ed. Isravl. and add-e. St. Petersburg: Peter (2009): 464.
Leontiev AA. “Activity, consciousness, personality”. M.: Smysl (2005): 431.
Martsinkovskaya TD. “History of psychology”. Moscow: Akademiya (2001): 538. (in Russian).
Nemov RS. Psychology. Kn. 1. General foundations of psychology. 4th ed. M.: Gumanit. Ed. VLADOS Center (2003): 688. (in Russian).
Papucha MV. “The inner world of man and his formation”. Dis. doct. psychol. Sciences. K.: Institute of Psychology. G.S. Kostyuk (2013): 400.
Pervin L and John O. “Psychology of personality: Theory and research”. Moscow: Aspect Press (2001): 607. (in Russian).
Platonov KK. “Structure and development of personality”. Moscow: Nauka (1986): 56-57.
Psychiatric states/Comp. and the general edition of L.V. Kulikov. SPb.: Piter (2000): 512. (in Russian).
Psychology of personality in the works of foreign psychologists. Comp. and the general edition of A.A. Rean. SPb.: Piter (2000): 320.
Psychology of personality: Collection of articles. A.B. Orlov. Moscow: Voprosy psikhologii (2001): 192. (in Russian).
Human psychology from birth to death. Ed. by A.A. Rean. SPb (2002): 656. (in Russian).
Psychology of self-awareness. Reader. Edited by Raigorodsky D.Y. Samara: "Bahrakh-M" (2003): 672. (in Russian).
Salvatore Maddi. “Theories of personality: a comparative analysis”. St. Petersburg: Rech (2002): 539. (in Russian).
Fernheim A and Haven P. “Personality and social behavior”. SPb.: Piter (2001): 358. (in Russian).
Frager R and Feydimen D. “Big book of psychology. Personality. Theories, exercises, experiments”. SPb.: Prime-Evroznak (2008): 704. (in Russian).
Hegglund B. “History of theology”. SPb.: Svetoch (2001): 370. (in Russian).
Kjell L and Ziegler D. “Theories of personality (Basic provisions, research and application)”. St. Petersburg: Piter Press (2003): 608. (in Russian).
Shantyr EE. “Interpretation of professions and issues of training in the field of psychological services”. Psychology and Psychotechnics 9 (2015): 942-950.
Shantyr EE. “Unification of basic concepts and practical terms Psychology”. Psychologist 2 (2015): 99-117.
Shekhovtsova LF. “Worldview foundations of humanistic and transpersonal psychology”. Shekhovtsova L. F. Khristianskoe worldview as the basis of psychological counseling and Psychotherapy. St. Petersburg: Society of Orthodox Psychologists of St. Petersburg Petersburg (2009): 24-32.
Shcherbak TI. “Development of the image of the self in the period of representation of intelligence Personality”. Dis. Cand. psychol. Sci.Odesa: Ministry of Education and Science of Ukraine DZ "South Ukrainian National. ped. Univ. them. K.D. Ushinsky (2013): 200.
Jung KG. Human. Moscow: AST-Press (2007): 470. (in Russian).

The use of radiation in diagnosis and therapy is common but not without fear of detrimental risks and a general feeling of uneasiness. Effects of LDR have not been adequately elucidated and more research is needed to unravel the underlying mechanisms. However, LDR is known to cause stimulations in a variety of cellular processes resulting in beneficial effects which offer new opportunities to harness the protection to normal cells and therapeutic outcomes through toxic effects. It is pertinent to recall that billions of years ago the living organisms from bacteria to humans evolved in high ionizing radiation background and they armed themselves with complex protective machineries for survival against external stressors. In the present time, average annual natural environmental radiation is estimated ~2.4 mSv which, of course, varies at various locations on the earth ranging from about 1 mSv in Japan to 260 mSv in Iran. Most interestingly, it is found that people residing in such natural high background radiation (HBR) areas live a normal life and there are no reported significant health issues.

The living organisms exhibit adaptation offering protection against radiation exposure and learn to live below certain threshold dose. Furthermore, a low radiation dose causes stress to cells which turn on genes at specific threshold of radiation dose. The radiation activated genes up-regulate the protection systems which produce enhanced positive effects e.g. prevention of cancer, risk prediction and suppression of diabetes etc. Presumably, the LDR induced positive effects arise due to intracellular production of reactive oxygen species (ROS) which initiate production of endogenous antioxidants for its neutralization and signaling processes. More importantly, LDR activate repair of the damaged DNA, induce the mechanism of apoptosis causing the self-destruction of cancerous cells. LDR could modulate excessive inflammatory responses, regulating lymphocyte counts, and controlling bacterial co-infections in patients with COVID-19. Also, it is known to boost immunity which can annihilate cancer cells as well as reduce or counter virus assaults. Overall, LDR initiates recruitment and rescue operation in the injured cell which results in protection against radiation in normal cells or to the pathogenic agents including COVID-19 virus attack. On the other hand, a higher dose of ionizing radiation overstresses the organisms and the genes are turned on/off at specific radiation doses. It is known that different genes are activated by high and low doses. Thus, the built in protection system in cells is overtaken at higher doses and harmful effects are observed. That is to say, the low dose induced beneficial effects are generally marred by high dose radiation exposures. Another important finding in radiobiology is the observation of damage to non-irradiated cells called bystander effect. The DNA damage, apoptosis and other effects in non-irradiated cells show different patterns. It remains to be seen how bystander effect will modify cancer therapy outcome, risk estimates(carcinogenesis) and protection against radiation. Evidently, the promise of LDR in therapy of cancer and other diseases (e.g.cardiovascular) needs to be isolated, identified and tested in clinic. More importantly, a new opportunity is in the sight to optimize a window of LDR doses, say between 10 mSv to 200 mSv, that needs to be tested and optimized in the therapy of chosen lung cancers and novel COVID -19 infection which locates in the lower respiratory system and causes pneumonia symptoms leading to breath deterioration and eventually death.

In the evolution of life, organisms have harnessed the low dose stimulation to their survival advantage. It is no surprise that extensive LDR research in environmental ranges at molecular, cellular, and animal level has shown no adverse or detrimental effects. Thus, the concern for likely safety of health issue is critical. In fact, the safety concerns of scientists from LDR therapy seem to entail from the Reports of International Commission for Radiation Protection (ICRP) which believes in Linear-No- Threshold (LNT) model which is based on the assumption that no dose is safe however small. The ICRP prefers to ignore biological fact of intrinsic cellular repair machinery and hence believes in no threshold. Radiobiological studies on the surviving population from Hiroshima and Nagasaki atom bomb have shown that the cancer rate increases in proportion to the amount of exposure to radiation at acute high doses. However, there is no convincing data that shows the increase in cancer rate with a low level of exposure. On the contrary, there are even reports indicating that the cancer rate declines in high background radiation studies in China, India Brazil and Iran. The observed adaptability and the built in intrinsic protection system in living organisms against radiation are ignored for establishing the regulation and standards for radioprotection. In this context, the observed threshold of LDR dose at which genes are turned on and the dose at which they are turned off are important transition from beneficial to harmful effects of radiation. Of course, the dose thresholds and the amounts of benefit and harm observed are the characteristics for each organism. But, the remarkable demarcation of response of organisms from a LDR to acute radiation dose (ARD) is frequently observed which needs re-examination for the validity of LNT model.

In summary, the studies on low dose radiation effects on living organisms needs re-focus and role of LDR therapy in fighting cancer merits re-examination, a fresh look at carcinogenic risk evaluation/prediction (in view of Adaptive response and bystander effects) and developing novel tools for treating COVID-19 appear highly urgent and it’s use in therapy deserves re-evaluation and rigorous analysis of the clinical data. International scientific community is divided on the carcinogenic risk of LDR but recent surge in publications on evaluation of low dose therapy in the treatment of pneumonia caused by the novel COVID-19 and cancer re-emphasizes the need for technical developments and brings new hope for saving human life.

References

BIER VII: Health Risks from Exposure to Low Levels of Ionizing.
Augusto Giussani and Francesca Ballarini. Risk at Low Doses: Scientific Knowledge, Uncertainties and Management, University of Milan, Italy (2002).
UNSCEAR. (2000) Sources and Effects of Ionizing Radiation: United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 2000 Report to the General Assembly with Scientific Annexes. United Nations Publications Sales No. E.00.IX.6, New York Wolff S (1998).
Wolff S. “The adaptive response in radiobiology: evolving insights and implications”. Environ. Health Perspect 108 (1998): 277-83.
Cuttler JM, Pollycove M and Welsh JS. “Application of low doses of radiation for curing cancer”. J.Am.Physic Surg 8.4 (2003): 108 -111.
Clarke RH. “Radiological protection phylosophy for the 21st century”. Workshop on internal dosimetry of radionuclides Occupational, public and medical exposure. Oxford (UK) (2003).
Ishii K., et al. “Decreased incidence of thymic lymphoma in AKR mice as a result of chronic, fractionated low-dose total-body X irradiation”. Radiat. Res 146.5 (1996): 582-5.
Calabrese EJ and Baldwin LA. “Toxicology rethinks its central belief”. Nature 421 (2003): 691-692.
Feinendegen LE, Pollycove M. “Biologic responses to low doses of ionizing radiation: detriment versus hormesis, part 1: dose responses of cells and tissues”. J.Nucl Med 42.7 (2001): 18N-27N.
Shu Zeng Liu. “Cancer control related to stimulation of immunity by low dose radiation”. Dose-Response 5 (2007): 39-47.
Feinendegen LE. “The role of adaptive responses following exposure to ionizing radiation”. Hum. Exp.Toxicol 18 (1999): 426-32.
Mishra KP. “Cellular sensitivity to low dose ionizing radiation”. J Radiat Cancer Res 12 (2021): 91-95.
Mishra K. “Low?dose radiobiology: Opportunities for new research and technology for anticancer and anti?COVID?19 strategies”. J Radiat Cancer Res 11 (2020): 73.
Seyed Mohammad Javad Mortazavi, Amirhosein Kefayat and Jing Cai. “Point/Counterpoint. Low-dose radiation as a treatment for COVID-19 pneumonia: A threat or real opportunity?”. Med Phys 47.9 (2020): 3773-3776.

Healthy relationships always suppose trust, respect, and appreciation between interest groups; sicknesses play down these fundamental components, annoying the beneficiaries.

Prosperous affairs or weak spots going down them continuously appear, soothing or distressing the individuals. Younger individuals are more candid, genuine, heartfelt, and open to challenging situations. Still, they have less life experience than adults or seniors. Old individuals are frequently registered with many diseases, including arterial hypertension and type 2 diabetes shading their performance. For all categories, illnesses get in the way of thinking and acting and may cause disruptions in interpersonal relationships. An unfair manifestation of judgment makes partners terminate the connection, amplifying mental suffering in the sick individual.

Rational thinking and performing duties gratifies people working and attract individuals, but imbalanced actions can harm their other relationships. People look for another collaborator when they are disappointed by unsafe collaboration. They usually need to prepare for such turning effects and want a more direct and effective way of interaction.

Persistent bad feelings disturb the human equilibrium, primarily affecting lipid profile and glycaemic control that alter cell functioning.

Therefore, people’s health ensures a prosperous social, professional, cultural, and emotional life. A deep look through the factors implying the appearance and evolution of various illnesses is necessary. A medical team’s mission is to identify all risk factors connected with the clinical manifestations of multiple diseases that affect reasoning and measures to attenuate or eliminate them when possible.

Disorder management has a different approach in this century. Person-centricity leads to a better- understanding of diseases, moving to their origin, and considering human life evolving and undergoing rational transformation.

People’s complex connectivity infers numerous parts that vary by age, instruction, setting, surroundings, and circumstances. The inability to select the most advantageous factors for enhancing professional and social life needs improvement.

Occasionally dire conditions cannot be avoided, and the individual must be prepared to deal with dilemmas. Successfully coping with unexpected problems defines the capacity to beat barriers, or if an inevitable fall occurs, rising above is preferable. The excellent position gained after falling depicts the victory against overcoming adversities, illuminating a path for restorative health and optimistic well-being improvement.

Sometimes illogical actions originate in intentional immoral thinking, finally repulsing, revolting, or shocking the recipients. Corrective and informative actions are indispensable to going back to normality. The artificial Intelligence supply and instruction hybrid model add benefit for remodelling unhealthy behaviour.

Acting as professionals, we gain recognition from the community we serve.

And so, mental activity may also be evaluated by the effectiveness of connections between individuals with various backgrounds and demographic data.

Individual reasoning change over time is expected. It should be better to have its improvement, but if decline appears, it has to be eased, and it is preferable not to fall again. Rising once more for the beauty of life in this natural and perceptible world that will end up sooner or later for each one is wanted.

Individual working reflects genetics, education, social connection, and environmental characteristics. It is advisable to maintain an equilibrium between intellectual activity and physical exercises. Moreover, intellect work can relax in the digital age, along with a personal choice from diverse virtual offerings aiding in recharging, ensuring a harmonious state of being.

People’s data fast circulates by media, helping individuals to better decide on their collaborators. Personal reputation, appreciation, trust, and respect are fundamental for long-lasting relationships. Good partnership work ensures a prosperous social, cultural, professional, and emotional life. Unsafe people interactions have detrimental effects on their health and, consequently, decline work efficiency and well-being. IT advancement facilitates blocking collaboration with dishonest or uneducated people.

The medical team’s mission is to detect the negative impact of unhealthy behaviour on individuals’ well-being and provide timely solutions for that, utilizing information technology resources for a swift recovery.

Immoral conduct in daily work is easily identified by using specialized electronic tools for monitoring; applying reasonable measures for remediation makes possible fast restoration of bad habits and ameliorates offensive people collaboration. Nowadays, corrective actions for harmful human behaviour are used more gently and with more permission, exploring self-reflection value for improvement.

AI-powered tools can assist in restoring health, expanding knowledge, and enhancing the overall quality of life, finally leading to increased life expectancy.

The latest technological advancement in healthcare delivery is used in clinical diagnosis, which may be established using only virtual patient data. Various IT devices are available for both rich and poor people in need. But just using a modest mobile phone makes the connection between the physician, nurse, and patient possible; online voice analysis combined with breath characteristics and face and hands info enables a rapid clinical diagnosis with no more time-consuming. This new practice model is more facile and accessible, gaining benefits for all parties implied in dealing with medical conditions: health professionals, patients, their families, pharmaceutical departments, and representatives of other trades connected for social support.

Recording people’s physical or online interactions allows us to revisit communication for analysis; this helps detect possible gaps, correct them, and improve business or corporate performance.

Customer experience reflects the professionalism of individuals collaboratively working and offering their products; the client’s knowledge, involvement, skills, emotional state, and proficiency are examined by gathering data from various touch-points and other communication channels. Consumer satisfaction ensures increased revenues, improved practice efficiency, and societal progress.

People’s interaction with robots replacing their labour is a new, more accurate, rapid, and cost-saving alternative in service mode.

As for each fact, there are two opposite facets of the advancement of technologies these days. The optimistic attributes of IT may fascinate us but are easily eclipsed by other elements with detrimental effects on individual health: more absorbed time to navigate them, a decreased program for physical activities or relaxation in nature, less time interacting in person, and disturbed slipping rhythm. These factors, if unbalanced, can lead to increased body mass index and brain disorders; sleep disruption represents a point start of other medical conditions. Ingenuity for an educational platform focussing on people’s health in the digital age is imperative.

A fair digital program for an individual ensures a healthy life expedition, attaining excellence in living in the natural and perceptible - audible and visible world.

References

World Health Organisation. Antimicrobial resistance: Global Report on Surveillance 2014. Geneva: WHO (2014).
Hassaine H and Boulanoir M. “Antibiotic resistance of Escherichia coli isolated from urinary tract infections at Tizi Ouzou hospital”. Akli Mohand Oulhadj-Bouira University, Morocco (2019): 74.
Ouedraogo AS., et al. “Emergence and spread of antibiotic resistance in West Africa: enabling factors and threat assessment”. Tropical Health Medicine 27 (2017): 147-154.
Toudji AG., et al. “Prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae strains isolated in Togo and their susceptibility to antibiotics”. International Journal of Biological Chemical Sciences 11.3 (2017): 1165-1177.
Kalambry AC., et al. “Beta-lactam resistance profile of enterobacteriaceae isolated from urine samples at the Mali Hospital”. Malian Journal of Infectiology and Microbiology 14 (2019): 6-13.
Rakotovao-Ravahatra ZD., et al. “Phenotypes of resistance of Escherichia coli strains responsible for urinary tract infection in the laboratory of the University Hospital Center of Befelatanana Antananarivo”. Pan Afr Med J 26 (2017): 166.
French Society of Microbiology Enterobacteriaceae. In: CASFM / EUCAST: French Society of Microbiology Ed (2019): 1-45.
Romli A., et al. “ESBL Enterobacteriaceae for urinary tract infections: epidemiology and resistance”. MOROCCO MEDICAL 33.1 (2011): 12-17.
Hailaji NS, Ould Salem ML and Ghaber SM. “Antibiotic susceptibility of uropathogenic bacteria in the city of Nouakchott – Mauritania”. Prog Urol 26.6 (2016): 346-52.
Sissoko T. “Urinary tract infections in Bamako: epidemiological and bacteriological aspects”. University of Bamako, Mali (2006): 103.
Sbiti M, Lahmadi K and Louzi L. “Epidemiological profile of uropathogenic enterobacteriaceae producing extended-spectrum beta-lactamases”. Pan African Medical Journal 28.29 (2017): 1-8.
El Bouamri MC., et al. “Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences”. Advances in Urology 16 (2014): 1058-62.
Elhani D. “Extended-spectrum beta-lactamases: the challenge is increasing”. Ann Biol Clin 70.2 (2012): 117-40.
Gonsu Kamga H., et al. “Resistance phenotypes of Escherichia coli strains responsible for community-acquired urinary tract infections in the city of Yaoundé, Cameroon”. African Journal of Pathology and Microbiology 3 (2014): 1-4.
Nguyen JC and Lambert T. “Phenotypic interpretation of antibiogram vis-à-vis aminoglycosides”. Francophone Journals Laboratories 445 (2012): 75-7.
Batard E., et al. “From antibiotic consumption to bacterial resistance: the example of Escherichia coli resistance to quinolones”. Therapeutic medicine 17.4 (2011): 294-301.
Tagajdid MR., et al. “Study of the resistance of Escherichia coli strains isolated in urine to fluoroquinolones and third-generation cephalosporins”. Medicine and infectious diseases 40.2 (2010): 70-3.

Reference

Gahlawat DK, Jakhar S and Dahiya P. “Murraya koenigii (L.) Spreng: an ethnobotanical, phytochemical and pharmacological review”. Journal of Pharmacognosy and Phytochemistry 3.3 (2014): 109-119.
Sangam S., et al. International Journal of Health Sciences and Research 5.1 (2015): 156-164.
Singh AP., et al. “LC-MS-MS characterisation of curry leaf flavonols and antioxidant activity”. Food Chemistry 127.1 (2011) 80-85.
Henry AB Trimen. “A hand-book to the flora of Ceylon”. Dulau and Co (2015): 1-1893.
Kumar S, Loveleena D and Godwin S. “Medicinal property of Murraya koenigii-A Review”. International Research Journal of Biological Sciences 2.9 (2013): 80-83.
AG Atanasov., et al. “Discovery and resupply of pharmacologically active plant-derived natural products: a review”. Biotechnology Advances 33.8 (2015): 1582-1614.
H Yuan., et al. “The traditional medicine and modern medicine from natural products”. Molecules 21.5 (2016): 559.
Narasimhan NS., et al. “Murraya koinigi, structures of mahanimbine,koenimbine, mahanine, koinine, koenigine and koenidine”. Indian J Chem 13 (1975): 993-995.
Rastogi RP and Mehrotra BN. “Compendium of Indian medicinal Plants”. Volume 2, Central Drug Research Institute, Lucknow and National Institute of Science Communication, New Delhi, 486-489 (1980-1984).
Math MV and Kattinaw YR. ------------- Br J. oral maxilloFac. Surg 59.4 (2021): 497-498.
Mandal S., et al. “Fitoterapia Antidiarrhocal activity of carbozole alkaloids form Murraya koenigii spreng (Rutaceae) seeds”. Fitoterapia 81.1 (2010): 72-74.
Mishra RK. Curry Leaves (Murraya koenigii spreng) (2018): 23-28.
Patil Rupali Arun. Mukund Langade Padmaya Babarao Dighade Pramod and Hiray Ashok Yogesh (2012).
Rupali Arun Patil., et al. “Antinociceptive acute and chronic administration of Murraya koenigii L. Leaves in exmerimental animal modes”. Indian J Pharmacol 44.1 (2012): 15-19.
Jaysinghe AN Sandamali., et al. “Cardioprotective Potential of Murraya koenigii (L.) sperm Leaf extract against Doxorubicin Induced cardiotoxicity in Rats”. Evid Based Complement Alternat Med (2020): 6023737.
Verma Nidhi and Kumari Dharmashila. “Amoliorating effect of Muraraya koenigii leaves (curry leaves) against paracetamol induced genotoxicity in mice sperm cells”. IJIRMF 6 (2020): 12.
Ningappa MB, Dinesha R and Srinivas L. “Antioxidant and free radical scavenging achivies of polyphenol-oriched curry leaf (Murraya koenigii L.,) extracts”. Food chemistry 106.2 (2008): 720-728.
Bhandari P. “Curry Leaf (Murraya koenigii) or cure leaf: Review of its curative propertics”. Journal of Medical Nutrition and nutraceuticals 1.2 (2012): 92.
Ghosh D., et al. “Protective effect of aqueous leaf extract of Murraya koenigii against leaf induced oxidative stress in rat liver, heart and kidney: A dose response study”. Asian journal of Pharmaceutical and Clinic research 5.4 (2012): 54-58.
Arulselvan P and Subramanian S. “Effect of Murraya koenigii Leaf extract on carbohydrate metabolism studied in streptozotocin induced diabetic rats”. Int JBiol chem 1.1 (2007): 21-28.
Nishan M and Subramaniam P. “Murraya koenigii (curry leaves). a review on its potential”. international journal of pharm Tech Research 7.4 (2015): 566-572.

Introduction: Very low birth weight (VLBW) is a term used to describe babies who are born weighing less than 1,500 grams (3 pounds, 4 ounces). Infants who are born preterm with low birth weight and secondary to intrauterine growth restriction, can be subjected to increased morbidity, mortality, and cost [5]. Babies with a very low birth weight are at a higher risk of motor development, depression, Attention deficits and other psychiatric conditions in adulthood, compared with those born a healthy weight [6]. The purpose of this study is to find out the effect of very low birth weight and gestational age on motor development in preterm infants at 18 months of corrected age.

Materials and Methods: This study is a observational study design and was conducted in VAPMS College of Physiotherapy, outpatient Department and R.K. MISSION hospital. A study sample of 50 subjects was selected on simple random sampling method. The study questionnaire was applied and the infants were prospectively evaluated using Alberta Infant Motor Scale (AIMS) for their gross motor development at 18 months of corrected age. The observational study was done for 20 minutes for each infant. In addition, the perinatal and the socio-environmental data were obtained from the parental interview. The assessment emphasizes the anti gravity movement of the limbs in prone, supine, sitting and standing positions, postural alignment, weight bearing of the body with further evaluation in attainment of gross motor skills.

Results: The sample was segregated into three sub group model and thus identified 3 motor trajectories among VLBW preterm infants: stably normal (n=36), slightly deteriorating (n=11), persistently delayed (n = 3). Infants with a normal trajectory manifested the typical motor performance with AIMS Z scores of 0.4 to 0.5. Infants with deteriorating trajectory displayed the motor performance in the typical range initially but then deteriorated from 12 months. Infants with a persistently delayed trajectory revealed a significant delay from 9 months. All the infants were observed at 18 months of corrected age.

Conclusion: The study concluded that very low birth weight has a significant effect on the motor development observed in preterm infant. The early motor trajectories were also a predictive of subsequent developmental outcomes in preterm infants specifically with VLBW. In addition the study emphasizes that socio-environmental factors are not associated with motor trajectories in preterm infants with VLBW.

Keywords: Very low birth weight; Preterm infant; Gross motor trajectories

Research supported the evidence stating that mental health is likely multifaceted by nature, that includes genetic, biochemical, physiological, and environmental factors. The Human Genome Project, completed in 2003, opened new avenues for genetic research. Since then, genome-wide association studies (GWAS) and other genetic analyses have identified specific genetic variants associated with mental health disorders. Genetic variations can contribute to an individual's susceptibility to mental health disorders.

Over the years, researchers have made significant progress in identifying and understanding various biomarkers associated with mental health disorders. In the mid-20th century, researchers started investigating the relationship between neurotransmitters and mental health. Scientists have learned that alterations in neurochemicals are related to mental diseases. For instance, the significant milestone was the discovery of antipsychotic drugs in the 1950s, which specifically targeted dopamine receptors and shed light on the involvement of neurotransmitters in conditions such as schizophrenia (Sawa &Snyder, 2003). Another early discovery was the neurotransmitter serotonin. These neurochemicals are released into the synaptic region in depressed individuals than in healthy individuals. Selective serotonin reuptake inhibitors (SSRIs), a class of drugs, work by increasing the quantity of serotonin in the synaptic region, which alleviates symptoms of depression (Bethesda, 2007). Several combinations of single nucleotide polymorphisms in an individual's genetic makeup and some environmental stressors may contribute to these mental conditions. When a person is stressed, the cortisol hormone is released into the bloodstream (Cay et al., 2018). In the 1980s and 1990s, the role of cortisol as a prognostic biomarker in mental health disorders gained attention. Studies found dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to abnormal cortisol levels. Cushing's syndrome (Lacroix et al., 2015) is caused by too much cortisol, while Addison's disease (Charmandari et al., 2014) is caused by adrenal damage and is associated with too little cortisol. Drugs related to cortisol (e.g., prednisolone) will suppress cortisol secretion from the adrenal gland if taken for a period. The inherited genetic error can cause disorders in the human body, such as Huntington's disease (HD). HD is caused by the mutation in the gene resulting in increased repetition of cytosine, adenine, and guanine (CAG). This error in the DNA codes for genes makes defective nerve cells in the brain gradually break down and die, causing the body to lose important signals to keep it in its proper function and response.

These breakthroughs emphasized the significance of neurotransmitter imbalances in mental health disorders and paved the way for further research in this field. Measuring these chemicals in the blood or the cerebrospinal fluid with neuroimaging techniques, mass spectrometry, and genetic testing can help identify these biomarkers. Advances in neuroimaging techniques like positron emission tomography (PET), magnetic resonance imaging (MRI), and functional MRI (fMRI) can reveal structural and functional brain abnormalities associated with mental health disorders. Brain imaging biomarkers help understand brain circuitry, identify treatment targets, and evaluate treatment response.

Multi-omics approaches, such as integrating multiple biological data sources, such as genomics, proteomics, metabolomics, and transcriptomics, have opened new avenues for biomarker discovery. These multi-omics approaches allow researchers to explore complex interactions and networks underlying mental health disorders. It's important to note that the field of mental health biomarkers is still evolving. Many biomarkers are in the early stages of research and require further validation and standardization before they can be implemented in clinical practice. Nonetheless, the ongoing discoveries in this field hold great promise for personalized approaches to diagnosis, treatment, and understanding of mental health disorders.

References

Bethesda. “Biological Sciences Curriculum Study”. NIH Curriculum Supplement Series. National Institutes of Health (US) (2007).
Cation MD and Ramos MC. “Accelerating Breast Cancer Biomarker Discovery by Mass Spectrometry Proteomics and Current Bioinformatics Tools”. Asian Pacific Journal of Cancer Biology 7.3 (2022): 275-283.
Glannon W. “Biomarkers in Psychiatric Disorders”. Cambridge Quarterly of Healthcare Ethics: CQ: The International Journal of Healthcare Ethics Committees 31.4 (2022): 444-452.
Sawa A and Snyder SH. “Schizophrenia: neural mechanisms for novel therapies”. Molecular Medicine (Cambridge, Mass.) 9.1-2 (2003): 3-9.

Background: In Bangladesh, Pharmacists have an advantage over other healthcare professionals as they have easier and more frequent access to the public.

Objective: This study aims to address this knowledge gap and provide valuable insights to guide future interventions.

Methods: The study was conducted through cross-sectional quantitative methods in purposively selected eight districts from October 2020 to December 2020. A structured questionnaire was distributed among a sample of pharmacists, and the collected data was analysed using statistical methods. The ethical clearance of the study was taken before data collection. Sixteen trained data collectors collected 627 data through face-to-face interviews with the Pharmacists using a pretested structured questionnaire. Descriptive analysis was performed, and quality control and risk management were performed strictly for maintaining the accuracy of the data.

Results: The study found that about 70% (n=438) pharmacies were found registered, and above 77% (n=483) pharmacies were owned by Pharmacists themselves. About 85.5% (n=536) had knowledge on counselling of patients in pharmacy but only 62% (n=389) had knowledge on SRH-related counselling. The highest duration of counselling of patients by Pharmacists was 1-5 minutes, 66.2% (n=355). Only 48.5% (n=304) had knowledge on complications and 69.7% (n=437) had knowledge on the side effect of SRH medicines. About 64.6% (n=405) of Pharmacists reported hearing the SRH-related issues from patients before selling medicine. About 80% (n=501) of Pharmacists reported having knowledge on menstrual hygiene, 49.4% (n=310) had knowledge of post-abortion care, and 56.8% (n=356) had knowledge of Postpartum family planning. About 76.6% (n=480) Pharmacists had knowledge of maternal complications, where 75.8% (n=475) mentioned haemorrhage and 71.1% (n=446) mentioned eclampsia as maternal complications. About 90.6% (n=568) of pharmacists mentioned that they required training on dispensing SRH-related medicine.

Conclusions: Though A grade (Graduate Pharmacist) and B grade (Diploma Pharmacist) Pharmacists had little knowledge of SRH medicine dispensing but C grade (Pharmacy Technician) had no proper knowledge and practices regarding SRH-related medicine dispensing. Most of the Pharmacists were in C grade, so their training on SRH-related medicine dispensing is very much essential. The findings contribute to evidence-based strategies for enhancing pharmacists’ involvement in promoting SRH and FP services in Bangladesh.

Keywords: Pharmacists; Sexual and Reproductive Health; Family Planning; Bangladesh

Background: Fistula in Ano is a chronic abnormal communication runs outward from anorectal lumen (int opening) to an external opening on the skin of perineum or buttock. History of ischiorectal, perianal abscess is the main hindering reason. Tuberculosis, IBD (Crohns or ulcerative proctocolitis), trauma can also lead to development of anal fistula. Sometimes termed as nonspecific, idiopathic or cryptoglandular and intersphincteric anal gland infection. chronic discharge, occasional pain and blood staining, foul smelling, cloths soiling and disturbance in religious purposes for muslims are the reasons to operate.

Objectives: To specify duration of healing in low variety fistula in Ano after surgery and staying time in Hospitals. Other concomitant issues in perioperative period.

Methodology: This cross sectional study was carried out in Bangabandhu sheikh Mujib Medical university from April to Sept 2012. Total 50 patients were selected as study population whom were admitted with low anal fistula and internal opening is below anorectal ring. Horse shoe, high variety fistula, associated disease (TB, IBD), malignancy were excluded from study population. Patient were grouped in A and B. A for Fistulectomy and B for fistulotomy. 25 patients in Group A, 25 patients in Group B. surgery was conducted by spinal anaesthesia and preoperatively 1 gm ceftriaxone and 1 bottle (500 gm) metronidazole given in each patient. Patients were discharged in 2^nd post operative day with some guidelines and education of treatment maneuver. First follow up after 7 days and 2^nd follw up after 4 wks.

Results: Total 50 patients admitted in BSMMU surgery Department and grouped in A (Fistulectomy) and B (Fistulotomy). Age range was 20-70 yrs and male are suffered more than female. low socioeconomic groups are presented more with history of anorectal abscess. Mean hospital stay was more in Fistulectomy with raised pain score than fistulotomy.

Conclusion: Anal fistula is a common cause of chronic pain and anal nuisance. Delineation of anal anatomy and identification of fistulas tract is important to prevent recurrence. Fistulotomy patient has less post operative pain with less hospital stay than fistulectomy in low variety anal fistula.

Keywords: Fistulectomy; Fistulotomy; Low variety fistula

References

Padmini Shukla and Shashi Alok. Pharmacognosy and Phytochemistry-I; Nirali Prakashan (2021): 1.1.
SB Gokhale and CK Kokate. Pharmacognosy and Phytochemistry-I; Nirali Prakashan (2019): 3.2-3.3.
G Jayapriya and F Gricilda Shoba. “GC-MS analysis of bio-active compounds in methanolic leaf extracts of Justicia adhatoda (Linn.)”. Journal of Pharmacognosy and Phytochemistry 4.1 (2015): 113-117.
Pharmacology and Morphology of Some Species of Adhatoda vasaka. International Journal of Pharmaceutical Research and Applications 6.4 (2021): 276-283.
Gauri Badgujar and Samiksha Bhagat. “Pharmacology and Morphology of Some Species of Adhatoda vasaka”. International Journal of Pharmaceutical Research and Applications 6.4 (2021): 276-283.
M Prathapa Reddy and TR Shantha. “Pharmacognostical and Physicochemical Evaluation on the Flowers of Justicia adhatoda L.”. Research Journal of Pharmacognosy and Phytochemistry 7.2 (2015): 73-90.
Dhankhar S. “Aegle marmelos (Linn.) Correa: A source of Phytomedicine”. J MediPlants Res 5.9 (2010): 1497-1507.
Santosh Kumar Singh., et al. “Pharmacognostic study and phytochemical screening of leaf of Adhatoda vasica (Acanthaceae)”. Journal of Medicinal Plants Studies 2.4 (2014): 29-31.
R Nithyatharani and US Kavitha. “Phytochemical Analysis of the Leaves of Adhatoda Vasica”. IJCRT 6.1 (2018): 451-454.
Thokchom P Singh and Okram M Singh. “Adhatoda vasica Nees: Phytochemical and Pharmacological Profile”. The Natural Products journal 1 (2011): 29.39.
R Parthasarathy and R Ilavarasan. “Pharmacognostical Studies on Thespesia populnea Bark”. Research Journal of Pharmacognosy and Phytochemistry 1.2 (2009): 128-131.
Khandelwal KR. “Practical Pharmacognosy (Techniques and Experiments)”. Nirali Prakashan (2008): 09-19.
Satish Kumar BN and Gobinda Mohan Behera. “Pharmacognosy, Phytochemistry and Pharmacology of Annona squamosa Linn”. Research Journal of Pharmacognosy and Phytochemistry 3.3 (2011): 93-102.
Tushar P Dukre, Ganesh N Wadekar and Harshad B Pawar. “Pharmacognostic and Phytochemical Evaluation of Herbal Plant: Alangium lamarkii”. Research Journal of Pharmacognosy and Phytochemistry 14.2 (2022): 65-68.
Kokate CK. “Practical Pharmacognosy”. 3rd edition, Vallabh Prakashan (1994): 107.
Gupta Abhishek and Joshi Apurva. “Pharmacognostic Study of Justicia adhatoda Linn. Leaf”. International Journal of Herbal Medicine 1.6 (2014): 01-04.
Khandelwal KR. “Practical Pharmacognostic Techniques and Experiments”. Nirali Prakashan (2010): 12.30-13.32.
Kokate CK, Purohit AP and Ghokale SB. “Pharmacognosy”. 39th edition, Nirali Prakashan 13 (2007): 536-537.

References

Shivshankar Kanhuji Chopkar. “Supreme God Power Always Exist in The Universe, Active as Soul In Human Being Body”. International Journal of Humanities and Social Sciences (IJHSS) 10.1 (2021): 99-104.
Law of conservation. The law of conservation of energy states that energy can neither be created nor destroyed - only converted from one form of energy to another. This means that a system always has the same amount of energy, unless its added from the outside (2020).
PR Motak and NR Baig. Fist Edition, Elements of thermal and statistical Physics, Sai Jyoti Publication, PAGE NO.30 TO 31 (2019).
Halliday Probeetresnick and Jean Walker, Extended Fifth edition, Fundamental of Physics (1997).
Christianity Bible. Search on Google: It can be found that “God is responsible for the creation of the Earth, world, and universe in human religion and mythology” which finds reference in the Holy Bible which is a revelation of God” (2019).
Sikh Religion. The word 'Sikh' in the Punjabi language means 'disciple', Sikhs are the disciples of God who follow the writings and teachings of the Ten Sikh Gurus. Aug 9, 2018 - He believed that a single divine force created the entire world and resided within it. In his belief, God was not separate from the world (2018).
Shri Lord Krishna. “Shrimad Bhagawat Gita'' in Dwapar Yug, Translated by Shri Pandrinath Thaware (2017): God power what’s in body as Soul that’s in Universe as Supreme God Power!” (Pindit Tech Brahmandi), Supreme power of God’s is the creator of everything in the Universe (1678).
Sikh Religion. The word 'Sikh' in the Punjabi language means 'disciple', Sikhs are the disciples of God who follow the writings and teachings of the Ten Sikh Gurus. Aug 9, 2018 - He believed that a single divine force created the entire world and resided within it. In his belief, God was not separate from the world (2018).
Judaism Religions. Judaism Religions is the world's oldest monotheistic religion, dating back nearly 4,000 years. Followers of Judaism believe in one God who revealed himself through ancient prophets (2018).
Zoroastrian. He believed that a single divine force created the entire world and resided within it. In his belief, God was not separate from the world and ... Judaism is the parent of both Christianity and Islam. It proclaims that there is only one God, whose name is Yahweh, and He is the creator and ruler of the universe (2018).

The evidence in clinical practice shows that extended and intense mental activities and sleep deprivation can be in front of heart disease for people in four or five decades. More intellectual and emotional engagement in daily work for a prolonged period leads to sleep schedule disruption. The body’s nervous system cannot adequately recover from sleep deprivation, resulting in accumulating fatigue. Unbalanced fatigue determines the nervous cells’ inefficiency in controlling bodily function, and chaotic heart activity can follow sooner or later in connection with adrenergic pathway activation. Therefore an unhealthy lifestyle can negatively impact mental and heart function, so informative programs are needed.

In the digital age, technological advancement facilitates fast disorders management.

An acute episode of heart disease imposes laboratory testing and specific investigations. Typically, the family physician’s clinic may not have all the necessary tools for a precise medical diagnosis, as specialized departments can do it in a public or private hospital. Their referrals to specific medical units ensure the best management of illnesses, and cardiology is at the top of necessity. A cardiologist is best equipped and finalizes an accurate diagnosis and treatment, while a family doctor can provide more information about the origin of heart disorders.

The family physician accumulates more info about the patient’s lifestyle since their longitudinal data are accounted for. Business continuity ensures endless patient observation, motivation, and the effectiveness of corrective measures applied when necessary. The cooperation of a family doctor with colleagues from other medical specialties is imperative for the sake of public health. Instant communications of interest for the patient and the medical team, discoveries of new drugs, and various alternative therapies can all make the patient’s recovery more straightforward and accessible in this digital world.

The person-centred approach offers another dimension for understanding and applying the knowledge in practice; a deep look at the origins of the clinical manifestation of the illnesses and utilizing advanced technologies to address them enables a short revitalization. In a clinical case analysis, possible cumulative internal and external risk factors must be considered: their magnitude, interdependence, time action, and individual vulnerability - to predict their adverse effects on people’s equilibrium.

Research data from the Hospital and the Primary Care Clinic supplies the gaps in the disease approach. Their collaborative work, rapid communication, and the use of a new AI algorithm in handling data lead to healthcare betterment, increase patient enjoyment, life quality, and expectancy, and offer a prosperous personal, professional, and social life in a world where time is our precious gift.

Headache is a universal experience. It is one of the most common complaints in the field of medicine & neurology. The article deals with the issue of ‘headache’ in the field of medical science. It does not consider ‘Migraine’. It hampers the quality of life in all age sections as headaches have multiple reasons. Headaches are a part of everyone’s lives. Most headaches are usually harmless but in some cases they\can be harmful too. The article covers both harmful and harmless headaches that hamper the quality of life. Medical science has not been successful to elicit the cause of each headache and thereafter treatment plans are multiple in nature, confusing and a definite plan has not been deduced.

Ancient references to headache, migraine & neuralgia can be found in the Ebers Papyrus (1200 BC). Evidence of trepanation of 9000 year old Neolithic skulls suggests the first headache treatment. Visual symptoms associated with the headache were described by Hippocrates who lived during 460-370 BC. The father of medicine from Greece on whose name the Hippocratic Oath is taken by the budding doctors across the globe was the first to scientifically elucidate headaches clinically through his observations. That is why Hippocrates is known as the first analytical epidemiologist. Aretaeus provided one of the earliest classifications of headache around 200 AD.

The reader will get an idea of the problem of headache at the global & national level through the eyes of clinical health in the beginning sections before delving in to the Homoeopathic system of the AYUSH platform. Currently, the AYUSH platform has regained its value in the era of the current pandemic. The pandemic has further escalated the issue of headache, further precipitated by the increased stress levels. In the absence of effective therapy in the modern medicine, the article delves into what homoeopathy can offer to deal with headache issues that fulfil the triad criteria of essential medicines as per the National List of Essential Medicines (NLEM). The criteria is that these medicines need to be effective clinically, clinically safe and should be without side effects. Thus Homoeopathy is the leading therapeutic system that can deal with headaches and can cover masses while being cost effective [1-3, 17-19].

Brief of the article

The current article looks into the aspects of headache during the life period out of which managing headaches is one of the main challenges.

The article looks into the brief history of public health programs on headache issues in India & the emergence of headache as an issue. As headaches are a cross cutting problem among many health conditions, there is no specific public health program on headaches. However, there are programs like National Programme for Prevention & Control of Cancer, Diabetes, Cardio Vascular Diseases & Stroke (NPCDCS) & National Mental Health Program (NMHP) that cover both the primary & secondary headaches. These health issues that cover both mental and physical aspects are triggering factors for headaches.

The article now moves on to the current situation of headaches in India & the role of Homoeopathy to deal with these headache disorders therapeutically as a component of Ministry of AYUSH. The article suggests the integration of medical pluralism in headache therapy through inclusion of Homoeopathy in the gamete of physical and mental health conditions that are related to headaches.

As each & every drug in Homoeopathy is only proved on human beings, all the drugs have a mental component as it is only human beings who can express their physical & mental symptoms during proving of the drugs as per the guidelines set by the Homoeopathic Research Councils (HRC) of each nation. In India, Central Council for Research in Homoeopathy, an autonomous body under the ministry of AYUSH lays out such guidelines.

The article gains more relevance during the current COVID 19 pandemic which has precipitated the stress levels of population since March 2020 and most of the adults are more prone to headache disorders during their life stage besides finding it difficult to manage these headaches [14, 15, 18, 19].

Keywords: Headache; Homoeopathic Materia Medica; Constitutional medicine; Nosode; Bach Flower Remedy; Bowel Nosode; Miasms

References

Arafat MO, Ahmed ZA and Arafat OS. “Comparison between generic drugs and brand name drugs from bioequivalence and thermoequivalence prospective”. Int. J. Pharm. Pharm. Sci 9 (2017): 1-4.
Jan Aushadhi: An Initiative of Government of India | Generic Medicine Campaign Improving Access to Medicines. Janaushadhi.gov.in.
Alfonso-Cristancho R., et al. “Definition and classification of generic drugs across the world”. Applied health economics and health policy 13.1 (2015): 5-11.
Al-Gedadi NA and Hassali MA. “Pharmacists' views on generic medicines: a review of the literature”. Journal of Generic Medicines 5.3 (2008): 209-218.
Approval of Generic Drugs.
Barbour RS. “Checklists for improving rigour in qualitative research: a case of the tail wagging the dog?”. Bmj 322.7294 (2001): 1115-1117.
Baumgärtel C. “Myths, questions, facts about generic drugs in the EU”. Generics and Biosimilars Initiative Journal (GaBI) 1.1 (2012): 34-8.
Canadian Drug Manufacturers Association. Pharmaceutical patent. The review of Bill C-19. Submitted by the Canadian Drug Manufacturers Association to the Standing Committee on Industry. Toronto: CDMA (1997).
Chadha A. “Daiichi Sankyo's generic (mis) adventure: the Ranbaxy takeover”. Emerald Emerging Markets Case Studies 2.8 (2012): 1-10.
Code of Federal Regulation, 21, Food and Drugs, Part 314.94, Content and format of an abbreviated application (1995): 134.
Davit BM., et al. “Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration”. Annals of Pharmacotherapy 43.10 (2009): 1583-s1597.
Dhamija P, Sharma PK and Kalra S. “Only generics (drugs/names): Is India ready?”. Indian journal of endocrinology and metabolism 19.5 (2015): 541.
Dighe SV. “A review of the safety of generic drugs”. In Transplantation Proceedings 31.3 (1999): 23S-24S.
Dipiro JT. Pharmacoeconomics: Principles, methods and applications, Pharmacotherapy: A pathophysiologic approach, 8th edition.
Dunne S., et al. “A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study”. BMC Pharmacology and Toxicology 14.1 (2013): 1.
European Generic Medicines Association. Percent of generic medicines: EU member states (1999).
European Medicines Agency. CPMP/EWP/QWP/ 1401/98 Rev.1. Guideline on the investigation on bioequivalence.
Gaither CA., et al. “Consumers' views on generic medications”. Journal of the American Pharmaceutical Association 41.5 (2001): 729-736.
Gallelli L., et al. “Safety and efficacy of generic drugs with respect to brand formulation”. Journal of pharmacology & pharmacotherapeutics 4.1 (2013): S110.
Garattini L and Tediosi F. “A comparative analysis of generics markets in five European countries”. Health policy 51.3 (2000): 149-162.
Generic Drugs.
Generic Drugs: Overview of ANDA Review Process.
Grabowski HG and Kyle M. “Generic competition and market exclusivity periods in pharmaceuticals”. Managerial and Decision Economics 28.4‐5 (2007): 491-502.
Hakonsen H., et al. “Generic substitution: additional challenge for adherence in hypertensive patients?”. Current medical research and opinion 25.10 (2009): 2515-2521.
Hassali MA., et al. “Physicians' views on generic medicines: a narrative review”. Journal of Generic Medicines 7.1 (2010): 30-9.
Himsmel W., et al. “What do primary care patients think about generic drugs?”. International Journal of Clinical Pharmacology & Therapeutics 43.10 (2005).
http:// www.brandindiapharma.in

Objective: To determine and analyze the frequency of fetal growth restriction (FGR-syndrome) in pregnant women with hypertensive disorders as a variant of perinatal complication.

Methods: A retrospective analysis of the delivery histories of 2735 women with singleton pregnancies at the regional perinatal center in 2020 was conducted, including 2680 live births (97.9%) and 55 stillbirths (2.21%). Hypertensive disorders during pregnancy were present in 272 women (9.95%). FGR-syndrome in women with hypertensive disorders was detected in 130 cases (47.8%), while in normotensive courses of pregnancies it was 28.2% (680 children from the total number).

Results: A detailed analysis of pregnancy course in 42 women with hypertensive disorders and FGR revealed that gestational hypertension was present in 6 (14.3%), chronic arterial hypertension in 6 (14.3%), and preeclampsia in 30 (71.4%). A high percentage of preterm deliveries occurred in women with hypertensive disorders - 22 (52.38%). The degree of prematurity of newborns according to gestational age was: I - 18 (81.82%), II - 2 (9.09%), III – 0, IV - 2 (9.09%). The number of low birth weight infants for gestational age was 28 (66.67%), and varitable FGR-syndrome of grade 1 (below the 10th percentile) was present in 6 (14.29%) infants, and grade 2 in 8 (19.05%) infants.

Discussion: According to the obtained data on the mass-growth parameters of newborns and analysis using the T. Fenton table (2013), it was established that true FGR-syndrome in women with hypertensive disorders was detected in 33.33% of cases, while in 66.67% there were low-weight babies for their gestational age.

Conclusions: Based on a retrospective study of the course of pregnancy and childbirth, it has been established that women with hypertensive disorders are a high-risk group for adverse perinatal outcomes and the birth of children with congenital anomalies. It is advisable to further analyze and organize possible methods of comprehensive diagnosis of changes in peripheral vascular resistance in the cardiovascular system of the mother and fetus in hypertensive disorders in order to prevent the aforementioned complications.

References

Alvarez V., et al. Epilepsy (2004).
Akani AF., et al. “Perception of epileptic disease by patients followed in neurology, at the Bouaké hospital, Ivory Coast”. African & Middle East Epilepsy Journal 8.4 (2016).
Apetse K., et al. “Perception of childhood and adult epilepsy by the population and caring personnel in Togo”. Epilepsies 22.2 (2010): 160-166.
Balogou A., et al. “Anxiety, depression and quality of life of epileptics in an urban environment in a developing country: Togo”. Epilepsies 22.1 (2010): 79-83.
Bandstra NF, Camfield CS and Camfield PR. “Stigma of epilepsy”. Canadian Journal of Neurological Sciences 35.4 (2008): 436-440.
Caelius A. “Acute illnesses, chronic illnesses”. English edition and translation IE Drabkin: University of Chicago Press (1950).
Diallo M, Diarra EA and Diallo L. “Problems of epilepsy management in a hospital center in Conakry”. African & Middle East Epilepsy Journal 4.3 (2015).
El Ghardallou M., et al. “Coping strategies and anxious and depressive symptoms among women with breast cancer, Sousse, Tunisia”. Journal of Epidemiology and Public Health 64 (2016): S221.
Féki I., et al. “Depression and coping strategies in elderly subjects with type 2 diabetes”. L'Encephale 45.4 (2019): 320-326.
1. HAS. “Epilepsy pathway: for work on the pathway, relevance messages and quality indicators”. Framework note Epilepsies Course (2022): 19.
Houeto SE. “Therapeutic itinerary for epileptics in the district of Djidja (Zou Department) in Benin”. Theses Online (2005).
Hosseini N., et al. “Striving for balance: Coping with epilepsy in Iranian patients”. Epilepsy & Behavior 18.4 (2010c): 466-471.
Knibb RC and Horton SL. “Can illness perceptions and coping predict psychological distress in allergy sufferers?”. British Journal of Health Psychology 13.1 (2008): 103-119.
Kouassi E., et al. “Social representations of epilepsy and therapeutic itineraries of parents of children in Abidjan”. Public Health 30 (2018): 703-712.
Lainé A., et al. “Specificity of coping strategies of patients in remission of Crohn 's disease: a qualitative study”. Psychological Practices 28.1 (2022): 17-27.
Lazarus RS and Folkman S. “Stress, appraisal, and coping”. New York, NY, US: Springer Publishing Company (1984).
Leventhal H, Meyer D and Nerenz DR. “The common sense representation of illness danger”. In S. Rachman (Ed.), Medical Psychology, New York: Pergamon 2 (1980): 7-30.
World Health Organization (WHO). Main points of reference on epilepsy (2022).
Pierre T. Stress, coping strategies and social representations of illness among HIV-positive people in Brazil (2001).
Pilard M, Brosset C and Junod A. “Social and cultural representations of epilepsy”. Med. Afr. Black 39 (1992): 652-657.
Polard A. “Reception of the crisis and the epilepsy story”. Contrast 38 (2013): 155-176.
Sow I. “Dynamic African Psychiatry”. Paris: Edition Payot (1977).
Unalan D., et al. “Perceived social support systems` and depression’s effects on attitudes regarding coping strategies for the disease in patients with epilepsy”. Neurosciences (Riyadh, Saudi Arabia) 20.1 (2015): 17-26.
Vergonjeanne M. “Epidemiology of epilepsy in low- and middle-income countries: building a reference tool for valid and shared methods”. TEL - Theses online (2021).

A study was carried out to find out the existing knowledge of students and to develop, implement and evaluate for nursing students about knowledge about safety measure and prevention of covid-19 among nursing students. In the present study non-experimental design was used. The study was conducted at V3 College of nursing at Rudrapur. 100 Nursing students were selected as sample by non-probability convenient sampling technique. Data were collected in 2 parts; part A includes the questions regarding their demographic characteristics and part B the knowledge questionnaire regarding safety measures and prevention of covid-19.1 Section A: description of sample in term of demographic variables. Section B: - it includes 34 questionnaires which are divided into 3 parts Introduction, Safety measures and Prevention.

The study shows that out of 100 samples most of the nursing students (63%) was having moderate knowledge, (36%) students were having inadequate knowledge and (1%) has adequate knowledge. It was revealed that majority of the students (54%) were belonged to the age group of 18-20 Years followed by (42%) age group of 21-23 years and (4%) students were from age group above 24 years. Maximum numbers of students (85%) were females and (15%) students were male. Maximum numbers of students (54%) were belonged to non- medical family background and (46%) students were belonged to medical family background. Majority that is (95%) had previous information about safety measures and prevention of covid-19 while only (5%) do not have previous information about safety measures and prevention of covid-19. Source of information like majority of information was found from television that is (37%), social media that is (35%), other source of information that is (20%) and newspaper that is (8%).

In demographic variables we found that the mean value of Age is 20.5 with SD=1.72, in Gender mean value of male was found 0.15 with SD=1.48 and mean value of female was found 0.85 with SD=8.41, in educational status for B.Sc. nursing mean value is 0.64 with SD=6.33 and mean value for GNM was found 0.36 with SD=3.56, In family income the mean value was 33.33 with SD=18.19, in medical family background the mean value was found 0.46 with SD=4.55 and in non-medical family background the mean value was found 0.54 with SD=5.34, in previous knowledge about covid-19 if yes the mean value was found 0.95 with SD=9.40 and if No the mean value was found 0.05 with SD=0.48 and source of information the mean value was found for newspaper 0.08 with SD=0.78, for television the mean value was found 0.37 with SD=3.66, for social media the mean value was found 0.35 with SD=3.46 and any other the mean value was found 0.2 with SD=1.97.

The chi square analysis was carried out to determine the association between knowledge level and demographic variables. It was evident from result that nursing students were influenced by their Gender, Family income, Family background, previous information about safety measures and prevention of covid-19, and source of information. Here the H1 was accepted for association of knowledge level with variables Gender, Family income, Family background, previous information about safety measures previous and prevention of covid-19 and source of information. By using inferential statistics knowledge level of students were associated with their selected demographical characteristics. In gender the chi square value was found(p=0.271) which is less than the table value at(p=5.99), in family income the chi square value was found(p=4.93) which is less than the table value at(p=9.49), in family background the chi square value was found (p=2.989) which is less than the table value (p=5.99) and previous knowledge about the safety measures and prevention of covid-19 the chi square value was found (p= 0.101) which is less than the table value at ( p=5.99), If yes, source of information the chi value was found (p=7.685) which is less than the table value (p=12.59) at the 0.05 level of significant which clearly indicated that there is association between the these above demographical variables and knowledge of students.

However, demographical variables such as age, and educational status were found to be non-significant. According to age chi square value was found (p=30.59) which is more than the table value (p=9.49), which is clearly indicate that there is no association between the age and knowledge of student. In education status the chi square value was found (p=9.5835) which is more than the table value (p=5.99) which is clearly indicated that there is no association between these demographic variables and knowledge of students.

On the basis of present study, the researcher concluded that most of the nursing students had moderate knowledge about safety measures andprevention of covid-19. Researcher assessed the knowledge about safety measures and prevention of covid-19 to prevent suffering from covid-19. Researcher also open-up new pathway for future studies on the topic for more generalization. This concluded that the how many students are aware about safety measures and prevention of covid-19.

Keywords: covid-19; safety measures; prevention; knowledge; students

Targeted group of people who are the candidate for transplantation and the donor selection criteria is a big chapter. In our common practices organ donation is still cumbersome in way of donor selection, non biasness, matching with patient and some medicolegal issues. Brain death donor or deceased donor would be the ideal organ donor though large, prompt, and dedicated group of medical people and logistics is the prime criteria and is demanding.

A successful Liver transplantation is combined success of two surgery, both donor and receipient and the donor is prime one. Completion of two successful surgery at a time is lead by chief transplant surgeon, co-surgeon, Anaesthetist, Medical team including paramedics, technicians, nurses, and postoperatively by dedicated critical care unit in comprehensive manner which is lead by ICU consultant.

Success is - return to home and maintain quality of life in both donor and receipient. Peroperative good surgical recovery is a finest work of a transplant surgeon and is directly a gift from Allah (swt). Liver surgery in Donor is segmental resection, lobectomy, partial hepatectomy. In receipient it’s a wide work in liver parenchyma, Major vascular structures and in biliary tree. This finest anastomosis is the key to successful outcome.

Immediate postoperative recovery is very vital. In donor –fluid management, nutrition and pain management with coverage of broad spectrum antibiotics and closely observe the immediate response of residue liver by biochemical analyzer. In receipient- start from whether receiving the organ in new host and then proper functioning of vascular and biliary anastomosis. Total calorie value estimation, fluid and pain management with control of sepsis is a finest co ordination. Every hours maintenance of intake output, meet up exact calorie demand, fluid management by measuring CVP (central venous pressure), orotracheal clearance and lungs care is the prime concern for good functioning of newer receipient tissues.

Execution of first 24 -72 hrs services –A group of ICU doctor, nurses, patient care attendant, ward boy, cleaners participation is mandatory. A good handover of Doctor – Doctor, Nurse – nurse is a safe transfer of patient to a safer one. In our common practices many mishaps are conducted by negligence, ignorance of medical team which was avoidable if prompt/alert action was taken immediately even in mid night. Should be kept in mind this initial hours of monitoring has no day night. This is in count of hours – for a good recovery.

A transplant surgeon should have the vast knowledge not only in surgery but also in critical care / Acute care services. Good co ordination is mandatory with critical care team and transplant team. In near future we wont loose any diseased with lack of organ and comprehensive services.

Spoken words extend human energy, interrelating with other energies and surroundings. This combination modifies their energetic picture in motion, which can maintain, improve, or decline their functionality. Evidence in clinical practice has shown that positive energy resulting from these interactions improves cell functionality; suitable and helpful word energy use in disorders management benefits everyone involved in patient care, including providers, clients, their dear ones, and families. Therefore, the medical team must model and use positive speech energy to improve patients’ emotional well-being, ultimately leading to increased satisfaction, better experience, business or corporate efficiency, enhanced reputation, and long-term client relationships. An increase in return on investment validates their work effectiveness, improving personal, professional, and social life satisfaction.

By contrast, aggressive words energy use in collaboration with others declines cell functionality in fragile areas, leading to disorders such as dyslipidaemia, type 2 diabetes, other endocrine diseases, arterial hypertension, and even brain haemorrhage or tumour. These disorders can be attributed to genetics and the frequency and magnitude of exposure to inappropriate communication. Words and tone misuse generate discomfort and decline the production process, altering mainly the emotional lives of collaborators. Deceptive people interactions harm the individual equilibrium.

Personal attitudes, words, and voice nuances validate individual thinking and abilities to use knowledge in collaboration with others. Expertise in the domain prepared for, fast and efficient data handling, building trustful, respectful relationships with partners, professional behaviour in society, and appropriate voice utilization in daily work are all essential to ensuring a prosperous personal, professional, social, and emotional life. These drivers contribute to the success of any endeavour.

Professionally speaking, sharing the presence, applying info in practice, and dealing with adversities make an individual esteemed and appreciated in the community they serve.

Unprofessional conduct in daily work causes detriment to all parties involved in affairs.

The healthcare industry professionals can utilize voice analytics for managing various disorders. They can focus on respiratory and heart functioning, nervous system control, distribution and composition of human body fluids, velocity, digestive, endocrine abnormalities, or environmental characteristics. Voice can be used as a clinical sign offering adequate details for analysis and decision-making in clinical practice.

Subjective or AI for voice analysis are options for disease management in the digital age, according to preferences and financial capacity, to adhere to new monitoring algorithms.

The speech analytics market has several major vendors, including Almawave, Avaya, CallMiner, Chorus.ai, Cogito, Dialpad, Genesys, Invoca, NICE, OpenText, Plum Voice, Prodigal, Qualtrics, Salesken, Talkdesk, Tether, and Verint. Speech analytics solutions are mainly utilized by industry verticals such as retail, telecom, banking, healthcare, travel, and hospitality. NICE, CallMiner, and Verint are the speech analytics industry’s top performers and market leaders.

Promising projects using AI for voice analysis conduct to healthcare advancement. AI provides a fast diagnosis, but even without technological progression, we can make a clinical diagnosis by just using an individual's face and hand info and listening to a few words.

In today's digital age, voice analytics has become an essential tool for businesses; analysing voice data allows them to gain valuable insights into clients' behavior and preferences. This info helps businesses to improve their clients' offerings, individualize marketing works, and ultimately increase revenue. With technological advancements, voice analytics has become more precise and effective; it is an increasingly current choice for businesses of all sizes.

It is a fact, although unknown to many, that the first hospital use of drug that would be named as antibiotic, was the so called pyocyanate prepared by Rudolf Emmerich and Oscar Low, two German physicians, in 1899 from Paeudomonas aeruginosa. However, the accidental discovery of penicillin by Alexander Fleming in 1928 was an event that re-defined treatment of infectious diseases, but was short-lived as it was soon discovered that microbial pathogens amplified their armamaterium to dwarf this very high hope.

Drug companies were very interested in Alexander Flemming’s discovery and started making penicillin for commercial purposes, which was widely used for treating soldiers with battle wounds and pneumonia during World War II. From mid- to late 1940s, it became widely accessible for the general public use. However, in the 1930s, the first commercially available antibacterial agent called Prontosil, a sulfonamide was developed by a German biochemist called Gerhard Domagk. In 1945, penicillin was introduced on a large scale in the treatment of bacterial infections, especially through the work of Howard Florey and Ernst Chain, who efficiently purified penicillin and scaled-up production.

The introduction of penicillin marked the beginning of the’ golden era of antibiotics’ classes for use in medicine, when antibiotics were discovered and introduced to the market between 1940 -1962. Each class contained several antibiotics which were discovered and modified versions of earlier types. Today, very few novel antibiotics are being developed while antimicrobial resistant bacteria that survive antimicrobial treatment are on the increase. These bacteria render most antibiotics ineffective or useless, which has further complicated this global health burden.

The time-line of the discovery of different classes of antibiotics in clinical use, otherwise known as “the discovery void’ refers to the period from 1987 until today, as the last antibiotic class was introduced for treatment of infectious diseases in 1987.

Bacteria use several mechanisms of drug resistance, some of the major ones of which include: 1) Drug inactivation using bacterial enzymes, 2) structural modification of drug’s target site by mutation, 3) reduction of drug intake through lowering of bacterial cell permeability, 4) drug efflux outside the bacterial cell membrane etc.

The AMR crisis due to increasing global incidence of infectious diseases is affecting the human population. This thus threatens human and animal health, and welfare for food and nutrition security, the environment, economic development as well as equity within societies.

Some causes of antibiotic resistance include: 1) over or under-prescription , 2) patients’ inability to complete antibiotic course, 3) overuse of antibiotics in livestock and fish farming, 4) poor sanitation and hygiene, 5) poor access to quality drugs, 6) poor infection and disease prevention and control in healthcare facilities, 7) lack of access to clean water, sanitation, and hygiene (WASH) for both human and animals, 8) self medication and 9) non-application of one health as a preventive strategy.

World Health Organization categorised antibiotic resistant bacteria into 3 groups, as mainly critical, high and medium priority; critical group include Pseudomonas aeruginosa, Acinetobacter baumannii and members of the family Enterobacteriaceae, aetiological agents of pneumonia and blood stream infections, the high and medium priority group include drug resistant bacteria like Salmonella that causes common infections like gastroenteritis, diarrhoea, food poisoning and Neisseria gonorrhoeae, a sexually transmitted pathogen.

The prevalence of drug resistance limits therapeutic options for the treatment of infectious diseases, thus contribute to the specter of “post-antibiotic era" in which most antibiotics are already ineffective.

The consequences of multiple drug resistance is the emergence of the superbugs, which are strains of bacteria, parasites, fungi, and viruses, that are resistant to most of the antibiotics and other medications used in the treatment of their infections. Superbug refers to bacteria which infections cannot be treated with two or more antibiotics. Examples of superbugs include drug resistant bacteria that cause pneumonia, complicated urinary tract infections (cUTI), skin infections etc. Infections by superbugs can however be successfully treated, although, they are much more challenging to treat and manage. A few examples are methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterbacteriaceae (CRE), vancomycin-resistant Enterococcus (VRE), multi-drug resistant Pseudomonas aeruginosa (MRPA) and multi-drug resistant Eshcerichia coli (MREC).

The loss of efficacy by antibiotics surely undermines man’s ability to fight and win the battle against infectious diseases and manage complications among vulnerable patients especially those undergoing chemotherapy, invasive treatment procedures, surgery and organ transplantation.

Various options are applied in the treatment of antimicrobial resistant bacterial infections such as combinatorial drug approaches, antimicrobial polymeric bio-material products, bio- nanotechnology approach, among others.

Therapy against superbugs particularly employ two major methods: 1) pathogen-directed therapeutics approach which decreases bacterial toxicity by alteriing their virulence factors and 2) the host-directed therapeutics approach which limits the superbug by modulating immune cells, enhance host cells’ functions and effectively modify disease pathology. Where the first line and second line antibiotic treatment options are limited by resistance or are unavailable, healthcare providers are compelled to use toxic antibiotics in the treatment of patients, which often result in high treatment cost, definitely less effective treatment characterised by high mortality, longer hospital stay, delayed recuperation and long term disability.

Conerted efforts are required to fight the spread of AMR, some of which are : 1) prevent infections from occurring and preventing resistant bacteria from spreading, 2) minimise the use of broad spectrum antibiotics and promoting the use of narrow spectrum antibiotics, 3) tracking drug resistant bacteria, 4) promoting development of new antibiotics, 5) building on the foundation of proven public health strategies, 6) immunization, 7) infection prevention and control, 8) protecting food supply, antibiotic stewardship and 9) minimizing person-to-person transmission or spread of infections, by screening, diligent treatment and education.

Preventive measures must be taken to minimise the menace of AMR, through rational use of antimicrobial drugs whenever necessary. Healthcare professionals should endeavour to promote drug safety awareness. The proper use of disinfectant must be practiced by both patients and health-workers, so as prevent nosocomial spread of multiple drug resistant bacteria.

In the global attempt at mitigating AMR, nearly 43 new antibiotics are in clinical development by the top 50 pharmaceutical companies with significant antibacterial properties against life-threatening infections, 18 of which have shown potential action against drug resistant Gram negatives and 10 others against Neisseria gonorrhoeae.

While attempts must be made to search for the best treatment strategies against super bugs, as resistance can easily be developed against new and novel antibiotics in the nearest future, rational antibiotic use and proper hygiene practices among patients and health-workers should be compulsory.

Communication skills with the people in need, as required, make their work different from that in other industries. The evidence in clinical practice shows the benefit of kind-hearted work for all parties: patients, their families, and the medical team. Medical professionals who resonate with people’s suffering are preferred to those who bring down the emotional involvement in care. Kind words, friendly attitudes, respect, generosity, encouragement, and consideration for helpless seniors aid in restoring and improving health, offering a warm, calming, and peaceful light that alleviates distress.

By contrast, disheartened doings disappoint the patient and decrease their loyalty towards their healthcare provider and adherence to the therapy plan. The negative experience during an episode of care may cause the patient and their loved ones to look for another provider from the offerings for future episodes of care. As a result, the provider may experience a decrease in their investment return, affecting their business continuity and growth, professional name, and advancement.

Therefore, how an individual applies the knowledge in practice, interacts with customers, collaborators, and other community members, and shares their presence impacts their reputation and quality of life.

The patient experience reflects the medical professional’s skills in handling their data and communicating with them in various contexts. A provider who carefully examines the medical and social history of the patient and makes alliances with them and their loved ones in managing disorders is likely to have better results in practice. By considering an individual's medical and social history, the provider can correlate past and existing data and make accurate decisions.

Respecting patient preferences in therapy plans is essential; reflecting on their financial situation and time availability, the most beneficial therapy options for them will be selected.

Patient involvement in the therapy plan supposes the art of communication with them, understanding their feelings determined by affected human body functioning, and reducing fears of possible remaining work impairment. Encouragement, lowering pain, and emotional support for them and their dear ones create a model of care for sustaining and advancing life quality, which benefits providers and end-users. As a result, their positive comments can increase the number of new customers, ensuring the healthcare business’ prosperity and continuity.

That’s why kind-hearted work ensures a better life; it should be acknowledged as essential in business development and advancing one's career.

Contrarily, deceptive people’s interactions affect their health and wealth.

The impact of different communication styles on patient’s experience, business continuity, and personal life should be comprehended.

How individuals interact with different parts of society defines their professional and social lives.

Background and Purpose: Usually resistance training can only be done in the active state. The difficulty of upper limb rehabilitation of stroke patients lies in the inability to complete resistance training on the antagonistic muscle groups with high muscle tension. The vast majority of stroke patients experience upper limb or arm extensor muscle weakness, and many lose the strength of their antagonistic muscle groups, preventing them from performing progressive resistance training, resulting in a large number of stroke patients with long-term upper limb disability. We took the lead in proposing induced passive resistance training to form passive resistance thinking and mode that activated antagonistic muscle groups in the upper limb of stroke, and selected stroke patients who were more than one year old and still had obvious flexion spasm in the upper limb as demonstration objects to observe the intervention effect of this method on abnormal muscle strength.

Methods: Functional acupuncture and passive resistance of upper extremity extensor group induced by Professor Yan Zhi were the main intervention methods. Implementation requirements are as follows: a) Selection of therapeutic positions. b) Selection of intervention site. c) Selection of strength and waveform. d) Real-time evaluation of intervention effects after intervention. e) Multi-task intervention training of upper limb extensor muscle group after treatment.

Results: After 20 minutes of intervention, flexor tension of upper limb, elbow joint, wrist joint and finger joint was improved obviously, extensor function of elbow and wrist joint was recovered obviously, elbow extension resistance function of left upper limb was recovered obviously. After one month of the above intervention treatment, the abnormal muscle tone of the left upper limb of the patient was significantly reduced, the elbow extensor strength score was increased from 0 to 5, and the flexion spasm of the upper limb was significantly improved in multiple scenarios.

Conclusion: The demonstration of this method highlights the significance of three aspects: A) Patients with upper limb flexion spasm more than 1 year after stroke with this method showed obvious intervention effect immediately. b) To confirm that functional acupuncture and medium-frequency induced passive resistance training are the most effective methods for the intervention of abnormal muscle tone in the upper extremity. c) The control of intervention dose and the repetition of precise rehabilitation training have a positive effect on the improvement and continuation of the therapeutic effect.

Keywords: Passive resistance training; Abnormal muscle tone; Stroke

Vaginal Microbiome and RPL

The vaginal microbiome plays a crucial role in women's reproductive health, particularly during pregnancy and the postpartum period. Research has shown that substantial changes occur in the composition of the vaginal microbiome following the end of pregnancy Nunn et al. (2021). These changes are associated with hormonal fluctuations, menstrual flow, cervical and vaginal secretions, and sexual activity (Walther-Antonio et al., 2014). Disruption of the vaginal microbiome has been linked to various pregnancy complications, including recurrent miscarriages, preterm birth, intrauterine infection, and stillbirth. Moreover, the maintenance of vaginal microbiota has been highlighted as an important factor in achieving ideal pregnancy outcomes (Celik et al., 2022). Furthermore, the vaginal microbiome has been studied in the context of premature ovarian insufficiency, recurrent implantation failure, and unexplained infertility, highlighting its potential role in RPL (Rezende et al., 2023; Patel et al., 2022; Lk et al., 2019). The vaginal microbiome undergoes significant changes during pregnancy, characterized by reduced diversity and increased stability, with a dominance of Lactobacillus species (MacIntyre et al., 2015; Serrano et al., 2019; Freitas et al., 2017; Walther-Antonio et al., 2014; Morselli et al., 2022; Nunn et al., 2021). Studies have identified specific microbial species that are commonly found in the vaginal microbiome, including Lactobacillus crispatus, Lactobacillus iners, Lactobacillus gasseri, and Lactobacillus jensenii, which are known to dominate the vaginal microbiome in healthy individuals (Doyle et al., 2018; Chang et al., 2020). The presence of other microbial species, such as Gardnerella vaginalis, Prevotella, and Megasphaera, has been associated with alterations in the vaginal microbiome and gynecological conditions (Putonti et al., 2021; Mu et al., 2019). Additionally, Grewal et al. (2022) reported low co-occurrence of L. crispatus, a species associated with vaginal bacterial stability, with other microbial species in RPL cases. Moreover, the association between gut dysbacteriosis and an imbalanced cytokine network in women with unexplained miscarriage has been identified, highlighting the potential role of gut microbiome dysbiosis in adverse pregnancy outcomes, including RPL (Liu et al., 2020). The microbiome in the female reproductive tract, including the endometrial and vaginal microbiota, has been associated with RPL, suggesting that microbiota composition may play a role in the etiology of RPL (Peuranpää, 2021; Peuranpää, 2022).

Need for studies in RPL and vaginal microbiome

Conducting studies on the relationship between the vaginal microbiome and recurrent pregnancy loss (RPL) is crucial for several reasons. Firstly, for investigating the vaginal microbiome in individuals experiencing recurrent pregnancy loss can help identify specific microbial factors or dysbiosis patterns associated with increased risk. This knowledge is essential for understanding the root causes of RPL. Secondly, these studies can lead to discovery of novel microbial biomarkers associated with recurrent pregnancy loss. Establishing such biomarkers could facilitate the development of diagnostic tools that help identify individuals at risk of RPL, enabling early intervention and personalized care. In addition, it can also contribute to the development of targeted therapeutic interventions based on the modulation of the vaginal microbiome. Understanding how specific microbial profiles influence pregnancy outcomes may lead to novel treatments or preventive measures. Studies can help in categorizing individuals into risk groups based on their vaginal microbiome composition. This risk stratification can guide healthcare providers in tailoring interventions and monitoring strategies for those at higher risk of recurrent pregnancy loss. Insights into the role of the vaginal microbiome in recurrent pregnancy loss can enhance the success rates of assisted reproductive technologies. Optimizing the microbiome environment may improve outcomes for individuals undergoing procedures like in vitro fertilization (IVF). Understanding the interplay between individual variations in the vaginal microbiome and recurrent pregnancy loss allows for personalized medical approaches. Tailoring interventions based on a person's unique microbial profile can enhance treatment effectiveness. As recurrent pregnancy loss has significant emotional and economic implications, studies on the vaginal microbiome can have a broader public health impact. Insights gained may lead to interventions that reduce the overall burden of RPL on individuals and healthcare systems. In summary, studies on the vaginal microbiome and recurrent pregnancy loss are essential for advancing our understanding of the underlying mechanisms, improving diagnostic capabilities, and developing targeted interventions to enhance reproductive outcomes for individuals experiencing RPL.

References

Aarts L and Schagen I van. “Driving speed and risk of road crashes: a review”. In: Accident Analysis and Prevention 38.2 (2006): 215-224.
Aldred R., et al. “Cyclist injury severity in spain: A bayesian analysis of police road injury data focusing on involved vehicles and route environment”. International Journal of Environmental Research and Public Health 17.1 (2020).
B.Team. what laws? Full-blown matatu chaos returns. Business Daily, Nairobi (2019).
Diaz Olvera L, Plat D and Pochet P. “Looking for the obvious: Motorcycle taxi services in Sub-Saharan African cities”. Journal of Transport Geography (2019): 102476.
Carsten OMJ and Tate FN. “Intelligent speed adaptation: accident saving and cost-benefit analysis”. In: Accident Analysis and Prevention 37 (2005): 407-16.
CPB, RIVM, RPBV & SCP. “Selectiefinveste-ren; ICES-maatregelen tegen het licht”. [Selective investment; ICES measures against the light]. (In Dutch). CPB Netherlands Bureau for Economic Policy Analysis, The Hague (2002).
Dutch Information Council. Advancing Sustainable Safety National Road Safety. Outlook for 2005-2020 (2005).
Dutch Ministry of Transport. Impact Assessment and Project Appraisal. Strategic environmental assessment and transport planning: towards a generic framework for evaluating practice and developing guidance (2004a).
ECMT. Resolutions of the Council of Ministers of Transport and Reports Approved in 1979. OECD Publishing, Paris (1980).
European Commission. Directive 2001/14/E.C., Brussels (2001).
European Commission. eSafety; Final report of the eSafety Working Group on Road Safety. European Commission, Brussels (2002).
European Commission. Roadmap to a single European transport area —towards a competitive and resource -efficient transport system, Luxembourg (2011).
Gichaga FJ. “The impact of road improvements on road safety and related characteristics”. IATSS Research, 40(2), Elsevier B.V (2016): 72-75.
Islam MM and Al Hadhrami AYS. “Increased motorization and road traffic accidents in Oman”. Journal of Emerging Trends in Economics and Management and Science 3.6 (2012): 907-914.
Kamau J., et al. Trend analysis and fatality causes in Kenyan roads: A review of road traffic accident data between 2015 and 2020 (2020).
Karim H and Magnusson R. “Road Design for Future Maintenance Problems and Possibilities”. Journal of Transportation Engineering 134 (2008): 523-531.
Kelly KJ. WHO: Kenya road deaths four times higher than NTSA reported. Daily Nation (2018).
Kenya government, WHO, Bloomberg Philanthropies (2022). The Kenya global road safety in collaboration with and other partners.
KNBS. Kenya National Bureau of Statistics (KNBS): Census report (2018).
Koornstra MJ., et al. Naaree duur zaam veilig wegverkeer: Nationale Verkeer sveiligheidsverkenning voor de jaren1990/2010.StichtingWetenschappelijk Onderzoek Verkeersveiligheid SWOV, Leidschendam (1992).
KRB. Kenya roads board (KRB): Road inventory and conditions report (2018).
La Torre RD., et al. Sustainability, to be economically viable, to all people. Transport Research Arena (2014).
Lau JH, Cook P and Baldwin T. Unimelb: Topic modelling-based word sense induction for web snippet clustering. In Second Joint Conference on Lexical and Computational Semantics (*SEM), Volume 2: Proceedings of the Seventh International Workshop on Semantic Evaluation (SemEval2013) (2013): 217-221.
Macharia WM., et al. “Severe road traffic injuries in Kenya, quality of care and access”. African Health Sciences 9.2 (2009): 118-124.
Manyara CG. “Combating road traffic accidents in Kenya: A challenge for an emerging economy”. Kenya After 50.1 (2016): 101-122.
Matijosaitiene and Navickaite. “Social reality and its cognition: the aspect of safety. What does a City Master Plan Tell about our Safety?”. Journal of Social Science 80.2 (2013).
Mok J, Landphair HC and Naderi JR. Comparison of Safety Performance of Urban Streets Before and After Landscape Improvements: 2 nd Urban Street Symposium (2003).
Mok JT., et al. “Dispersion less slow light using gap solutions”. Nature Physics 2.11 (2006): 775-780
Mogambi H and Nyakeri F. “Media priming of road traffic accidents in Kenya: Praxis, patterns, and issues”. SAGEOpen 4 (2015).
Mohammed AA., et al. “A review of the traffic accidents and related practices worldwide”. The Open Transportation Journal 13.1 (2019): 65-83.
Murumba S. Motorcycle registrations spike on popularity of ‘boda boda’ transport. Business Daily (2017). [Online].
Naderi JR. “The relationship between landscape installations and safety of pedestrian activity, Transportation Research Record”. 2003 - Journal. Sage Pub.Com (2003).
NTSA. National Transport and Safety Authority (NTSA) (2020). [Online].
OECD. Road Safety. Impact of new Technologies. Organisation for Economic Co-operation and Development OECD, Paris (2003).
Oei. The Netherlands, cost-benefit analysis (CBA) is considered an indispensable tool in evaluating transport infrastructure projects. A research programme on the effects of infrastructure (OEI) was launched in 2000, resulting in guidelines about the way CBA needs to be calculated and presented (2001).
Osoro AA, Ng Z and Yitambe A. “An analysis of the incidence and causes of road traffic accident in Kisii, Central district, Kenya”. IOSR Journal of Pharmacy 5.9 (2015): 2250-3013.
Rasmussen J. “Skills, Rules, and Knowledge: Signals, Signs, and Symbols, and Other Distinctions in Human Performance Models”. IEEE Transactions on Systems, Man, and Cybernetics, SMC-13 (1983): 257-266.
Reason J. Human Error. Cambridge University Press, Cambridge (1990).
Ray PD, Huang BW and Tsuji Y. Cellular signaling (2012).
Rosenblatt and Bahar. Selection of Vehicle Restraint System. A comparative study in 21 countries (1998).
R. of K. (GoK). Traffic Act (Act No. CAP. 403). KenyaLaw.org (2018). [Online].
Sapkota D, Bista B and Adhikari SR. “Economic costs associated with motorbike accidents in Kathmandu, Nepal”. Frontiers in Public Health 4 (2016): 273.
Soehodho S. “Public transportation development and traffic accident prevention in Indonesia”. IATSS Research 40.2 (2017): 76-80.
SWOV. Road crash costs. Fact sheet February 2005. SWOV, Leidschendam (2005a).
SWOV publication R-2006-5. SWOV Institute for Road Safety Research - Leidschendam, the Netherlands.
Tingvall C and Haworth N. “Vision zero: an ethical approach to road safety and mobility”. In: Proceedings of the 6th ITE International Conference- Road Safety and Traffic Enforcement, Melbourne (1999).
VNG IPO, Ven W and UVW. Declaration of Intent from the Minister of Transport, Public Works and Water Management, the Interprovincial Consultation IPO, the Association of Dutch Municipalities VNG and the Union of Water Boards UVW about the Sustainable Safety Start program. [Declaration of intent by the Minister of Transport, the Association of the Provinces of the Netherlands, the Association of Netherlands Municipalities and the Association of Water Boards concerning the Start-up Programme Sustainable Safety]. (In Dutch). Ministry of Transport, Public Works and Water Management/Association of the Provinces of the Netherlands/Association of Netherlands Municipalities/Association of Water Boards, Den Haag (1997).
Wang, B., et al. “A Hierarchical Topic Modelling Approach for Tweet Clustering”. In: Ciampaglia, G., Mashhadi, A., Yasseri T. (eds) Social Informatics 2017, Lecture Notes in Computer Science, Springer, Cham 10540 (2017).
Wang D., et al. “Road traffic accident severity analysis: A census-based study in China”. Journal of Safety Research 70 (2019): 135-147.
Wegman FCM and Aarts L. (eds.) Continue with Sustainable Safety. National Road Safety Outlook for the years 2005-2020. [Advancing Sustainable Safety; National Road Safety Outlook for 2005-2020]. SWOV Road Safety Research Foundation, Leidschendam (2005).
Wegman F., et al. SUNflower+6. A comparative study of the development of road safety in the SUNflower+6 countries. Final report. SWOV Institute for Road Safety Research, Leidschendam (2005a).
Wegman F., et al. Sustainable Safety in the Netherlands: the Vision, the Implementation and the Safety Effects. Contribution to the 3rd International Symposium on Highway Geometric Design, Chicago. R-2005-5. SWOV Institute for Road Safety Research, Leidschendam (2005b).
World Health Organization. Road safety in ten countries: Kenya (2009). [Online]
World Health Organization. Global status report on road safety (2015). [Online]
World Health Organization. Global status on road safety (2016). [Online].
World Health Organization. Global status report on road safety (2018). [Online].
Yousefzadeh-Chabok S., et al. “A time series model for assessing the trend and forecasting the road traffic accident mortality”. Archives of Trauma Research 5.3 (2016).
Zheng Z., et al. “Determinants of the congestion caused by a traffic accident in urban road networks”. Accident Analysis & Prevention 136 (2020): 105327.
Zusha. The life you can save (2018). [Online].

Road traffic accidents are on the increase despite interventions implemented by states, stakeholders and partners. World Health Organization (2018) has reported that more than 1.35 million people die every year on the world’s roads, making road traffic injuries a leading cause of death globally. Most of these deaths occur in low- and middle-income countries where rapid economic growth has been witnessed in recent years, in spite of COVID 19 pandemic, which interfered with global health and economies. In Kenya 3500 people die each year due to road crashes, while nearly 1000 are left with life threatening disabilities.

The purpose of this study was: To investigate major determinants that are associated with road traffic accidents which have also been identified by other researchers that have directly or indirectly contributed to accidents causation both in developed and in developing countries, particularly in Asia and Africa including Kenya. A systematic review was used to review the most current researches that have been conducted on road traffic accidents that caused deaths and injuries to significant road users. Literature search was conducted, using Google-scholar and Pub med. The review used 58 most current studies from a total of 120.

The study findings: Revealed that there is an increase in the number of vehicles praying on the roads, coupled with an increase of population and especially those using vehicles, and motorcycles. Intentional violation of traffic rules was reported. Poor implementation of road safety network, poor planning and design of road infrastructures were identified. Poor mechanical conditions of vehicles, over speeding, overloading, uncontrolled and mixed traffic environment were equally cited. Again, road “users” and drivers’ behavior, have significantly contributed to the increase of road traffic accidents, contributing to mortalities and morbidities. The commonly affected people are pedestrians and passengers who are between 15-29 years of age.

Conclusion: Factors contributing to accidents causation include; increased vehicles and vehicular use and human factor leading to intentional violation of traffic rules; bad roads, over-speeding and over-loading was identified to be associated with road traffic accidents. Likewise, use of unroadworthy vehicles, errors of other significant road users, poor implementation of road safety measures and poor planning and design of road infrastructures were also identified.

Recommendations: Sustainable road safety to be based on individual road user’s decision, geared towards personal responsibility, tailoring traffic environment to human characteristics by training and education, improving road network, control of speed, direction and mass to vulnerable road users.

Keywords: road traffic accidents; traffic injuries; morbidities and mortalities; sustainable safety

The WHO defined palliative care as “an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial, and spiritual” [1]. In other words, it is a holistic care that improves the quality of life of the patients as well as their families. Evidence from various studies reveal that more than 90% of the cancer patients spend most of their time in hospital during their terminal period and about 70% of them die in hospital settings without their nears and dears in front of them. These patients often get a curative care only and are usually devoid of the “total care’ that includes physical, social, psychological and spiritual support.

India is a resource poor country; with shortage of manpower, money and materials in healthcare. Therefore, to deliver palliative care at the grassroot level for the rural poor population of India, it should be delivered by a multidisciplinary team comprising of family members, community volunteers, social workers, spiritual leaders in addition to the doctors and nurses who can provide symptomatic care to the patient. A good example of this is the Neighbourhood Network of Palliative Care (NNPC) in Kerala which is the first WHO Collaborating Centre for Community Participation in palliative care.

Though with limited awareness and coverage, history of palliative care in india dates back to 20 years or mid- 1980s when people used to think that palliative care is for cancer patients only. So, the first facilities to deliver palliative care in India were within cancer centres at places like Ahmedabad, Bangalore, Mumbai, Trivandrum, and Delhi. Another milestone in the history of palliative care development in India was establishment of Indian Association of Palliative Care (IAPC). The first hospice in India, Shanti Avedna Ashram, in Mumbai, Maharashtra, was opened by Professor D’Souza in 1986. Can Support in Delhi was established in 1997 which was the first centre in North India to deliver home care palliative care services. The availability of morphine was again a big hurdle in India. The Narcotic Substances and Psychotropic Substances (NDPS) act of India in 1985 further added to the difficulty in the procurement of morphine leading to a remarkable drop in its use in the subsequent years. In 1998 Indian government gave instructions to all state governments to amend their narcotic regulations, but the response was not good. Various workshops were held in lot of states regarding this issue and among them Kerala showed a significant improvement in access to opioids. Two important events that contributed to the progress of palliative care were designation of the Institute of Palliative Medicine at Calicut, Kerala, as a WHO Collaborating Centre for Community Participation in Palliative Care and Long-Term Care in 2010 and of Pallium India’s Trivandrum Institute of Palliative Sciences (TIPS) as a WHO Collaborating Centre for Training and Policy on Access to Pain Relief in 2012 [2].

But inspite of increasing progress in the field of palliative care in India, only 1% of Indian population has access to it. India is rated lowest among all countries in the use of opioids. National programme for palliative care was formulated in 2012 but it is lost under lack of funds [3]. Need of an hour is to include palliative care in the primary health care so that it is accessible and affordable to all rich and poor. Not only the health care professionals but the general community should be made aware that palliative care is the continuum of care that should be started with the diagnosis of any long term or life limiting illness. Volunteers with leadership qualities should be included in the programme to enhance community participation and make the general community more receptive. The emphasis needs to be shifted from the quantity of life to the quality of life. Efforts have been started by the government and a lot of barriers have been overcome but still lot is needed to be done. The policies and programmes that are made need to be implemented stringently to bring about a change.

References

Inhalational/smoke burn is most fatal one in terms of acute laryngeal edema, acute lung injury, ARDS. This all are survival priority in time dealing matters and sometimes difficult to manage even in dedicated higher centre.

Skin and soft tissues burn has space to contribute by medical professionals, as ensuring time fashioned critical care services can maximize the survivability and reduce the morbidity and mortality. More than 40-50% burn are the major priorities of critical care.

Ideal Burn care management starts from zero hours of occurrence. ECF - ICF fluid, ions disequillibrium are starts just after burn which is very rare about the onset of physiological imbalace in any sort of injury/ diseases. Starling law of forces are the key factors for maintaining Ph, acid base balace and homeostasis which is disrupt just after burn within seconds. Parkland formula is very much useful for burn care. In recent burn care guidelines crystalloids and colloids (FFP, Albumin, plasma expander, Blood and blood products) are needed even in 1st 24 hrs of burn injury. Crystalloid induced dilutional coagulopathy are concerning factors in definitive care and recent guidelines practicing 2ml fluid instead of 4ml for initial regime of fluid. 1st 24 hrs focused care are the pivotal factors for recovery of burn patients. After 48-72 hrs of good urinary balance (0.5 ml/kg/ hr) and early prediction of sequential (Mechanical ventilation, pain care, sepsis control, lung care, partial parenteral nutrition, stomach and gut care) morbidity during the recovery process are important factors for good outcome.

Sometimes burn patients delays time to reach the proper care unit and got some mixed treatment and fluid care. This patients should manage by proper history taking of receiving fluids, consumption of time after incidence, percentage of burn, body wt, co morbidity, age of patient and respective physicians clinical eyes.

Good burn care by bottom way of top (patient care attendant, Nurse, paramedics, physiotherapy, attending duty doctor, administrator, consultant and patients legal guardian) is the ultimate hope for survival of whatever the percentage of burn. 20% burn can kill a patient by sepsis and more than 80% burn can survive with team care.

Histopathologic Implications of Transgender Surgeries

The gender transition process for many transgender individuals usually involves gender-affirming surgeries, such as phalloplasty, vaginoplasty and mastectomy. Thus, anatomical pathologists will find themselves interpreting more unique anatomical changes because of the increasing demand for these surgeries.

As far as the gender transition process is concerned, the field of anatomical pathology will continue to play a crucial role in the pre-operative assessment, intraoperative evaluation, and post-operative examination of specimens obtained from transgender surgeries. Histopathological analyses of tissue specimens are crucial for confirming successful surgical outcomes and diagnosing complications. Thus, Pathologists must be aware of the diverse anatomical variations emanating from gender-affirming surgeries and adapt their diagnostic approaches accordingly.

Standard diagnostic breast pathology criteria may not be completely applicable to mastectomy specimens from transgender surgeries; therefore, anatomic pathologists will need to collaborate with surgeons to establish comprehensive guidelines considering both diagnostic accuracy and the unique needs of transgender patients.

The creation of neo-vaginal and neo-phallic tissues in transgender surgeries introduces new considerations for anatomical pathology practice. Evaluating these reconstructed anatomical structures requires a good understanding of the surgical procedure and the ability to recognize and separate normal histological features from surgically induced changes. Standardized reporting systems will have to be developed to ensure communication between surgeons and pathologists, ensuring accurate interpretation of pathological findings.

Patient-Centered Approach to care

Transgender, individuals often face unique healthcare challenges such as stigmatization and discrimination; so it becomes imperative that anatomical pathologists should prioritize cultural competence and sensitivity in their interactions with transgender patients, ensuring that pathology reports and discussions are conducted with empathy, respect and confidentiality.

Suggestions for Education and Training

To navigate these evolving challenges, continuous education and training initiatives are essential for anatomical pathologists in the realm of transgender medicine. Pathology residency training programs and professional development courses should introduce transgender healthcare considerations that will enhance the skills and awareness of pathologists, to foster a more inclusive and competent pathology workforce.

Conclusion

The increasing prevalence of transgender surgeries requires a thoughtful evaluation and consideration of their impact on the practice of anatomical pathology. Pathologists must adapt their diagnostic approaches to accommodate the unique anatomical changes resulting from gender-affirming surgeries while maintaining a patient-centered focus. Collaboration between surgeons, pathologists, and educators is important to develop guidelines that ensure the delivery of accurate and culturally competent anatomical pathology services for transgender individuals.

References

Coleman E., et al. “Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7”. International Journal of Transgenderism 13.4 (2012): 165-232.
Schechter LS and Berli JU. “Transgender Surgery: A Review and Update on Surgical Techniques and Outcomes”. Plastic and Reconstructive Surgery 137.3 (2016): 537e-552e.
Morrison SD., et al. “Surgical Training and Experience of U.S. Transgender Surgeons”. JAMA Surgery 151.5 (2016): 471-477.

Data about an individual social history and accomplishments circulate online rapidly. This makes potential collaborators anticipate the effects of cooperation with them on their business advancement and make informed decisions when needed.

People are interested in selling their products and services and buying others as necessary since no one can produce, own, or know everything. To do that, they select from the offerings of their providers. The professional must convey their actions in an enjoyable interaction with customers and partners, presenting the quality of their products and fulfilling customers’ needs. The customers quantify the worth of the offering and interaction with providers. Suppose they are delighted by this exchange of goods and services. In that case, they will maintain the relationship with those providers and talk with friends, loved ones, and other community members about their joyful collaboration. Provider reputation attracts new customers, determining the provider’s business continuity and expansion, ensuring a successful professional and social life.

An increase in investment return validates the client’s positive experience and predicts their loyalty.

No one wishes to collaborate with providers offering inferior services or products with deceptive interactions because that alters their emotional health and financial status. In these circumstances, the client looks for other contributors from the present, and that decreases provider investment return, which affects their business stability.

So, customer loyalty reflects the provider’s professionalism in creating, presenting, and selling products. The quality of offerings and interactions with collaborators and clients influences an individual work-life value in the community.

Provider professionalism is a key to attaining excellence in the virtual and real world. Expertise in a selected field, fast and effective handling of data in practice, communication skills with collaborators, and acting in line with social norms define professionalism.

In healthcare, emotional care investment for people suffering differentiates their work from others.

Insensitivity to people’s altered health dissatisfies the patient, his family, and other dear ones. It determines a low adherence to the therapy plan and poor clinical outcomes, making them look for another provider for the next episode of care. This action frustrates the medical team and decreases investment return, affecting business continuity and growth.

By contrast, kind-hearted work improves patient adherence to the therapy plan and clinical outcomes and maintains a pleasant collaboration that benefits providers and end users.

Customer loyalty reflects their preference to continue collaboration with a provider based on their experience and provider reputation that fast circulates online.

Client experience anticipates devotion or disloyalty to a provider. Each can be an esteemed professional in the community they serve or refused by the clients, according to their product quality and interaction with them.

Patient sentiment analysis using AI to integrate their touch points predicts the evolution of return on investment, which defines a business trajectory in a new, highly competitive digital medical market.

AI in Early Diagnosis and Predictive Analytics

Artificial intelligence's capacity to aid in early diagnosis and predictive analytics is among its most notable contributions to critical care. To detect trends and patterns that could indicate the start of serious illnesses, machine learning algorithms can sift through mountains of patient data, including imaging scans, laboratory results, and vital signs. Artificial intelligence systems can improve patient outcomes by detecting tiny changes in a patient's health status and alerting healthcare providers to probable issues. this enables early intervention and keeps patients well.

Furthermore, predictive analytics powered by AI can forecast patient deterioration, allowing healthcare teams to proactively allocate resources and tailor treatment plans to individual patient needs. This proactive method may lead to fewer adverse events and unnecessary treatment escalations, which could improve patient safety and satisfaction.

Personalized treatment and care coordination

AI technologies are also empowering healthcare providers to deliver personalized treatment and optimize care coordination in critical care settings. Algorithms powered by artificial intelligence may analyze data relevant to each patient, taking in to account their traits, medical history, and therapeutic response, to provide personalized treatment suggestions.in addition to better clinical outcomes, this individualized approach to therapy reduces the likelihood of side effects and superfluous interventions.

Moreover, AI-driven care coordination tools facilitate seamless communication and information sharing among multidisciplinary care teams, ensuring that all providers are equipped with up-to-date patient information and treatment plans. This enhanced coordination promotes continuity of care, reduces medical errors, and fosters a collaborative approach to critical care management.

Remote monitoring and telemedicine

The integration of AI in critical care extends beyond the hospital walls, enabling remote monitoring and telemedicine solutions that enhance access to specialized care and support patients in diverse geographical locations powered remote monitoring systems can continuously track vital signs and physiological parameters, providing real-time data to health care providers and triggering alerts in case of abnormal findings. this capability not only enables early intervention but also reduces the burden on in-person critical care facilities, particularly in underserved areas.

Furthermore, AI-driven telemedicine platforms facilitate virtual consultations, enabling critical care specialties to remotely assess and advise on complex cases, this approach expands access to expert care, promotes timely interventions, and improves patient outcomes, particularly in regions with limited access to critical care expertise.

Challenges and considerations

While the potential of AI in critical care is vast, there are significant factors and obstacles to consider. serious thought must be given to data security and privacy, the ethical consequences of making decisions with AI, and the necessity of rigorously validating AI algorithms. To fully realize AI promise in health care, it is vital to eliminate gaps in access to critical care solutions enabled by AI and to ensure fair deployment across varied patient groups.

Conclusion

To conclude Artificial intelligence is poised to revolutionize critical care by enhancing early diagnosis, enabling personalized treatment, facilitating remote monitoring, and optimizing care coordination Patient safety, privacy, and equity must be the priorities when healthcare organizations apply AI solutions, and the problems that come with this adoption must be addressed. with thoughtful integration and ongoing advancements in artificial intelligence. finally, We must ensure that the promise of AI in healthcare is used responsibly and ethically as we move into this improved future by acting as watchful stewards of ethical practice.

The recent epidemiological transition from Communicable Diseases (CD) to Non Communicable Diseases (NCD) has reiterated the theory that NCDS which was prevalent among the rich are no longer restricted to the rich only [4]. The NCDs have gripped the poor as well. The progress in reducing poverty in India from 2013-14 to 2022-2023 is highly encouraging. During this 9 period, in our nation, about 25 crores or 250 millions of individuals have exited from Multi Dimensional Poverty (MPI) [5, 6].

The basic strategy to reduce the impact of poverty on health is to reduce the Out of Pocket Expenditure (OOPE) on health expenses. The Ayushman Bharat Jan Arogya Yojana (AB-JAY) fulfills the criteria of this strategy. The second large scale intervention is the Ayushman Arogya Mandir (AAM) where the basic health units like sub centres are converted to Health & Wellness Centers (HWCs). These HWCs provide comprehensive services & AYUSH services are also an integral part of this intervention [7, 8].

Out of the components of AYUSH, the most cost effective, therapeutically active system of medicine with zero side effects is Homoeopathy of AYUSH. Masses can be covered easily with homoeopathy while benefiting from these three properties. Integration of this system while linking the public through the existing public health system of homoeopathy will reduce their family’s OOPE. This reduction will lead to reduction in poverty of the household [9].

Integration of this system will lead to a process in the body that addresses food security. Govern of India is currently distributing free food grains through the Public Distribution System, Pradhan Mantri Garib Kalyan Yojana & Antodaya Yojana. Whenever these households receive the free food grains, the homoeopathic medicines will help to optimize the benefits of these schemes through optimum utilization in the body. This way the trio of Availability, Accessibility & Utilization (AAU) the concept of food security will be complete [10, 11].

Consumption of these varieties of cereals, pulses by the poor households will also help to address nutrition security as reduction in OOPE on health will help them to purchase & consume locally produced green vegetables, green leafy vegetables & fruits. Currently, 10% of the total 130 million use Homoeopathy & hence, 10 million people in India can benefit from this integration [12].

References

Park JE and Park K. Text book of preventive & social medicine, 11th edition, M/s Banarasi Bhanot publishers, Jabalpur.
Singh M and Saini S. Conceptual Review of Preventive & Social Medicine, second edition, 2019-2020, CBS publishers & distributors Pvt Ltd.
Wagstaff A. Poverty & Health Sector Inequalities, Bull World Health Organ, 2002, 80:97-105. The World bank.
GOI, Home Ministry, SRS Bulletin on CBR, CDR, IMR (2022).
Chand R and Suri Y Multi. Dimensional Poverty in India since 2005-06, A discussion paper, NITI Ayog, UNDP, Jan (2024).
Poverty Alleviation Report, C. Rangarajan Committee (2014).
Pradhan Mantri Garib Kalyan Yojana, PMGKY, NIC, GOI, https://indiabudget.gov.in/pmgky
HWC. https://ab-hwc-nlp.gov.in>home>aboutus.ayushmanBharat-Health&Wellness
GOI, Ministry of AYUSH, NLEAM (2022).
IFPRI, International Food Policy Research Institute. https://www.ifpri.org>topic>foodsecurity.
National Food Security Act, GOI (2013). https://nfsa.gov.in
Popularity of Homoeopathy in India (2023). bjainpharma.com/blog/popularity-of-homoeopathy-in-India,

Mpox disease, caused by Mpox virus, a double-stranded DNA virus, genus Orthopoxvirus of the family Poxviridae has an incubation period of 6 to 13 days but can range from 5 to 21 days. The symptoms are quite diverse and this makes a number of rash-associated illnesses close differential diagnosis. This study aims to review the common symptoms associated with the disease during outbreaks in Imo State between 2017 and 2023 and the implications for surveillance.

Surveillance data from the Surveillance Outbreak Response Management and Analysis System (SORMAS) was extracted between January 2017 and December 2023 across the 27 Local Government Areas (LGAs) of Imo State. A line list of 231 suspected cases was downloaded into an excel template and analyzed using SPSS ® version 20 software. Analysis was done using descriptive statistics and associations were tested using Fischer’s exact at 0.05 level of significance.

Of the 231 suspected cases, 57.1% (132) were males, 42.9% (99) were females and the modal age group was between the ages of 0-4 (32.5%). About one-fifth (21.2%, n = 49) were confirmed positive, 27 males (55.1%) and 22 females (44.9%), (p>0.05). Modal age group was 20-24 (22.4%, n=11), 18% (9) were children under 14 years, p>0.05.

Fever was a constant presentation with 68.4% (n=158) and 65.3% (n=32) of suspected and confirmed cases respectively presented with varying degrees of fever. Other modes of presentation among the confirmed cases are conjunctivitis (12.2%, n=6), cough (16.3%, n=8), photosensitivity (14.3%, n=7), fatigue (36.7, n=18 and headache (45%, n=22). Only 5.6% and 4% of suspected and confirmed cases, respectively, had knowledge of contact with an infectious source. Only 12.2% (n=6) presented with one form of lymphadenopathy contrary to literature. This might be associated with the clinical skills of the cadre of health workers who are responsible for surveillance activities at the LGA (district) level in the State. This study has been able to describe the symptomatology of Mpox during outbreaks between 2017 and 2023 Imo State. The findings have significant implications for capacity building of surveillance actors in order to improve early case detection and response.

Keywords: Mpox; Symptomatology; Outbreak; Surveillance

Lesson two (2). The acute phase is followed by a chronic process that we call "POSTCOVID SYNDROME". This phase of the disease has a duration of 18-24 months, and sometimes more. And it is the main danger for those who have had a mild, moderate or severe form of the course. For some patients, it has the appearance of mild discomfort.

Lesson three (3). "POSTCOVID SYNDROME" is dangerous for the sudden development of thrombosis and related complications. As shown by the analysis of the development of the pandemic in many countries, 80-85% of patients suffer this infection in mild to moderate severity. And only 15-20% of patients due to concomitant diseases require hospitalization and round-the-clock monitoring by medical personnel. During this period of the chronic phase of the disease, it is necessary to monitor the most informative markers of the possible development of thrombosis: the dynamics of D-dimers, prothrombin time, fibrinogen levels, and the number of platelets in the blood of those who have been ill.

In practice, such large-scale monitoring is not possible. As you know, the recommended treatment to prevent thrombosis is oral anticoagulants. And for detoxification, it is recommended to use plasmapheresis. However, both of these recommended treatments have a number of significant drawbacks and contraindications, especially with their long-term use.

Lesson Four (4). We offer an alternative method - "SYSTEM METHOD OF LEECHING” (SML). The proposed method is based on 30 years of experience in the use of SML in elderly people with multiple organ pathology and children treated at the Academy of Hirudotherapy in St. - Petersburg.

Our experience in the treatment of "POSTCOVID SYNDROME" in the period 2020-2023 has shown the high effectiveness of SML.

Lesson Five (5). There are convincing statistics on the high morbidity and mortality of doctors who worked in the "Red Zone" during the pandemic. First of all, we are talking about nurses and surgeons, that is, about medical personnel who have to contact the bodies of sick people for the longest time. At first glance, it seems that this is due to the violation of the epidemic regime by medical personnel.

However, the author argues that in this case, the factor of remote interaction of the "Aquasystem of a Sick Person" with the "Aquasystem of a Healthy Person" by means of wave radiation may play a role. As evidence, the author cites the discovery of Academician Kaznacheev V.P. and co-authors entitled: "The phenomenon of intercellular distant electromagnetic interactions in the system of two tissue cultures" (Number and date of priority: 122, dated 15.02.1966) and supplements this discovery with his own experimental results on humans, using ultraviolet irradiation of volunteers as a model.

Lesson six (6). Many of our patients note that during the pandemic they were sick 2-3 times.

This suggests that having been ill with one strain of coronavirus, the human immune system is not able to protect against other antigenic variants (strains) of coronavirus. These facts make you wonder, against which strains of coronavirus do you need to prepare a vaccine for the population?.

In addition, many materials have been proven and published on severe post-vaccination complications, including deaths or stillbirths in pregnant women who were vaccinated during pregnancy. In the author's article (Krashenyuk A.I. Pandemic "COVID-19 - POSTCOVID SYNDROME": A System Method of Leeching is a New and Effective Treatment. Journal of Virology Research & Reports, 2023, volume 4(2):1-12).

This problem is being discussed. And this topic is described in even more detail in the author's recently published book "COVID-19 - POSTCOVID SYNDROME". Ed. "ASTERION". SPb, 220p.

Lesson Seven (7) The problem of rehabilitation of convalescents. Since this is a long process that takes 18-24 months or more, the question arises, what to do, how to rehabilitate people? Our experience shows that the safest and most effective method is the use of the "SYSTEM METHOD OF LEECHING” (SML).

References

Krashenyuk AI. “The Renaissance of hirudotherapy in Russia: The end of XX and the beginning XXI century”. «5th International Meeting on Traditional & Alternative Medicine & International Conference on Acupuncture and Meridian Studies», Rome, Italy, 2019. Journal of Regenerative Medicine 8 (2019): 42.
Krashenyuk AI. “Clinical case of Conservative Leech Treatment of Neurinoma of the Brain”. Acta Scientific Medical Sciences 4.1 (2020): 108-110.
Krashenyuk AI. “Neurotrophic (Neural Stimulating) and Neuromediator Effects of Hirudo medicinalis. Pathogenetic Mechanism of Treatment of Diseases of the Nervous System of the Human”. Acta Scientific Medical Sciences 4.3 (2020): 01-06.
Krashenyuk AI. “Coronavirus COVID-19 - Theoretical and Practical Substantiations for Reducing Mortality from Complications”. Acta Scientific Medical Sciences 4.6 (2020): 115-123.
Krashenyuk AI. “Aquapathogenesis is the Nature of Human Diseases. Dynamic Hirudotests: New Possibilities of Integral Diagnostics of the State of Human Bodies and his Systems - Study of the Dynamism of the Human Aquasystem”. Acta Scientific Medical Sciences 4.10 (2020): 76-90.
Krashenyuk AI and Burkhonov AB. “Aseptic Necrosis of the Joints, As A Complications of “POSTCOVID SYNDROME” (Clinical Case)”. Journal of Clinical Case Studies, Reviews & Reports 4.3 (2022): 1-6.
Krashenyuk AI. “Hirudotherapy and Scientific Arguments Substantiation of Pathogenic Treatment “POSTCOVID SYNDROME””. J. Inter. Medicine Research & Reports 1.2 (2022): 1-10.
Krashenyuk AI. ““COVID-19”: Is there any legitimate optimism in the treatment of “POSTCOVID SYNDROME “and complication from vaccination?”2nd Edition of International Conference on TRADITIONAL MEDICINE, ETNOMEDICINE AND NATURAL THERAPIES. VIRTUAL EVENT. Tokyo, Japan (2022): 22-23.
Krashenyuk AI. ““COVID-19” - “POSTCOVID SYNDROME” Pandemic: Solutions of the Problem are Visible in the Application of Modern Hirudotherapy and Integrative Medicine”. Open Access Journal of Biomedical Science 4.3 (2022): 1907-1909.
Krashenyuk AI. ““COVID-19” - “POSTCOVID SYNDROME” Pandemic: How to Protect Doctors and Nurses in the “Red Zone” of Hospital?”. J. of Medical & Clinical Nursing 3.4 (2022): 1-9.
Krashenyuk AI. “"COVID-19” - “POSTCOVID SYNDROME" Pandemic: Complex Treatment with Medical Leeches, Including Detoxification”. Confirmation of the Validity of the Theory "HOMOTOXICOLOGY" of H. - H. RECKEVEG. Journal of Clinical Epidemiology & Toxicology 3.4 (2022): 1-7.
Krashenyuk AI. “"COVID-19” - “POSTCOVID SYNDROME" Pandemic: The Problem is solved by Information Medicine – Hirudotherapy”. PriMera Scientific Medicine and Public Health 1.4 (2022): 05-09.
Krashenyuk AI. Method of treatment by medical leeches. RUSSIA. Invention Patent No. 2787525. Application No. 2021136998. Priority of invention December 13, 2021 Date of state registration in the State Register of Inventions of the Russian Federation: 2023.
Krashenyuk AI. ““COVID-19” - “POSTCOVID SYNDROME” Pandemic: High Risks for Pregnant Women”. Acta Scientific Medical Sciences 7.2 (2023): 71-82.
Krashenyuk AI. “Pandemic “COVID-19 - POSTCOVID SYNDROME”: A System Method of Leeching is a New and Effective Treatment”. Journal of Virology Research & Reports 4.2 2023: 1-12.
Krashenyuk AI. “Pandemic “COVID-19 - POSTCOVID SYNDROME”. This name of pandemic allows us to better understand the meaning of the use of hirudotherapy in treatment”. “5th Edition of International Conference on Traditional Medicine, Ethnomedicine and Natural Therapies” Hybrid Event held on May 22-23, 2023 in Tokyo, Japan. Book of Abstracts “Traditional Medicine -2023” (2023): 52-53.
Krashenyuk AI. Pandemic “"COVID-19 - POSTCOVID SYNDROME". OBSERVATIONS AND CONCLUSIONS. EXPERIENCE OF LEECH TREATMENT"”. Monograph. St. Petersburg, Izd. ASTERION (2023): 218.
Krashenyuk AI. “Pandemic “COVID-19 - POSTCOVID SYNDROME”: was it possible to save the doctors and staff of the “Red zone” of hospitals from illness and death?”. Conference Program, Day 3, p.9. «3rd International Conference on Tissue Engineering & Regenerative Medicine», London, UK (2023).
Krashenyuk AI. “Pandemic “COVID-19 - POSTCOVID SYNDROME”: Hirudotherapy as an effective and Dominant monotherapy”. Webinar Program, Oral speakers, p.16.«3rd International Webinar on «Global Healthcare and Nutrition», Dubai, UAE (2023).

Can we have another suitable choice instead of cake in different delicious events, or can we at least use cakes that are less harmful? We have some suggestions in this regard: 1) Natural sugar sources obtained from fruit juices may be used instead of crystal sugar in cake formulations [3]. 2) Pawpaw Fruit Puree may be used in cake formulations as fat replacement [4]. 3) Cowpea (Vigna unguiculata) flour may be used instead of wheat flour [5]. 4) Vegetable and apple pomace which are rich of fibers may be used. Pumpkin is an essential vegetable and is a rich source of protein, vitamin A and C, antioxidant, beta carotenes, carbohydrates, minerals, flavonoids and phenols though low in fat and calories [6]. 5) Using cakes in smaller sizes, for example, using cupcakes instead of cakes in large size. 6) Mixing the fruits together and putting them in cake molds and then adding a substance like gelatin and making them like a cake and using them as birthday fruits instead of birthday cake. 7) Making cake-free boxes special for birthday, having places for candles. People can throw away these boxes after blowing out their birthday candles.

More other routes may be introduced in order to change birthday habits to healthier and happier ones. It is enough to test some of these routes in birthdays, ceremonies, etc. Let’s begin.

References

Bozorgnia M, Gharibzadeh S and Bozorgnia A. “Brief and Minimal Preventive Instructions to Maximize the Effectiveness”. Am J Biomed Sci & Res 20.1 (2023).
Drewnowski A and Schwartz M. “Invisible fats: sensory assessment of sugar/fat mixtures”. Appetite 14.3 (1990): 203-217.
Bilgicli N and Akbulut M. “Effects of different pekmez (fruit molasses) types on chemical, nutritional content and storage stability of cake”. Journal of Food Quality 32.1 (2009): 96-107.
Wiese TD and Duffrin MW. “Effects of substituting pawpaw fruit puree for fat on the sensory properties of a plain shortened cake”. HortTechnology 13.3 (2003): 442-444.
Oyeyinka S., et al. Cake production from wheat (Triticum aestivum) and cowpea (Vigna unguiculata) flours using date fruit as a sweetener (2014).
Khanam T., et al. “Nutritionally enric hed cake using vegetable and fruit waste: A review”. Journal of Pharmacognosy and Phytochemistry 8.3 (2019): 722-725.

Faith can provide us with stability and wealth when we follow the rules given to us by the teachings of God and his chosen disciples. Living in a clean environment and being fair, respectful, trustworthy, and honest can lead to a prosperous and fulfilling life. When we maintain our wholesome nature, we become closer to divine energy, which can significantly and positively influence our existence. Being mindful in our work and caring for ourselves and others reward us with better inner workings; its energy can align with the Universe’s positive energy and resonate with it, improving well-being. We must strive to create positive outcomes in all our endeavors.

Individuals must emphasize the benefits of reasonable work and a healthy lifestyle in a suitable environment to maintain and improve their welfare. When feeling unwell, taking the time to reflect on past actions and attitudes in daily interactions with others can help identify any harm caused and allow steps to be taken to rectify the situation. This can be a small step towards restoring the body’s functioning, as mental health is essential in governing all bodily functions.

God invites us not to make more mistakes. Errors cause harm to both the receiver and the person who created the error. The negative energy of the thoughts and emotions associated with these errors can also disturb the contributor’s mental and energetic state, leading to more or less clinically expressive disorders.

Healing human disorders means dealing with darkness and restoring light to the affected area; to do that, we need assistance with thought power. Considering divinity as an indefinite spring, our thinking expects support in troubled times; to receive this help, we must be diligent in our daily lives and struggle to align ourselves with the Universe’s positive energy. By doing so, we can refine our microcosm and achieve overall welfare.

People aspire to perfection but must have an appropriate configuration to achieve it. With dirty life arrangements, you can never be bright. By cleaning up our surroundings, purifying our thoughts, and engaging in proper work, we can attain a peaceful inner life that interrelates with divine energy.

Human sweethearts are changeable over time, and they want another one - a stable adoration that can support them through life’s ups and downs. God continuously sustains and reinforces them when they follow Its principles.

In today’s digital age, it has become increasingly important to have a basic understanding of different religions across the globe due to the rising movement of people. When managing medical disorders, it is necessary to approach discussions with patients regarding their religious beliefs appropriately. Medical teams must honour people's opinions on divine creation and human life. Furthermore, their relationship with the patients and their families should facilitate patients’ involvement in decision-making concerning their viewpoints and practices relating to the existing divine.

Saffron (Crocus sativus L.) is an aromatic plant with 3500 years of age. Saffron is often known as the most expensive medicinal plant. Iran currently produces one of the best saffron. Countries such as Australia, Canada, the United States of America, China, and some Central African countries also produce this plant [3].

Clinical research suggests that Saffron may be used as a preventive and therapeutic anti-inflammatory and antioxidant agent, regenerator of unsaturated fatty acids in the body, a free radical absorber and an anti- oxidative stress. Therefore, researchers recommend the consumption of saffron and its compounds in the diet [4, 5].

It is worth noting that one of the most important factors which increases alcoholism is the feeling of euphoria caused by the release of dopamine neurotransmitter in the brain after drinking alcohol. On the other hand, interest to ethanol consumption may be related to factors such as price, availability, and shape and beauty of glasses [6].

Based on abovementioned points, we recommend using healthy non-alcoholic drinks that can create the same happiness as alcohol. We specially offer saffron containing drinks that have beneficial therapeutic properties as well. Saffron aqueous extract has been able to increase dopamine in the brain of mice [7] and also it has been shown that saffron in young men increase the dopamine [8].

We suggest that producing saffron beverage in proper volumes and beautiful packages may be a good way to decrease alcohol consumption disadvantages as well as maintaining the happiness of drinking cool delicious drinks.

References

Yasin YJ and Banoub JAM. “Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016”. GBD 2016 Alcohol Collaborators. Lancet 392 (2018): 1015-35. In this Global Health. Lancet 392 (2018): 1684-735.
World Health Organization. Global status report on alcohol and health 2018. World Health Organization (2019).
Dai RC, Nabil WNN and Xu HX. “The history of saffron in China: From its origin to applications”. Chinese Medicine and Culture 4.4 (2021): 228-234.
Cerdá-Bernad D., et al. “Saffron against neuro-cognitive disorders: an overview of its main bioactive compounds, their metabolic fate and potential mechanisms of neurological protection”. Nutrients 14.24 (2022): 5368.
Nanda S and Madan K. “The role of Safranal and saffron stigma extracts in oxidative stress, diseases and photoaging: A systematic review”. Heliyon 7.2 (2021): e06117.
Di Chiara G. “Alcohol and dopamine”. Alcohol health and research world 21.2 (1997): 108.
Ettehadi H., et al. Aqueous extract of saffron (Crocus sativus) increases brain dopamine and glutamate concentrations in rats (2013).
Moghadam BH., et al. “Impact of saffron (Crocus Sativus Linn) supplementation and resistance training on markers implicated in depression and happiness levels in untrained young males”. Physiology & behavior 233 (2021): 113352.

Mental health is essential for work efficiency; processing data speed and rational response differentiate people. They must interact to sell their products and buy others’ goods since no one can own everything. Communication reflects an individual’s energetic mental state, influencing energy transmission through thoughts and words. Their power in the functioning of the human body was observed in clinical practice. Individual attitudes can inform us about rational or irrational data processing and the vibrational model of interrelated actions. Cool or kind-hearted work, adaptability, flexibility, and the ability to overcome barriers are some metrics for evaluating mental activity. Perception, analysis, and response to data tell apart people’s genetics, education, and networking. Usually, emotional distress results from unsafe interaction with others or one’s surroundings; it can manifest in mental health variances following functional abnormalities in fragile areas of the human body since the mind’s activity governs bodily functions. People’s vulnerability to deceptive interactions with others varies. The impact of such communications on mental activity is observed in their subsequent actions. Attenuated or explosive reactions toward others in different situations, uncontrolled emotions often accompanied by irregularities in heart function, a decrease in accomplishments, and social isolation are some common clinical manifestations of altered mental health. Poor sleep that frequently follows and exacerbates the disturbed mental health must be accounted for.

Words used, attitudes, and surroundings depict individual views; cultivating good habits enhances work and facilitates social acceptance. It is essential to advise individuals about the negative consequences of their exposure to improper collaborative work, working in an unhealthy environment, and adopting unsafe habits that may harm their health. By pondering all the factors influencing us, we can care for ourselves and others.

The relationship between stimulus intensity, duration, and response is sometimes linear in impacted regions. Variability in individual responses to the same stimulus characteristics predicts uncertainty, and doubt may limit coping with creativity.

In today’s digital age, artificial intelligence can detect mental disorders rapidly and provide suggestions for corrective actions promptly. By focusing on improving mental well-being, promoting self-care practices, and maintaining clean surroundings, individuals and communities can experience positive impacts on health and overall societal progress.

IT devices provide a variety of on-demand programs for education and entertainment. Discussions with loved ones, listening to preferred musical programs, watching movies, viewing art from famous artists, and exploring nature images relax and stimulate different brain areas, helping in recovery.

People’s actions illustrate their thinking; when it is not working correctly, it must be restored, and continuous efforts should be made to improve it. Their actions illuminate the thoughts and words’ power to change around and in the inner area, with outcomes that can surprise or sometimes prove anticipatory facts.

Migraine is defined as an episodic headache associated with certain features, such as sensitivity to light, sound, or movement or “a recurring syndrome of headache associated with other symptoms of neurologic dysfunction in varying admixtures” [6]. The symptoms of migraine are recurrent severe headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound. It affects millions of people worldwide, making it one of the most common and disabling conditions worldwide [7]. There are different phases, including a premonitory phase, transient neurological symptoms (i.e., migraine aura), an intense headache attack, and a postdrome phase [8].

Pathophysiology

The pathophysiology of migraine is still not well understood. Few of the proposed mechanisms surrounding the onset of migraine headaches are given below:-

Genetic Studies

The genetic or the inherited component plays a very important role in the pathophysiology of Migraine. Studies have shown that individuals with a family history of migraines are more likely to experience migraines themselves, indicating a genetic predisposition to the disorder. Various genes and genetic factors have been implicated in migraine susceptibility, including those related to neuronal excitability, neurotransmitter function, and vascular regulation [9]. There is an unexplained but epidemiologically well-established predisposition that relates to methyl tetrahydrofolate reductase gene mutation C677T that is certainly overrepresented in migraine with aura [10]. The presence of aura seems to be associated, in rarer inherited cases, such as CADASIL or autosomal-dominant retinal vasculopathy with cerebral leukodystrophy, with structural protein dysfunction [11]. and perhaps with an embryonic syndrome that includes patent foramen ovale [12].

Neuropeptide studies

Activation of the trigeminal nerve triggers the release of signaling molecules including calcitonin gene-relate d peptide (CGRP), resulting in secondary cerebral vasodilation, plasma protein extravasation and mast cell degranulation, all contributing to symptoms of migraine. Although, this theory does not explain the pathophysiology of migraine, CGRP can be considered as the initial trigger of trigeminal nerve stimulation causing migraine headaches [10]. It is also apparent that the dilatation of blood vessels is the result of neuronal inflammation, not the cause of migraine headaches. The roles of 5-HT and CGRP have been well documented. CGRP is a potent vasodilator that causes pooling of blood in the cerebral vasculature parallel to decreased levels of 5-HT [11, 12].

5-HT receptors, especially 5-HT1B, 5-HT1D and 5-HT1F receptors play a crucial role in migraine [13]. 5-HT1F receptors are expressed in the CNS, including major regions of migraine pathophysiology such as cortex, hypothalamus, the trigeminal ganglia, trigeminal nucleus caudalis (TNC) and in low concentrations on the cerebral blood vessels like the Middle Cerebral Artery without vasoconstrictive properties [14-16]. Additionally, 5-HT1B, 5-HT1D, but not 5-HT1F, receptors were found on cerebral microvascular smooth muscles and all three subtypes were expressed on astrocytes. These findings, along with pharmacological evidence that selective 5-HT1F receptor agonists lack vasoconstrictive effect, prompted Cohen et al. to hypothesis that the function of this receptor subtype may be related to blood-brain barrier physiology rather than vascular contractility [17]. Triptans have been the drug of choice for migraine over the last three decades. These 5-HT1B and 5-HT1D receptor agonists act on the blood vessels and nerve endings in the brain to inhibit the release of vasoactive neuropeptides (CGRP and Substance P) by trigeminal nerve innervating the intracranial vessels and dura mater [18, 19]. But triptans are not recommended for individuals with history of cardiac and cerebrovascular diseases and those who are at risk for developing such diseases because of their vasoconstrictive action [20]. Besides having limited efficacy, triptans are contraindicated in pregnancy and breastfeeding women [21-23].

Thus, there arose a need to develop more selective treatment for migraines that lack any cardiovascular and cerebrovascular side effects. Drugs targeting neurons (trigeminal pathway) were suggested and 5-HT1F receptors were considered as a contemplated victim for it.

Pharmacology

Lasmiditan is the first of a new group of headache medicines that are being called the "ditans." Lasmiditan is unique as it is the only drug in its class which works specifically on the 5-HT_1F receptor as compared to triptans that primarily act via 5HT_1B/1D agonism. They do not cause vasoconstriction in contrast to triptans. It contains a pyridinoyl- piperidine scaffold instead of an indole group [24]. The mention of offsite interaction with the 5HT1F receptor suggests that there may be other mechanisms through which the triptans exert their therapeutic effects. The exact role of 5HT1F receptors in the context of migraines and triptan therapy is an area of ongoing research, and understanding these interactions may contribute to the development of more effective migraine treatments. It is important to note that while triptans can be effective for many people with migraines, they are not suitable for everyone, and their use should be discussed with a healthcare professional to ensure proper diagnosis and appropriate treatment [25]. The precise mechanism of action is not fully understood, but there are several proposed ways in which 5HT1F receptor activation may contribute to its activity in migraine treatment. Some of the effects associated with 5 HT 1F receptor agonist include decreased plasma protein extravasation, decreased c-fos expression, suppressed neuronal firing within the trigeminal nucleus caudalis, inhibition of CGRP release from perivascular fibres, direct anti nociceptive action.

While these proposed mechanisms provide insights into how Lasmiditan may work in treating migraines, it's important to note that the exact interplay of these effects and the overall mechanism of action are still subjects of ongoing research. As with any medication, individuals should consult with their healthcare providers for a thorough understanding of its benefits, potential side effects, and suitability for their specific condition [25, 26]. Lasmiditan is highly lipophilic and hence crosses the blood brain barrier which leads to central nervous system abnormalities [27].

Pharmacokinetics

Lasmiditan is administered orally with bioavailability of about 40 % [27]. Lasmiditan can be taken with or without food as the co-administration of drug and a high fat meal was not found to produce a clinically significant difference in exposure [28]. The median peak time to peak plasma concentration is 1.8 hours and the onset of action is 30 to 60 mins post ingestion [29]. The fact that Lasmiditan is primarily metabolized by non- CYP enzymes suggests that the influence of CYP inhibitors or inducers on its pharmacokinetics is unlikely. This can be advantageous in terms of drug interactions, as it reduces the risk of significant alterations in Lasmiditan levels when co-administered with medications that affect CYP enzymes. On the other hand, the “gepant” class of medications which includes Ubrogepant and Rimegepant, is metabolized by CYP3A4 enzymes. CYP3A4 is a major hepatic enzyme involved in the metabolism of various drugs, and its activity can be influenced by inhibitors or inducers. Therefore, when these “gepant” medications are used concurrently with strong CYP3A4 inhibitors or inducers, it can lead to significant changes in plasma concentrations, potentially affecting their efficacy and safety. In summary, the difference in the metabolic pathways of Lasmiditan and the “gepant” competitors contributes to variations in their susceptibility to drug interactions with CYP inhibitors or inducers. It is essential for health care professionals to be aware of these differences when prescribing or adjusting medication regimens to minimize the risk of adverse effects and ensure optimal therapeutic outcomes. Lasmiditan undergoes oxidation on the piperidine ring to form metabolites M7 and M18, as you mentioned, is a combination of M7 and M8 pathways. These metabolites are considered pharmacologically inactive, meaning they do not contribute significantly to the therapeutic effects of the drug. Regarding excretion, a small portion of the active drug of around 3% is excreted in the urine unchanged. This indicates that a minor fraction of the administered Lasmiditan is eliminated from the body without undergoing significant metabolism [30]. The majority of Lasmiditan is excreted in the urine as the metabolite S-M8, accounting approximately 66% of the total excretion. S-M8 is likely a metabolite formed through some specific metabolic pathway, and while it may be inactive, the elimination of the drug through this pathway contributes to its overall clearance from the body. Understanding the metabolism and excretion of the drug excretion of a drug is crucial for assessing its pharmacokinetic profile, potential drug interactions, and overall safety. It also provides insights into how the body processes and eliminates the drug, which can be important for dose adjustments and considerations in specific patient populations [30].

Adverse effects

Lasmiditan, being a CNS (central nervous system) depressant, can lead to significant adverse events when co-administered with other CNS depressants, such as alcohol. The potential for serious driving impairment is noted, and it's emphasized that patients should refrain from driving a motor vehicle for at least 8 hours after each dose of lasmiditan. This caution is crucial for patient safety, as impaired driving can pose risks to both the individuals taking the medication and others on road [31]. Alternative therapies such as rimegepant and ubrogepant are considered to have a high safety profile with relatively low adverse effects. Dizziness, a common adverse event reported in lasmiditan trials (16% to 18% of participants), is mentioned to occur at less than 2% for both ubrogepant and rimegepant. This suggests that these alternative medications may be associated with a lower incidence of dizziness, making them potentially more tolerable for some individuals [32]. Considering the potential for CNS adverse effects and driving impairment with Lasmiditan, healthcare providers may need to carefully assess individual patient profiles, consider alternative therapies, and provide appropriate guidance on driving restrictions and potential risks.

Abuse Potential

Lasmiditan is a schedule V controlled substance. This classification is determined based on its potential for abuse and the perceived risks associated with its use. In abuse potential studies, lasmiditan was compared with alprazolam, a Schedule IV controlled substance. The "drug liking" scores for lasmiditan were higher than placebo but lower than alprazolam, indicating a lower abuse potential compared to alprazolam. As a result, lasmiditan was classified as a Schedule V controlled substance, while alprazolam remained in the higher Schedule IV category. It's worth noting that the classification of a drug as a controlled substance is influenced by various factors, including its pharmacological properties, abuse potential, and safety profile. The Schedule V classification suggests a lower potential for abuse relative to substances in higher schedules. Drugs like, rimegepant and ubrogepant, are not controlled substances. This difference in regulatory classification may be attributed to variations in their pharmacological profiles and abuse potential.

Understanding the controlled substance status of medications is important for healthcare providers, as it affects prescribing practices, dispensing regulations, and patient education on the responsible use of these substances to mitigate potential risks associated with abuse or misuse [33].

Dosage and Administration

Lasmiditan is available in 50 mg and 100 mg tablets, and the recommended dosing is 50 mg, 100 mg, or 200 mg taken orally as needed for the acute treatment of migraine attacks. It's important to note that a second dose of lasmiditan has not been shown to be effective in clinical studies [34].

Comparison of Ditans with Triptans

Triptans, act primarily on 5HT1B receptor, exert their effects through vasoconstriction. However, their use is contradicted in patients with cardiovascular or cerebrovascular diseases due to this mechanism. Triptans’ efficacy varies, and approximately 40% of migraine attacks do not respond to them adequately. It is uncertain if there is significant CNS component to their efficacy, and the ability of some triptans to penetrate the blood brain barrier is limited. Lasmiditan provides a different mechanism of action compared to triptans.

It is highly lipophilic and capable of crossing the BBB, potentially acting in the central nervous system. This property distinguishes Lasmiditan from triptans and may contribute to its efficacy in migraine treatment. It's important to note that while the CNS effects of lasmiditan are observed, they don't necessarily prove that its efficacy against migraines is solely mediated in the CNS. There is preclinical and ex vivo evidence suggesting that lasmiditan may inhibit both PNS and CNS pain pathways, including the trigeminal nerve, through the modulation of neuropeptides and neurotransmitters such as CGRP and glutamate. The distinct pharmacokinetic and mechanistic features of lasmiditan make it an intriguing alternative for migraine treatment, especially in cases where triptans may not be suitable or effective. The ability to penetrate the BBB and potentially modulate both PNS and CNS pathways adds to the understanding of how lasmiditan may provide relief for migraine sufferers [35].

Drug Interactions

Lasmiditan administration is associated with mean decreases in heart rate, ranging from 5 to 10 beats per minute, which is higher than the decreases observed with a placebo (2 to 5 beats per minute). This indicates a cardiovascular impact of Lasmiditan [36]. Participants in phase III trials who reported taking concomitant heart rate-lowering medications, such as β-blockers, did not experience adverse reactions compared to other treatment participants. This suggests that, in clinical studies, the use of lasmiditan in combination with heart rate-lowering medications was generally well-tolerated [37]. Given its classification as a CNS depressant, caution is advised when using lasmiditan in conjunction with alcohol or other CNS depressant medications, including antiepileptic medications like valproic acid and topiramate used for migraine prophylaxis [38]. As with all drugs interacting with serotonin, there is a theoretical risk of serotonin syndrome with lasmiditan. Caution is recommended when using lasmiditan concomitantly with serotonergic drugs. A medical review of data from phase III studies assessed the risk of serotonin syndrome, and while five possible cases were identified, none were severe or serious, and they did not meet the Hunter Serotonin Toxicity Criteria. The risk of serotonin syndrome with lasmiditan is considered somewhat theoretical, and warnings are included out of caution. It's noted that alternative therapies, such as rimegepant and ubrogepant, do not carry the serotonergic risk associated with lasmiditan. The mechanism of action for rimegepant and ubrogepant involves CGRP signaling rather than serotonin agonism.

Understanding the cardiovascular effects and potential risks associated with lasmiditan is crucial for healthcare providers when making treatment decisions and counseling patients. Individual patient characteristics, medical history, and concurrent medications should be carefully considered to ensure the safe and effective use of lasmiditan for migraine treatment [30].

References

Stovner L., et al. “The global burden of headache: a documentation of headache prevalence and disability worldwide”. Cephalalgia 27 (2007): 193-210.
Available from WHO headache disorders.
Szperka C. “Headache in Children and Adolescents”. Continuum (Minneap Minn) 27 (2021): 703-31.
Eatherall MW. “Acute neurology in a twenty-first century district general hospital”. J R Coll Physicians Edinb 36 (2007): 196-200.
Ender J., et al. “Setting up a specialist headache clinic in primary care: general practitioners with a special interest in headache”. Headache Care 1 (2004): 165-171.
Goads by PJ. “Chapter 422: migraine and other primary headache disorders”. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine 20/E (Vol1 & Vol2). New York, NY: McGraw-Hill Education (2018).
Amiri P., et al. “Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities”. Front Neurol 12 (2022): 800605.
Andreou AP and Edvinsson L. “Mechanisms of migraine as a chronic evolutive condition”. J Headache Pain 20 (2019): 117.
Feigin VL., et al. “Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016”. Lancet Neurol 18 (2019): 459-80.
Shibata Y. “Migraine Pathophysiology Revisited: Proposal of a New Molecular Theory of Migraine Pathophysiology and Headache Diagnostic Criteria”. Int J of Mol Sci 23.21 (2022): 13002.
FDA approves new treatment for patients with migraine.
Frederiksen SD., et al. “Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches”. J Cereb Blood Flow Metab 39.4 (2019): 610-632.
Deen M., et al. “Serotonergic mechanisms in the migraine brain - a systematic review”. Cephalalgia 37.3 (2017): 251-264.
Addla R., et al. “A Novel Abortive Agent for Migraine Therapy - From Triptans to Ditans”. Int J PharmSci Rev Res 80.2 (2023): 144-51.
Bouchelet I., et al. “Differential expression of sumatriptan-sensitive 5-hydroxytriptamine receptors in human trigeminal ganglia and cerebral blood vessels”. J Pharmacol Exp Ther 50.2 (1996): 219-23.
Pascual J., et al. “[3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors”. Eur J Pharmacol 295 (1996): 271-74.
Bouchelet I., et al. “No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery”. Br J Pharmacol 129.3 (2000): 501-08.
Cohen Z., et al. “Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization”. J Cereb Blood Flow Metab 19.8 (1999): 908-17.
Frederiksen SD., et al. “Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches”. J Cereb Blood Flow Metab 39.4 (2019): 610-632.
Razzaque Z., et al. “Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation”. Br J Clin Pharmacol 47.1 (1999): 75-82.
MaassenVanDenBrink A., et al. “Coronary side-effect potential of current and prospective antimigraine drugs”. Circulation 98.1 (1998): 25-30.
Uwe Reuter, Heike Israel and Lars Neeb. “The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine”. Ther Adv Neurol Disord 8.1 (2015): 46-54.
Cameron C., et al. “Triptans in the acute treatment of migraine: A systematic review and network meta-analysis”. Headache 55.4 (2015): 221-35.
Nelson DL., et al. “Preclinical pharmacological profile of the selective 5-HT1F receptor agonist Lasmiditan”. Cephalalgia 30 (2010): 1159-69.
Rubio-Beltrán E., et al. “Characterization of binding, functional activity, and contractile responses of the selective 5-HT 1F receptor agonist Lasmiditan”. Br J Pharmacol 176 (2019): 4681-95.
Oswald JC and Schuster NM. “Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice”. J Pain Res 11 (2018): 2221-27.
Negro A, Koverech A and Martelletti P. “Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potentiall”. J Pain Res 11 (2018): 515-526.
FDA approval.
Ashina M., et al. “Onset of efficacy following oral treatment with lasmiditan for the acute treatment of migraine: integrated results from 2 randomized double-blind placebo-controlled phase 3 clinical studies”. Headache 59 (2019): 1788-1801.
Beauchene JK and Levien TL. “Lasmiditan: Acute Migraine Treatment Without Vasoconstriction”. A Review. J Pharm Technol 37.5 (2021): 244-253.
Pearlman EM., et al. “Effects of lasmiditan on simulated driving performance: results of two randomized, blinded, crossover studies with placebo and active controls”. Hum Psychopharmacol 35 (2020): e2732.
Färkkilä M., et al. “Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study”. Lancet Neurol 11.5 (2012): 405-413.
Wilbraham D., et al. “Abuse potential of lasmiditan: a phase 1 randomized, placebo- and alprazolam-controlled crossover study”. J Clin Pharmacol 60 (2020): 495-504.
Basutkar RS., et al. “Optimal Dosing of Lasmiditan in the Management of Acute Migraine Attack: A Systematic Review and Meta-analysis”. Ann Indian Acad Neurol 24.2 (2021): 155-163.
Clemow DB., et al. “Lasmiditan mechanism of action - review of a selective 5-HT1F agonist”. J Headache Pain 21.1 (2020): 71.
Ferrari MD., et al. “Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan—a randomized proof-of-concept trial”. Cephalalgia 30 (2010): 1170-1178.
Shapiro RE., et al. “Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials”. J Headache Pain 20.1 (2019): 90.
Krege JH., et al. “Safety findings from phase 3 lasmiditan studies for acute treatment of migraine: results from SAMURAI and SPARTAN”. Cephalalgia 39 (2019): 957-966.

The social media channels have absolutely changed our communication mode and have facilitated us with sharing our life with our friends, family, and any other community situated at any part of the world. But such pressure of living up to a digitized perfect life, coupled with the fear of missing out (FOMO), in turn creates inadequacy, loneliness, and anxiety.

One of the major concerns with digital talk is the mistreatment of users through cyberbullying or online harassment. The power of being anonymous online may send some into the online space to be mean and hurtful, with some serious psychological effects on the victim. More so, the virality associated with such cyberbullying or online harassment may elevate the negative, thereby elevating feelings of shame and isolation.

This, in fact, has been fueled by the advent of social media sites, which encourage one to base their life against others' highlight reels. This induces a cycle of comparison that grates at self-esteem and fosters a warped sense of reality in which everyone seems to be living a more glamorous and fulfilling life than you.

Furthermore, misinformation happens in digital dialogues with viral rumors and online conspiracy theories flowing across social media platforms like wildfire. Together, they serve to not only spread suspicion about reliable sources of information but be responsible for increasing states of anxiety and uncertainty about the world that surrounds us.

However, social media carries the potential to promote mental health and form supportive communities during these hard times. A positive shift in a digital dialogue might foster a healthier online habitat where empathy, authenticity, and meaningful connections can be established.

Some proactive approaches to digital well-being include setting time slots to go off the grid or to allow a balance between online and offline life, filtering our online social circles, and paying attention to the quality of content. Other steps include fixing screen time limits, curating digital social circles with positive vibes, and appraising content critically. Furthermore, the promotion of digital and media literacy skills will assist in navigating the online realm and sifting fact from fiction.

This is why, as users, we have to put more emphasis on self-care and taking care of our mental health in the digital space. This might mean taking breaks from social media platforms, ensuring plenty of offline activities for fun and fulfillment, and reaching out to trusted friends or family members—or even mental health professionals—for support whenever necessary.

Besides, it is upon these social media companies to focus their efforts on well-being by including protective measures against cyberbullying, promoting digital literacy, and fostering cultures of kindness and respect online. This can be done through a concerted effort involving all parties, and that is when success is likely to be achieved in maximizing the good that social media can offer and minimizing the harm that can be implicated on the mental health of each. In short, the mental health impact of social media seems complicated and asks for an approach that may work only when it is comprehensive. Create digital well-being: be mindful in your use, utilize it well, and act together to harness the power of digital discourse so that the world has a more inclusive, empathetic, and supportive global village.

People’s illusion of independence provides them joy, but they all depend on each other to sell and buy their products, as necessary, since no one can own or know everything.

Being respectful, honest, and friendly in relationships leads to a good reputation, a successful professional and social life, and a better inner life – core elements for a healthy existence.

Disappointment in relationships with animate or inanimate surroundings grants the darkness to come into your inner life, disturbing personal health and interaction with others. In such circumstances, unhealthy eating habits, more alcohol use, and improper communication are often noticed, and they do not represent a good solution. Route cause analysis of the problem, balancing stressors with other beneficial habits that provide well-being, such as lectures of interest, selected musical programs, the comfort of virtual or real communication with friends and loved ones, walking, painting, and writing must be considered. Favoured and exciting things and actions and professional support from loyal friends, dear ones, and experts in this field can alleviate depression. Sadness and frustration bring sleep disturbance, which can be the starting point for many dysfunctions in the human body; quickly repaired, we provide a light way for life in this perceptible, temporary world.

When a relationship fails, the inner voice can guide personal advancement and creativity for remediation to attain a peaceful inner life.

Doubts and emotional involvement frequently make us oscillate in decisions; each verdict has its way of predicting life’s hazardous game.

Standing trustworthy, kind, and polite usually protects us from disillusionment and extends our relationships.

Life’s ups and downs continuously appear, preferable to making us more robust, more prudent, and wiser in breaking barriers.

Choosing a positive work environment, having loyal collaborators, being honest and respectful, having friendly connections with others, and aligning with social norms contribute to a successful personal, professional, and social life. This, in turn, leads to a peaceful inner life and overall well-being.

Taking time to think about our role, accomplishments, and pitfalls, identifying our weaknesses and strengths, working to overcome obstacles, helping the creators of errors repair their inaccuracy, and being careful in choosing partners/collaborators benefit us by offering a shining inside private and holy room - a peaceful light for relaxation and meditation.

Cherishing and delightful moments in this natural and ephemeral world are essential to a prosperous and healthy existence.

Aim: Prostate cancer, one of the most common cancer among men and a cancer that can vary significantly in its aggressiveness, will cause more deaths in the future with its increasing incidence. Gleason score has been defined as the most reliable and autonomous predictor of prostate cancer outcomes. The study aim to determine the variables affecting Gleason score and indirectly to establish prognostic indicators for prostate cancer.

Material and methods: The variables in the data set were analyzed according to the dependent variable categories Independent sample test and Mann Whitney U test were used in statistical analyses and p<0.05 was considered significant. Analyses were performed with IBM SPSS 26.0. In the modeling phase, the relationship between the grouped form of Gleason score and other variables was examined with Multilayer Perceptron and Radial Basis Function Neural Network methods. The dataset was divided into training and test datasets in a 70:30 ratio. The results are reported using accuracy, balanced accuracy, sensitivity, specificity, PPV, NPV and F1 score as performance metrics.

Results: The data set used in the study consists of variables belonging to 97 patients. The mean age of the patients was 63.87 years. Patients were divided into two groups: those with a Gleason value of 7 and above and those with a Gleason value below 7. There were 35 patients with a Gleason value below 7 and 62 patients with a Gleason value above 7. According to the results obtained from the modeling, the best result was obtained from the Multilayer Perceptron model. accuracy, balanced accuracy, sensitivity, specificity, positive predictive value, negative predictive value and F1 score were 96%, 100%, 93.3%, 90.9%, 100%, 95.2%, respectively.

Conclusion: The study obtained highly accurate classification results when modeling with Gelason score categories and other independent variables. This shows that machine learning models can be used effectively and successfully in medical data. Furthermore, important variables were identified and their indirect associations with prostate cancer were revealed. In the future, more detailed research on prostate cancer can be conducted by focusing on these variables.

Keywords: Prostate cancer; Gleason score; modelling; classification

Background: The recent results published in the annual report HOLOGIC GLOBAL WOMEN’S HEALTH INDEX have shown that Italian women are among the least involved in cancer prevention programs: in fact, only 11% have undergone an organised screening pathway in the last 12 months, while the average in Europe is 20%.

Aim: Through an active call, a path of proactive medicine has been realized by attracting all women between 40 and 74 whose computerized medical records did not show the execution of a mammography in the last two years.

Material and Methods: Starting from MilleWin medical records management software, MilleGPG search engine has been used to extract from the total number of patients (1630) all women between 40 and 74 years who had not performed a mammography in the last two years. The women were contacted by telephone by the clinic nurse, who ascertained that the mammogram had not been performed during the previous two years and, in compliance with the regional guidelines of breast cancer screening, short motivational counselling was carried out to highlight the importance of prevention and achieve individual empowerment in order to increase adherence to screening. In detail, for the achievement of the goal, a dematerialized prescription was sent to women aged between 40 and 44, those aged 44 to 49 were sent a dematerialised prescription with an exemption code, while women aged 50 to 74 were redirected to organised regional screening. Women with a previous diagnosis of breast cancer were excluded from the active call.

Results: In a group of 874 women, out of a total of 1630: 53 were in the 40-44 age group, 72 in the 45-49 age group, 313 in the 50-74 age group, and 36 (4%) had had a breast cancer. The extrapolation of the data from the medical records showed that there were no results of mammography performed in the previous two years in: 24 out of 53 in the 40-44 age range, 37 out of 72 in the 45- 49 age range and in 156 out of 313 in the 50-74 age range.

All these patients were contacted by phone with a confirmation of not having performed a mammography in 11 out of 24 women in the 40-44 age group; in the 45-49 age group 4 out of 37 women had performed one more than 2 years ago and 10 had never performed one; in the 50-74 age group 60 out of 156 women had performed a breast screening more than 2 years ago while 5 had never performed one. 37 patients never answered the active call. The total analysis showed that 217 women were not reported in the folder, 37 of these did not respond, 90 had performed the test without declaring it and 90 other were redirected to screening.

Conclusions: Our study project confirmed that Italian women adhere less to cancer screening than women in other European states, the reasons are multiple but the prevailing cause is the workload and the same dedication to the family that characterizes the Italian woman as the caregiver of the whole family. Despite the many reasons, the numerous organizational obstacles and the different strategies between the Regions, the structuring of a proactive medical path allows to increase the adhesion to cancer screening by realizing without additional costs a support and a strengthening in Primary Care to the network of organized screening. This project shows that proximity medicine also serves to produce health and not only to provide social and health care, and that the “microteam” of the Primary Care Physician can be a valid territorial unit in cancer screening.

Keyword: cancer screening; proactive medicine; proximity health services; motivational; counselling

The major industrialised countries have significantly contributed to global warming with unprecedented magnitude. It is worth noting that the major polluters are; China, India, and United States of America including Brazil. These countries have many industries which emit their affluence to the atmosphere, inform of ‘black carbon dioxide and methane gases’. This has led to global warming and climate change. Melting of junks of ice in North Pole and Alaska increased the volume of water in seas and oceans of the world thus causing unprecedented floods. Again, the widespread use of fossil fuel, and episodes of wild fire has significantly damaged the environment and contributed to global warming and climate change.

The world’s energy systems are still dominated by fossil fuels. However, it is imperative that countries scale down the use of fossil fuel usage to save the planet earth. Again, carbon dioxide usage should be taken out of the power sector by phasing out coal facilities. There is a dire need to increase the uptake of renewable energy around the world. Limit global warming to 1.50C and reduce greenhouse emissions. The said countries have promised to reduce fossil fuel and industrial pollution by 25 to 30 percent by 2030. It is easier to say but are we likely to witness tangible action?

Global actors need to institute actions to limit climate change, and avoid unacceptable risks to global health. Fund initiatives for climate change and implementation public health measures to reduce number of deaths from cancer, respiratory and cardiovascular diseases that are caused by air pollution, risks from extreme weather events, infectious disease, diminishing water supplies, and food insecurity. Public health specialists have a fundamental role in leading by example, primarily by: a) Raising awareness of the health effects of climate change and the potential health co-benefits of low carbon pathways. b) Contributing to the development and implementation of measures to limit climate change and protect people in workplaces, and communities; c) Working to minimize the environmental impacts on health systems, while improving health services.

References

Acuña Acuña EG. “Analysis of the Impact of TIC on Higher Education in Latin America”. International Journal of Educational Technologies 9.1 (2022): 15-29.
Acuña Acuña EG. “Application of Data Mining and Internet of Things (IoT) for Biomedical products”. Technology Review International Magazine Technology, Science and Society 13.1 (2023).
Acuña Acuña EG. “Strategies to Promote Research in Engineering Students in Latin American Universities”. New trends in qualitative research 17 (2023): e867.
Alhatem A, Wong T and Lambert WC. “Revolutionizing diagnostic pathology: The emergence and impact of artificial intelligence—what doesn't kill you makes you stronger?”. Clinics in Dermatology (2024).
Alvarez-Alvarez C and Obregón-Agüero E. “Analysis of reading plans in secondary education centers”. Biblios Journal of Librarianship and Information Science 85 (2023): 81-93.
Araújo CA. “Bibliometrics: historical evolution and current issues”. In question 12.1 (2006): 11-32.
Gupta M, Pandey D and Kumar P. “Digital transformation in robotic rehabilitation and smart prosthetics”. Digital Transformation in Healthcare in Post-Covid-19 Times. Academic Press (2023): 79-93.
Hall MJ., et al. “Innovations in pediatric prosthetics”. Journal of the Pediatric Orthopaedic Society of North America 3.1 (2021): 221.
Lestari WD., et al. “Optimization of 3D printed parameters for socket prosthetic manufacturing using the Taguchi method and response surface methodology”. Results in Engineering 21 (2024): 101847.
Philippi D., et al. “Scientific and technical human capital in university-business technology transfer: the case of a radical innovation”. Management & Technology Magazine 23.4 (2023): 508-527.
SANTOS ADM., et al. “Industry 4.0 as a facilitator of sustainability for small and medium-sized businesses”. Academia Latin American Journal of Administration. Print advance (2024).
Silveira CZ and Dias TMR. “The reuse of research data from the perspective of Information Science”. Biblios Journal of Librarianship and Information Science 86 (2024): 41-57.
van Dun DH and Kumar M. “Social enablers of Industry 4.0 technology adoption: transformational leadership and emotional intelligence”. International Journal of Operations and Production Management 43.13 (2023): 152-182.
Vieira LP and Pereira RM. “Effects of smoking on labor income: new evidence for Brazil”. Economy. Print advance (2024).
Yadav S., et al. “Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry”. Intelligent Pharmacy (2024).
Yang Y., et al. “Linking relationship-specific investments and sustainability performance: The mediating role of supply chain learning”. International Journal of Operations and Production Management 43.8 (2023): 1329-1356.
Zamora Cordero M., et al. “Optimizing mechanical design for an additively manufactured prosthetic leg”. Procedia Computer Science 232 (2024): 2973-2983.

Introduction: This study shows into the technological revolution of connected medical devices, which are redefining the landscape of disease monitoring, diagnosis, and treatment. It explores how the integration of cutting-edge technologies is propelling personalized and remote healthcare services.
Objectives: The primary aim is to evaluate recent advancements in connected medical devices and their impact on enhancing disease monitoring and diagnostic accuracy. The research explores how these technologies are reshaping healthcare dynamics and identifies associated challenges and opportunities.
Methodology: A qualitative approach anchors the research, linking investigative questions with theoretical frameworks and empirical findings. The study scrutinizes wearable devices and implantable systems, integrating a comprehensive literature review with expert interviews and data analysis. This methodological framework enables an in-depth understanding of the interplay between technological innovation and medical practice.
Results: Findings highlight that connected medical devices significantly enhance precision and efficiency in healthcare delivery, enabling real-time patient monitoring and improved clinical decision-making. While technical, ethical, and regulatory challenges are identified, the study also underscores innovative solutions to address these hurdles effectively.
Conclusions: The research emphasizes the importance of qualitative methodologies in examining the realm of connected medical devices. It stresses the need for a robust methodological framework to assess both technological advances and associated challenges thoroughly. This study contributes to a deeper understanding of how connected medical devices are transforming healthcare, highlighting the need for integrated and multidisciplinary approaches to maximize their benefits and mitigate risks. The analysis concludes that connected medical devices could be the key to a future where digital health is at the core of a more inclusive and resilient healthcare system. This study acts as a catalyst in the debate on the digitization of healthcare, proposing strategic directions for future research and policies.
Keywords: Connected medical devices; Remote monitoring; Digital diagnosis; Health technology; Hyperconnectivity

Aim: To define and evaluate the role of Apulian General Practitioners in regarding the prescribing appropriateness of antibiotics and the importance of counseling for patients, to identify and manage the problem of ABR, particularly in the context of upper respiratory tract infections.
Materials and methods: the survey was conducted through the administration of a questionnaire consisting of 10 items addressed to the GPs of the Apulian territory, in the period from January to April 2024, by email, instant messaging and social media.
Results: 180 General Practitioners were interviewed, (58% women 42% men) of which 45% GPs with >1500 patients, 32% urgent care doctors, 16% GPs with 1200-1500 patients, 3% GPs with 1000- 1200 patients and 5% GPs with 800-1000 patients.
65% of GPs (n:117) prescribe an average of 5 antibiotics per week, 22% of GPs (n:39) prescribe 6-10 antibiotics and 13% (n:24) more than 10 antibiotics. Patients ask for antibiotics for the following reasons: pharyngitis (68%), urinary tract infections (69%), cough (40%), acute bronchitis (44%), otitis (23%), sinusitis (18%), cold (16%), other flu symptoms (15%). General Practitioners report that every day on average at least one patient requires a prescription for an antibiotic for a pharyngitis. In 33% of cases it is a woman (33%), very insistent (52%), arguing the need to resume her work activity as soon as possible (34%), for self-diagnosis (32%) for comparison with family members with similar symptoms who would have been prescribed an antibiotic (32%), for having started home therapies, residues of previous therapies.
GPs report a patients’ poor awareness about side effects, compared to the deep-rooted belief that the antibiotic guarantees a quicker and better resolution of symptoms.The proposals to stem the phenomenon from the GPs interviewed suggest patient education to limit improper requests (79%), counseling not to use antibiotics in viral infections (77%), information on individual adverse events linked to abuse (56%), empowerment regarding the impact on the global health of the planet and the growing difficulty in treating infections caused by resistant germs (52%), synergistic action with pharmacists (48%), greater diffusion and training for the application of treatment guidelines in primary care (19%) and more frequent updating on the issue of AMR (15%).
Regarding the use of diagnostic tests such as the rapid test for beta hemolytic streptococcus, although little used in general practice, the majority of participants (80%) consider it strategic to avoid inappropriate antibiotic therapies and guide the patient towards its use of symptomatic. 83% of GPs recommend the use of anti- inflammatory-analgesics for the management of "sore throats" and confirm the need to combat the abuse of antibiotic therapy requests.
Conclusions: Antibiotic resistance is a multifactorial public health issue that requires urgent prevention and control actions at global and cross-sectoral. General Practitioners in Apuglia have a fundamental role on the correct use of antibiotics. It is necessary to promote health education and patient counseling, citizen empowerment about good hygiene practices (use of DPI, hand washing, etc.), attention to environmental contamination (e.g. waste disposal); to encourage adherence to vaccination and the appropriate use of antibiotic or symptomatic therapies for themselves and for the community; to reduce the tendency to self- prescribe antibiotics and the adverse events related to it, such as the percentage of treatment failures and healthcare costs; to apply the guidelines in pharmaceutical prescriptions; to join collaborative, research and innovation initiatives to combat ABR.
A possible helpful tool may be the use of rapid diagnostic tests to reduce the inappropriate prescription of antibiotics. We need to move from a simple idea of appropriateness in prescription to an overall cultural appropriateness of a healthcare nature.
In fact, General Practitioners can act effectively only with other stakeholders, to trigger virtuous processes, respecting the skills and responsibilities of each individual, in order to always be able to operate for the best clinical outcome, in the absence of ethical conflicts. At the same time, we hope for more training opportunities for healthcare workers, pharmacists and veterinarians, in integrated multi-sectoral events, according to the principles of One Health.
Keywords: antibiotic resistance; General Practitioners; sore throat

References

Dhanush Krishna BJ, Suguna RY and Satyanarayana MU. “Serum insulin levels and lipid profiles of streptozotocin induced diabetic wistar rats”. J. Ind. Vet. Assoc., Kerala 10.2 (2014): 26.
World Health Organization. Traditional Medicine, Fact sheet. NA 134 (2001).
Nnam NM, Onyechi UA and Madukwe E. “Nutrients and phytochemical composition of some leafy vegetables with medicinal significance Nig”. J. of Nutr. Sci 33.2 (2012): 15-19.
Fifa TV., et al. “In vivo biological effects of two antidiabetic medicinal plants used in Benin as folk Medicine”. J Clinc. Proteomics (2013).
Elizues RC., et al. “Use of traditional medicine intreatment of diabetesin eastern Uganda, A qualitative exploration for reasons for choice”. Journal of International Health and Human Right 3 (2013): 145-147.
Harborne JB. “Phytochemical methods: a guide to modern techniques of plant analysis”. Chapman and Hill, London, (1973): 182-201.
Boham BA and Kocopal -Abiyazan R. Flavonoid and condensed tannin from the leaves of hawiian vaccinium vaticulatium and V. calycinium Parcific science (1994).
Olivera CS. Nutraceutical phytochemicals and antioxidants, Extension fact sheet HYG.5050 (2003).
Lorke D. “A new approach to practical acute toxicity testing”. Arch. Toxicol 53 (1984): 275-289.
Lott JA and Turner K. Evaluation of trunders glucose oxidase method for measuring the blood glucose, AHM Viswanatheis (1975).
Albers JJ, Warmick GR and Cheng MC. “Determination of high density lipoprotein (HDL)-cholesterol Lipid”. Journal of Lipid Biochemistry 13 (1978): 926-932.
Assman GN., et al. Determination of low density lipoprotein cholesterol Clinical Chemical Acts 140 (1984): 77-83.
Trinder P. “Determination of blood glucose using an oxidase peroxide system with non-carcinogenic chromogen”. Journal of Clinical and Chemical Pathology 22 (1969): 158-161.
Allian CE., et al. “Enzymatic determin ation of serum Cholesterol”. J of Clin Chem 20 (2012): 470-475.
Reitman S and Frankel S. “Colorimetric Point Method”. American J. Pathology 28 (1957): 56-63.
Bamisaye FO., et al. “Evaluation of hypoglycemic and toxicological effects of extracts of Morinda lucida in hyperglycemic albino rats”. International Research Journal of Biochemistry and Bioinformatics 3.2 (2013): 37-43.
Akroum S. “Analytical and Biological Study of Natural Flavonoids”. Ph.D thesis. pp. 113, Mentouri University of Constantine, Algeria (2011).
Ugochukwu HN and Babady NE. Antioxidant effects of Gongronema latifolium in hepatocytes of rat models of non-insulin dependent diabetes mellitus (2002).
Kenjiro TD., et al. “Inhibition of alpha glucosidase and alpha amylase by flavonoids”. J. Nutr. Sci 52.2 (2006): 149-153.
Alyemeni ME, Basahy AG and Sher HP. “Physico-chemical analysis and mineral composition of some sesame seeds (Sesamum indicum L.) grown in the Gizan area of Saudi Arabia”. J. Med. Plants Res 5.2 (2011): 270-274.
Morel ST. “Phytochemical and biological evaluation of Derrisferruginea Benth”. (Fabaceae). University of Angers, Int. J. Curr. Microbiol. App. Sci 2.8 (2011): 1-13.
Hanhineva KZ, Torronen RP and Bonica-pons II. “Impact of dietary polyphenol on carbohydrate metabolism”. Int.J Moi Sci 11.4 (2010): 1365-1402.
Otamere HO., et al. “Lipid profile in diabetes mellitus; what impact has age and duration”. British Journal of Pharmacology and Toxicology 2.3 (2011): 135-137.
Inbaraj SD and Inbaraj GJ. “Comparative study of lipid and glycemic effects of pioglitazone, rosiglitazone with glibenclamide in patients with type 2 Diabetes and Dyslipidemia”. Global Journal of Pharmacology 8.1 (2014) 107-113.
Ugochukwu SC, Arukwe UI and Onuoha I. “Preliminary phytochemical screening of different solvent extracts of stem bark and roots of Dennetia tripetala G. Baker”. Asian Journal of Plant Science and Research 3.3 (2013): m 10-13.
Edet EN., et al. “Effect of Gongronema latifolium Leaf Extract on some Liver Enzymes and Protein Levels in Diabetic and non-Diabetic Rats”. J. of Pharm. and med (2012).
Rajkapoor B., et al. “Protective effect of Phyllanthus polyphyllus on acetaminophen induced hepatotoxicity in rats”. Pakistan Journal of Pharmaceutical Sciences 21 (2008): 57-62.

References

Statistics versin8.0 data analysis and visualization program---
American people through the United State Agency for International Development (USAID) (2022).
Mahgoub O., et al. “Effects of feeding ensiled date palm fronds and by product concentrate on performance and meat quality of Omani sheep”. Anim. Feed Sci.Technol 135 (2007): 210-221.
Denek N and A Can. “Feeding value of wet tomato pomace ensiled with wheat straw and wheat grain for Awassi sheep”. Small Rumin. Res 65 (2006): 260-265.
Omar AJM. “Effect of feeding differentlevels of sesame oil cake on performance and digestibility of Awassi lambs”. Small Rumin. Res 46 (2002): 187-190.
Obeidat BS and BH Alowaily. “Using sesame hull in Awassi lambs diets:its effect on growth performance and carcass characteristics and meat quality”. Small Rumin Res 91 (2010): 225-230.
MAR. Planning Administration Annual Report. Khartoum, Sudan: Ministry of Animal Resources (2003).
Boyazoglu J and Morand –Fehr P. “Mediterranean dairy sheep and goat products and their quality”. A review. Small Rumin. Research 40 (2001): 1-11.
Belal S Obeidat and Firas F Gharaybeh. “Effect of feeding sesame hull on growth performance, nutrient digestibility, and carcass characteristics of Black goats kids”. Asian. J. Anim. Sci 24.2 (2011): 206-213.
Babikir AB. “Effect of sesame residues (song) in fattening diets on increasing weight of Hammari lambs”. M.S.c (Ainm. Prod.) Thesis, Univer. Of Kordofan, Sudan (2020).
Ismail K., et al. The effect of adding waste sesame seeds to diets on performance, carcass characteristics ad meat fatty acid composition of Karayaka lambs 69 (2022): 183-189.
Obeidat BS and BH Alowaily (2011).
Obeidat BSAY Abdullah and FA Al-Lataifeh. “The effect of partial replacement of barley grains by Prosopis juliflora pods on growth performace, nutrient intake, and digestibility and carcass characteristics of Awassi lambs fed finishing diets”. Anim. Feed Sci. Technol 46 (2008a): 42-54.
Lanza M., et al. “Peas (Pisum sativum L) as an alternative protein source in lamb diets: growth performance, carcass and meat quality”. Small Rumin. Res 47 (2003): 63-68.

Health system designers often fail to consider the overwhelming nature of the tasks they assign to the average individual in modern society. This exhaustion leads individuals to disregard health and treatment advice and lack the willingness to carry out these actions.

It is necessary to execute many of these acts using various and pleasurable approaches. Enjoyment and reinforcement play a crucial role in driving motivation, facilitating learning, experiencing emotions, and maintaining physiological balance (allostasis) [1]. As an alternative, individuals are encouraged to engage in enjoyable physical activities, such as swimming, rather than engaging in monotonous and tedious repetitive movements.

Meanwhile, one approach to administering certain compounds to the digestive system involves the consumption of appetising foods or specialised chewing gums.

Here are some items that can be made using chewing gum: A chewing gum that includes vitamin B6 and ginger is designed to prevent car sickness and aeroplane sickness. Another option is mint chewing gum, which has basic properties that help avoid bloating or refluxing. Edibles or saffron gums can be used to energise, while herbal gums with therapeutic effects, such as those containing turmeric, can help reduce joint inflammation. So, based on the advantages of using chewing gum as an innovative method of delivering drugs, such as its ability to simultaneously provide local and systemic delivery, protect against acids and enzymes, have low first pass metabolism, enhance alertness and cognitive function, and maintain good stability, it can be inferred that chewing gum will become increasingly popular among patients and in the market in the coming years. Some examples are: remedies for motion sickness, pain, smoking, dental caries, tooth decay, various mouth diseases, otitis media, gastrointestinal problems, oral fungi, and inflammatory issues [2, 3].

Chewing gum is an effective oral delivery system that offers increased effectiveness, the ability to remove gum at any time, reduced risk of overdosing, and no water requirement. It provides protection against chemical or enzymatic attacks in the gastrointestinal tract, making it popular among children and teenagers. Chewing gum has a low first-pass effect. It is suitable for rapid delivery and has fewer side effects. It also has good stability against light, oxygen, and moisture. Chewing gum can help alleviate xerostomia, improve work performance, and reduce pain and swallowing difficulties after tonsillectomy. It also stimulates alertness and reduces food cravings [2, 4, 5].

Chewing sugar-free gum (SFG) decreases the amount of Streptococcus mutans bacteria in the mouth compared to individuals who do not chew gum. Given the extent of variation in the impact and the moderate quality of the trials analysed, further study is necessary to investigate the potential of sugar-free gum as a preventive intervention for reducing the presence of cariogenic oral bacteria [6].

Paying attention to subtle details, such as suggesting that industrial drugs and supplement producers create different types of chewing gum and various foods, is a seemingly straightforward approach that can enhance the efficacy of health recommendations and facilitate the delivery of specific substances. The technology required to introduce chewing gum as a viable substitute for various types of tablets in the healthcare system is not yet developed and comprehensively understood. This is due to the need for further exploration and acquisition of information and knowledge on the manufacturing of chewing gums.

References

Sander D and Nummenmaa L. “Reward and emotion: an affective neuroscience approach”. Current Opinion in Behavioral Sciences 39 (2021): 161-167.
Aslani A and Rostami F. “Medicated chewing gum, a novel drug delivery system”. Journal of research in medical sciences 20.4 (2015): 403-411.
Indhumathi S and Kumar KS. “A review on medicated chewing gum and its role in mouth ulcers”. Research Journal of Pharmacy and Technology 13.1 (2020): 481-484.
Imfeld T. “Chewing gum—facts and fiction: a review of gum-chewing and oral health”. Critical reviews in oral biology & medicine 10.3 (1999): 405-419.
Asija R, Patel S and Asija S. “Oral dosages form: Medicine containing chewimg gum: A review”. Journal of Drug Delivery and Therapeutics 2.6 (2012).
Nasseripour, M., et al. “A systematic review and meta-analysis of the role of sugar-free chewing gum on Streptococcus mutans”. BMC oral health 21.1 (2021): 217.

The increasing development of digital technologies in recent years has led to a concomitant increase in the availability of data in ICUs. For this vast amount of information to be useful, it must be processed and analyzed to extract meaningful information. However, its size and complexity often exceed the capabilities of traditional tools, motivating ongoing research efforts to develop new analytical techniques better able to address these challenges. This effort has resulted in the maturation of disciplines such as artificial intelligence, machine learning (ML), data mining (LLM), parallel computing, and many others. Despite these advances, countless challenges of modern computing remain unaddressed and strategies to extract knowledge from complex data will undoubtedly persist as an active area of research in the years to come.

Real-time risk estimation of isolated pathologies provides interpretable information to understand the different risks of patients with multiple pathologies using electronic health records (EHRs) in an ICU patient; However, in this case there are fundamental problems when formulating hypotheses such as sample selection bias, imprecise variable definitions, implementation limitations, frequency of variable measurement, subjective treatment assignment and model overfitting.

Decision-making and predictive models (CDSS), on the other hand, are not yet widely developed with the current known health systems. However, their potential based on massive data sources, allows with the structured data of data lakes, to perform artificial intelligence (AI) to improve training and control for algorithms according to the different requirements and security that we must carry out and that we will build for the different syndromes. Here we present an CDSS model that captures data from public ICUs and we show in our report the potential data mining, for later analysis with different predictive models.

We highlight that with the current results of a public ICU, through a Smart ICU there is 0.003% that corresponds to EHR data and only 3.97% is structured data in data lakes that are susceptible to useful algorithms -at the present time- for an CDSS system.

Keywords: Data sources; Intensive Care Units; CDSS; Artificial Intelligence; Interoperability; EHR

Whether in-person or virtual transactions, effectiveness requires three essential elements for the benefit of producers and buyers:

The exchange of quality products.
Skills in presenting and selling the products.
Trustful and respectful relationships among collaborators.

The quality of product exchange depends on expertise in the domain prepared for and the production process. Nobody wants to buy goods or services of inferior quality, as it leads to unsatisfactory usage, affects their finances, and wastes time. This disappoints buyers and drives them to seek other suppliers for future transactions, ultimately reducing the provider’s return on investment and negatively impacting their business stability and growth.

Skills in presenting and selling products involve effectively communicating the value of preferred products at a lower cost than the competitor while showcasing higher quality.

Trustful and respectful relationships among collaborators provide them with the comfort of communication. The pricing decisions made by providers reflect their fairness in business. If the producers overestimate their goods and set an inflated price, the buyers will be disappointed when compared with their competitors’ offerings. They will consider them as disrespectful and untrustworthy providers and avoid further relationships with them.

If a buyer is unaware of the prices of a particular product in the market and the provider overcharges them, this can also negatively impact the buyer and may lead them to seek similar products elsewhere later. The buyer is likely to share their dissatisfaction with others, causing a negative ripple effect on the provider's reputation. This can result in decreased investment returns and instability for the provider's business.

Hence, a disrespectful relationship impacts all parties involved in exchanging products.

People must recognize the importance of being fair in all dealings. Unfair practices in selling products or services can harm consumers’ inner lives and discouragement disrupts their overall balance.

By contrast, product quality offerings, price adjustments to the customer’s financial capabilities in a given area, philanthropic activities when required, and providing necessary goods to help those in need are essential for a better life.

In summary, the way we treat others when selling our products reflects our reputation in the community; it provides information about how we establish and maintain relationships with those interested in our products. This, in turn, impacts our social and professional life trajectory in a constantly changing virtual and real world.

Each selects their path for advancement according to personal preferences and being informed.

References

Almulla MA. “The effectiveness of the project-based learning (PBL) approach as a way to engage students in learning”. Sage Open 10.3 (2020).
Bell S. “Project-based learning for the 21st century: Skills for the future”. The clearing house 83.2 (2010): 39-43.
Brown K, Covell K and Abramovitch R. “Time course and control of emotion: Age difference in understanding and recognition”. Merrill-Palmer Quarterly 37 (1991): 273-287.
Burns JM. “Leadership”. Harper & Row (1978).
Butler P and Farah H. “‘Put learners first’: Unesco calls for global ban on smartphones in classrooms”. The Guardian (2023).
Cialdini RB. “Influence: The psychology of persuasion (Rev. ed.)”. Harper Business (2021).
Cohen M. “Companies are learning that Gen Z isn’t the easiest generation to work with”. CNBC (2023).
Coleman NV and Williams P. “Looking for my self: Identity-driven attention allocation”. Journal of Consumer Psychology 25.3 (2015): 504-511.
Crump JR. “Learning by doing: Implementing community service-based learning”. Journal of Geography 101.4 (2002): 144-152.
Cunnington R. “Neuroplasticity: How the brain changes with learning”. IBE-Science of learning portal (2019).
Denham SA and Grout L. “Socialization of emotion: Pathway to preschoolers’ emotional and social competence”. Journal of Nonverbal Behavior 17 (1993): 205-227.
Drucker PF. “Managing in a time of great change”. Truman Talley Books (1995).
Eldridge A. Generation Z. Britannica (2024).
Eisenberg N and Fabes RA. “Empathy: Conceptualization, assessment, and relation to prosocial behavior”. Motivation and emotion 14.2 (1990): 131-149.
Feinberg RA. “The social nature of the classical conditioning phenomena in people: a comment on Hunt, Florsheim, Chatterjee, and Kernan”. Psychological Reports 67.1 (1990): 331-334.
Fischer KW, Shaver PR and Carnochan P. “How emotions develop and how they organize development”. Cognition and emotion 4.2 (1990): 81-127.
Florida National University. Why is Community Service Important? (2013).
Francis T and Hoefel F. “‘True Gen’: Generation Z and its implication for companies”. McKinsey & Company 12 (2018): 1-10.
Gardner HE. “Multiple intelligences: New horizons in theory and practice”. Basic books (2006).
Gardner HE. “The minds new science: A history of the cognitive revolution”. Basic books (1987).
Goleman D. “Working with emotional intelligence”. Bantam (1998).
Goleman D. “Emotional intelligence: Why it can matter more than IQ”. Bantam (1995).
Guo P., et al. “A review of project-based learning in higher education: Student outcomes and measures”. International Journal of Educational Research 102 (2020): 101586.
Hazard R. “Project-based learning for sustainable development: An open educational research framework for design”. In The Barcelona Conference on Education 2023: Official conference proceedings (2023): 879-893.
Häkkinen P., et al. “Preparing teacher-students for twenty-first-century learning practices (PREP 21): A framework for enhancing collaborative problem-solving and strategic learning skills”. Teachers and Teaching 23.1 (2017): 25-41.
Higgins ET. “Beyond pleasure and pain: How motivation works”. Oxford University Press (2012).
Ho WYW. “Principal component analysis: development and initial validation of the mirror effects inventory”. BMC Psychology 11.1 (2023): 363.
Hong R. “Rising school drop-out rates among boys a growing worry”. The Phnom Penh Post (2023).
Hunt E. “Is modern life ruining our powers of concentration?”. The Guardian (2023).
James C. “7 business strengths (& weaknesses) of Gen Z”. LinkedIn (2023).
Jollands M, Jolly L and Molyneaux T. “Project-based learning as a contributing factor to graduates’ work readiness”. European Journal of Engineering Education 37.2 (2012): 143-154.
Kahn BE and Baron J. “An exploratory study of choice rule favored for high-stakes decisions”. Journal of Consumer Psychology 4.4 (1995): 305-328.
Krajcik JS and Shin N. “Project-based learning”. In Sawyer, R. K. (Ed.). The Cambridge Handbook of the Learning Sciences, Cambridge University Press (2014): 275-297.
Krajcik JS and Blumenfeld PC. “Project-based learning”. In Sawyer, R. K. (Ed.). The Cambridge Handbook of the Learning Sciences, Cambridge University Press (2006): 317-334.
Khmer Times. Students told to sharpen skills, become business leaders (2023).
Klemm WJ. “How does learning change the brain?”. Psychology Today (2020).
Lazarus RS. “Cognition and motivation in emotion”. American Psychologist 46.4 (1991): 352-367.
LeDoux JE. “The emotional brain: The mysterious underpinnings of emotional life”. Simon & Schuster (1998).
LeDoux JE. “Emotional memory systems in the brain”. Behavioural brain research 58.1-2 (1993): 69-79.
Lee D, Huh Y and Reigeluth CM. “Collaboration, intragroup conflict and social skills in project-based learning”. Instructional science 43.5 (2015): 561-590.
Lift Learning. The history of project-based learning (PBL) (2021).
Loyens SM., et al. “Problem-based learning as a facilitator of conceptual change”. Learning and Instruction 38 (2015): 34-42.
Manning G and Curtis K. “The art of leadership”. McGraw-Hill Education (2009).
Marino MT., et al. “An analysis of factors that affect struggling readers’ achievement during a technology-enhanced STEM astronomy curriculum”. Journal of Special Education Technology 25.3 (2010): 35-48.
Mayer JD and Geher G. “Emotional intelligence and the identification of emotion”. Intelligence 22.2 (1996): 89-113.
Mayer JD and Salovey P. “Emotional intelligence and the construction and regulation of feelings”. Applied and preventive psychology 4.3 (1995): 197-208.
Miller EC and Krajcik JS. “Promoting deep learning through project-based learning: A design problem”. Disciplinary and Interdisciplinary Science Education Research 1.1 (2019): 1-10.
Salovey P and Sluyter DJ. (Eds). “Emotional development and emotional intelligence: Educational implications”. Basic Books (1997).
Salovey P and Mayer JD. “Emotional intelligence”. Imagination, Cognition and Personality 9.3 (1990): 185-211.
Shoichet CE. “Debunking this myth about Baby Boomers also reveals something about Gen Z”. CNN (2023).
Sviatko M. “Beyond classrooms: How project-based learning fosters the development of emotional competencies”. ResearchGate (2023).
Sviatko M. “Cambodia’s pathway to Education 4.0”. Journal of Accounting, Finance, Economy, and Social Sciences 5.1 (2020): 1-8.
Thompson RA. “Socioemotional development: Enduring issues and new challenges”. Developmental Review 13.4 (1993): 372-402.
Turk DB and Berman SB. “Learning through doing: A project-based learning approach to the American civil rights movement”. Social Education 82.1 (2018): 35-39.
Wintre MG and Vallance DD. “A developmental sequence in the comprehension of emotions: Intensity, multiple emotions, and valence”. Developmental psychology 30.4 (1994): 509-514.
World Bank. (n.d.). GDP per capita (current US$) - Cambodia. World Bank Open Data.
Yuliani Y and Lengkanawati N. “Project-based learning promoting learner autonomy in an EFL classroom”. Indonesian Journal of Applied Linguistics 7.2 (2017): 285-293.

The aim of the study: To conduct a medical and sociological survey among doctors in 4 Commonwealth of Independent States (CIS) countries for the effectiveness of the implementation of secondary prevention of noncommunicable diseases (NCDs) in outpatient healthcare.

Material and methods: Outpatient doctors from 6 cities in 4 CIS countries participated in the simultaneous study. A total of 210 doctors of therapeutic profile took part in the survey: Bishkek (Kyrgyzstan) - 42 doctors, Minsk (Belarus) - 37 doctors, Astana, Shymkent, Aktobe (Kazakhstan) - 55, 30, 10 doctors, Baku (Azerbaijan) - 36 doctors. The survey was carried out according to a questionnaire previously prepared by the National Research Center for Therapy and Preventive Medicine, which consisted of 11 blocks of questions. Answers to each question were offered in several gradations.

Results: In three countries, patients in the age range of 50-59 years prevailed among men who applied to the primary health care unit, whereas in Azerbaijan, men aged 60-65 years were dominant. In the CIS countries, patients most often go to the polyclinic for chronic forms of CHD. In Azerbaijan, Kazakhstan and Belarus, the incidence of type 2 diabetes with or without complications is more than 20%. Doctors in large cities of the CIS countries do not recommend non-drug treatment methods in up to 10% of cases. Preferential drug provision differs slightly between the analyzed cities. In Kazakhstan and Belarus, doctors note about 70% of cases when 75% of the target level is reached. In Kyrgyzstan and Azerbaijan, the same level is reached 2-3 times less often. In Kazakhstan, Belarus and Kyrgyzstan, there is a relatively high frequency (satisfaction in 75% of cases), while Azerbaijani doctors claim that 52% are not satisfied and 44% of cases are partially satisfied with interaction with specialized hospital doctors. In Azerbaijan and Belarus, 75% of the staffing of outpatient clinics prevails. In Kyrgyzstan, in 84% of cases, 100% staffing is detected. At the same time, in Kazakhstan, 50% and 75% staffing levels have a comparable frequency. In these countries, a similar pattern is being monitored for the provision of secondary medical staff at the polyclinic level.

Conclusion: Patients with CHD and type 2 diabetes mellitus predominate among patients with NCDs observed in polyclinics. Adherence to therapy is insufficient in every second case. Coverage of preferential drugs and achievement of target levels of the main risk factors among patients.

Keywords: secondary prevention; non-communicable chronic diseases; medical and sociological survey; doctors; CIS countries

By contrast, gaps in instruction, inadvertent communication with those implied in relationships, inflated prices, not sharing the presence well, and not aligning with social norms attract the provider’s lousy name, which in turn leads to their business decline and negatively impacts the provider’s career and social life.

The clients, collaborators, and providers must all make the same effort to maintain and strengthen their relationships. Disrespectful interactions can negatively impact their inner life, leading to conditions such as depression, arterial hypertension, type 2 diabetes, and even brain hemorrhage or tumors in vulnerable individuals.

Maintaining truthful and well-mannered relationships is crucial for sustaining and advancing practice. In the present digital age, individuals can block unsafe communications by using specific functions of IT devices. The offenders can reflect on their past improper attitudes or words toward the blockers and try to correct their unprofessional behavior.

Overtiredness reduces work efficiency, following common mistakes; when they exceed limits, they amplify the adverse effects on both the receiver and the sender. Preferably, we should avoid errors rather than deal with their negative impact on people’s lives.

Depressed providers do not offer quality services, which decreases the client’s desire to participate in collaborative work and consequently devalues their work.

By contrast, joyful providers deliver services of quality increase and delight the end users.

AI is used to score the sentiments of people implied in relationships, gaining insights about their work efficiency and continuity and how each variable can be modified in the best direction to their advantage in a constantly evolving world.

Nowadays, conversational AI, chatbots, virtual assistants, and AI/ML [machine learning] for business operations are the top investment areas, with leaders like Qualtrics and Verint. AI offers a new method to generate and communicate knowledge, benefiting clinicians and patients and enabling them to make better-informed decisions. AI tools complement, not replace, the healthcare providers’ decisions and autonomy.

Humans’ high aspirations lie in their physically perceptible existence. Loved ones, friends, and other connected community members want to interact virtually or in person as long as possible for the beauty of the mind and soul, and our mission is to support this.

Artificial and human intelligence may embrace people’s wishes for a better life and continuity.

References

Abdelkhalek ST., et al. “Classification of Phytochemicals in Plants with Herbal Value”. In S. C. Izah, M. C. Ogwu, & M. Akram (Éds.), Herbal Medicine Phytochemistry: Applications and Trends. Springer International Publishing (2023): 1‑39.
Aboriginal AI of and Studies TSI. “Guidelines for ethical research in Indigenous studies”. Australian Indigenous Law Reporter 8.1 (2003): 85‑94.
Adejayan AA., et al. “Evaluation of the anti-asthmatic and antitussive potentials of methanol leaf extract of Napoleona vogelii in rodents”. Biomedicine & Pharmacotherapy 109 (2019): 120‑126.
Adeleye OA., et al. “Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019”. Future Journal of Pharmaceutical Sciences 7.1 (2021): 72.
Adesina SK, Johnny II and Olayiwola G. “Plants in respiratory disorders I-anti-asthmatics, a review”. British Journal of Pharmaceutical Research 16.2 (2017a): 1‑22.
Adesina SK, Johnny II and Olayiwola G. “Plants in respiratory disorders II antitussives”. Br. J. Pharm. Res 16.3 (2017b): 1‑21.
Ahmad Khan MS and Ahmad I. “Herbal Medicine”. In New Look to Phytomedicine. Elsevier (2019): 3‑13.
Akerele O, Heywood V and Synge H. (Éds.). “Conservation of Medicinal Plants”. Cambridge University Press (1991).
Akunne (formerly Okoye) T., et al. “Safe African Medicinal Plants for Clinical Studies”. In Toxicological Survey of African Medicinal Plants (2014): 535‑555.
Almusaed A and Almssad A. “Housing”. BoD – Books on Demand (2018).
An M., et al. “Anti-asthma and antitussive effects of a fermented extract of a mixture of Ramulus mori, Anthriscus sylvestris, and Salvia plebeian”. Food Science and Biotechnology 30.9 (2021): 1257‑1268.
Balogun O., et al. “Innovations in drug delivery systems: A review of the pharmacist’s role in enhancing efficacy and patient compliance”. World Journal of Advanced Research and Reviews 20 (2023): 1268‑1282.
Bansal G, Kaur I and Kaur J. “Herbal health products quality through stability studies: A global regulatory concern”. Applied Clinical Research, Clinical Trials and Regulatory Affairs 4.1 (2017): 26‑35.
Barik CS., et al. “A review on therapeutic potential of polyherbal formulations”. International Journal of Pharmaceutical Sciences and Drug Research (2015): 211‑228.
Bhakta T., et al. “Studies on Antitussive Activity of Cassia fistula (Leguminosae) Leaf Extract”. Pharmaceutical Biology 36.2 (1998): 140‑143.
Biharee A., et al. “A Comprehensive Study on Natural Products and their Bioactive Constituents to Cure Respiratory Diseases”. The Natural Products Journal 14.2 (2024): 32‑70.
Breman E., et al. “Plant diversity conservation challenges and prospects—The perspective of botanic gardens and the Millennium Seed Bank”. Plants 10.11 (2021): 2371.
Builders P. “Herbal Medicine”. BoD – Books on Demand (2019).
Balogun O., et al. “Innovations in drug delivery systems: A review of the pharmacist’s role in enhancing efficacy and patient compliance”. World Journal of Advanced Research and Reviews 20 (2023): 1268‑1282.
Jacob D., et al. “Indigenous Knowledge and Phytochemistry: Deciphering the Healing Power of Herbal Medicine”. In Herbal Medicine Phytochemistry: Applications and Trends (2023): 1‑53.
Kassahun T., et al. “Ethnobotany, traditional use, phytochemistry and pharmacology of Cymbopogon citratus: Review article”. International Journal of Herbal Medicine 8.4 (2020): 80‑87.
Chaachouay N and Zidane L. “Plant-Derived Natural Products: A Source for Drug Discovery and Development”. Drugs and Drug Candidates 3.1 (2024): 184‑207.
Chaitanya MVNL., et al. “Traditional African Medicine”. In Natural Medicinal Plants. IntechOpen (2021).
Chirwa DM. “Access to medicines and health care in sub-Saharan Africa: A historical perspective”. Md. J. Int’l L 31 (2016): 21.
Enegide C and Charles CO. “Ocimum Species: Ethnomedicinal Uses, Phytochemistry and Pharmacological Importance”. International Journal of Current Research in Physiology and Pharmacology (IJCRPP) (2021): 1‑12.
Fayiah M., et al. “Value of Herbal Medicine to Sustainable Development”. In S. C. Izah, M. C. Ogwu, & M. Akram (Éds.), Herbal Medicine Phytochemistry. Springer International Publishing (2024): 1429‑1456.
Fischer NH, Isman MB and Stafford HA. “Modern Phytochemical Methods”. Springer Science & Business Media (2012).
Franova S, Nosalova G and Mokry J. “Phytotherapy of cough”. Advances in phytomedicine 2 (2006): 111‑131.
Harborne AJ. “Phytochemical methods a guide to modern techniques of plant analysis”. Springer science & business media (1998).
Heinrich M., et al. “Ethnopharmacological field studies: A critical assessment of their conceptual basis and methods”. Journal of ethnopharmacology 124.1 (2009): 1‑17.
Hubert BJ., et al. “Anti-inflammatory activities of fruit and leaves extract of lannea microcarpa england K. Kraus (anacardiaceae)”. Int J Pharm Pharm Sci 7 (2015): 177‑182.
Imosemi I. “A review of the medicinal values, pharmacological actions, morphological effects and toxicity of Ocimum gratissimum linn”. European journal of pharmaceutical and medical research 7 (2020): 29‑40.
Iwu MM. “Handbook of African Medicinal Plants, Second Edition”. CRC Press (1993).
Jacob D., et al. “Indigenous Knowledge and Phytochemistry: Deciphering the Healing Power of Herbal Medicine”. In Herbal Medicine Phytochemistry: Applications and Trends (2023): 1‑53.
Jamshidi-Kia F, Lorigooini Z and Amini-Khoei H. “Medicinal plants: Past history and future perspective”. Journal of herbmed pharmacology 7.1 (2017): 1‑7.
Janzen JM and Green EC. “Medicine in Africa”. Encyclopedia of History of Science, Technology, and Medicine in Non-Western Cultures (2008): 1‑17.
Kadam ST and Pawar AD. “Conservation of medicinal plants: A review”. Int. Ayurvedic Med. J 8 (2020): 3890‑3895.
Kaggwa B., et al. “Safety and Efficacy of Medicinal Plants Used to Manufacture Herbal Products with Regulatory Approval in Uganda: A Cross-Sectional Study”. Evidence-Based Complementary and Alternative Medicine (2022): 1‑21.
Karal A and Çelik H. “Drugs and Natural Products Used in COPD”. International Journal of Innovative Research and Reviews 6.1 (2022).
Kassahun T., et al. “Ethnobotany, traditional use, phytochemistry and pharmacology of Cymbopogon citratus: Review article”. International Journal of Herbal Medicine 8.4 (2020): 80‑87.
Keter LK., et al. “Validation of safety and efficacy of antitussive herbal formulations”. African Journal of Pharmacology and Therapeutics 2.1 (2013).
Koffuor GA., et al. “Anti-tussive, muco-suppressant and expectorant properties, and the safety profile of a hydro-ethanolic extract of Scoparia dulcis”. Int J Basic Clin Pharmacol 3.3 (2014): 447‑453.
Kumar B and Bhat R. “Cassia fistula: A Comprehensive Analysis of its Phytochemical Constituents and Pharmacological Activities” 11.6 (2024): 688‑693.
Kunle OF, Egharevba HO and Ahmadu PO. “Standardization of herbal medicines-A review”. International journal of biodiversity and conservation 4.3 (2012): 101‑112.
Lawal IO., et al. “Ethnobotanical survey of plants used for treating cough associated with respiratory conditions in ede south local government area of Osun State, Nigeria”. Plants 9.5 (2020): 647.
Malú Q., et al. “Ethnomedicinal, chemical, and biological aspects of Lannea Species—A Review”. Plants 13.5 (2024): 690.
Maroyi A. “Lannea microcarpa: A review of its medicinal uses, phytochemistry and pharmacological properties”. Journal of Pharmacy and Nutrition Sciences 8.4 (2018): 168‑177.
Martin GJ. “Ethnobotany: A methods manual”. Routledge (2010).
McFarlane C. “South Africa: the rise of traditional medicine”. Insight on Africa 7.1 (2015): 60‑70.
Meher A. “Antitussive evaluation of formulated polyherbal cough syrup”. Journal of Drug Delivery and Therapeutics 2.5 (2012).
Mokgobi MG. “Views on traditional healing: Implications for integration of traditional healing and Western medicine in South Africa”. [PhD Thesis, University of South (2012).
Mollica A., et al. “A study on chemical characterization and biological abilities of Alstonia boonei extracts obtained by different techniques”. Antioxidants 11.11 (2022): 2171.
Mule Geetanjli T., et al. “Formulation and In-vitro Evaluation of Poly-herbal Cough Syrup” 2.6 (2023): 127‑132.
N’Guessan K, Assi-Kaudjhis C and Kouassi KH. “Ethnobotanical study of antitussive plants used in traditional medicine by Abbey et Krobou populations, in the south of Côte d’Ivoire”. International Journal of Advances in Pharmacy Biology and Chemistry 4.2 (2015): 513‑522.
Nishimoto Y., et al. “Glycyrrhizin attenuates mucus production by inhibition of MUC5AC mRNA expression in vivo and in vitro”. Journal of Pharmacological Sciences 113.1 (2010): 76‑83.
Nosalova G., et al. “Herbal polysaccharides and cough reflex”. Respiratory Physiology & Neurobiology 187.1 (2013): 47‑51.
Ogidi OI and Emaikwu NG. “Utilization Methods and Practices of Herbal Medicine in Africa”. In Herbal Medicine Phytochemistry: Applications and Trends (2024): 1367‑1393.
Onwuegbuzie AJ. “Seven steps to a comprehensive literature review: A multimodal and cultural approach” (2016).
Organization WH. “WHO guidelines on good manufacturing practices (GMP) for herbal medicines”. World Health Organization (2007).
Ozioma E-OJ and Chinwe OAN. “Herbal medicines in African traditional medicine”. Herbal medicine 10 (2019): 191‑214.
Ozolua R and DI U. “Evaluation of the Anti-asthmatic and Antitussive Effects of Aqueous Leaf Extract of Ocimum gratissimum in Rodents”. Medicinal & Aromatic Plants 05 (2016).
Paul A., et al. “Pharmaceutical application of bio-actives from alstonia genus: current findings and future directions”. In advanced structured materials (2021): 463‑533.
Pérez-Padilla R., et al. “Respiratory health effects of indoor air pollution”. The International Journal of Tuberculosis and Lung Disease 14.9 (2010): 1079‑1086.
Pourova J., et al. “Proposed mechanisms of action of herbal drugs and their biologically active constituents in the treatment of coughs: An overview”. PeerJ 11 (2023): e16096.
Raja W., et al. “In vivo antitussive activity of a pectic arabinogalactan isolated from Solanum virginianum L. in Guinea pigs”. Journal of ethnopharmacology 156 (2014): 41‑46.
Reichman JH. “Intellectual property in the twenty-first century: will the developing countries lead or follow?”. Houston law review/University of Houston 46.4 (2009): 1115‑1185.
Rimmer M. “Indigenous Intellectual Property: A Handbook of Contemporary Research”. Edward Elgar Publishing (2015).
Rozas LW and Klein WC. “The Value and Purpose of the Traditional Qualitative Literature Review”. Journal of Evidence-Based Social Work 7.5 (2010): 387‑399.
Saraswathy GR., et al. “Antitussive medicinal herbs-an update review”. International Journal of Pharmaceutical Sciences and Drug Research (2014): 12‑19.
Shah V, Shah V and Santani DD. “Asthma and plants used for asthma-An overview”. Research journal of pharmacology and pharmacodynamics 4.5 (2012): 328‑338.
Shang J-H., et al. “Pharmacological evaluation of Alstonia scholaris: Anti-tussive, anti-asthmatic and expectorant activitie”s. Journal of ethnopharmacology 129.3 (2010): 293‑298.
Sharma A, Bhardwaj G and Cannoo D. “Overview of Phytochemistry and Pharmacology of Adhatoda vasica” (2018).
Sharma A, Kumar A and Jaitak V. “Pharmacological and chemical potential of Cassia fistula L-a critical review”. Journal of Herbal Medicine 26 (2021): 100407.
Shoaib A. “A systematic ethnobotanical review of Adhatoda vasica (L.), Nees”. Cellular and Molecular Biology 67.4 (2021): 248‑263.
Stewart MK., et al. “Participatory development and implementation of a community research workshop: Experiences from a community-based participatory research partnership”. Progress in community health partnerships: research, education, and action 3.2 (2009): 165‑178.
Sultana S., et al. “Cough suppressant herbal drugs: A review”. Int. J. Pharm. Sci. Invent 5.5 (2016): 15‑28.
Šutovská M., et al. “Antitussive activity of polysaccharides isolated from the Malian medicinal plants”. International journal of biological macromolecules 44.3 (2009): 236‑239.
Šutovská M., et al. “Possible mechanisms of dose-dependent cough suppressive effect of Althaea officinalis rhamnogalacturonan in guinea pigs test system”. International Journal of Biological Macromolecules 45.1 (2009): 27‑32.
Tan OJ., et al. “Improving oral bioavailability of medicinal herbal compounds through lipid-based formulations – A Scoping Review”. Phytomedicine 90 (2021): 153651.
Velavan S. “Phytochemical techniques-a review”. World Journal of Science and Research 1.2 (2015): 80‑91.
WHO. 1: WHO guidelines on good herbal processing practices for herbal medicines. WHO Technical Report Series (2018).
Wang H., et al. “Advancing herbal medicine: Enhancing product quality and safety through robust quality control practices”. Frontiers in Pharmacology 14 (2023): 1265178.
Wankhar W., et al. “Phytochemicals screening and antimicrobial efficacy of Scoparia dulcis Linn (Scrophulariaceae) against clinical isolates”. Journal of Pharmacognosy and Phytochemistry 3.6 (2015): 17‑21.
Wireko I and Béland D. “The challenge of healthcare accessibility in sub-Saharan Africa: The role of ideas and culture”. European J. of International Management 7.2 (2013): 171.
Ziment I. “Herbal antitussives”. Pulmonary Pharmacology & Therapeutics 15.3 (2002): 327‑333.

Systematic documentation of traditional medicinal knowledge along with uses of herbs and dose administration play a pioneering role in the research and development of modern medicine. Worldwide more than 4,20,000 flowering plants are reported to date and more than 50,000 plants are used as medicine for kinds of ailments. In the context of the Indian traditional medicine system, more than 43% of the total flowering plants are recognized as medicinal values.

Much research has proven that the Indian traditional medicine system includes one of the oldest and finest medical sciences in the world. Collectively this medical system consists of AYUSH, which means Ayurveda, Yoga, Unani, Siddha, and Homeopathy. The treatment of any health issues with AYUSH can include Drug therapy, Acupuncture massage, Psychotherapy, Yoga, and Surgical techniques. According to the Sushruta Samhita, there are eight kinds of surgical methods mentioned under the surgical techniques viz., Resection, Incision, Stab, Puncture, Extraction, Puncture and collaterals, Suturing, and bandaging.

Ayurveda has been a fascinating subject since back to two decades among health and medicine researchers. It is the oldest collection and documentation of medical systems that originated back to 5000 B.C. In Ayurveda, there are eight divisions found i.e., Kayacikitsa (Internal medicine), Salya Tantra (Surgery), Salakya (Otolaryngology), Kaumarabhrtya (Gynecology and Pediatrics), Bhutavida (Psychiatry), Agada Tantra (Toxicology), Rasayana Tantra (Gerontology) and Vajikarana (Eugenics and Expediting). Ayurvedic treatments developed a close relationship between body and mind which makes them holistic therapy.

On the other side, Chinese herbal medicine (CHM) is a major part of the Chinese traditional medicine system. CHM is significantly used as an important source in new drug discovery. A Nobel Prize awarded You-you Tu (2015) discovered a therapeutic drug Artemisinin from the Chinese herbal plant Artemisia annua L. Artemisinin is used as a drug to treat malaria. According to the literature, one-third of the clinical drugs are extracted from CHM in China. For thousands of years, CHM has been the main source of treatment and prevention traditionally for various health issues in China. CHM not only provides a drug but also gives food flavors, pigments, and cosmetics ingredients. The CHM market recognized globally in recent years. According to the statistical data, CHM consumption is boosted by 400000 tons annually. These data support the importance of the Chinese traditional medicine system.

In conclusion, both the Indian traditional medicinal system and the Chinese traditional medicine system are still recognized as primary healthcare treatment for the majority of the people. Many drugs are discovered from natural resources and plants due to their traditional use in many parts of the world. The ethnic knowledge of herbal drugs navigating to the new drug discoveries at the labs. There are need for effective documentation of the traditional knowledge of herbal drugs. It may help the scientific community to achieve drug development for untreatable ailments.

No one can be perfect in every situation; human imperfection is a common trait.

Each person is a unique construction that evolves differently in varied environments. A suitable workplace, loyal and friendly collaborators, lovely persons or animals around, and healthy habits facilitate the development and use of an individual's full potential. By contrast, excessive envy, lack of interest or support in personal advancement, and interaction with uneducated people with inappropriate behaviour decline creativity and work efficiency.

A professional in the healthcare industry spends many years, even decades, gaining expertise in the specific field and continuously updating knowledge. More new information makes us realize that the oceanic body of data is partly available for use and understanding. So far, no one may be proud of knowing and perfectly operating them.

Humility: 'Be like the bamboo: the higher you grow, the deeper you bow' - Chinese proverb.

There is a work hierarchy, and each practice has its work value. Being professional in relations with others is mandatory.

Handling data quickly and efficiently ensures you can maintain the equilibrium between the production process and relaxation. Experts in the domain who accumulate fatigue can make errors in practice, which harm both the receiver and the creator of the error. In those moments, they realize they are worthless. Saying sorry when you make an error is necessary – be professional. You must recognize your failure and do your best to repair the fault. Intense adverse reactions from offended people may destroy the vulnerable construction of the offender. Therefore, a professional approach to such conditions is required.

Passion can cause an individual to deviate from norms in daily life, and errors in social life can cause grief for others. Consequently, the individual realizes they aren't perfect, and their ignorance and arrogance decline.

Even having the best intentions and selecting the best way for the best doings, unexpected barriers may arise to fail. Failure confirms your weakness in checking, avoiding, blocking, and getting rid of them.

Vigilance decreases at the end of life since time slowly undermines everything. Sometimes, this happens early, originating in medical conditions. As a result, your capabilities change, making you aware of your limits in the community.

Each can best do a specific work, as instructed. Achieving a high position with a low education is inadvertent. Inappropriate self-importance follows failure, provoking distress around. Self-regarding your power and adjusting when it does not fit the requirements is essential. Friends, loved ones, and specialists in a specific area make you aware of your misunderstanding and act to take a good path. When your desires exceed realities, more self-reflection on your limits validates your imperfection, experiencing humility.

Like in a beehive, there is an order in life and the world. We must respect and be respected by each contributor empowered by God.

The Bible: 'Do not think of yourself more highly than you ought to think'.

God’s supremacy is eternal.

References

Tamene A., et al. “Water treatment at the point-of-use and treatment preferences among households in Ethiopia: A contemporary systematic review and meta-analysis”. PloS One 17.10 (2022): e0276186.
World Health Organization (WHO). Progress on Drinking Water, Sanitation and Hygiene. (2020).
UNICEF. State of the World's Children (2019).
WHO. Water-related Disease Prevention (2021).
IPCC. Impacts, Adaptation, and Vulnerability. Air Conditioning Change (2021).
Water Aid. India's Water Crisis and Solutions (2020).
Global Water Partnership (GWP), Integrated Water Resources Management (2018).
UNESCO. Transboundary Water Cooperation (2021).
WHO. Assessment of household water treatment options. Health-based objectives and specifications (2012).
Amadou ID, Mayassine D and Abdou KD. “Study of factors associated with the treatment of drinking water in a semi-urban environment in Dakar”. Cheik Anta Diop University of Dakar (2018).
Ognansan YS. “Health risks associated with drinking water sources in district no. 2 of Lomé-commune”. Int.J. Biol.Chem (2017): 2341-2351.
Yelognisse CLHH. “Improving the conditions of access to drinking water for drinking water in rural areas of Benin, study of local practices”. University of Quebec in Montreal (2007): 45‑96.
GBD. “Global Burden of Disease Study Results”. Inst Health Metr Eval (2018).
United Nations Development Program (UNDP), Water Governance for Resilience (2017).
WHO. Guidelines for drinking-water quality. 4th Edition (2017).
WHO, UNICEF. Global Water, Sanitation, and Hygiene Report (2020).
World Resources Institute (WRI), Water Quality Risks and Contamination (2021).
WHO. Gender, Water and Sanitation (2015).
Kazadi ZA. “Contribution to the study of the quality and management of drinking water in the Kisangani region”. Unpublished thesis. Faculty of Sciences (2012): 245.
Malteser I. “Guidelines on Water, Hygiene and Sanitation for Field Actors”. Funded by European Union (2014): 25‑98.
Clasen T., et al. “Household Water Treatment to Prevent Diarrhea”. PloS Med (2007).
Kayobola KT. “Rural drinking water supply in the DRC in the face of Sustainable Development Goal 6”. Thesis. Selmus University of Science and literature (2010): 11-36.
Oxfam. Access to Safe Water in Low-Income Communities (2020).
United Nations Development Programme. Water Issues in the Democratic Republic of Congo: Challenges and Opportunities (2011): 43.
Berihun G., et al. “Household water treatment practices in Sub-Saharan Africa”. Front Public Health (2023).
Berihun G., et al. “Drinking water contamination potential and associated factors among households with under-five children in rural areas of Dessie Zuria District”. Northeast Ethiopia. Front Public Health 11 (2023): 1199314.
Prüss-Ustün A., et al. “Burden of disease from inadequate water, sanitation and hygiene in low and middle-income settings: a retrospective analysis of data from 145 countries”. Tropical Med Int Healt 19.8 (2018): 894‑905.
WHO. Preparing a healthy environment for children (2003): 20.
World Bank. Water Supply and Sanitation Sector Review (2019).
United Nations. Sustainable Development Goals Progress Report (2022).
World Economic Forum. The Water Crisis and Sustainable Solutions (2019).
INS. Multiple Indicator Cluster Survey. Kinshasa, Democratic Republic of Congo. Survey Results Report (2018).
Linangelo SB., et al. “Problems of access to drinking water in rural areas in the DRC”. Case of the urban-rural city of Bumba. Int J Innov Sci Res 37.2 (2018): 130‑138.

References

Ndumba AK, Dizal NM and Ndimba B. “Biomedical waste in health facilities in Kintambo health zone. Kinshasa Province, Capital of DR Congo: Management and Risks”. Int J Soc Sci Sci Stud.; 3.1 (2023): 2254‑82.
N'guessan K, Yéo Kaj, Kouassi and Kpangui Barima. “Management of solid waste at the Daloa Regional Hospital and associated risks”. About Engineering Dev. 2021 ; Central-western Côte d'Ivoire (sn) (2021).
WHO. “Progress on water, sanitation and hygiene”. 2017 update and SDG assessment. JMP report (2017).
Vonan Kouadio F, Guei Solar M and Kokore JF. “Biomedical waste management”. Case of the Bouaké University Hospital. To master [the Internet] (2023).
World Health Organization. “Overview of technologies for the treatment of infectious waste and sharp/sharp waste from healthcare facilities”. Report (2019).
Capooor MR and Parida A. “Current perspectives on biomedical waste management in the context of COVID-19”. Indian Med Microbiol.; SL (2021): 171-8.
WHO. “Management of waste from solid care activities in primary health care centres”. Decision support guide (2005): 72.
WHO. World Health Statistics. Health personnel, health infrastructure and essential medicines. World Health Statistics (2009): 149.
WHO, UNICEF. WASH in healthcare facilities. report (2019).
Odonkor ST and Mahani T. “Medical Waste Management in Ghanaian Hospitals”. Assoc Public Health Environ Chall (2020).
Maffouamene MC., et al. “Knowledge, Attitudes and Practices on the Management of Infectious Waste in Health Facilities in the Central Region of Cameroon”. SN Health Sciences and Diseases (2023).
Senker NB., et al. “Obstacles to the effective management of anatomical biomedical waste at the Provincial General Referral Hospital of Kinshasa”. International Journal of Social Sciences and Scientific Studies. March 18 (2024): 3578‑95.
Kanyingu NA, Mukinay DN and Senker NB. “Biomedical waste in health facilities in the Kintambo health zone, City Province of Kinshasa Capital of DR CONGO: management and risks”. International Journal of Social Sciences and Scientific Studies 25 (2023): 2254‑82.
Kubali V. “Biomedical waste management at the HPGR in Bukavu (Eastern DR Congo)”. Am J Innov Res Appl Sci 10.2 (2020): 68-73.
Oleko WO. “Biomedical waste management in four hospitals in Kisangani. DR Congo”. J Adv Med Life Sci V7I2.01.1477144 (2018).
Lakbala P and Lakbala M. “Knowledge, attitude and practice of hospital staff management”. Gest Waste Rech 31.7 (2013): 729-732.
Owusu-Dabo E., et al. “Biomedical waste management in Ghana: a study in two health facilities”. J Environ Health 75.3 (2012).
Agyeman DO and Dzodzomenyo M. “The State of Biomedical Waste Management in Ghana: Practices and Challenges”. Int j about stud 73.2 (2016): 302‑14.
Assi-Kaudjhis C., et al. “Study of Biomedical Waste Management in Côte d'Ivoire”. Cah Public Health 5 (2014): 14-22.
Kouadio LP., et al. “Biomedical waste in Côte d'Ivoire: State of play and perspectives”. Rev. Afr Public Health 12.4 (2017).
WHO. “Healthcare waste”. Checklist (2000).
Sushma MK., et al. “Dental biomedical waste management and awareness about waste management policy among private dental practitioners in Mangalore city, India”. Tanzan Dent J 16.2 (2010): 39-43.
Odonkor ST and Tahiru M. “Biomedical waste management (BWM) at the regional hospital center (CHR) of Ziguinchor”. Department of preventive medicine and public health, Faculty of medicine, pharmacy and dentistry, Cheikh Anta DIOP University 13 (2003): 1-10.
Ndiaye P., et al. Biomedical waste management (BWM) at the regional hospital center (CHR) of Ziguinchor: Preventive medicine and public health department, Faculty of medicine, pharmacy and dentistry, Cheikh Anta DIOP University. Cahiers Sant (2003): 1-10.
Koffi N., et al. “Solid waste management at the Daloa regional hospital (central-west of Côte d'Ivoire) and associated risks”. Environ Engineering Dev 1 (2021): 26‑32.
WHO. Safe management of health care waste (2014).
WHO. Safe management of medical waste (Health care waste) - Summary. World Health Organization. 2017; WHO/FWC/WSH/17.05). License: CC BYNC-SA 3.0 IGO.
Jana S., et al. “Waste-derived biomaterials as building blocks in biomedical field”. J Mater Chem 10.4 (2022): 489‑505.

Lack of knowledge in the specific field, inability to handle data quickly and efficiently in practice, heartless work, inadvertence in communication, untruthful and disrespectful interactions with collaborators, deviations from social norms, and sharing unwell the presence disappoint in a relationship, leading to its termination.

Inadvertent interactions between people disturb their equilibrium, leading to disorders such as metabolic abnormalities, type 2 diabetes, arterial hypertension, depression, and even brain haemorrhage or tumours in vulnerable individuals.

Providing emotional support during difficult times benefits both end users and providers; volunteering positively impacts their well-being, life quality, and expectancy.

Compassion and empathy enable us to deliver the best possible care, and compassionate care dimensions significantly impact the healing disorders process. Kind words, friendly attitudes, generosity, and honest and respectful relationships with the clients - especially seniors in need- facilitate more adherence to the therapeutic plan with good results; consequently, patient’s positive experience increases return on investment, business stability, and expansion, provider reputation, and their career advancement, financial capabilities, and personal satisfaction.

By contrast, cool-hearten work discourages the end users, usually making them seek care from other providers. This situation undermines relationships and creates business instability, negatively affecting the provider’s professional, social, and personal life.

Burnout, a usual concern in the healthcare system, can lead to errors in practice, even for experts with a history of successful results. The mistakes lead to poor clinical outcomes, dissatisfied end users, decreased return on investment, business instability, and provider bad name, affecting their lives and society’s advancement. Burnout is a serious issue that we must address with concerted efforts to find practical solutions. Effective prevention strategies using AI, a technological advancement in this era, can help prevent burnout and provide the best instruction at a low cost, improving work efficiency metrics. AI offers hope for a more efficient healthcare system. Virtual assistants guide users in attaining specific, required information and operate them in their best interest. AI aids in efficient data management workflows, reducing the burden on healthcare professionals and allowing them to be more engaged in patient care.

According to personal investment in their work and their ability to collaborate – virtually or in-person - with others, each can be an esteemed professional in the community they serve or marginalized and ignored by them.

Expertise and how we interact with others depict individual life trajectories.

Science and love illuminate around.

References

Yelognisse CLHH. “Improving the conditions of access to drinking water for drinking water in rural areas of Benin, study of local practices”. University of Quebec in Montreal (2007): 45‑96.
Tamene A., et al. “Water treatment at the point-of-use and treatment preferences among households in Ethiopia: A contemporaneous systematic review and meta-analysis”. PloS One (2022): e0276186.
WHO. “Evaluation of domestic water treatment options”. Health objectives and specifications (2012).
Prüss-Ustün A., et al. “Burden of disease from inadequate water, sanitation and hygiene in low and middle-income settings : a retrospective analysis of data from 145 countries”. Tropical Med Int Healt 19.8 (2018): 894‑905.
Malteser I. “Water, Hygiene and Sanitation guidelines for practitioners”. Funded by European Union (2014): 25-98.
Berihun G., et al. “Drinking water contamination potential and associated factors among households with under-five children in rural areas of Dessie Zuria District. Northeast Ethiopia”. Front Public Health 11 (2023): 1199314.
WHO. Preparing a healthy environment for children (2003): 20.
Ognansan YS. “Health risks related to drinking water sources in district n°2 of Lomé-commune”. Int.J. Biol.Chem (2017): 2341-2351
INS. “Multiple Indicator Cluster Survey”. Survey results report (2018).
Linangelo SB., et al. “The problem of access to drinking water in rural areas of the DRC”. Urban-rural town house of Bumba. Int J Innov Sci Res 37.2 (2018): 130-138.
Sridhar M, Okareh O and Mustapha M. “Assessment of Knowledge, Attitudes, and Practices on Water, Sanitation, and Hygiene in Some Selected LGAs in Kaduna State”. J Environ Public Health (2020): 6532512.
Kazadi ZA. “Contribution to the study of the quality and management of drinking water in the Kisangani region”. Unpublished thesis, Faculty of Sciences (2012): 245.
Mokili kanda EJ. “Study of the quality and management of drinking water in rural areas of the DRC”. Faculty of Science/Department of Science/Biotechnology (2022): 12-52, 111-122.
Misenga tshimanga M., et al. “Drinking water management in households in the Lukelenge health zone (case of Kizito health area)”. Glob Sci J GSJ 10 (2022): 1704-1711.
Amadou ID, Mayassine D and Abdou KD. “Study of factors associated with drinking water treatment in semi-urban Dakar”. Cheik Anta Diop University of Dakar (2018).
Kamanzi J and Nkurunziza D. “The role of women in water management in rural households in sub-Saharan Africa”. Rev Afr Sociol 12.3 (2018): 45-59.
M bassa L and Tchounga P. “Impact of educational level on water-related hygiene practices in fishing communities in Cameroon”. J Santé Publique Trop 8.2 (2017): 102-110.
Soboksa N., et al. “Water supply, sanitation and hygiene interventions and childhood diarrhea in Kersa and Omo Nada districts of Jimma Zone, Ethiopia: a comparative cross-sectional study”. J Health Popul Nutr (2019): 45.
Ouédraogo S and Diallo A. “Knowledge and perceptions of waterborne diseases in peri-urban areas of Burkina Faso”. Health 5.1 (2019): 67-75.
Nguyen TH and Tran LM. “Effectiveness of water hygiene education campaigns in rural communities in Vietnam”. Int J Water Health Educ 14.4 (2020): 210-222.
USAID-UNICEF-RDC. “National survey on the situation of children and women”. Analysis report. UNICEF (2002).
Smith JA and Clark PR. “Perceptions versus reality: drinking water quality in rural Kenyan communities”. Water Qual Health J 9.3 (2016): 156-168.
Ali S and Ahmed R. “Adoption of home water treatment practices in low-income areas of Bangladesh”. J Environ Health Res 12.2 (2015): 85-93.
International Water Association (IWA), World Health Organization (WHO). Propotion of Tap Water Drinking and Public Relation Practices in Water Utilities Water Safety Plans. 6e atelier IWA-JWWA (2011).
Basandja Longembe E, Panda Lukongo KJ and Losimba Likwela J. “Knowledge, Practice and Satisfaction of beneficiaries of the National Schools and Villages Post-Certification Sanitation Program in Tshopo Province, DRC”. International Journal of Innovation and Applied Studies (2023): 515.
Pradhan S., et al. “Evaluation of domestic water treatment and storage practices”. Int J Community Med Public Health 5.3 (2018): 1060‑3.
Hothur R, Arepalli S and Veena Bhadreshwara A. “A CAP study on water, sanitation and hygiene among residents of Parla village, Kurnool district, Andra Pradesh”. J Int Medicine Community Public Health 6.5 (2019): 2081.
Diawara M and Coulibaly K. “Access to drinking water and use of unimproved sources in Mali: Challenges and prospects”. Afr Water Resour J 7.1 (2017): 220-229.
Gonzalez L and Martinez F. “Relationship between unsafe water sources and waterborne disease incidence in Latin America”. J Public Health Epidemiol 10.5 (2017): 220-229.
Likilo Yowa W. “Drinking water and sanitation in the peri-urban environment of the city of Kisangani”. Faculty of Sciences, Biotechnology (2014): 14 25.
Ngoyi KC., et al. Household water management in the city of Kamina XIV.1 (2015).
Kouadio EF. “Factors associated with quality and assessment of health risks related to drinking water in seven localities of Côte d'Ivoire”. Unique doctoral thesis (2021): 71-85.
Patel M and Shah S. “Use and efficacy of household water purifiers in urban India”. J Water Sanit Hyg Dev 5.4 (2016): 500-509.
Fernandez A and Lopez G. “Influence of community perceptions on home water treatment practices in Ecuador”. Community Health Hyg J 3.1 (2017): 55-63.
Kouassi Y and Traoré S. “Improving drinking water infrastructure and reducing inequalities of access in Côte d'Ivoire”. J Sustain Water Infrastruct 11.2 (2021): 75-88.

References

Ndumba AK, Dizal NM and Ndimba B. “Biomedical waste in health facilities in the Kintambo health zone. Kinshasa Province, Capital of the DR Congo: management and risks”. Int J Soc Sci Sci Stud 3.1 (2023): 2254‑82.
Vonan Kouadio F, Guei Solar M and Kokore JF. “Biomedical waste management”. Case of the Bouake University Hospital. Master [Internet].
Koffi N., et al. “Solid waste management at the Daloa regional hospital (central-west of Côte d'Ivoire) and associated risks”. Environ Engineering Dev 1 (2021): 26‑32.
WHO U. “Progress in water, sanitation and hygiene”. 2017 update and assessment SDGs. JMP Report (2017).
World Health Organization. “Overview of technologies for the treatment of waste disposal infectious And of Sharps waste from healthcare facilities”. Report (2019).
WHO. “Management of solid health care waste in primary health care settings”. Decision support guide (2005): 72.
Sanogo M., et al. “Contribution to the establishment of a sustainable biomedical waste management system at Gabriel Touré Hospital”. The Hospital Pharmacist (2007): 143-147.
WHO. World health statistics. Health workforce, health infrastructure and essential medicines. World Health Statistics (2009): 149.
Capoor MR and Parida A. “Current perspectives of biomedical waste management in context of COVID-19”. Indian Med Microbiol (2021): 171‑8.
Jana S., et al. “Waste-derived biomaterials as building blocks in the biomedical field”. J Mater Chem 10.4 (2022): 489‑505.
Kubali V. “Management of biomedical waste at the HPGR in Bukavu (Eastern DR Congo)”. Am J Innov Res Appl Sci. 10.2 (2020): 68-73.
OLEKO WO. “Biomedical Waste Management in four Hospitals in Kisangani. DR Congo”. J Adv Med Life Sci (2018).
WHO. Safe management of wastes from health-care activities (2014).
Singh T, Ghimire T and Agrawal S. “Awareness on biomedical waste management among dental students of different dental colleges of Nepal”. BioMed Research International (2018): 1742326.
Nfor E., et al. “Study on the training of health personnel in biomedical waste management in Cameroon”. J Environ Manag Health (2020).
Lakbala P and Lakbala M. “Knowledge, attitude and practice of hospital staff management”. Waste Manag Res 31 (2013): 729-732.
Sushma MK., et al. “Dental biomedical waste management and awareness about waste management policy among private dental practitioners in Mangalore city, India”. Tanzan Dent J 16.2 (2010): 39‑43.
Odonkor ST and Tahiru M. “Biomedical waste management (BWM) at the regional hospital center (CHR) of Ziguinchor”. Department of preventive medicine and public health, Faculty of medicine, pharmacy and dentistry, Cheikh Anta DIOP University 13 (2003): 1-10.
Mugabi B, Hattingh S and Chima S. “Assessment of knowledge, attitudes and practices of health workers regarding medical waste management in a tertiary hospital in Botswana: a quantitative cross-sectional study”. Niger J Clin Pract (2018): 1627-38.
Harhay MO., et al. “Health care waste management in developing countries: challenges and opportunities”. Global Public Health Review (2019).
Odonkor ST and Mahani T. “Healthcare waste management in Ghanaian hospitals”. Assoc Public Health Environ Chall (2020).
Koffi N., et al. “Solid waste management at the Daloa regional hospital (central-west of Ivory Coast) and associated risks”. Environ Engineering Dev 1 (2021): 26‑32.
WHO, UNICEF. WASH in health care facilities: global baseline report (2019).
Pokou KCO. National Plan for the Management of Sanitary Waste.
Gupta S., et al. “Assessment of infrastructure for biomedical waste management in India: a case study”. International Journal of Waste Management (2018).
Ndiaye P., et al. “Biomedical waste management in the Regional Hospital Center of Ziguinchor” Sante 13.3 (2003): 171-6.
Kane M. “Inventory of dioxin sources in sub-Saharan Africa. Identification of dioxin precursor wastes based on endogenous management practices (Senegal)”. Report. Basel Convention Regional Centre for French-speaking African Countries (2005): 14.
WHO. “Hospital waste management”. Studies Report (EURO 97): 1‑47.
Abor PA and Bouwer A. Influence of infrastructure on biomedical waste management in health facilities (2017).
Kubali Mwisa V., et al. “Management of biomedical waste at the provincial general reference hospital of Bukavu”. Am J Innov Res Appl Sci (2020): 68‑73.

Introduction: The objective of this study was to observe biomedical waste management practices in health care facilities in the City of Kisangani and to identify factors associated with effective biomedical waste management.

Materials and Methods: A cross-sectional study with analytical aim was carried out among 422 professionals and managers of health care establishments in Kisangani and was conducted from June 15 to August 15, 2024 in secondary and tertiary care establishments of the city. Data collection was done through direct observations and questionnaires administered to health personnel. Frequencies and crude odds ratios (ORb) with 95% confidence intervals (CI) were calculated to assess the associations between certain factors and biomedical waste management.

Results: The results of this study show that the majority of healthcare providers have insufficient knowledge on the definition of biomedical waste management (BMWM), with 93.6% of them reporting not knowing it, and 64.5% have not been trained on MBWM. Among the trained providers, the majority (68.7%) received the training more than 36 months ago. In addition, 69.7% of providers do not apply biomedical waste sorting, and 78.2% do not have WHO recommended codified waste bags.

The infrastructure available for waste management is also inadequate, with 71.8% of providers reporting the presence of a non-functional incinerator, 71.3% indicating the presence of a functional placenta pit, ash pit and glass crusher, 69% reporting the presence of non-functional hand hygiene stations, and 77% citing the unavailability of means of transporting biomedical waste.

Finally, analysis of associated factors shows that the availability of functional incinerators (OR = 4.3; p < 0.000), placenta, ash pits and functional glass crushers (OR = 0.03; p < 0.000), means of waste transport (OR = 5.6; p < 0.000), and hand hygiene stations (OR = 0.12; p < 0.000) are strongly associated with better management of biomedical waste in health care facilities.

Conclusion: This study showed insufficient management of biomedical waste in health care facilities in the city of Kisangani. Interventions aimed at strengthening staff capacities and investing in infrastructure are necessary.

Keywords: Observational study; management; biomedical waste; health care establishments; City of Kisangani. Tshopo; DRC

Technological advancements offer unprecedented facilities. They provide tools to reinforce thoughts and the mind’s ability to overcome grief or barriers when they arise. Invigorating mind activity enhances bodily functions. Harmonized mental and physical activities improve blood flow through vessels and increase oxygen transport to cells, finally improving their functioning.

In today's digital age, people with limited ability for physical exercise due to medical conditions - such as bone or joint issues, muscle disorders, heart failure in stage 3 or 4, and/or neurological conditions – can significantly benefit from technology. IT devices can help them stay connected with loved ones, virtually discuss topics of interest, admire nature, and enjoy modern or classical artwork. They can also watch their favourite movies and musical programs. Taking pleasure in real or virtual preferred bird or animal company, varied food preparation and an attractive environment with no air or noise pollution makes their life good-looking and charming.

Caring for people in need supposes effectively communicating with them and their family members, showing devotion, and engaging in supportive acts in collaborative work. Maintaining a balance between work and recreational activities is essential for fostering good relationships among all parties involved. Disproportionate emotional and material commitment affects work efficiency, and fatigue from caring for others can negatively impact personal health. Caregivers can support others through love, respect, or a sense of obligation. Excessive involvement in caring for loved ones can lead to burnout, causing them to have feelings of disheartenment. Moreover, individuals who are suffering tend to be more sensitive to the attitudes of their caregivers. A lack of genuine care can disappoint them and alter their emotional well-being, making them more vulnerable.

Distress can be attenuated by using IT devices for fun and reinforcement, as well as by engaging in recreational activities in nature, especially for those without physical exercise limitations.

It is preferable to maintain a professional and pleasant relationship with the people suffering and their relatives since this promotes better clinical outcomes, enhances the patient experience, increases their adherence to the therapy plan, delights family members, and leads to a provider's good name that facilitates their career advancement, financial status improvement, and esteem in the community.

Cool-hearted work disappoints all players in relationships, making them change providers, which alters their personal, professional, and social lives.

Compassionate care aids in healing disorders. It supports us in living better lives.

Sooner or later, all pass through an unknown, eternal, infinite space. We aim to make this transition more acceptable and less painful, caring for ourselves as well.

Embracing technological advancements enables us to uncover their incredible benefits by smoothly reducing distress that arises in challenging times.

As foresaid, the practice of surgery is currently understood more and practiced with ease, courtesy of improved technological innovations coupled with investigations and making fairy accurate investigations leading to accurate diagnosis. Thus, making it easier for any form of intervention. Regarding surgical intervention, it is worthwhile to note that, surgical practice has equally made significant improvement aided by technological advancement.

Successful management of brain tumours, craniotomies including sophisticated brain surgery is now done with little efforts. Pathological problems are easily detected by use of CT scan and brain scan with precission accuracy. Crypto-surgery and laser surgery are an every day practice which have made experienced surgeons and novice to be more competent in their surgical practices. Some of these investigations are currently done in out-patient basis just to reduce congestion, and in-patient occupancy in major hospitals. In earlier or former days patients undergoing Brain surgery used to experience life-threatening complications which contributed to high mortality and morbidity rate. But now it is no long true, recovery is quite good. All that is required following surgery is good nursing care practices and recovery is achieved within the shortest time possible. Intensive care (and high dependence) unit including renal dialysis has contributed a lot to patient overall management.

Again, earlier in the century, particularly in low- and middle in-come (developing) countries, surgery for the removal of benign prostatic hypertrophy was bloody- messy and cumbersome, requiring continuous bladder irrigation and riddled with a number of complications. But now it is quite easy with the use of advanced technology of using props and diatomy machines in reducing blood loss during and after surgery.

Likewise, gall stones and kidney or renal stones are clashed and removed with ease using modern technology. Fundamentally, many surgeries which in the past were complicated and unattainable are now conducted with ease and utter precission. Therefore majority of patient requiring one day of observation in the ward after surgical intervention.

Although much progress has been made, however, advances in technological innovation is still promising further progress. However, professionals should not shy off or neglect the human touch and interaction as well as therapeutic communication in order to provide holistic care. As medicine and surgery advances, likewise, conditions and diseases are equally opening new frontiers to cause untold human suffering. Therefore, professionals must fundamentally keep abreast to new innovative development in scientific technology in tackling and addressing human suffering. This can be achieved mainly through continuous medical education.

References

Descartes R. “Collected works”. 2 volumes. Russian translation. Мoscow: Misl (1989): 654.
Sechenov IM. “Reflexes of the brain”. Мoscow: Ministry of education of the USSR (1953): 31-117, 32, 33, 36, 37.
Pavlov IP. “Collected works”. Volumes 1-5. Мoscow-Leningrad: Academy of sciences of the USSR III.part 1 (1949): 104, 323-340, 349.
Lapin IP and Oxenkrag GF. “Intensification of the central serotoninergic processes as a possible determinant of thymoleptic effect”. Lancet 1 (1969): 132-136.
Freud S. “The self-portrait”. Russian translation – St. Petersburg: The East European Psychoanalytic Institute (2006): 256.
Bechterev VМ. “The Future of psychiatry: Introduction into pathological reflexology”. St. Petersburg: Nauka 1997): 23.
Dubrovsky DI. “The problem of the consciousness and the brain: a theoretical solution”. Мoscow: Kanon+, RООI Rehabilitation (2015): 208.
Reshetnikov ММ. “Mental disorder”. St. Petersburg: The East European Psychoanalytic Institute (2008): 272.
Reshetnikov ММ. “Critical postmaterialism in psychology and psychiatry”. Neurological Bulletin XLIII.2 (2011): 66-69.
Lacan J. “Function and field of the speech and the language in psychoanalysis”. The presentation at the Congress in Rome, the Institute of Psychology at the University of Rome on September 26 and 27, 1953. Russian translation. Мoscow: Gnosis (1995).
Reshetnikov ММ. “The non-material theory of the psyche”. Journal Forum of young scientists 6.22 (2018): 1-7.
Reshetnikov MM. “What is the Psyche? What are we Curing?”. Journ. Anthropology 6.3 (2017): 11-15.
Reshetnikov MM. “Problem of Relation between Brain and Mind in Physiology, Medicine and Psychology”. Journ. of Psychiatry and Psychiatric Disorders 1.6 (2017): 313-316.
Reshetnikov MM. “During Two Thousand Years We Were Looking for the Psyche in a Wrong Place (Ideas Live Their Own Life)”. International Journal of Current Innovations in Advanced Research 1.4 (2018): 82-87.
Reshetnikov MM. “Non-Material Theory of the Psyche: Historical Prerequisites, Argumentation and Practical Implications”. International Journ. Psychology & Psychological Research 3.5 (2018): 1-7.
Reshetnikov MM. “Non-material Nature of the Psyche. Psychological Review”. American Psychological Association 6.2 125 (2018): 1035-1047.
Wiener N. “Cybernetics, or control and communication in the animal and the machine”. Мoscow: Sovetskoe radio (1968): 325.
Gubachev JМ and Stabrovsky ЕМ. “Clinical and physiological basis of psychosomatic relationship”. Leningrad: Medicine (1981): 176.
Laborit H. “Metabolic and pharmacological basis of neuro-physiology”. Russian translation. - Moscow: Medicine (1974): 168.
Lubovsky VI. “Development of verbal regulation of activity in children, normal and pathological”. Мoscow: Pedagogics (1978): 224.
Petrovsky VA. “Psychology of non-adaptive activity”. Мoscow (1992): 45.
Bartra R. “Society's Fascination with the Wild Outsider”. The Artificial Savage: Modern Myths of the Wild Man. Michigan (1997): 13-37.
Luria АR. “Small book of the large memory”. Мoscow (1968): 88.
Godfrua J. “What is psychology”. 2 volumes. Russian translation. The 2nd edition. Volume1. Мoscow: Mir, 1996. – 496 p.
Grimak LP. “Reservations of the human psyche”. Moscow: Lenand (1989): 238.
Rizzolatti G., et al. “Premotor cortex and the recognition of motor actions”. Cognitive Brain Research 3 (1996): 131-141.
Rizzolatti G, Fogassi L and Gallese V. “Mirrors in the Mind”. Scientific American Band 295.5 (2006): 30-37.
Freud S. “The Studio of Hosteria”. Russian Translation. St. Petersburg: The East European Psychoanalytic Institute (2005): 454.
Gardner RA and Gardner BT. “Comparative psychology and language acquisition”. In T.A. Sebok and J.-U.Sebok (eds.): Speaking of Apes: A Critical Anthology of Two-Way Communication with Man. New York: Plenum Press (1980): 287-329.
Engels F. “The Part-Paid Labor in the Transition from Ape to Man”. Marx, K. Engels F. Collected works. Russian translation. Moscow: Politizdat 20 (1961): 827.
Terekhov PG. Sechenov I.M. and materialist psychologists. Moscow: Academy of psychology of the Ukrainian SSR (1957): 55-109.
Lenin VI. “Collected works”. The 4th edition, Volume 1 Moscow: The state edition of the political literature 1941-1967.

Prices of services differ among providers, and buyers’ preferences when selecting from offerings vary according to their financial capacity, provider reputation, waiting time, interaction skills between parties, the art of sharing their quality products, and presence. Pleased end users wish to maintain their relationships with those providers and spread the provider’s good name in the community. By contrast, people who are displeased about their suppliers look at another one from the present.

Products the medical team delivers to their collaborators include communicating diverse data to them or their loved ones.

Delivering bad news in clinical practice is inevitable. It may refer to unwanted patient behaviour, laboratory data, alarming disease evolution, or even a patient’s death.

The impact of such news on individuals differs according to the information transferred to the patient’s family members or other loved ones, timeline delivery, skills in sharing bad data, and the vulnerability of intended recipients.

The worst possible data transmitted to patients’ loved ones are those referred to their worse disease prognosis, imminent death, or even death. It is better to communicate such traumatic life events sequentially and not in the evening when people’s tiredness is common. Evidence in clinical practice shows that inappropriately delivering lousy news in the evening determined brain haemorrhage in vulnerable individuals. Therefore, a timeline to share such news and skills is required.

Hope for improvement works for individual well-being, but extensively using it in specific severe evolution through an end disappoints the users. A professional in the healthcare industry must calibrate their intent to protect their partners in harmful situations: decide when it could be applied, to whom, and how long. Using a promise to a great extent of recovery when the disease evolution announces the end acts inadvertently for the end users. It is better to use suggestions about an improbable shift from recovery in advance to protect yourself from a possible patient family’s blame for inaccuracy in data transmission.

Compassionate care is essential in aiding people passing critical life moments. Encouragement, kind words, respectful and friendly attitude, and volunteering when possible help a lot in troubled times.

As an echo, a licensed professional in the healthcare industry will receive appreciation, even love, from the community they serve, ensuring their good reputation, practice standing and advancement, and pleased inner voices that are essential for their health and well-being.

By contrast, cool-hearted work, including inappropriately sharing lousy news, disheartens the end users, decreases return on investment, affects provider reputation and their practice standing, career advancement, and financial stability, and creates distress that can lead to sleep disturbance and unhealthy individual habits.

How we interact with customers in delightful or sorrowful moments and aid them in troubled times defines our life trajectory, ensuring different paths for personal well-being and advancement; individual detrimental feelings can lead to failure in advance.

An individual’s greatest aspiration is to successfully navigate the complexities of this objective, ephemeral world while cherishing the gratitude of those they have served, especially in their most challenging life events.

References

WHO: (2022): 11 figures on water, sanitation and hygiene in schools.
WHO/UNICEF (2000-2021) s: Progress on Drinking Water, Sanitation and Hygiene in School.
John BESCODO (2022): Dilapidation, Dirt, Lack of Privacy. The State of School Toilets Puts Students Off: A Descriptive Study in Sub-Saharan Africa.
Dieudonné NG. Evaluation of the implementation of the WASH (Water Sanitation and Hygiene) concept in schools: Case of some high schools in the city of Yaoundé (Doctoral dissertation, Masters Thusis) (2016).
Jean Damien. School Toilets, A survey makes a worrying diagnosis: a study carried out on hygiene and sanitation in Bamako (2019).
Zoulkifl Salou Bachirou., et al. “Availability and functionality of hygiene and sanitation infrastructure in public schools in Benin” (2019).
UNICEF (2019): Study on water, hygiene and sanitation in primary schools in the city of Kinshasa.
UNICEF and WHO (2020): JMP (Joint Monitoring Programme): a joint initiative of UNICEF and WHO that monitors global water, hygiene and sanitation programmes in schools in sub-Saharan Africa.
Ouedraogo DJ, Barry AA and Diawara. Sanitation and Health in West Africa: A Systematic Review (2020).
Assefa B., et al. Factors influencing the use of improved pit latrines in urban areas of Ethiopia: a cross-sectional study (2019).
UNICEF (2019): Study on water, hygiene and sanitation in primary schools in the city of Kinshasa.
Diop A, Ndiaye M and Seye A. Evaluation of the impact of a hygiene education program on the knowledge, attitudes and practices of primary school students in Senegal (2022).
Konan (2021): Effect of an educational intervention on menstrual hygiene among adolescent girls in schools.
WHO-UNICEF (2019): WASH framework guidelines and toilet availability in schools.
UNESCO (2021):Inclusive Education: Towards Quality Education for Learners with Disabilities.
UNESCO (2019): Accessibility of schools for students* with disabilities in the United Kingdom: a national study conducted by UNESCO in 2019 in England.
University of Toronto (2019): Perceptions of Students with Disabilities on School Accessibility: A Qualitative Study.
Claire de Saint Martin (2019): The voice of students with disabilities: a study conducted in France focused on the recommendation, design and construction of compliant ramps.
UNESCO (2020): Impact on the availability of trash cans in schoolyards: Global report.
World Bank (2020): Assessment of the availability of trash cans in schools.
WHO (2021): Impact of open burning of school waste on children's respiratory health in low- and middle-income countries.
UNICEF (2020): Accessibility to drinking water; WASH in schools in low-income primary and secondary schools.
UNICEF (2019): Study on water, hygiene and sanitation in primary schools in the city of Kinshasa.
Caritas Congo (2019): Program to improve access to water, hygiene and sanitation in Catholic schools.
ECC (Church of Christ in Congo) (2019): Actions in schools to raise awareness of the importance of water, hygiene and sanitation.
UNDP, Ministry of National Education (2011): Water, hygiene and sanitation improvement program in the city of Kisangani.
UNICEF (2018): Access to drinking water, sanitation and hygiene in primary schools in Kisangani.

Key Roles of Supramolecules in Chemotherapy:
Drug Delivery Systems

Supramolecular assemblies can encapsulate chemotherapy drugs, improving their solubility and stability.
They help target drugs directly to cancer cells by taking advantage of specific interactions with cancer cell markers, reducing the impact on healthy cells.
Examples include liposomes, micelles, and nanoparticles, which are all forms of supramolecular systems that can deliver chemotherapy agents in a controlled and sustained manner.

Targeting

Supramolecular complexes can be engineered to recognize specific cancer biomarkers or overexpressed receptors on tumor cells. This targeting ability reduces the need for chemotherapy drugs to circulate throughout the body, thereby decreasing systemic toxicity and side effects.

Controlled Release

Some supramolecular systems can release chemotherapy drugs in response to specific triggers, such as changes in pH, temperature, or the presence of certain enzymes. This feature allows for localized and controlled release of the drug, ensuring it acts primarily on the tumor.

Reducing Drug Resistance

By modifying the structure of the supramolecule or the way it interacts with the chemotherapy agent, it's possible to overcome mechanisms of drug resistance that cancer cells develop. This could be done by preventing the drug from being expelled from the cell or by improving drug uptake.

Examples of Supramolecular Systems in Chemotherapy:

- Cyclodextrins: These are cyclic oligosaccharides that can form supramolecular complexes with chemotherapy drugs, improving their solubility and stability in the body.
- Polymeric Micelles: These self-assembled nanoparticles have hydrophobic cores that can encapsulate hydrophobic drugs, enhancing drug solubility and prolonging circulation time.
- Dendrimers: These are branched, tree-like macromolecules that can carry multiple drug molecules on their surface, offering both targeted delivery and controlled release.

Advantages of Supramolecular Systems in Chemotherapy

- Targeted drug delivery: By directing drugs specifically to cancer cells, supramolecules reduce harm to healthy tissues.
- Improved solubility and stability: Many chemotherapy drugs are poorly soluble in water, which can limit their effectiveness. Supramolecular complexes can enhance drug solubility and stability, improving their bioavailability.
- Reduced toxicity: By controlling the release and targeting of chemotherapy agents, supramolecules help minimize the systemic toxicity typically associated with chemotherapy.

Challenges

- Complex synthesis and design: Engineering supramolecular systems for specific drug delivery can be complex and costly.
- Long-term safety: The long-term safety of these delivery systems is still under investigation, as their breakdown products in the body need to be carefully considered.

In summary, supramolecules are an exciting field in cancer chemotherapy, offering the potential for more effective, targeted, and less toxic treatment options. Research is ongoing to improve the design, functionality, and clinical application of supramolecular systems in cancer therapy.

Forensic Toxicology involves the detection and analysis of substances like drugs, alcohol, and poisons in biological samples, which often plays a critical role in determining the cause of death or identifying substances involved in a crime. However, the complexity arises from the vast variety of substances, the need for precise testing, and the intricate interpretation of results, all of which demand advanced knowledge, specialized equipment, and meticulous procedures. The accuracy and reliability of toxicological analysis are essential, making it one of the most demanding aspects of forensic investigations.

As the field of forensic toxicology develops and expands, forensic toxicologists endure multiple challenges, such as the advent of new drugs, their analysis and divergences in the interpretation of toxicological findings. However, forensic toxicology faces numerous challenges. These include the complexity of detecting a wide variety of substances, especially newer or synthetic drugs that may not be part of standard testing panels. The development of more sophisticated substances, such as designer drugs, can evade traditional detection methods. Additionally, the ability to accurately quantify and interpret results can be complicated by various factors, including the time of exposure, the metabolic rate of individuals, and the potential interactions between different substances.

Forensic toxicology plays a critical role in determining the presence of drugs, alcohol, poisons, or other toxic substances in the human body, especially in the context of legal investigations. However, below mentioned several limitations and challenges hinder its full potential and accuracy:

Collection and Preservation of Samples

The integrity of biological samples (blood, urine, hair, etc.) is vital for accurate testing. Improper collection, handling, or storage can lead to contamination or degradation of the sample, affecting the results. Certain substances may also degrade over time or under specific storage conditions, leading to the loss of important evidence.

Detection Techniques Limitations

Current detection methods may not identify all substances, especially new or emerging drugs that haven’t yet been incorporated into standard testing panels.

Testing for complex mixtures of substances may be difficult, as some compounds can interfere with others, causing false negatives or false positives.

Interpretation of the Findings

The interpretation of toxicological results often depends on various factors such as the timing of sample collection, the individual’s metabolic rate, and the dosage of the substance. Different individuals may respond differently to the same substance, which complicates drawing clear conclusions in forensic investigations. Some substances may be detected in the body long after the toxic effects have worn off, making it difficult to establish the cause of death or the timeline of intoxication.

Legal and Ethical Concerns

Forensic toxicology often operates within the confines of the legal system, where there may be pressure for results to conform to a particular narrative. The potential for bias, intentional or unintentional, can affect the objectivity of toxicological analyses. Privacy and consent issues may arise when testing for certain substances, especially when dealing with non-consensual testing or invasive methods. Legal and ethical issues are critical considerations in various fields, particularly in contexts where decisions and actions directly impact individuals' rights and well-being. These concerns often involve balancing the pursuit of justice with respect for privacy, fairness, and transparency. Legal challenges may include adhering to laws and regulations, while ethical dilemmas frequently arise when determining what is morally right or wrong in complex situations. Navigating these issues requires careful thought, clear guidelines, and a commitment to upholding both legal standards and ethical principles.

New Emerging Substances and Psychoactive Drugs (NPS)

The rise of new psychoactive substances (NPS) presents a challenge as these drugs may not be included in standard toxicology tests. Their chemical structures may vary widely, making them difficult to detect using traditional methods. As illicit drug manufacturers constantly develop new substances, forensic toxicologists need to stay ahead by constantly updating testing protocols and acquiring new analytical tools.

Budgetary and Resource Limitations

Comprehensive toxicological testing can be expensive, particularly when multiple substances need to be screened or when specialized techniques are required. Financial and resource limitations may restrict the number of tests that can be performed, especially in high-volume cases. Limited funding may also affect the development and availability of advanced technology in forensic toxicology labs.

Accuracy of Post-Mortem Toxicology

In post-mortem toxicology, the interpretation of results can be complicated by factors like the post-mortem redistribution of substances, which can alter the concentrations of drugs or poisons in various body fluids and tissues. The cause of death may be obscured by the presence of substances that are naturally occurring in the body or could be introduced after death, further complicating the investigation.

Legal and Procedural Obstacles

Variations in the legal standards and procedures for forensic toxicology across different jurisdictions can create inconsistencies in how toxicology evidence is handled, analyzed, and interpreted in court. Toxicological reports may be contested by defense attorneys, who may argue for alternative interpretations of the data, requiring forensic toxicologists to be highly meticulous in their analysis and presentation of findings.

These challenges highlight the complex nature of forensic toxicology and underscore the need for continuous advancements in technology, methodology, and training to address the evolving demands of the field. In short, while forensic toxicology is a vital tool in the justice system, its challenges require ongoing advancements in science, technology, and procedures to ensure accurate and reliable outcomes.

References

Hinton JJ, Veiga MM and Beinhoff C. “Women and Artisanal Mining: Gender Roles and the Road Ahead”. The World Bank (2003).
Yakovleva N. “Corporate Social Responsibility in the Mining Industries”. Corporate Social Responsibility and Environmental Management (2007).
United Nations Environment Programme. “Practical Guide: Reducing Mercury Use in the Artisanal Gold Mining and Panning Sector”. Geneva: United Nations Environment Programme (2012).
Donoghue A. “Occupational health hazards in mining: an overview”. Occupational Medicine 54.5 (2004): 283-289.
Mthembu S, Hlongwa M and Shongwe M. “The impact of informal settlements on health outcomes: a case study of informal settlements in South Africa”. BMC Public Health 19.1 (2019): 1234.
Lissau A., et al. “HIV and tuberculosis among miners in South Africa: an emerging health crisis”. Int J Tuberc Lung Dis 18.3 (2014): 346-353.
Pommier de Santi V., et al. “Malaria in French Guiana linked to illegal gold mining”. Emerging Infectious Diseases 22.2 (2016): 344-346.
Calys-Tagoe BN., et al. “Injury profiles associated with artisanal and small-scale gold mining in Tarwwa, Ghana”. International Journal of Environmental Research and Public Health 12.7 (2015): 7922-37.
Long NR, Renne EP and Basu N. “Understanding the social context of the ASGM sector in Ghana: A qualitative description of the demographic, health, and nutritional characteristics of a small-scale gold mining community in Ghana”. International Journal of Environmental Research and Public Health 12 (2015): 12679-12696.
International Labor Organization. “The burden of gold: child labor in small-scale mines and quarries”. World of Work 54 (2005): 16-20.
Cirimwami L, Baguma G and Mushagalusa O. Mining and biodiversity: the case of Twangiza Mining in eastern DRC (2016).
Mangambu Mokoso JD, Asimbo Bondoo N and Ekele Mbenga R. “Perspectives on the Environmental Impacts of Semi-Industrial Mining Projects in the Congo Basin: Case of the Aruwimi River (Basoko Territory, DR Congo)”. European Scientific Journal, ESJ 17.29 (2021): 328.
International Labour Organization. “Mining and Child Labor”. Geneva: ILO (2021).
Hilson G and Pardie S. “Artisanal Gold Mining and Rural Development Policies in Ghana”. Resour Policy 57 (2018): 87-94.
Banchirigah SM. “Challenges with Eradicating Illegal Mining in Ghana: A Perspective from the Grassroots”. Resour Policy 32.1-2 (2017): 29-38.
Human Rights Watch. “A Poisonous Mix: Child Labor, Mercury, and Artisanal Gold Mining in Mali”. (2019).
World Health Organization. “Water, Sanitation, and Hygiene in Mining Communities”. WHO Report (2020).
UNICEF. “Drinking Water and Sanitation in Mining Areas of the DRC”. UNICEF Report (2021).
Bose-O'Reilly S, Lettmeier B and Roider G. “Mercury Exposure and Health Impacts among Individuals in the Artisanal and Small-Scale Gold Mining Community: A Comprehensive Review”. About Health Perspective 116.1 (2018): 1-9.
Pierrot J, Underne M and Kuchcik L. “Tobacco: what is the health risk?”. Rev Prat 62.3 (2012): 333-6.
Hill C and Laplache A. “Smoking and mortality: epidemiological aspects”. Weekly epidemiological bulletin 22.23 (2003): 98-100.
Joint United Nations Programme on HIV/AIDS (UNAIDS). “HIV and Mining Communities”. UNAIDS Report (2021).
Corno L and de Walque D. “Mines, Migration and HIV/AIDS in Southern Africa”. J Afr Econ 19.1 (2018): 33-73.

I will use this opportunity to inform about recent radiation biology developments that can significantly improve curative radiation oncology. Interestingly, while developing an improved cell survival formulation better applicable for normal tissue responses [1, 2] we found that most normal issues that have a wild type TP53 gene are also linked to Low Dose Hyper-Sensitivity (LDHS [3-5]). Because about ½ Gy or 18 DSBs are needed to start full DNA repair capability in the cell by starting non-homologous end joining and homologous recombination by phosphorylation of p53 at the serine 15 and 20 sites [3, 6, 7]. This LDHS in normal tissues is an effect of the cellular cancer avoidance system developed to induce Low Dose Apoptosis (LDA) to avoid misrepair before the DNA repair system is fully functional. Instead, after a single low dose irradiation the caspase 3, that performed the apoptosis, will remarkably remember the cell loss and induce a compensatory accelerated repopulation of the missed cell to recover homeostasis [8]! This is in contrast to most tumors that commonly are associated with a mutant p53 that instead often is associated with a Low Dose Radiation Resistant (LDRR [3]) phenotype and therefore generally are rather radiation resistant at low doses generally without LDA. This mechanism makes most tumors more difficult to treat at low doses making effective IMRT the method of choice for curative treatments. However, the LDHS of most normal tissues implies that as soon as we need to go above about 0.5 Gy to treat the underlying tumor it is better to continue up to about 2 Gy (as in classical parallel opposed treatments [6]) since now we have full repair induced and we should use the thereby induced radiation resistance to increase the dose to the tumor using IMRT. In fact the optimal radiation tolerance of most normal tissues is in the range 1.8-2.3 Gy/Fraction as was established through the last 80 years of radiation therapy [9]. However, using IMRT the tumor dose should be much higher now, than the classical parallel opposed beam ≈2 Gy/Fr, since we now generally k¬now we face a LDRR tumor that need higher doses per fraction for cure, as the increasingly popular ultra-hypo-fractionation schedules propose [3, 10-13]. The 2 Gy/Fr to normal tissues at risk fractionation schedule was proposed already 1999 [14] and it is really the best way to describe the tumor boost and the resultant dose per fraction increase in the tumor to reach about ≈3-4 Gy to avoid too massive cell kill in large tumors. A total tumor dose reduction of about ≈10 Gy is achievable by this type of tumor boost as described recently [3, 4, 7].

A common ethical problem is ambition conflict when several specialists treat the same patient within the same specialty or in different areas of medicine. Various (conflicting) views and priorities in choosing treatment tactics should be discussed to achieve agreement between specialists considering the patient's interests above all other issues. Generally, when a patient is treated by a physician who cares about one’s dignity and actively engages with them, the patient tends to pay closer attention to personal health and gains a better understanding of health problems and treatments available. Effective communication between physician and patient in collaborative decision-making has been shown to positively influence health outcomes and achieve mutual health goals, resulting in better treatment adherence and increased patient satisfaction.

Alternatively, healthcare providers should be aware of the factitious disorder imposed on self or Munchausen syndrome, the difficult-to-diagnose condition that presents a major challenge to medical ethics. The syndrome of deliberate simulation of physical and/or psychological symptoms is a mental health condition that occurs when the subject appears sick or intentionally makes yourself ill. People with this condition, in an attempt to escape from real problems and conflicting life situations, pretend to be ill or intentionally harm themselves to deceive medical personnel, attract their attention, and get care. In such situations, physicians may feel frustrated and powerless due to their inability to prevent patients' destructive behaviors. Although the causes of factitious disorder are poorly understood, bioethics can serve as an effective tool to address this issue. Adhering to bioethical principles enables physicians to implement an appropriate model of patient-physician relationships considering clinical circumstances to achieve the patient's trust and understanding. Regardless of which model of physician-patient interaction is applied—be it Deliberative, Paternalistic, Informative, or Interpretive—the physician's primary goal remains consistent: to foster an honest and open environment that ensures confidentiality and provides support.

Enduring values like empathy, care, and compassion are the starting points for healthcare ethics. In his book "Civilization and Ethics," Albert Schweitzer a Nobel Peace Prize winner wrote: Ethics is nothing other, than Reverence for Life. According to Schweitzer, the basic principle of the Reverence for Life concept is that: All life is valuable and important, and that no life should be sacrificed without compassionate consideration of the life lost compared to the greater good the sacrifice may yield. Empathy and compassion for others are profound feelings that demand special spiritual effort. In professional medical ethics, the capacity for empathy and sympathy serves as the moral foundation for healing activities—the principle of “do good.” The principle of Reverence for Life has become central to medical ethics and morality, gaining universal and international recognition.

Medical practice is regulated by two complementary instruments: professional ethics and law. Together, they establish ground rules that guide human behavior. Law consists of rules and regulations that serve as externally enforced mechanisms for maintaining social order. Ethics comprises principles that are more subjective and addressed to one's morals and values guiding individuals to perform their duties with integrity. Ethics constrain a person's actions, but one acts rightly not out of fear of punishment; rather, one cannot act otherwise due to their inner convictions and moral values.

To be successful, a physician's professional activity must be founded on moral values, along with internal control, patience, and responsibility. The lack of these qualities is not mitigated by clinical proficiency, medical skill, or the most advanced equipment and facilities. Think of moral values and a positive attitude as a prerequisite for success. The Latin winged expression Aliis inserviendo consumor (I am consumed in serving others) is and continues to be the motto of compassionate healers.

The illusion of perfection in a person ultimately leads to disappointment sooner or later, as human perfection is unattainable. Experiencing upset and possibly facing disruption from others is inevitable—human imperfection is a universal trait.

Minor daily work deficiencies, including slight communication inadvertence, are common for everyone. However, exceeding tolerance limits for unsafe interactions among individuals can lead to their disorders, which are more or less clinically expressive, depending on individual vulnerability, time exposure, and word and thought energy sent and received from all players in a relationship. The degree of distress varies among individuals, and its effects can range from minor to significant clinical manifestations of bodily systems impacted by it.

Additionally, time slowly undermines everything; human work capacity diminishes as people age, requiring support from their loved ones, friends, or community members. A lack of mental and/or physical strength results in a feeling of dependency on others—another disheartening thought about needing assistance.

Ameliorating their suffering has evolved in the digital age. Telemedicine—a new trend in the healthcare industry—prevents burnout, saves time and travel expenses, provides home comfort for applying knowledge in practice, and revitalizes and pleases them with their work.

IT advancements benefit home care and institutional supervision of individuals in need. An interdisciplinary team connected online can quickly adjust the medication therapy plans and monitor the patient's condition, making the approach more effective.

Virtual and real-world interaction skills positively and negatively impact providers and end users.

Communication skills are key in managing individual disorders. Providers' verbal and nonverbal interaction with their collaborators, partners, and the end users facilitates or impedes adherence to the therapy plan and finally influences clinical outcomes.

The provider's kindness and friendly attitude benefit the end users, determining optimistic and constructive thinking that improves the individual's evolution with the disorder. Pleased end users discuss their provider fulfillment with their loved ones, family members, and community members, which extends their enjoyment to others, amplifies good feelings in society, and finally increases the provider's good reputation, return on investment, business stability and growth, creativity, work efficiency, finances, and personal health and well-being.

Positive emotions created by providers for end users act as medicine. Favorable emotions can reinforce them, while adverse, harmful feelings diminish the abovementioned elements.

The service price offered by the providers significantly impacts the buyers. Disproportionate prices of offerings that are not accessible to clients disappoint them and their families, and they frequently must look to other offerings. That creates frustration, making them more vulnerable. By contrast, volunteering makes needy people think differently when possible: it fosters encouragement, increases hope for better outcomes, and aids recovery. Their devotion to the provider is acknowledged.

Some people experience distress caused by medical conditions or just thinking about the transition to another life form. In challenging times, a team must provide both material and emotional support to prevent individual burnout caused by the continuous care of loved ones or others in distress. Providers and end-users must use IT advancements for instruction and relaxation in the digital age. This way, patients can go away in peace, and their relatives and caregivers will retain their best memories of them over time.

Stakeholders may participate in supportive programs for both providers and end-users.

The provider's service quality to their clients influences their feelings and lives. Kindheartedness is an essential service.

When our generosity complements our offerings, we can be a small light in the darkness for those suffering

References

Aldrich J. “Fisher and Regression”. Statist. Sci 20.4 (2005): 401-417.
Demidenko E. “Mixed Models: Theory and Applications with R”. Wiley Series in Probability and Statistics (1981).
Galton F. “Typical laws of heredity”. Nature 15 (1877): 492-495, 512- 514, 532-533.
Hajiyev AH. “Regression Models with Increasing Numbers of Unknown Parameters”. In: International Encyclopedia. Statist. Sciences, Springer (2011): 1208-1211.
Hajiyev AH. “Nonlinear Regression Models with Increasing Numbers of Unknown Parameters”. Russian Acad. Sci., Mathem 79.3 (2009): 339-341.
Hajiyev AH. “Linear Regression Models with increasing numbers of unknown Parameters”. Russian Acad.Sci., Doklady, Mathematics 399.3 (2004): 1-5.
Huber PJ. “Robust regression: Asymptotics, conjectures and Monte Carlo”. The Annals of Statistics 1 (1973): 799-821.
Legendre A.-M On Least Squares. Translated from the French by Professor Henry A Ruger and Professor Helen M Walker, Teachers College, Columbia University, New York City (1805).
Prohorov YuV and Rozanov YuV. “Probability theory. Basic concepts-limit theorems-random processes”. Springer (1969).
Rao CR. “Linear Statistical Inference and its Applications”. John Wiley Series in Probability and Statistics (1973).
Seber GF. “Linear Regression Analysis”. NY, Wiley Ser. Probab. and Statistics (2003).
Sheinin O. “Gauss and the method least squares”. Jahrbucher fur Nationalokonomie und statistic 219.3+4 (1999): 458-467.
Shiryaev AN. Probability. Springer-Verlag, New York-Berlin- Heidelberg (2013): 580.
Sun Q, Zhou WX and Fan J. “Adaptive Huber Regression”. Am Stat. Assoc 115.529 (2020): 254-265.
Stanton JM. “Galton, Pearson, and the Peas: A brief history of linear regression for statistics instructors”. Journal of Statist. Education 9.3 (2001).
Wand MP. “Comparison of Regression Spline Smoothing Procedures”. Computational Statistics 15 (2000): 443-462.
Wang L, Wu Y and Li R. “Quantile regression for analyzing heterogeneity in ultra-high dimension”. Journal of the American Statistical Association 107 (2012): 214-222.
Wu CF. “Jacknife, bootstrap, and other resampling methods in regression analysis”. Ann. Statist 14.4 (1986): 1261-1350.
Wu CFJ and Hamada MS. “Experiment. Planning, Analysis and Optimization”. Wiley, Ser. Probability and Statistics (2009).
Yao F, Muller H-G and Wang J-L. “Functional linear regression analysis for longitudinal data”. Ann. Statist 33.6 (2005): 2873-2903.
Yule GU and Pearson K. “On theory of consistence of logical class- frequences, and its geometrical representation”. "Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences (1997): 287-299.
Zaks Sh. “Theory of statistical inference”. John Wiley Sons (1972).
Zapf A, Wiessner C and König IR. “Regression Analysis and Their Particularities in Observational Studies”. Dtsch Arztebl Int 121.4 (2024): 128-134.

Introduction

The history of Brazilian science is marked by unique trajectories that, in addition to reflecting specific social and institutional contexts, highlight the active role of its protagonists in building the scientific field. In this scenario, the work of Blanka Wladislaw (1917table2010) represents one of the most relevant contributions to the consolidation of Organic Chemistry in Brazil, both in higher education and scientific research.

Education and Integration into the University Environment

A Polish immigrant, Blanka arrived in Brazil at the age of 14, bringing with her a solid European humanistic education that valued reading, observation, and critical thinking. Her admission to the Faculty of Philosophy, Sciences and Letters of the University of São Paulo (USP) in 1939 marked the beginning of an academic journey closely connected to European professors such as Heinrich Rheinboldt and Heinrich Hauptmann, both fundamental in structuring Chemistry education in the country.

During her undergraduate studies, Blanka stood out for her interest in laboratory activities and her affinity for Organic Chemistry. With Hauptmann’s support, she began her doctoral studies a few years after graduation, completing them in record time. Her research on sulfur compounds was published in international journals, inaugurating a new line of investigation at the university.

Postgraduate Studies and Innovation in Organic Electrochemistry

In the 1950s, with a scholarship from the British Council, Blanka conducted postdoctoral research at Imperial College in London, where she came into contact with new methodologies in the field of Organic Electrochemistry. Upon returning to Brazil, she introduced these techniques to the Chemistry Department at USP, which represented a significant advancement for research in the area. Her tenure thesis, defended in 1958, addressed the application of electrolytic methods to the synthesis of α-lipoic acid, and was also published abroad.

Following these contributions, Blanka structured a research group that became renowned for its scientific productivity and for training new academic and industrial professionals. Among her mentees are names such as Hans Viertler, Roberto Rittner, and Paulo Olivato, who later also took on academic roles at USP.

Commitment to Scientific Training and Institutional Challenges

Throughout the interview, Blanka emphasized the importance of the inseparability of teaching and research, arguing that a university professor must also be a researcher. This perspective, which was not yet predominant in Brazilian universities at the time, was consolidated in the practices of her department and influenced the organization of postgraduate programs at USP and other institutions.

Blanka also warned of the risks of academic talent being lost to industry due to salary disparities. Although she viewed the strengthening of ties between the university and the productive sector positively, she believed it was essential to ensure adequate conditions for young researchers to remain in academia.

Final Considerations

Blanka Wladislaw’s trajectory is emblematic of scientific development in Brazil in the 20th century, revealing the challenges faced by women scientists, immigrants, and pioneers in still-developing fields. Her contribution goes beyond Organic Chemistry, extending into the realm of scientific policy and the training of qualified human resources.

By combining academic excellence, methodological innovation, and institutional commitment, Blanka Wladislaw stands as a central figure in the history of Brazilian science. Her legacy remains alive in the research institutes she helped build and in the generations of scientists she trained.

The World Health Organization (WHO) has declared AMR one of the top 10 global public health threats. According to a 2019 report, drug-resistant infections claim at least 1.27 million lives annually, and this number is projected to rise to 10 million by 2050 if no action is taken. The economic toll is equally staggering, with estimates suggesting that AMR could cost the global economy $100 trillion by mid-century. These figures are not mere statistics—they represent a future where modern medicine as we know it could be rendered obsolete.

The challenge of AMR is compounded by the lack of new antibiotics in the pharmaceutical pipeline. Developing new drugs is a costly and time-intensive process, and many pharmaceutical companies have shifted their focus to more profitable areas, such as chronic diseases. The result is a stark imbalance: while resistance is growing, the arsenal of effective antibiotics is shrinking. This gap underscores the need for innovative approaches, including the development of alternative therapies such as bacteriophages, immunotherapies, and vaccines.

Addressing AMR requires a multifaceted strategy. First, there must be a global effort to promote the responsible use of antibiotics. This includes stricter regulations on prescriptions, public awareness campaigns to discourage self-medication, and the implementation of antibiotic stewardship programs in healthcare settings. Second, the agricultural sector must reduce its reliance on antibiotics, particularly for non-therapeutic purposes. Policies that incentivize sustainable farming practices and restrict the use of medically important antibiotics in animals are critical.

Third, international collaboration is essential. AMR knows no borders, and a fragmented approach will only exacerbate the problem. Governments, healthcare organizations, and researchers must work together to share data, resources, and best practices. Initiatives like the Global Antibiotic Research and Development Partnership (GARDP) and the WHO’s Global Action Plan on AMR are steps in the right direction, but they require sustained funding and political will to succeed.

Finally, investment in research and development must be prioritized. Governments and private sectors must collaborate to create incentives for the development of new antibiotics and alternative treatments. Public-private partnerships, grants, and regulatory reforms can help reignite the pipeline of antimicrobial drugs.

The fight against AMR is not just a scientific challenge—it is a test of our collective resolve. It calls for a paradigm shift in how we view and use antibiotics, recognizing them as precious resources rather than infinite solutions. The stakes are high, and the window of opportunity is narrowing. If we fail to act, we risk entering a post-antibiotic era where even the simplest infections could become deadly. The time to act is now, before the crisis becomes irreversible.

In the words of Alexander Fleming, the discoverer of penicillin, "The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism." Let us heed this warning and take decisive action to preserve the power of antibiotics for generations to come. The future of global health depends on it.

References

Bahuchet S. In the forest of Central Africa: The Aka and Baka Pygmies. History of a forest civilization. Edition PEETERS-SELAF,. Paris (1992): 423. (Collection Ethnosciences,; vol. Tome I).
Nke Ndih J. “Management of forest ecosystems by the Bakola/Bagielli Pygmies and neighboring Bantu in Southwest Cameroon in the face of neoliberal exploitation”. Catholic University of Louvain (2014).
NKE NDIH J. “Biodiversity and health among the Bakola/Bagyéli Pygmies”. Proceedings of the Bamako Conference on Development, Environment and Health,. Montr IEPF SIFEE (2007): 439-449.
BAHATI P. “Analysis of factors hindering Pygmies' access to health care in the Goma and Karisimbi health zones”. ULGL (2009).
SALOMONE G and TAGLIONI F. “The Health Marginalization of the Pygmy Islands of Likouala”. HAL-SHS (2008).
MAGILU MM., et al. “Medicinal plants used by Pygmies (Mbute) to combat malaria in the Mambasa area, Ituri, Zaire”. Semantic Sch (1996).
Ebelpoin A. “The Aka Pygmies of the Central African Republic, between traditional and modern medicine”. AFP Sakoungou Central Africa (2022).
LEWIS J. The Batwa Pygmies of the Great Lakes region (2001): 40.
Soengas BL. “The Substance of the Babongo Pygmies Put to the Test of Agriculture”. Doctoral School of Natural and Human Sciences, GABON (2010).
Michel Matarasso. “Reading Claude Levi-Strauss. Wild Thought and First Logic”. French Review of Sociology 4-2 (1963): 195-205.
Langwick. “Bodies, Politics, and African Healing: The Question of Disease in Tanzania”. Indiana University Press (2011).
Auge Marc. “The Anthropology of Illness”. In: L'Homme 26 (1986): 97-98. Anthropology: State of the Art (1986): 81-90.
Feierman and Janzen. “The Social Foundations of Health and Healing in Africa”. University of California Press (1992).
Prince and Marsland. “Making and Unmaking Public Health in Africa: Ethnographic and Historical Perspectives”. University of Edinburgh Research Explorer (2014).
Paul J Ross, Nina L Etkin and Ibrahim Muazzamu. “The Greater Risk of Fewer Deaths: An Ethnodemographic Approach to Child Mortality in Hausaland”. Journal of the International African Institute 61.4 (1991): 502-512.
Feierman. “The Social Roots of Health and Healing in Modern Africa”. published in African Studies Review (1985).
Mbembe A. “On the Postcolony”. Illustrated Edition; Publisher, University of California Press (2001).
Levesque., et al. “Patient-Centered Access to Health Care: Conceptualizing Access at the Interface of Health Systems and Populations”. International Journal for Equity in Health (2013).
Bussmann and Sharon. “Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture”. J Ethnobiol Ethnomed (2006).
Foster and Anderson. “Medical anthropology”. New York (1978): 354.

References

Hardas S, Deshmukh P and Poojary M. “Glimpse of Pharmacy Profession in India”. Journal of Drug Delivery & Therapeutics 2.2 (2012): 4-7.
Goa College of Pharmacy. (n.d.). Pharmacy profession in Goa.
Basak SC and Sathyanarayana D. “Pharmacy education in India”. American Journal of Pharmaceutical Education 74.4 (2010): 68.
The Pharmacy Act, (n.d.). Government of India (1948).
World Health Organization. The role of the Pharmacist in the healthcare system. WHO (1997).
Singh P., et al. “Diagnostic innovations in India during COVID-19: A review of development and impact”. Indian Journal of Medical Research 153.1 (2021): 6-13.
Gupta P and Sinha S. “RT-PCR and antibody tests for COVID-19: Developments and challenges”. Indian Journal of Clinical Chemistry 35.1 (2020): 1-4.
Dholakia S., et al. “Medical device innovations in India during COVID-19”. Indian Journal of Medical Technology 16.2 (2021): 12-17.
Sharma P and Kapoor S. “Monoclonal antibodies for COVID-19: A review of early research and applications”. Indian Journal of Clinical Immunology 22.1 (2020): 30-35.
Basak S and Sathyanarayana D. “Community pharmacists as frontline healthcare providers: Opportunities for improving public health in India”. Southern Med Review 2.1 (2009): 11-14.
Bhatia V., et al. “Community pharmacists as frontline healthcare providers: Opportunities for improving public health in India”. International Journal of Community Pharmacy (2020).
Sharma S., et al. “The role of community pharmacists in the management of chronic diseases in India”. Indian Journal of Pharmaceutical Sciences (2019).
Singh S., et al. “Pharmacist-patient collaboration for enhanced medication adherence in India”. Journal of Pharmacy Practice and Research (2021).
“Clinical pharmacy practice in India: An overview”. Journal of Pharmacy and Bioallied Sciences 7.3 (2015): 161-174.
AAPC (American Academy of Professional Coders). What is Medical Coding? (2015).
AAPC (American Academy of Professional Coders). What is Medical Billing? (2015).
AHDI (Association of Healthcare Documentation Integrity). AHDI Answers Frequently Asked Questions About Medical Transcription (2015).
World Health Organization. Pharmacovigilance. Essential Medicines and Health Products (2015).

Yet, India continues to rely heavily on dry temperature-based thresholds for its heat warnings and mitigation strategies. While helpful, this approach omits a critical component: humidity. In a tropical country like India, where relative humidity frequently exceeds 70% during peak summer months, ignoring this factor results in a severe underestimation of the population's heat exposure. The concept of "felt heat” addresses this gap. It combines air temperature and relative humidity to better reflect the actual thermal discomfort experienced by the human body. Agencies like National Oceanic and Atmospheric Administration (NOAA) in the United States already use this metric to communicate health risks more effectively.

In cities like Kolkata, where average summer humidity reached 74.4% in 2023 and peaked at 81.3% in 2020, the combined effect of high humidity and temperature makes the heat not only uncomfortable but lethal. Recent reporting by the Times of India notes that Kolkata now ranks among the most dangerous metros in India during summer, due to this exact heat-humidity punch.

Felt heat has deeply unequal consequences for India’s vulnerable populations. Outdoor workers, including construction labourers, sanitation workers, and gig economy delivery personnel, are on the frontlines of exposure, often working without shade, hydration, or rest. Elderly individuals, children, and pregnant women suffer disproportionately due to reduced thermoregulation. People living in informal settlements face additional burdens: overcrowded housing, poor ventilation, limited access to water, and lack of cooling mechanisms all amplify the impact of extreme heat.

The response to this crisis cannot be confined to healthcare institutions alone. What India needs is a whole-of-society, inter-sectoral approach that links heat mitigation with urban planning, labour policy, water and sanitation, and housing. While cities like Ahmedabad have pioneered low-cost interventions such as reflective cool roofs and shaded bus stops under their Heat Action Plans, these efforts must now evolve into systemic policies that build resilience across sectors.

Felt heat should be the standard metric guiding India's heat response. Incorporating it into early warning systems and city planning will allow for a more realistic understanding of urban thermal stress and enable targeted interventions. Heat resilience must be embedded into affordable housing design, public space development, and infrastructure planning.

India’s climate future demands that we stop treating heat as a seasonal nuisance and start recognizing it as a structural hazard. With 2024 serving as a stark warning, the time to adopt a felt heat lens in our risk frameworks is now. Failure to do so would mean continuing to overlook the invisible yet intensifying crisis at our doorstep.

References

Times of India (2025). Kol rank soars on killer heat-humidity punch.
ScienceDirect (2025). Assessing thermal comfort in hot and humid (tropical) climates.
AP News (2025). In one Indian city, reflective paint and bus stop sprinklers offer relief from killer heat.
World Meteorological Organization (2024). 2024 Confirmed as Hottest Year on Record.

Data-Independent Acquisition (DIA) Mass Spectrometry, especially using SWATH-MS (Sequential Window Acquisition of All Theoretical Mass Spectra), is still the most advanced and comprehensive approach to breast cancer proteomics. The latest ultra-high-resolution mass spectrometers and DIA make it easier to find the unique protein expression patterns in breast cancers, which helps identify protein biomarkers for diagnosis, prognosis, and treatment response. These patterns are like molecular "fingerprints" that help guide precise, targeted treatments. Coupled with AI, it allows a new perspective on these multi-omic profiles and medical images in real time, which is the best help for diagnosis, risk assessment, and personalized medical care planning.

Nanotechnology has also brought us the "Cancer in a Drop" age, which includes liquid biopsy platforms that can find tumor-derived materials, including circulating tumor DNA (ctDNA), exosomes, and proteins in a single drop of blood. Researchers are looking at nanorobotics and soft robotics to see whether they can precisely administer therapies directly onto tumors or act as in vivo sensors for minimally invasive interventions.

Enhanced imaging systems like photoacoustic computed tomography (PACT), photon-counting computed tomography (PCCT), wearable ultrasound, contrast-enhanced spectral mammography (CSEM), digital breast tomosynthesis (DBT), and AI models that use radiomics now offer very accurate and non-invasive ways to diagnose with great detail. Enhanced by AI, these systems help doctors find tumors earlier and more accurately using the images developed using ionizing radiation and contrast agents. PACT, however, is the only approach to imaging that is safer for repeated use since it uses laser light and ultrasound, both of which are non-ionizing forms of energy.

The convergence of these new ideas represents a significant shift in breast cancer care from broad, invasive procedures and one-size-fits-all therapies to precision oncology based on early detection, real-time analytics, and patient-specific strategies. Automated Next-Gen Oncology through Robotics and Analytics, or simply "ANORA," may soon redefine cancer and its complete transformation, envisioned as the union of advanced imaging, multi-omic profiling, AI-powered diagnostics, and nanorobotic delivery platform. ANORA is not merely a concept; it is a call to action—towards patient care that is profoundly more gentle, exact, and rapid.

References

Cation MD and Ramos MC. “Accelerating Breast Cancer Biomarker Discovery by Mass Spectrometry Proteomics and Current Bioinformatics Tools”. Asian Pacific Journal of Cancer Biology 7.3 (2022): 275-283.
Roberto Borea., et al. “Cancer in a Drop: advances in liquid biopsy in 2024”. Crit Rev Oncol Hematol (2025).
Tong X., et al. “Panoramic photoacoustic computed tomography with learning-based classification enhances breast lesion characterization”. Nat Biomed Eng (2025).
UCL Research. “Hand-held 3D photoacoustic scanner for cancer diagnosis”. Nat Biomed Eng (2024).
Berg WA., et al. “Contrast‑enhanced mammography non‑inferior to MRI in dense breast patients (SCEMAM)”. Radiology (2025).
Berg WA et al. “TOCEM interim: enhanced detection in high-risk dense women”. Radiology (2024).
Katalinic A., et al. “Nationwide AI‑supported mammography screening (PRAIM) increases detection rate”. Nat Med (2024).
Yang Z and Liu C. “Research on the application of radiomics in breast cancer: bibliometrics and visualization (Medicine)”. Medicine 103.35 (2024): e39463.
Lee J., et al. “A deep learning approach for virtual contrast enhancement in CESM”. Biosens. Bioelectron (2024): 102398.

Objectives: Delaying parenthood is prevalent among women in high-income countries, with the average age of childbirth being 30 in Europe. Factors like finding a compatible partner, education, and professional advancement contribute to this issue. Lack of knowledge about fertility potential and aging affect fertility. Understanding the age-related relationship is crucial for informed decision-making. The purpose of this study was to determine how well-informed women were about the efficacy of assisted reproductive technologies in treating infertility, as well as how aging affects fertility.

Methods: A cross-sectional study was conducted in infertility clinic at king Salman Bin Abdulaziz medical city with patients in in Al Madinah City, Saudi Arabia. A validated questionnaire was used to interview the women. The total knowledge score (TKS) is the sum of two scores: knowledge and awareness of the effects of aging on fertility advanced maternal age, or (AMA) and pregnancy outcomes when using assisted reproductive technology (ART). The questionnaire also includes socio-demographic information. The availability of the data was enabled by women who answered a questionnaire and gave their informed consent.

Results: There were estimated to be 85 women (41.9%) in the age group ≤ 35. The women reported having been infertile for three to five years was (38.0%). Women who answered the questionnaire stated that ovulatory (29.1%), unexplained (22.2%), and male factors (12.3%) were the most common causes of infertility. Of the participants, 45.3% had completed their university education, while 43.4% reported making less than 5,000 SAR. Their doctors (26.6%) and the Internet/TV (25.1%) were their primary sources of fertility-related information. The (TKS) mean was 34.8%, the (AMA) was 39.0%, and the (ART) was 30.6%. Fertility knowledge was found to be low.

Conclusions: The study highlights a lack of information on aging's impact on fertility and the potential benefits of assisted technology. It suggests that women should have more knowledge about reproduction to prevent infertility and improve preconception health. Fertility health education should be integrated into health promotion programs, focusing on social media and healthcare settings.

Keywords: TKS; AMA; ART; Fertility; Age; Awareness

At the same time, timely access to quality healthcare remains a significant challenge worldwide. In India, for example, over 2.4 million people die prematurely each year due to inadequate access to appropriate healthcare at critical moments. Long patient wait times, fragmented medical records, and overwhelmed hospital systems—especially during crises like COVID-19—have exposed severe gaps in healthcare delivery. Patients often face difficulties transferring medical data across hospitals, and overcrowded systems make scheduling appointments unpredictable and inefficient.

Blockchain-based healthcare systems offer transformative solutions to address these inefficiencies. By adopting a decentralized model for managing patient records and appointments, these systems ensure that sensitive data remains secure, tamper-proof, and accessible only to authorized users. One key feature is a smart appointment scheduling system that reduces waiting times by allowing patients to view doctor availability and book, reschedule, or cancel appointments in real time. Another important element is the secure sharing and updating of medical records via smart contracts, enabling doctors, researchers, and pharmacists to collaborate while safeguarding patient privacy. Role-based access control further strengthens data security by granting specific permissions to different stakeholders—such as admins, doctors, patients, pharmacists, and researchers—tailored to their responsibilities. Collectively, these innovations aim to enhance healthcare efficiency, protect patient privacy, and foster medical research through a trusted, transparent digital ecosystem.

These blockchain healthcare systems rely on a robust, modern technology stack to deliver security, efficiency, and intelligent data management. Ethereum serves as the foundational platform, providing a decentralized, permissionless blockchain environment where smart contracts govern patient records and healthcare transactions securely. MetaMask acts as a secure gateway for authenticated users—including patients, doctors, and researchers—to interact seamlessly with the blockchain. Ganache offers a controlled local blockchain environment for safe development and testing of smart contracts before deployment on the Ethereum mainnet. To support intelligent data analysis, Python 3.13 is employed to integrate machine learning models that identify patterns in medical records and predict patient behavior. Additionally, TabPFN, a specialized machine learning model based on transformer architecture, is used for rapid and accurate classification of structured healthcare data, such as symptoms and diagnostic patterns, helping to enhance the precision and speed of medical data analysis. Together, these technologies form a scalable, transparent, and secure digital infrastructure that advances patient-centric healthcare management.

The Smart Tele-Healthcare system further extends these capabilities by combining blockchain, IPFS, and IoT technologies to securely monitor the health of bedridden and remotely located patients. Various IoT sensors continuously track vital parameters such as blood pressure, blood sugar, and body temperature, enabling real-time monitoring without hospital visits. Health data is stored on IPFS for scalable and efficient retrieval using unique hash identifiers, while blockchain ensures the immutability and controlled access of sensitive records through smart contracts. Authorized healthcare providers, caregivers, and patients can securely view and update medical information via cryptographically secured IDs, enhancing privacy and trust. Moreover, machine learning analyzes the sensor data to detect health trends and provide early warnings, supporting timely interventions and personalized care. This integrated approach significantly improves healthcare access and quality for patients needing continuous supervision outside traditional clinical settings.

By addressing long-standing issues such as appointment inefficiencies and fragmented health data, these blockchain-powered applications represent a significant advancement toward a more resilient, equitable, and technologically sophisticated healthcare ecosystem. In alignment with the mission of PriMera Scientific Medicine and Public Health, these innovations showcase the power of digital trust in delivering quality care safely, securely, and at the right time.

These models include highly complicated frameworks that incorporate anatomical and physiological data, as well as empirical and semi-mechanistic methodologies. The benefit of PBPK modeling is that it can simulate various physiologies across different age groups.

How is a PBPK model built? The organs that are most important to the drug's absorption, distribution, excretion, and metabolism, their physiological/pharmacological function, or volumes are explicitly represented in a PBPK model. Usually, these include the gonads, thymus, adipose tissue, muscle, bone, skin, stomach, spleen, pancreas, gut, liver, kidney, brain, lungs, and stomach. The arterial and venous blood compartments connect the tissues, and each one has its own permeability, tissue-partition coefficient, volume, and blood flow rate. Such information is typically found in the database of the PBPK software that is available when specialized software packages are utilized.

The creation of a number of commercial platforms that incorporate physiological databases and apply PBPK modeling techniques, including GastroPlus (Simulations Plus, Lancaster, PA), SimCyp (SimCyp, Sheffield, UK), and PKSim and MoBi (Bayer Technology Services, Leverkusen, Germany), has recently made it easier to use sophisticated full-blown PBPK models. Extrapolations to new clinical situations, such as distinct treatment regimens or patient subgroups are a crucial use of PBPK models.

The applications of the models include

Pediatric extrapolations, where, with the support of the US Food and Drug Administration, a reference PBPK model for an adult population, is scaled to specific life stages in children.
Extrapolations to diseased populations, such as those with cirrhosis or hepatically compro mised liver disease.
Assessing potential drug-drug interactions (DDI), such as by taking competitive inhibition of a metabolizing enzyme into account.
Simulating particular dosing schemes to scale between various treatments scenarios.
Changing the relevant compound/formulation parameters to evaluate the effects of various medication formulations.
Cross-species extrapolation is one of the advanced applications [2].

To sum up, PBPK models can be a useful tool for drug development, especially when it comes to the ability to create a priori simulations. Consequently, pharmaceutical corporations and regulatory bodies such as the US Food and Drug Administration are using them more and more.

Prospects for PBPK evaluation in the future to evaluate a) drug-drug interactions mediated by drug transporters or drug metabolizing enzymes, drug exposure in patients with renal and/or hepatic organ impairment, b) dosing regimen prediction, sampling timepoint selection, and dose validation in pediatric patients from newborns to adolescents, d) maternal-fetal drug disposition during pregnancy and e) pH-mediated drug-drug interactions in patients treated with proton pump inhibitors are valuable [3].

With the increasing complexity of diseases and the growing need for individualized therapy, PBPK modeling is essential, and we have to put an effort into building our expert scientific personnel in this field in the coming days.

References

Aaron UU, Abbey SD and Azuonwu O. “Antifungal Activity Assessment of Selected Locally Sold Over-The-Counter Azole against Candida albicans Isolates from Hospital and Community Settings of Rivers State, Nigeria”. Journal of Natural Sciences Research 7.9 (2017): 1102-111.
Aaron UU, Abbey SD and Azuonwu O. “Comparative Analysis of Candida albicans Isolates Obtained from Hospital and Community Settings of Niger Delta, Nigeria”. EPRA International Journal of Advanced Research and Development 4.2 (2017): 24-31.
Aaron UU, Abbey SD and Azuonwu O. “Antifungal Resistance Surveillance: A Tool Necessary for Monitoring Azole Resistance Potentials in Candida albicans Isolates from Niger Delta Communalities in Nigeria”. Current Studies in Comparative Education, Science and Technology 4.1 (2017): 81-93.
Aboud S., et al. “Genital Tract Infections among HIV-Infected Pregnant Women in Malawi, Tanzania and Zambia”. International Journal of Sexually Transmitted Diseases and AIDS 19.12 (2008): 824-832.
Akinbiyi AA, Watson R and Feyi-Waboso P. “Prevalence of Candida albicans albicans and Bacterial Vaginosis in Asymptomatic Pregnant Women in South Yorkshire. United Kingdom. Outcome of a prospective Study”. Archives of Gynecology and Obstetetrics 278.5 (2008): 463-466.
Al-akeel RA., et al. “Prevalence and Comparison for Detection Methods of Candida albicans species in Vaginal Specimens from Pregnant and Non-Pregnant Saudi Women”. African Journal of Microbiology Research 7.1 (2013): 56-65.
Bammert GF and Fostel JM. “Genome-Wide Expression Patterns in Saccharomyces cerevisiae: Comparison of Drug Treatments and Genetic Alterations Affecting Biosynthesis of Ergosterol”. Antimicrobial Agents and Chemotherpy 44 (2000): 1255-1265.
Boehm J., et al. “Kex2-Dependent Invertase Secretion as a Tool to Study the Targeting of Transmembrane Proteins Which are Involved in ER-Golgi Transport in Yeast”. Embo Journal 13.16 (1994): 3696-3710.
Chen C., et al. “An Iron Homeostasis Regulatory Circuit with Reciprocal Roles in Candida albicans albicans Commensalism and Pathogenesis”. Cell Host Microbe 10.2 (2011): 118-135.
Chong PP., et al. “Genetic Relatedness of Candida albicans Strains Isolated from Women with Vaginal Candidiasis in Malaysia”. Journal of Medical Microbiology 52 (2003): 657-666.
Ciardo DE., et al. “Internal Transcribed Spacer Sequencing versus Biochemical Profiling for Identification of Medically Important Yeasts”. Journal of Clinical Microbiology 44 (2006): 77-84.
Daniel WW. “Biostatistics: A Foundation for Analysis in the Health Sciences”. 7 Edition (1999): 755.
Erdogan A and Rao SS. “Small Intestinal Fungal Overgrowth”. Current Gastroenterology Reports 17.4 (2015): 16.
Felsenstein J. “Confidence Limits on Phylogenies: An Approach using the Bootstrap”. Evolution 39 (1985): 783-791.
Fernandes R, Viegas A and Cerqueira F. “Candida albicans species Distribution in Clinical Samples. Revista da Faculdade de Ciencias da Saude”. Porto: Edições Universidade Fernando Pessoa (2009): 264-271.
Ga-Yeon K, Jae-Sik J and Jae KK. “Isolation Frequency Characteristics of Candida albicans species from Clinical Specimens”. Mycobiology 44.2 (2016): 99-104.
Goehring RV. “Mims' Medical Microbiology”. 4th Edition (2008): 656.
Gow NAR. “Microbe Profile: Candida albicans albicans: A Shape-Changing, Opportunistic Pathogenic Fungus of Humans”. Microbiology 163.8 (2017): 1145-1147.
Jombo GA., et al. “Symptomatic Urogenital Candidiasis and Therapeutic Management on Women Taking Oral Contraceptive Pills”. Journal of Microbiology and Antimicrobials 2.9 (2010): 118-122.
Jukes TH and Cantor CR. “Evolution of Protein Molecules”. Mammalian Protein Metabolism (1969): 21-132.
Martins N., et al. “Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment”. Mycopathologia 177.5-6 (2014): 223-240.
Mohamadi J., et al. “Antifungal Drug Resistance Pattern of Candida albicans. Spp. Isolated from Vaginitis in Ilam-Iran during 2013-2014”. Bioinformation 11.4 (2015): 203-206.
Mohamadi J., et al. “Antifungal Drug Resistance Pattern of Candida albicans. Spp. Isolated from Vaginitis in Ilam-Iran during 2013-2014”. Bioinformation 10 (2014): 667.
Nagia MMA., et al. “Internal Transcribed Spacer for Identification of Yeast Species Isolated from Cancer Patients at the Isotope and Radiation Center, Khartoum, Sudan”. F1000Research 7.443 (2018): 1-14.
Ringdahi EN. “Treatment of Recurrent Vulvovaginal Candidiasis”. Journal of American Family Physician 61 (2010): 3306-3312.
Rosamond J and Allsop A. “Harnessing the Power of the Genome in the Search for New Antibiotics”. Science 287 (2000): 1973-1976.
Schoch CL., et al. “Nuclear Ribosomal Internal Transcribed Spacer (ITS) Region as a Universal DNA Barcode Marker for Fungi”. Proceedings of the National Academy of Sciences of the United States of America 109.16 (2012): 6241-6246.
Tavakoli M., et al. “Upregulation of the ERG11 Gene in Candida albicans krusei by Azoles”. Daru Journal Pharmaceutical Sciences 18.4 (2010): 276-280.
Wang ZK., et al. “Review Article: Fungal Microbiota and Digestive Diseases”. Alimentary Pharmacology & Therapeutics 39.8 (2014): 751-766.
Wang H., et al. “Rapid Detection of ERG11 Gene Mutations in Clinical Candida albicans albicans Isolates with Reduced Susceptibility to Fluconazole by Rolling Circle Amplification and DNA Sequencing”. BioMed Central Microbiology 9 (2009): 167.
Wu Y., et al. “Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits”. Nat Commun 10.1 (2019): 58.
Mayer FL, Wilson D and Hube B. “Candida albicans pathogenicity mechanisms”. Virulence 4.2 (2013): 119-128.
Ikenyi CL, Ekuma A and Atting I. “Antifungal susceptibility and detection of mutant EGR11 gene in vaginal Candida isolates in University of Uyo Teaching Hospital, Uyo, Nigeria”. African Journal of Clinical and Experimental Microbiology 21 (2020): 226-232.
Victorio GB., et al. “Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans”. Mem Inst Oswaldo Cruz 112.5 (2017): 370-375.
https://worldwidescience.org/topicpages/a/albicans+double+infection.html
Jukes TH and Cantor CR. “Evolution of Protein Molecules”. Mammalian Protein Metabolism (1969): 21-132.
Karl WH, Joseph TN and Thomas DE. “Upregulation of ERG Genes in Candida Species by Azoles and Other Sterol Biosynthesis Inhibitors”. Antimicrobial Agents Chemotherapy 44.10 (2000): 2693-2700.
Shin HS, Park YB and Shin DS. “Isolation Frequency of Candida species from Clinical Specimens Kor”. Journal of Mycology 38 (2010): 146-151.

References

Ozkan U., et al. “MRI Of omphalopagus conjoined twins with a Dandy-Walker malformation: prenatal true FISP and HASTE sequences”. Diagn. Interv. Radiol 16 (2010): 66-69.
Umayange A., et al. “Conjoined twins in west African dwart goats, Capri hircus - case report”. Journal of research in Veterinary science 5.2 (2025): 106-110
Spencer R. “Theoretical and analytical embryology of conjoined twins: part II: ‎adjustments to union”. Clin Anat 13.2 (2000): 97-120.
Bahlmann F. “Monochorionic twin pregnancy and the following problems”. Z. Geburtshilfe Neonatol 6 (2009): 234-237.
Benirschke K. “The monozygotic twinning process, the twin-twin transfusion syndrome and acardiac twins”. Placenta 11 (2009): 923-928.
Elliot GF. Developmental Biology, 8th edn. Sunder land, MA: Sinauer (2006): 266-287.
Spiers ZB., et al. “Monocephalic thoracopagus tetrabrachius in twin lambs, Pathologists Corner Can”. Vet. J., 51. University of Maryland Medical Center, 2011: Ask the expert; www.University of Maryland Medical center (2010).
Binanti D and P Riccaboni. “Thoraco-omphalopagus conjoined twins in Chamois-colored domestic goat kids”. Anat. Histol. Embryol 41 (2011): 15962.
Chen H. “Atlas of genetic diagnosis and councelling”. Springer-Ver-lag, New York (2012): 495-505.
Elnady F and Sora M-C. “Anatomical exploration of dicephalous goat kid using sheet plastination”. Congenit Anom 49 (2009): 66-70.
Kulawik M., et al. “Cephalothoracopagus (monocephalic dithoracic) conjoined twins in a pig (Sus scrofa f. domestica): a case report”. Veterinarni Medicina 62.08 (2017): 470-477.
Corbera JA., et al. “Congenital duplication of the caudal region (mono cephalus dipygus) in a kid goat”. Anat. Histol. Embryol 34 (2007): 61-63.
Olopade JO, TO Omobowale and OO Igado. “Congenital dysgenesis (brachiomelia) of the forearm amongst West African Dwarf triplet kids in Nigeria: a Case Report”. Sahel J. Vet. Sc 9 (2011): 47-49.
Cazabon EP and AO Adogwa. “A case of cephalotho racopagus in sheep in Trinidad and Tobago”. Can. Vet. J 44 (2003): 56-58.
Hiraga T and SM Dennis. “Congenital duplications”. Vet. Clin. North Am. Food Anim Pract 9 (1993): 145-161.
Mazaheri Y., et al. “A case of conjoined twins (Thoraco-ompha-lopygopagus tribrachius tetrapus) in lamb”. Veterinary Research Forum 5.1 (2014): 73-76.
Samuel MO., et al. “A case of omphalo-ischiopagus (dice-phalic dithoracic abdominopagus tetrascelus tetrabrachius) in lambs”. Anatomy Histology Embryology 43.4 (2014): 320-323.
Schneevoigt J., et al. “Parapagus conjoined twin calf: a case study-focused on CT and cardiac abnormalities”. Anatomia Histologia Embryologia 43 (2014): 64-70.
Roberts J. “Veterinary obstetrics and genital diseases”. Delhi, India: CBS Publishers & distributors (2004): 73-74.
Nichols BL. “Co-joined Twins in Birth Defects Compendium”. 2nd edn. London and Basingstoke: Macmillan press Limited (1979): 44.
Noden DM and A de Lahunta. 1985 The Embryology of Domestic Animals Development Mechanisms and Malfor mations Baltimore MD: Williams and Wilkins. Nottidge, H. O., T. O Omobowale, J. O Olopade, O. O. Oladi ran, and O. O. Ajala, 2007: A case of craniothoracopagus(monocephalus thoracopagus tetrabrachius) in a dog. Anat. Histol. Embryol. 36, 179-181.
Turkish Society of Radiology. Roberts, S. J (ed), Gestation Period Embryology, Fetal Membranes and Placenta in Veterinary Obstetrics and Genital Disease (Theriogenology) 3rd edn, AnnArbor MI: Edward Brothers (1986): 51.
Saperstein G. “Congenital defects and hereditary disor ders in ruminants”. In: Large Animal Internal MEDICINE, 3rd edn (B. P Smithed.), St. Louis, MO: Mosby (2002): 1465-1555.
Schoenhaus SA., et al. “Pregnancy in a hermaphrodite with a male predominant mosaic karyotype”. Fertil. Steril 90 (2008): 2016.e7 e10
Vanderzon DM., et al. “Parapagus conjoined twins Holstein calf”. Department of Biomedical sciences, University of Guelph, Guelph, Ontario, Canada, NIG2W1; Anat. Rec 251 (1998): 60-65.
Komisarek J and Dorynek Z. “Genetic aspects of twinning in cattle”. Journal of Applied Genetics 43.1 (2002): 56-68.
Lonergan P., et al. “Embryo development in dairy cattle”. Theriogenology 86 (2016): 270-277
Andreu-Vázquez C., et al. “Clinical implications of induced twin reduction in dairy cattle”. Theriogenology 76 (2011): 512-521.
James LF., et al. Biomedical applications of poisonous plant research. Journal of Agricultural and Food Chemistry 52 (2004): 3211-3230.
Logrono R., et al. “Heteropagus conjoined twins due to fusion of two embryos: Report and review”. American Journal of Medical Genetics 73 (1997): 239-243.
Potter EL and Craig JM. “Pathology of the Fetus and the Infant”. Chicago: Book Medical (1975).
Silvia-del-Rio N, Colloton JD and Fricke PM. “Factors affecting pregnancy loss for single and twin pregnancies in a high-producing dairy herd”. Theriogenology 71 (2009): 1462-1471.
Tansel T and F Yazicioglu. “Cardiac and other malformations in parapagus twins”. Archives of Gynecology and Obstetrics 269 (2004): 211-213.
Happold DCD (ed), Mammals of Nigeria, Oxford: Clarendon Press Oxford 1-3 (1987).
Ahmed A., et al. “A rare case of congenital dicephalic iniodymus defect in non-descript caprine neonate”. J Livest Sci 6 (2015): 10-2.
Ramadan RO. “A dicephalic goat with other defects”. J Vet Med 43 (1996): 1-10, 337-43.
Jerome A, Sarath T and Arunmozhi N. “Dystocia due to a conjoined twin monster in a buffalo”. Buffalo Bull 29 (2010): 229-31.
Dhami AJ, Panchal MT and Kavani FS. “Dystocia due to monster in a buffalo”. Indian J Anim Reprod 21 (2000): 162-4.
Simon MS, William BJ and Kannan TA. “A rare case of conjoined twin monster (Ischiopagus) in a she buffalo”. Indian J Anim Reprod 30 (2009): 90-1.
Schneevoigt J., et al. “Parapagus conjoined twins calf: a case study focused on CT and cardiac absorbates”. Anat Histol Embryol 43 (2014): 64-70.
David NR. “Animal Growth and Developments”. Bed ford: Edwards Arnolds publishers (1978): 18.

Pleased end-users spread good words about the providers to their loved ones and other community members, which attracts new customers, boosts the provider's reputation, supports business stability and expansion, facilitates career advancement, improves finances, stimulates creativity, and provides satisfaction with their work.

Disappointment in collaboration can be caused by product exchanges of poor quality, long wait times to receive items, inappropriate communication with producers and other partners, a bad reputation of the provider, and an environment design that causes discomfort.

Distressed collaborations impact both producers and end users. If such unsafe cooperation extends, it alters their inner world. It initiates a cascade of other disorders such as sleep disturbance, dyslipidemia, depression, then arterial hypertension, affected heart function, type 2 diabetes, obesity, and even brain hemorrhage or tumors in vulnerable individuals.

Distressed end users often share their dissatisfaction with a provider with their family, friends, or colleagues close to them. Usually, their loved ones resonate with their moral suffering, projecting unsafe thought energy around them. When combined with inappropriate words, this energy during possible conflicting discussions can amplify the negative impact on human functioning. Prolonged exposure to hostile surroundings forces leads to human disorders that are, to varying degrees, clinically evident, ultimately affecting work efficiency and, consequently, society's progress.

Fortunately, technological advancements provide quick solutions during worrying times, such as listening to a preferred music program, watching movies, engaging in chosen lectures, chatting with friends and family, enjoying digital art, or admiring the color harmony of nature. These activities help people relax, build resilience, and make it easier to overcome barriers.

Informative programs about how interactions with others influence people's life paths are crucial. They help individuals choose their routes based on their preferences, tolerance, and future goals. Honest and respectful collaboration is essential, as dishonesty and disrespect can harm vulnerable individuals.

Paying attention to how people interact when exchanging their product quality, price, communication skills, and alignment with social norms is an essential part of public health.

People constantly change their thoughts and actions as time slowly erodes everything; the effects of their collaborative work are often unpredictable. Various external factors can shift their balance, leading to potentially uncontrolled communication styles with others.

We must consider people's diversity in our interactions, understand and assist others in need—whether mentally or physically—to overcome their challenges when possible, and strive to rise as many times as failure inevitably will come our way.

As the day slowly turns into night, everyone's light quietly fades away.

References

Abdus Shahid M., et al. “Remote sensing application to study the coastal shrimp farming area in Bangladesh”. Geocarto International 7.2 (1992).
Carper WJ, Lillesend TM and Kiefer RW. “The use of Intensity-Hue-Saturation transformations for merging SPOT panchromatic and multispectral image data”. Photogrammetric Engineering and Remote Sensing 56.4 (1990): 459-467.
Carter V Stewart. Seasonal Colour Infrared photographs for mapping inland wetlands on U.S Geological survey Proceeding of American society of Photogrammety (1977): 143-161.
Chavez PS Jr and Bowell Jo A. “Comparison of the spectral information content of Landsat Thematic Mapper and SPOT for three different sites in the Phoenix, Arizona region”. Photogrammetric Engineering and Remote Sensing 54.12 (1988): 1699-1708.
Chavez PS Jr, Berlin GL and Tarabzouni MA. “Discriminating lithologies and surficial deposits in the Al Hishma plateau region of Saudi Arabia with digitally combined Landsat- MSS and SIR-A images: Proceedings of the National Conference on Resource Management Applications: Energy and Environment”. San Francisco, California 4 (1983): 22-34.
Jensen J.R “Remote Sensing of Environment-An Earth resource perspective”. Prentice Hall, Upper Sandal River.
Lauer DT and Todd WJ. Land cover mapping with merged Landsat RBV and MSS stereoscopic images: Proceedings of the ASP Fall Technical Conference, American Society of Photogrammetry, San Francisco, California, (1981): 680-689.
Moore and North. “Flood Inundation in the south eastern United states from aircraft and satellite imagery”. Water Resource Bulletion (1974): 1082-1097.
Negri DS and Shines. “A Thermal Infrared survey of Savannah River Plant. Gesch1990,Use of NDVI and Land surface temperature for drought Assessment: Merits and Limitations”. J. Clim (1985): 618-633.
Price JC. “Combining panchromatic and multispectral imagery from dual resolution satellite instruments”. Remote Sensing of Environment 21 (1987): 119-128.
Töyrä. “Towards Operational Monitoring of a Northern Wetland Using Geomatics-Based Techniques”. Remote Sensing of Environment 97.2 (2000): 174-191.
Tripathi NK and Patil AA. On the role of Remote sensing in Environmental Impact Analysis of Shrimp farming (2000).
Vibulsresth S, Ratanasermpong S and Dowreang D. Mangrove monitoring using satellite data (1993).
Venkataratnam L and Thammappa S. “Mapping and Monitoring prawn farming areas through Remote Sensing Techniques”. Geocarto International 12.2 (1997).
Zhou J, Civico DL and Silander JA. “A wavelet transform method to merge Landsat TM an SPOT panchromatic data”. International Journal of Remote Sensing 19.4 (1998): 743-757.

The Looming Threat of Zoonoses and AMR

Zoonoses, diseases that cross from animals to humans, account for about 75% of all emerging infectious diseases. They thrive at the human-animal-environment interface, exploiting gaps created by deforestation, climate change, and intensive farming. From my work investigating outbreaks at the Maine Center for Disease Control, I've seen how foodborne illnesses and vector-borne threats can explode without warning. One Health calls us to break traditional silos, ensuring veterinarians monitor wildlife, doctors treat patients, and environmental scientists safeguard habitats. It's about proactive surveillance, like the zoonotic virus detection I did in Nigerian labs using RT-PCR, to catch threats before they explode [2, 3].

A Call for Collective Action

But there is hope. The One Health model calls us to work collaboratively across disciplines and sectors—public health, veterinary medicine, agriculture, environmental science, and beyond. Tackling AMR means ensuring responsible use of antimicrobials, strengthening surveillance systems, and investing in preventive measures like vaccination, sanitation, and safe food systems. It also means empowering communities with knowledge, because behavior changes at the grassroots often determines whether interventions succeed or fail [4].

As a keynote speaker on One Health innovation at global summits, I've witnessed its power to foster collaboration. The fight against zoonoses and AMR is not won in isolation but through partnerships that value equity, respect culture, and prioritize prevention. It's personal—protecting families like those I served in Nigeria and Virginia. The time to act is now. By embracing One Health, we protect not only our present but the health of generations to come [5].

References

Sami DG and Chun S. “Strengthening Health Security at Ground Border Crossings: Key Components for Improved Emergency Preparedness and Response—A Scoping Review”. Healthcare 12.19 (2024): 1968.
Nichol AA. “Emerging Infectious Diseases at the Intersections of Human, Animal, and Environmental Health”. AMA Journal of Ethics 26.2 (2024): 99-102.
World Health Organization. Antimicrobial resistance. World Health Organization (2023). https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
Pokharel S, Raut S and Adhikari B. “Tackling antimicrobial resistance in low-income and middle-income countries”. BMJ Global Health 4.6 (2019): e002104.
Working Together to Fight Antimicrobial Resistance - PAHO/WHO | Pan American Health Organization. www.paho.org. https://www.paho.org/en/together-fight-antimicrobial-resistance

Since there is only a few viable clonogenic cell left in the tumor during the last week of a curative treatment it is unsuitable to try to use high ionization density ions to hit them. This is so even if they generally are our sharpest tool available to treat malignant tumors, but only if we know precisely where the clonogens are and where to aim the beam to hit the cell nuclei, but also if there are so many cells that their exact locations is unimportant! In fact, if we know precisely where e.g. 2n cells are located we need just n ions since each ion can hit at least 2 cells in one shot when we know where they are! If we don't, according to Heisenberg’s wonderful thinking, applied on this simplistic case, we need a beam at least as large as the tumor if we wish to be sure to hit them all (actually a little bit bigger if there is also uncertainties in the beam patient set up [8]) and not least we need also to consider the quantum biology of curative radiation therapy so we don't get a microscopic ion beam cold spots on some of the clonogens. However, at the beginning of a treatment with millions of hypoxic radiation resistant tumor cells, ion beams are the most effective treatment since independent of where we aim the ions, we will hit thousands of tumor cells. If you have an ion path through millions of cells its effect on the tissue is well described by the dose averaged pencil beam dose distribution as it is the average response that counts and it is given by taking the average effect on the millions of cells which is exactly the definition of the mean dose distribution of the beam over cell nuclear sizes! If there is only a few clonogens left such a mean energy deposition kernel is too crude, and we have to look at the probability that at least one of the remaining clonogens is missed by the beam and may repopulate the tumor [9]! And today we know very well that this may happen since caspase 3 is likely to step in after the treatment trying to recover normal tissue homeostasis after the treatment inducing accelerated repopulation which is known to also affect possibly remaining tumor clonogens [9].

As discussed in a previous communication [5, 10] the low and high dose apoptosis makes the optimal daily fractionation window being at about 2 Gy/Fr of low ionization density high energy electrons or photons to minimize normal tissue damage for a given dose to the underlying tumor as proven by ≈80 years of radiation therapy experience. Fortunately, at this dose level there is approximately only a single DDSB induced in normal tissues so we should not go to higher doses to spare them from high ionization density DDSB! For ions this requires that the ionization density in the entrance or plateau region should also be as low as possible to retain the clinically established fractionation window also for light ions! The best way to achieve this is by using the lightest ions from Helium and Lithium to Boron as these ions has lower biological effectiveness both in the plateau and fragmentation tail regions without losing much of their effectiveness in the Bragg peak [4]. Actually Carbon ions have higher apoptotic and senescent responses per unit dose some 5 cm in front of the Bragg peak than at the Bragg peak itself which is undesirable as it very often affects normal tissues [4]. At the same time these light ions also reduces the risk for microscopic cold spots in the tumor as high ionization density is linked to a reduced probability for cure at high doses [5]. In fact, the higher the ionization density along the ion track the higher is the local  -ray multiplicity and biological effect and thus the microscopic heterogeneity is higher (as the dose is close to zero between ions) requiring still higher absorbed doses to counteract the increased risk for microscopic cold spots on tumor clonogens. This results in a decreased dose response slope of heavier ion beams and at the same time an increased early risk of normal tissue damage and reduced cure at high doses and will thus result in an unnecessarily reduced complication free cure [4-7]! One way to get rid of them would be to use a deterministic microscopically uniform ion grid in the form of a 7m step size perfect hexagonal grid, but it is not so easy to make [4]. Therefore, treatments with Carbon and heavier ions would benefit by delivering the last 10 to 15+ Gy-Equivalent dose by low ionization density electrons or photons resulting in a steeper dose response due to high microscopic uniformity, a reduced normal tissue damage, better tumor cure and thus an improved complication free cure [5, 7]! In conventional thinking the few remaining tumor clonogens may not even be so hypoxic that they need a high ionization density then and we could avoid microscopic cold spots and get a steep dose response slope with improved complication free cure by such a low ionization density treatment roundup! This means that the higher ionization densities that are presently contemplated in Germany and Japan with Oxygen and Neon ions really should be avoided as we already passed the optimal therapeutic ion beam with Carbon ions and even Boron ions may sometimes benefit from such a low ionization density roundup for example when treating close to sensitive organs at risk. This conclusion is also in line with the early Neon ion treatments in Berkeley (1970s, [4]) that didn't show sufficient improvements compared to the conventional treatments at the time. We therefore need to use the lightest ions with uttermost clinical care to really benefit from their interesting clinical possibilities ensuring minimal normal tissue damage and maximum complication free cure [4].

References

Munro TR and Gilbert CW. “The relation between tumor lethal dose and the radiosensitivity of tumor cells”. Brit. J. Radiol 34 (1961): 246-51.
Brahme A. “Dosimetric precision requirements in radiation therapy”. Acta Radiol. Oncol 23 (1984): 379-391.
Brahme A and Lorat Y. “The Dual Double Strand Break: the Key Effector of Curative Radiation Therapy”. Biophysica 3 (2023): 668-694.
Fundamental Molecular Understanding of Quantum Biology Optimized Curative Radiation Oncology: Identifying Optimal Molecular Tumor Diagnostics, Dose Fractionation and Intensity & Quality Modulated Electron, Photon & Light Ion Beams. Eliva Press, Chisinau, Moldova (2024).
Brahme A. “TP53 and the Ultimate Biological Optimization Steps of Curative Radiation Oncology”. Cancers 15.17 (2023): 4286.
Brahme A. “New Radiation Therapy Optimization Principles Based on recent Developments in Molecular Radiation Biology”. Ann Case Rep 9 (2024): 101625.
Brahme A. “Improving Radiation Therapy Efficacy Considering DNA Repair, TP53 Mutations, Microscopic Heterogeneity and Low & High Dose Apoptosis”. Sub to Frontiers in Oncology (2025).
Kaver G., et al. “Stochastic optimization of intensity modulated radiotherapy to account for uncertainties in patient sensitivity”. Phys. Med. Biol 44 (1999): 2955-2969.
Zhao M., et al. “Caspase-3 knockout attenuates radiation-induced tumor repopulation via impairing the ATM/p53/Cox-2/PGE2 pathway in non-small cell lung cancer”. Aging 12 (2020): 21758-21776.
Brahme A. “Recent Developments in Molecular Radiation Biology Can Improve Radiation Oncology”. PriMera Scientific Medicine and Public Health 6.5 (2025): 19-20.

It has been known for many years that the last few radiation therapy treatment fractions can increase the tumor cure from a few percent to 80-90 % with classical photon or electron beam treatments [1, 2]. This is indicating that the loss of the last few clonogenic tumor cells are determining the therapeutic outcome and the probability of cure. Interestingly, this also means that both the therapeutic beams and the tumor are Quantized and the treatment outcome is largely dependent on the probability that all tumor clonogens are lethally hit by the particles of the therapeutic beam weather they are primary electrons or secondary electrons in photon and ion beams. In fact, it has recently been demonstrated that the therapeutic entity of most if not all radiation beams is the low energy secondary so called  -electrons or  -rays of energy below ≈1 keV that are capable of delivering a local dose of about 1M Gy to 10 nm size objects. Such critical energy deposition sites are the periphery of the nucleosome and  -rays can induce a very severe Dual Double Strand Break (DDSB) on their DNA as it is wound two turns around the nucleosome [3]. Unfortunately, this kind of damage is very hard to handle by the most common DNA repair system for DSB´s, namely the Non Homologous End Joining process (NHEJ) as the resulting DSB´s are as close as 80 base pairs or 35 nm from each other. The two DNApk molecules needed for repair dose not generally have room enough for each other to work on the DNA [3, 4]. Even if the damage sometimes can be repaired by a switch to the Homologous Recombination DSB repair machinery, this is one of the most severe damage events to nuclear DNA that may often lead to cell death [3, 4]. The interesting fact that the these  -rays are produced by practically all therapeutic beams and it make them the key Effectors of all curative radiation therapy as discussed in further details recently [3-7]. As proven in some of these studies [4, 7] the Relative Biological Efficiency of light ion beams is closely related to the mean  -ray multiplicity along the ion track as they are produced new almost as fast as they are absorbed along the track. The RBE in front of the Bragg peak of Boron, Carbon and Nitrogen ions is about 3, corresponding to ≈3  -rays in average along every section of these high ionization density ion tracks.

The hidden burden of undiagnosed diabetes is equally alarming. Approximately 43% of adults with diabetes 252 million individuals remain unaware of their condition [1]. This burden disproportionately affects low and middle income countries (LMICs), which account for 81% of the global diabetes population [1].

The economic implications are staggering. Global healthcare expenditure attributed to diabetes exceeded USD 1.015 trillion in 2024 [1]. The World Health Organization estimates that diabetes and diabetes-related kidney disease resulted in over 2 million deaths in 2021, with hyperglycemia contributing to approximately 11% of all cardiovascular deaths globally [2].

Drivers of the Global Epidemic
Several interconnected factors fuel this crisis

Urbanization and sedentary lifestyles: Reduced physical activity from motorized transport and desk-based work.
Dietary transitions: Traditional diets replaced by energy-dense, nutrient-poor foods driven by aggressive marketing [3].
Obesity epidemic: The most significant modifiable risk factor, with rising childhood obesity particularly concerning [4].
Population aging: Increased life expectancy extends diabetes risk exposure.
Social determinants: Poverty, poor education, and weak healthcare systems amplify disease burden [5].

Evidence-Based Public Health Priorities
Primary Prevention

Prevention remains the most cost-effective strategy. Evidence-based interventions include taxation of sugar-sweetened beverages, restrictions on unhealthy food marketing, and urban planning promoting active transportation [4].

Enhanced Screening and Early Detection

With nearly half of diabetes cases undiagnosed [1], expanding access to systematic screening is critical. Digital health innovations offer promising approaches to extend healthcare reach in underserved populations [2, 5].

Universal Access to Essential Therapeutics

Despite insulin's century-old discovery, this life-saving medication remains inaccessible for millions globally. The WHO's recent inclusion of GLP-1 receptor agonists in the Essential Medicines List (2025) represents significant progress [6].

Health System Integration

Effective diabetes care must be integrated within primary healthcare systems rather than restricted to specialized centers. This ensures care continuity and improved cost-effectiveness [5].

Addressing Health Inequities

Comprehensive strategies must address fundamental causes of health inequity, including access to education, safe environments for physical activity, and affordable nutritious foods [5].

Conclusion

The global diabetes epidemic threatens to overwhelm healthcare systems and reverse decades of health progress. Effective response demands comprehensive multisectoral collaboration: evidence-based government policies, healthcare provider focus on prevention and early detection, continued research innovation, and meaningful community engagement.

While diabetes remains preventable and manageable, current trajectories indicate that inaction will exact enormous human and economic costs. Through decisive action prioritizing prevention, ensuring equity, and establishing universal access to care, this crisis can be addressed. The time for action is now.

Key Messages

Diabetes affects 589 million people worldwide in 2024, projected to reach 853 million by 2050.
Nearly 43% of cases remain undiagnosed, mostly in low- and middle-income countries.
Global health spending on diabetes surpassed USD 1 trillion in 2024.
Prevention, early detection, affordable medicines (including insulin and GLP-1 drugs), and stronger primary care systems are critical to reversing the trend.
Equity-focused policies addressing social determinants of health are essential to reduce disparities and ensure global progress.

References

International Diabetes Federation. IDF Diabetes Atlas, 11th edition. Brussels, Belgium: International Diabetes Federation (2024). https://diabetesatlas.org
World Health Organization. Diabetes Fact Sheet. Geneva: WHO (2023). https://www.who.int/news-room/fact-sheets/detail/diabetes
NCD Risk Factor Collaboration (NCD-RisC). “Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies”. Lancet 387.10027 (2016): 1513-1530.
Malik VS and Hu FB. “Global obesity: trends, risk factors and policy implications”. Nat Rev Endocrinol 18.7 (2022): 467-478.
Bommer C., et al. “Global economic burden of diabetes in adults: projections from 2015 to 2030”. Diabetes Care 41.5 (2018): 963-970.
World Health Organization. WHO Model List of Essential Medicines, 23rd List. Geneva: WHO (2025).

Adolescence is a vulnerable period when there is transition from childhood to adulthood. This is the age of experimentation when physical, emotional, behavioural and social changes occur including exposure to many hardships of life including poverty, abuse, or violence, that make adolescents vulnerable to mental health issues. Anxiety and depression are very common issues among adolescents which further lead to their poor physical and social health. This becomes a vicious cycle and causes life long disadvantage to the individual, community as well the nation as adolescents are going to be the part of our economically productive age group [3].

Determining factors for mental health issues among adolescents are academics, peer pressure, family pressure, some childhood trauma, increase use of social media leading to behaviour addictions and sometimes cyberbullying. Loss of joint family patterns have made them ‘alone’; in many cases where both the parents are working and adolescents in their tender age usually spend most of their time on internet surfing which exposes them both to the so called ‘good’ and ‘bad’ stuff. There is no one in the family to answer their questions, so they seek the help of their peers who are also of the same age group. Moreover, some adolescents who are well behaved, sincere and good in academics also get lost in this competitive world where they have a fear of not achieving their goals or not meeting the expectations of their parents. They cannot handle the stress of failure which makes them vulnerable to mental health issues. Easy access to illicit drug has also contributed to mental health issues in adolescence. Even after realisation most of them are reluctant to talk and seek help due to social stigma attached with the drug abuse, which can further lead to many emotional and behavioural issues.

Although there is a limited data on the treatment gap in adolescents, the overall treatment gap for mental disorders in India is around 90% [4]. The question arises how to identify and overcome the barriers of treatment seeking in adolescents. Foremost cause is lack of awareness and strong stigma surrounding mental health prevent them from seeking treatment. It is said that only one-third of the families (37.5%) of adolescents perceive that their children had any mental health issue [5]. Their erratic behaviour is many times ignored and considered as a part of their growing up issues by the family, thus delaying support and treatment seeking. Due to lack of sharing and fear, problems remain unidentified and untreated and progress to a level when it is difficult to handle.

Last but not the least, there is lack of mental health infrastructure for adolescents. Though Government has started many measures like Mental Health and Normalcy Augmentation System (MANAS) app in 2021 to integrate wellness efforts and provide counselling services, use of telemedicine and video consultations for psychiatric services and Adolescent Friendly Health Clinics (AFHCs) under National health Mission and UNICEF to offer medical advice and counselling services to adolescents; still, we are lagging behind and submerged portion of iceberg is increasing day by day.

More efforts are needed to reach upto the grass root level to identify the problem and stringent IEC activities and behaviour change communication for the adolescents as well as their families. More life skills to be added in the school curriculum so that healthy habits can be inculcated at the earliest in the children for making them healthy and responsible adolescents and then adults.

References

WHO. https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health
UNICEF. Technical report research and compilation of project. Child and adolescent mental health service mapping: India (2024). https://www.unicef.org/india/reports/child-and-adolescent-mental-health-service-mapping-india-2024
Hugh-Jones S., et al. “Safeguarding adolescent mental health in India (SAMA): study protocol for codesign and feasibility study of a school systems intervention targeting adolescent anxiety and depression in India”. BMJ Open 12 (2022): e054897.
Gautham MS., et al. “The National mental health survey of India (2016): prevalence, socio-demographic correlates and treatment gap of mental morbidity”. Int J Soc Psychiatry 66 (2020): 361-72.
Nebhinani N and Jain S. “Adolescent mental health: Issues, challenges, and solutions”. Ann Indian Psychiatry 3 (2019): 4-7.

References

Ellis SG., et al. “Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty”. Circulation 82 (1990): 731-40.
Holmes DR., et al. “Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung, and Blood Institute”. Circulation 83 (1991): 927-36.
Lefèvre T., et al. “Coronary angioplasty in acute myocardial infarction: clinical and angiographic results”. J Am Coll Cardiol 19 (1992): 926-33.
Brener SJ., et al. “Frequency and long-term impact of recurrent ischemia after successful percutaneous coronary intervention”. Am J Cardiol 68 (1991): 1131-5.
Ellis SG., et al. “Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty”. Circulation 82 (1990): 731-40.
Dautov R., et al. “Outcomes of primary percutaneous coronary intervention in patients with large thrombus burden”. Catheter Cardiovasc Interv 88 (2016): 1080-7.
Kawasaki T., et al. “Angiographic and clinical outcomes of manual thrombus aspiration in primary percutaneous coronary intervention: evidence from a large Japanese registry”. Euro Intervention 8 (2013): 1445-53.
Stone GW., et al. “Comparison of angioplasty with stenting, or both, in acute myocardial infarction”. N Engl J Med 346 (2002): 975-66.
Khan M., et al. “Safety and efficacy of manual thrombus aspiration in patients undergoing primary PCI”. Catheter Cardiovasc Interv 73 (2009): 143-50.
Ong P., et al. “Diagnosis of coronary microvascular dysfunction in the clinic”. Circulation 135 (2017): 2054-68.
Niccoli G., et al. “Myocardial no-reflow in humans”. Circulation 119 (2009): 2107-16.
Doll JA., et al. “Management of complications during percutaneous coronary intervention: insights from the Seattle PCI Complication Conference”. Seattle PCI Complication Conference (2019).
Ali ZA., et al. “Optical coherence tomography compared with intravascular ultrasound and angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomized controlled trial”. JACC Cardiovasc Interv 9 (2016): 211-23.

For decades, computer chips became smaller and faster every two years, a pattern known as Moore’s law. But as chips shrink to atomic scales, electrons begin “leaking” through barriers, signaling the physical limits of classical computing. Meanwhile, medical data are exploding: full-genome sequencing, high-resolution imaging, and global disease modeling demand unprecedented computing power. Quantum computers, which use qubits capable of existing in multiple states at once, can process vast possibilities in parallel, far beyond the limits of traditional bits.

Drug discovery illustrates this power. It is like solving a massive three-dimensional puzzle where millions of molecules must be tested against a single protein. Classical supercomputers can only analyze a fraction of these interactions over years. Quantum systems, however, can directly model molecules according to physical laws, exploring billions of combinations simultaneously. For doctors, this means they can identify treatment options much sooner, shifting from years of waiting to quick and accurate therapy recommendations.

Quantum AI, when combined with cognitive analytics that learn from both data and human input, makes disease prediction far more powerful.

It can simulate how infections spread in a city and recommend preventive public-health strategies.
It can integrate lifestyle information, blood-test results, and wearable-sensor data to estimate a person’s risk of heart disease or cancer years in advance.
A doctor could meet a patient with a full “risk map” already prepared, helping to start preventive treatment rather than waiting for illness to show up with a stethoscope.

Genomics adds another dimension. Each individual’s genome contains billions of base pairs, producing enormous datasets. Quantum algorithms can search these sequences more efficiently and with greater accuracy than classical tools.

They can detect rare mutations responsible for inherited diseases such as cystic fibrosis, Huntington’s disease, sickle-cell anemia, and BRCA-related cancers.
They can also compute polygenic risk scores for complex conditions—such as diabetes, Alzheimer’s, or schizophrenia—where multiple genes and environmental factors interact.

This empowers doctors to counsel families on hereditary risks and plan lifestyle interventions or gene therapies decades before symptoms arise.

One of the most promising applications of Quantum AI and secure computing lies in telemedicine. In remote areas such as tribal villages where hospitals are inaccessible and patients often lack timely medical support. With secure telemedicine platforms powered by post-quantum cryptography (PQC), patient data can be safely transmitted to city hospitals. Quantum AI can then analyze symptoms, medical scans, and sensor data in real time.

A local health worker might upload a patient’s vitals from a remote village.
A cloud-based Quantum AI system could match these inputs with disease models and propose treatment options instantly.
Doctors in urban hospitals could securely review results and guide frontline health workers, even over weak internet connections.

This bridges the urban rural healthcare divide while protecting the privacy of sensitive medical information.

Yet, with these new opportunities come new risks. Unlike passwords or bank details, medical data cannot be changed if stolen—a person’s DNA or health history follows them for life. Exposed records could enable identity theft, insurance discrimination, or even targeted cyberattacks. Worse still, such breaches undermine patient trust, discouraging people from sharing the very data that drive medical progress. To address these challenges, strong safeguards are essential. Post-quantum cryptography, secure cloud infrastructures, and strict ethical frameworks must accompany every advance in quantum health care.

Quantum technology also threatens today’s encryption methods. Algorithms like Shor’s could eventually break widely used security systems. To stay ahead, hospitals and research institutions are adopting PQC standards recently finalized by NIST in 2024, including CRYSTALS-Kyber, CRYSTALS-Dilithium, and SPHINCS+. These tools are designed to secure patient records, medical devices, and telemedicine platforms even in a quantum-powered future. For health systems, PQC will serve as the shield that keeps sensitive genomic and clinical data safe.

Tomorrow’s physicians may rely more on quantum simulators and intelligent digital advisors than on stethoscopes. Medical education will need to evolve, teaching not only biology and ethics but also quantum computing and data science, so future doctors can wield these tools responsibly.

Quantum AI and Cognitive Analytics are no longer the stuff of science fiction. They are becoming practical partners in modern medicine—accelerating drug discovery, enabling earlier disease prediction, and guiding families through genetic risks. By embracing these technologies carefully and ethically, healthcare can become more personal, preventive, and effective for all.

Adolescent obesity represents an escalating public health burden with multifactorial etiology encompassing behavioral, environmental, psychosocial, and physiological determinants. Recent epidemiological trends indicate that the prevalence of obesity among adolescents has surpassed that of undernutrition in numerous regions globally. This narrative review delineates a multidimensional approach to addressing adolescent obesity, emphasizing health promotion, early prevention, and policy-level interventions. Governmental initiatives such as the Fit India Movement, FSSAI’s nutritional guidelines, and CBSE’s school-based wellness programs aim to foster physical activity and nutritional literacy. The influence of urbanization, impulsive food purchasing behavior, food marketing strategies, and increased accessibility to energy-dense, nutrient-poor foods are critically examined. Moreover, psychosocial comorbidities—particularly depression, anxiety, low self-esteem, body dissatisfaction, and binge-eating disorders—are highly prevalent among obese adolescents, necessitating integrated mental health interventions. The role of Cognitive Behavioral Therapy and structured psychological counselling is explored as a therapeutic adjunct. Physical inactivity, prolonged screen time, and lack of access to recreational infrastructure contribute significantly to the obesogenic milieu. Technological tools, including health applications and screen-time monitors, are proposed as potential enablers of behavior modification. The review advocates for age- and sex-specific intervention strategies, incorporation of mindful eating practices, parental involvement, and community-level participation. Emphasis is placed on longitudinal evaluation, feedback mechanisms, and tailored interventions based on urban-rural disparities and socioeconomic stratification. A multidisciplinary, context-sensitive, and evidence-based framework is essential to mitigate the trajectory of adolescent obesity and its associated long-term cardiometabolic sequelae.

Keywords: Adolescent obesity; Preventive health services; Nutritional behaviour; Physical inactivity; Cognitive Behavioral Therapy

Some desired goods or services might be out of reach due to cost or production limits. Their absence from the products we want can make us feel sad. Feeling unhappy, we can send out a similar type of mental energy, causing the surroundings to resonate accordingly. As long as this continues, it can lead to a negative self-image about achieving desired goals. Discouragement can deepen negative mental states and reduce work effectiveness.

Desiring what is hard to obtain can cause stress. Some people struggle to achieve their goals, but others lack the courage, energy, or resources to break through the barriers.

Helping people achieve their goals serves as a transition from darkness to light, illuminating their inner world. Acts of generosity in those moments bring them joy, making both the receiver and the giver feel pleased. Products that were once unavailable or expensive but desirable become accessible, turning sadness into happiness.

There are many goods to meet people's needs, but not all are essential for everyone.

Some items may not be necessary for us, but they enhance the environment's look. When the price is reasonable, we tend to buy them, which makes us happy. In theory, wanting unnecessary products just because they look good doesn't justify the costs. If the price is too high, we still find some happiness in receiving a little support. However, when that support is missing, we feel down because our desires aren't fulfilled, which can negatively impact our health. Long-term emotional pain might even cause physical suffering.

Other products are vital for our lives. Sharing these items at inflated prices causes discomfort for buyers and fosters feelings of disrespect, which can negatively impact their well-being and lead to personal issues. Implementing price control through a different framework for essential goods is necessary to safeguard public health. Generosity in providing vital goods in people's lives offers a healthier way to combat poverty or tough situations.

Helping others during tough times is one of the most powerful ways to heal. It is also one of the best methods to support those who need emotional stability. In these moments, people often remember painful feelings and the individuals who help them get through them. They tend to respond positively later by giving good feedback about the helper, repaying the money, or showing other signs of appreciation and gratitude.

Helping the wealthy or those chasing unnecessary products isn't justified.

Acting generously whenever and wherever needed earns us respect and appreciation as professionals in our community.

The journey from darkness to inner enlightenment in the digital age is exciting; moving from shadows to internal illumination gives us the energy to thrive and stay healthy.

Big-heartedness inspires and energizes; it brightens everything around and eases sorrow.

References

Patil A, Goldust M and Wollina U. “Herpes zoster: A Review of Clinical Manifestations and Management”. Viruses 14 (2022): 192.
Nair PA and Patel BC. “Herpes Zoster”. European Handbook of Dermatological Treatment (2023): 409-416.
Mirinaviciute G., et al. “The burden of herpes zoster disease in Norway”. Vaccine 38 (2020): 3501-3507.
Oleszko M., et al. “Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients”. Diseases 13 (2025).
Weinberger B. “Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond”. Immun Ageing 18 (2021).
WHO’s work on the UN Decade of Healthy Ageing (2021-2030). https://www.who.int/initiatives/decade-of-healthy-ageing
Life expectancy at birth, total (years) - European Union | Data. https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=EU
Curran D., et al. “Meta-Regression of Herpes Zoster Incidence Worldwide”. Infect Dis Ther 11 (2022): 389-403.
Shingles (Herpes Zoster) | Shingles (Herpes Zoster) | CDC. https://www.cdc.gov/shingles/
Cohen JI. “Clinical practice: Herpes zoster”. N Engl J Med 369 (2013): 255-63.
Dai YX., et al. “Cigarette smoking and risk of herpes zoster: a population-based cohort study in Taiwan”. Clin Exp Dermatol 46 (2021): 1293-1298.
Giannelos N., et al. “The Incidence of Herpes Zoster Complications: A Systematic Literature Review”. Infect Dis Ther 13 (2024): 1461.
de Gomensoro E, Del Giudice G and Doherty TM. “Challenges in adult vaccination”. Ann Med 50 (2018): 181-192.
Doherty TM, Del Giudice G and Maggi S. “Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion”. Ann Med 51 (2019): 128-140.
Grabar S., et al. “Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort”. Clin Infect Dis 60 (2015): 1269-1277.
Parikh R., et al. “Herpes Zoster Recurrence: A Narrative Review of the Literature”. Dermatol Ther (Heidelb) 14 (2024): 569-592.
Dooling KL., et al. “Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines”. MMWR Morb Mortal Wkly Rep 67 (2018): 103-108.
Shingrix® (zoster vaccine recombinant, adjuvanted) prescribing information. Research Triangle Park, North Carolina: GlaxoSmithKline; 2018. - Cerca con Google.
James SF., et al. “Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine”. Ann Pharmacother 52 (2018): 673-680.
Boutry C., et al. “The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70”. Clin Infect Dis 74 (2022): 1459-1467.
Cunningham AL., et al. “Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older”. J Infect Dis 217 (2018): 1750-1760.
Parikh R, Widenmaier R and Lecrenier N. “A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations”. Expert Rev Vaccines 20 (2021): 1065-1075.
Janssen ERC., et al. “The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers”. Vaccine 41 (2023): 6042-6047.
Cook IF. “Best vaccination practice and medically attended injection site events following deltoid intramuscular injection”. Hum Vaccin Immunother 11 (2015): 1184-1191.
Gao W., et al. “Bibliometric analysis and visualization mapping of herpes zoster vaccine publications from 1999 to 2024”. Front Med (Lausanne) 12 (2025).
Orru S., et al. “Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020”. Euro Surveill 28 (2023).
Aquino MR., et al. “Delayed allergic skin reactions to vaccines”. Allergy Asthma Proc 43 (2022): 20-29.
Shingrix | European Medicines Agency (EMA). https://www.ema.europa.eu/en/medicines/human/EPAR/shingrix
Thompson H, Nichols L and Santiago TG. “Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine”. BMJ Case Rep 14 (2021).
Assmann G, Schmidt M and Sester M. “Scattered pustular lesions 10 days after Shingrix vaccination in systemic sclerosis patient after successful autologous non-myeloablative haemopoietic stem-cell transplantation”. BMJ Case Rep 17 (2024).

Background: Malnutrition is common in children with cancer and is associated with worse treatment tolerance, increased infections, relapse risk and reduced survival. This review synthesizes recent evidence about the prevalence of nutritional problems in paediatric oncology, mechanisms linking nutrition to outcomes, and the effect of nutritional assessment and interventions (counselling, oral nutritional supplements, enteral and parenteral nutrition) on prognosis and survival.

Methods: A focused literature search (PubMed, PMC, Scopus, Web of Science) was performed for reviews, guidelines, consensus statements and clinical studies published 2017-2025 using terms “paediatric cancer”, “malnutrition”, “nutritional support”, “enteral nutrition”, “parenteral nutrition”, “survival” and “outcomes”. Priority was given to systematic reviews, consensus statements and large retrospective cohort studies and guideline documents.

Results: Malnutrition at diagnosis and during therapy remains common globally and is associated with treatment interruptions, higher infection rates and worse overall survival. Consensus statements and paediatric-focused reviews recommend early screening, standardized assessment (weight/BMI, MUAC, triceps skinfold, clinical evaluation) and proactive, tiered interventions starting with counselling and ONS and escalating to enteral nutrition (EN) or home parenteral nutrition (HPN) when indicated. Evidence shows that enteral feeding is effective at maintaining or improving weight and nutritional indices and may improve treatment tolerance; parenteral nutrition can correct severe deficits but carries higher infection risk. Observational cohort data link malnutrition to poorer survival and some studies suggest that timely nutritional interventions (standardized screening with early EN/HPN) reduce hospital admissions, improve tolerance to therapy and are associated with better short-term clinical outcomes; however high-quality randomized data examining survival as a primary endpoint are limited.

Conclusions: The preponderance of evidence supports routine nutritional screening and early, multidisciplinary nutritional intervention in paediatric oncology as part of standard supportive care. There is a need for standardized screening protocols, prospective trials of targeted nutritional strategies, and implementation research—especially in lower-resource settings—examining whether early aggressive nutrition improves long-term survival endpoints.

References

Kumar S. and Choudhury S. “Ancient Vedic Literature and Human Rights: Resonances and Dissonances”. Cogent Social Sciences 7 (2020): 1858562.
Gravlee GS. “Hope in Ancient Greek Philosophy. In: van den Heuvel, S.C. (eds) Historical and Multidisciplinary Perspectives on Hope”. Springer, Cham (2020).
Vidyashree S and Bharadwaj A. “Transcending Knowledge: Holistic Education through Upanishadic Insight”. International Journal of Novel Research and Development 8.8 (2023).
Nwosu EE. “Comparative study of religion” Methods, Theories and Issues in the Study of Religion (2021).
Social Anthropology/Anthropologie Sociale 28.2 (2020): 482-495.
Debbarma B. “Ethics and Religious Learning: Developing Morality through Religious Teachings”. International Journal of Arts & Education Research 13.4 (2024).
Zhou M and Brown D. “Educational Learning Theories” (2014).
Raymond J Ankrum. “Utilizing Teacher Leadership as a Catalyst for Change in Schools”. Journal of Educational Issues 2.1 (2016).
World Health Organization. “Constitution” (2025).
Kisling and Das. “Prevention Strategies”. StatPearls (2023).
UNESCO. “What you need to know about education for health and well-being” (2025).
Tuvblad C and Beaver KM. “Genetic and environmental influences on antisocial behavior”. J Crim Justice 41.5 (2013): 273-276.
Committee on Defining Deeper Learning and 21st Century Skills. “In: Education for life and work: Developing transferable knowledge and skills in the 21st Century”. Pellegrino JW, Hilton ML, editors. National Academies Press; Washington, DC (2012).
Bandhu D., et al. “Theories of motivation: A comprehensive analysis of human behavior drivers”. Acta Psychologica 244 (2024).
Irudayaselvam S. “The power of proactive learning: enhancing retention and engagement in education”. International Collaboration Book Chapter (2023).
Ghaleb BDS. “Towards A Dynamic Model of Human Needs: A Critical Analysis of Maslow's Hierarchy”. International Journal of Multidisciplinary Approach Research and Science 2.3 (2024): 1028-1046.
Mahmoudi., et al. “Holistic Education: An Approach for 21 Century”. International Education Studies 5.2 (2011).
Morris TH, Bremner N and Sakata N. “Self-directed learning and student-centred learning: a conceptual comparison”. Pedagogy, Culture & Society (2023).
Vaughn KE, Srivatsa N and Graf AS. “Effort Praise Improves Resilience for College Students with High Fear of Failure”. Journal of College Student Retention: Research, Theory & Practice 25.2 (2023): 378-397.
Dweck CS and Yeager DS. “Mindsets: A View from Two Eras”. Perspectives on Psychological Science 14.3 (2019). 481-496.
Upreti R. “Inculcating Empathy: Building a Compassionate Society” (2024).
Đurisic M and Bunijevac M. “Parental Involvement as an Important Factor for Successful Education”. CEPS Journal (2017).
Pronk N., et al. “Promoting Health and Well-being in Healthy People 2030”. J Public Health Manag Pract 27.6 (2021): S242-S248.
Trifonova A., et al. “Teaching AI to the Next Generation: A Humanistic Approach”. Digital Education Review (2024).

References

Chaudhary SR., et al. “Surgical Management of Congenital Anal and Rectal Defects in Farm Animals”. Intas Polivet 11.2 (2010): 140-142.
Dreyfuss DJ and Tulleners EP. “Intestinal atresia in calves: 22 cases (1978-1988)”. Journal of the American Veterinary Medical Association 1954 (1989): 508-513.
Durmus AS. “Congenital intestinal atresia in calves”. Indian Veterinary Journal 86.7 (2009): 737-738.
Ettinger SJ and Feldman EC. “Textbook of Veterinary Internal Medicine”. 6th ed. Elsevier Saunders (2005): 1416.
Loynachan AT, Jackson CB and Harrison LR. “Complete diphallia, imperforate ani (type 2 atresia ani), and an accessory scrotum in a 5-day-old calf”. Journal of veterinary diagnostic investigation 18.4 (2006): 408-412.
Ryu J, Kang SG and Yun J. “Surgical Repair of Atresia Ani with Rectovaginal Fistula in an African Buffalo (Syncerus caffer)”. Journal of veterinary clinics 35.3 (2018): 111-113.
Sharun K., et al. “Arthrogryposis multiplex congenita and perosomus acaudatus complicated with atresia ani in a buffalo calf”. Res. J. Vet. Pract 7.1 (2019): 35-38.
Singh AP. “Congenital-malformations in ruminants-a review of 123 cases”. Indian Veterinary Journal 66.10 (1989): 981-985.
Veena P., et al. “Correction of atresia ani and recto-vaginal fistula in a buffalo calf-A case report”. Buffalo Bulletin 35.4 (2016): 495-497.
Khan S., et al. “Surgical Management of Atresia ani et recti in a Buffalo Calf”. Theriogenology Insight: An International Journal of Reproduction of Animals 9.2 (2019) 73-76.
Wiedemann S, Fries R and Thalle G. “Genomewide Scan for Anal Atresia in Swine Identifies Linkage and Association with a Chromosome Region on Sus scrofa Chromosome”. Genetics 171.3 (2005): 1207-1217.
Brown CC, Baker DC and Baker IK. “Alimentary system”. In: Jubb K.V.F., Kennedy P.C. & Palmer N. (Eds). Pathology of Domestic Animals. 5th edn. New York: Academic Press (2007): 3-296.
Campos FK., et al. “Congenital diseases in cattle diagnosed by the Veterinary Diagnostic Center (CEDIVET) of the Federal University of Pará, during the period from 1999 to 2009”. Brazilian Animal Science 1 (2009): 13-18.
Carvalho YNT., et al. “Anal Atresia Associated with Rectovaginal Fistula in a Calf: A Review”. PUBVET 6.33 (2012): 1-15.
Dantas AFM., et al. “Congenital malformations in ruminants in the semi-arid region of northeastern Brazil”. Brazilian Veterinary Research 30.10 (2010): 807-815.
Chauhan PM., et al. “Atresia Ani: A Congenital Defect & Its Successful Management in Non-Descript Calf”. International Journal for Agro Veterinary and Medical Sciences 5.6 (2011): 520-522.

Treatment of diabetic mellitus (DM) and related complications is available although cost of conventional medicines is relatively high and accompanying side effects beg for alternative therapeutic and management methods. Previous studies demonstrated the antioxidant and anti-inflammatory qualities of Zingiber officinale and Mondia whitei although the scientific knowledge on their efficacy in ameliorating DM-induced infertility is obscure. This study investigated the histomorphometric and histoarchitectural impacts of ethanolic Z. officinale and M. whitei root extracts on the hypothalamus, anterior pituitary and testis (HPT) in diabetic male albino rats. Thirty-six rats were assigned nine groups of six treatment groups and three controls groups. All animals except normal control were administered with alloxan monohydrate to induce DM. Treatment groups were administered with Z. officinale or M. whitei at 200, 400, 800 mg/kg for 28 days, normal control (normal saline), diabetic control (alloxan monohydrate alone) and positive control (alloxan monohydrate and clomiphene citrate). Testicular weight/volume, seminiferous tubule diameter/epithelial height, Leydig cell volume for histomorphometry as well as hypothalamic, anterior pituitary and testicular histology were done. Neuronal degeneration and gliosis in the hypothalamus, decreased number of gonadotropes in the pituitary, disruption of seminiferous epithelium, and Leydig cell atrophy were observed in diabetic controls. Leydig cell volume (501±92.3 µm³), testicular weight (1.02±0.3 ml), and testicular volume (1.11±0.22 ml) all showed significant decrease (p<0.01) in comparison with the normal control group testicular weight (2.71 ± 1.2), testicular volume (2.98 ± 0.71) and Leydig cell volume LCV (1250 ± 212.4). At 800 mg/kg, Z. officinale improved testicular weight: 2.51±0.5 ml; Leydig cell volume: 1291±236.3 µm³, normalized hypothalamic and anterior pituitary histology. Similarly, M. whitei at 800 mg/kg improved testicular weight: 3.38±1.9 ml; Leydig cell volume: 1432±346.7 µm³; p<0.001 vs. diabetic controls with testicular weight 1.03±3ml; leydig cell volume 501±92.3µm³, improved pituitary vascularization, and hypothalamic histology. Mondia whitei at 800 mg/kg performed better than Z. officinale specifically regarding Leydig cell metrics, testicular weight, and volume. Conclusion: Both Z. officinale and M. whitei demonstrated pro-reproductive effects along the HPT axis. However, at 800 mg/kg, M. whitei exhibited greater restorative effects, on histoarchitecture and testicular histomorphometry.

Keywords: Zingiber officinale; Mondia whitei; Diabetic infertility; restorative; Testicular histomorphometry; Hypothalamic-pituitary-testicular axis

Every year, approximately 52 percent of all European children are treated (treated) with some form of complementary and alternative medicine, often even without the knowledge of their pediatrician. Herbal medicines and aromatherapy products have been increasingly used worldwide in the last decade not only for the prevention of diseases in adults, but also for the health care, treatment (care) and prevention of diseases in children. For children, unlike adults, there are few types of medicinal plants and aromatherapy products intended for health care or disease prevention. Studies that would reveal the experiences of parents using phytotherapy and aromatherapy products for children under 3 years of age have not been conducted in Lithuania, while the use of aromatherapy and phytotherapy is very widespread and common.

Objective: to reveal the experiences of parents using phytotherapy and aromatherapy products in the daily care and care of children under 3 years of age.

The study was conducted by recording all interviews (with the consent of the informants). Parents were selected using the convenience sampling method, after a public invitation to participate in the study was published on social networks. 11 parents agreed to participate in the study. The study was conducted on October 1, 2025. – 2025. November 30. Research methods: scientific literature review; semi-structured interview; qualitative content analysis.

Conclusions. 1. For children, unlike adults, there are few types of medicinal plants and aromatherapy products intended for health or disease prevention. This is the most sensitive group, for which phytotherapy and aromatherapy should be used very carefully and in small doses, taking into account age and the suitability of the product for use according to the age of the child. 2. The study revealed that parents prefer to use aromatherapy, but not phytotherapy products or products, in their daily care for their children under three years of age. Most parents advocate the use of aromatherapy when aromatherapy products are inhaled through the respiratory tract. 3. The study revealed that parents give their children under three years of age immunity-boosting teas, cranberries, and honey for preventive purposes. Only a small proportion of parents indicated that they vaporize various essential oils with antibacterial effects at home to prevent diseases.

Keywords: phytotherapy; aromatherapy; parents experiences; Lithuania

A reasonable price for services or products received signals to consumers that they are respected and that their appreciation of offerings is valued. By contrast, inflated prices disappoint consumers, prompting them to seek other options. Time-consuming, and the displeasure generated by producers setting high prices amplifies the negative impact of a disrespectful relationship initiated by providers toward clients. Typically, customers leave because of offenders, given the negative memories of that relationship.

An overestimated product price can be generated by a producer with or without a mental impairment. Intentionally inflating charges reflects a mindset that dishonours and harms consumers. Collective corrective and specific actions are required to improve exchanges.

Unintentionally setting a higher price requires medical attention for repair.

Ideas exchange for improvement plays a major role in relationships. External influences can alter the exchange, with or without ill intent, as their mind is functioning.

Dysfunction in the appreciation of the quality and price of goods, services, or ideas for exchange disappoints producers and consumers, who will gradually withdraw from such collaboration.

Personal judgement can be altered genetically or by medical conditions developed over time: arterial hypertension, dyslipidaemia, type 2 diabetes, and other endocrine disorders.

Collaborators can set boundaries for collaboration with people who exhibit mental impairment. Continuing to collaborate with them adds repetitive, sorrowful moments to their lives, slowly disturbing their balance. Human imperfection is a common trait. Accepting unsafe collaboration for an extended period weakens personal quality of life and reduces life expectancy.

Offended individuals can prompt their collaborators to be more attentive to their misconduct in the relationship. Offenders can respond to such alerts in varying ways, ranging from minimizing to amplifying the negative impact on the harmed individuals. Their reactions reflect their cognitive functioning and suggest avenues for improvement.

If individuals are offended, they may become more fragile and sensitive to others' communication, and inappropriate collaboration with those who inflate prices for their products or who underestimate the value of their exchanges can further increase their vulnerability. They can also exhibit inappropriate behaviour toward offenders to varying degrees, and can display mental impairments in relationship with others.

There is a mix of responses among players in a relationship that leads to multiple directions of relationship evolution. Unstable relationships are associated with functional disorders in the human body.

No one is so bad as circumstances. Some people set inflated prices to survive vulnerable life moments; others adore wealth, and still others shun it. Someone who is hurt in a relationship may lack the courage to move forward with it.

As flowers differ in color and perfume, so do people. The life course is always picturesque.

Background: The therapeutic landscape for type 2 diabetes (T2D) and obesity has shifted from a glucocentric paradigm to one focused on organ protection and weight management. While Glucagon- like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now cornerstones of care, concerns regarding “iatrogenic sarcopenia” have emerged. Current evaluations often rely on Dual-energy X-ray Absorptiometry (DXA), which fails to capture muscle quality. This study aims to synthesize evidence from advanced imaging trials to clarify how these drugs remodel skeletal muscle and to propose a phenotype-guided prescribing framework.

Methods: We conducted a systematic review following PRISMA 2020 guidelines, searching PubMed, Embase, and Cochrane Library up to January 2026. We prioritized randomized controlled trials (RCTs) utilizing Magnetic Resonance Imaging (MRI) proton density fat fraction (PDFF) or Computed Tomography (CT) radiodensity (Hounsfield Units, HU) to assess myosteatosis and muscle quality, alongside functional outcomes (e.g., gait speed).

Results: Analysis of landmark trials (SURPASS-3 MRI, STEP 1, SLIM LIVER) reveals distinct remodeling patterns. Incretin-based therapies (e.g., Tirzepatide, Semaglutide) induce significant weight loss and absolute lean mass reduction. However, Tirzepatide significantly reduced muscle fat infiltration (-0.36%, p<0.0001) beyond what weight loss alone predicts, indicating a “quality optimization” effect. Despite muscle volume loss, functional metrics (gait speed) were preserved or improved, attributed to an enhanced power-to-weight ratio. Conversely, SGLT2 inhibitors (e.g., Dapagliflozin, Empagliflozin) demonstrated a “muscle-sparing” profile. Dapagliflozin increased paraspinal muscle radiodensity (+1.61 HU, p<0.01) without mass loss. Empagliflozin rapidly improved gait speed (+0.08 m/s, p<0.001) in frail older adults, suggesting bioenergetic enhancement.

Conclusions: GLP-1 RAs and SGLT2 inhibitors exert heterogeneous effects on the musculo-adipose unit. Incretins act as “Quality Optimizers” via deep lipid clearance, while SGLT2 inhibitors act as “Mass Preservers” and bioenergetic enhancers. We propose a “Cardiogeriatric Vulnerability Phenotype” framework to guide precision prescribing, ensuring metabolic benefits translate to long-term functional independence.

Keywords: Skeletal muscle quality; Myosteatosis; GLP-1 receptor agonists; SGLT2 inhibitors; Sarcopenia; Phenotype-guided therapy

References

Gulla G., et al. “Navigating antimicrobial use in Indian freshwater aquaculture: regulatory frameworks and sustainable alternatives”. Journal of Indian Fisheries Association (2023).
Sumithra T Gopakumar., et al. “In vitro efficacy of aquaculture antimicrobials and genetic determinants of resistance in bacterial isolates from Indian aquaculture disease outbreaks”. Lett Appl Microbiol 77.10 (2024): ovae088.
Yuting Deng., et al. “Global distribution of antimicrobial resistance genes in aquaculture”. One Health Advances (2025).
Nallaiah H., et al. “Prevalence, antimicrobial resistance, and resistance gene cassettes detection in bacterial pathogens isolated from freshwater ornamental fishes”. Indian Journal of Animal Research (2025).
Mohammed EAH. “Antibiotic Resistance in Aquaculture: Challenges, Trends Analysis, and Alternative Approaches”. Antibiotics (Basel) (2025).
Milan Milijasevic., et al. “Antimicrobial Resistance in Aquaculture: Risk Mitigation within the One Health Context”. Foods (2024).
Abdelazeem M Algammal., et al. “Prevalence, antimicrobial resistance pattern, virulence determinants, and AMR genes of emerging multidrug-resistant Edwardsiella tarda in Nile tilapia and African catfish”. Aquaculture (2022).
Ranjit Kumar Nadella., et al. “Categorization of antibiotic resistant bacterial populations from shrimp aquaculture environment of Andhra Pradesh, India”. Aquaculture (Elsevier) (2025).
Lavanya Chethurajupalli., et al. “Antimicrobial Resistance of Aeromonas Species Isolated from Cultured Indian Major Carp, Labeo rohita: Possible Public Health Concern”. ResearchGate (2021).
“Surveillance data of the Indian Network for Fishery and Animal Antimicrobial Resistance (INFAAR)”. (FAO/ICAR report) (2022).
Neelam Taneja and Megha Sharma. “Antimicrobial resistance in the environment: the Indian scenario”. Indian J Med Res 149.2 (2019): 119-128.
Murugadas Vaiyapuri., et al. “Antimicrobial resistance in Vibrios of shrimp aquaculture: incidence, identification schemes, drivers and mitigation measures”. AMR-Insights (2021).
“Antimicrobial Resistance in Aquaculture: emerging crisis and environmental dissemination”. MDPI Antimicrobials (2025).
Schar and coauthors (from preprint review): Trends in AMR emergence, transfer and dissemination in aquaculture systems (2024).
Md Javed Foysal., et al. “Prevalence of opportunistic pathogens and AMR in urban aquaculture ponds”. J Hazard Mater (2024).
Regional clinical pathogen AMR study: Prevalence of multidrug-resistant Klebsiella pneumoniae from freshwater fish farms in Andhra Pradesh, India (2024).

Chronic use of “Night” Labelled Sleep-inducing Tablets

Melatonin mouth spray is used by some mothers to induce the sleep of their children by the knowledge of sleep-inducing capabilities of those products for adults. Melatonin tablets and mouth sprays are good moving in GCC for the age group above 18 even they are having the habit of strong coffee before sleep. Most of the youngsters now using “Night” labelled tablets which are made for pain related sleep but as OTC public use even with lifestyle disorders like Diabetes, Hypertension, etc. to get good sleep at night. At the same time, the use of chlorpheniramine maleate is also very common as sleep inducing pills.

Use of Wellness products without proper evidence of needs

Different strengths of Vitamin D, Biotin, Vitamin C, Magnesium, Calcium, etc. and other products which affect strongly in the body like L- Tryptophan, Ashwagandha, Chromium, etc. also widely used without proper needs and only with the awareness of few online promotions and customers own thoughts. So, the time crosses to consider the wellness products awareness and their classifications as OTC & Non-OTCs based on the dose & type of products with patients’ health related parameters.

Over consumption of Pain Killers may cumulate Diabetes & CKD cases in future

Public has the wrong concept of pain killers to relieve the pain related to delivery and they used pain killers as OTC including Ibuprofen which is not safe in that time of gestation without informing the reason as well the about the patient details towards the Pharmacists and in that someone felt angry towards the Pharmacists if they ask some queries related with their health conditions while dispensing medicines. Public having the tendency to take Diclofenac powder dosage form and sometimes tablets also for throat pain related with cold & flu. There is a chronic use of Diclofenac for different types of pain even if they have Diabetes, Hypertension, etc. Paracetamol included cold & flu labelled tablets & other formulations widely used if they don’t have pain or fever. Instead of anti-allergic medicine patients have the habit of taking an anti-allergic paracetamol combination, which means miss use of Paracetamol. Hypertensive patients having sever head ach also prefer Diclofenac like strong pain killers without even monitoring BP & other symptoms of stroke.

Self-treatment by double the dose for the fastest heal

Most adults have two tablets of 500mg paracetamol together to relief their pain or fever & they are getting good results. So, they are habituated to intake two dose at the same time without taking any instructions from the health care practitioners to get fast heal. Some patients take two capsules of Amoxycillin 500mg TID instead of one capsule TID of doctor prescription. Same way OTC paracetamol suppositories, diclofenac suppositories. also may not be used based on the baby body weight.

Conclusion

Majority of people in the Gulf & Middle East countries depend on the community Pharmacies than hospitals by the concept of saving their finance as well as time while they are having common types of mild illness as well as for the wellness products. However, this leads to double dose, misuse & overuse by the influence of few online promotions. Most of them are not aware of its future health complications and so, we need to educate & give proper awareness about drug safety towards the public, including youngsters, by using different health education channels. So that we can generate healthy people in future.

Acknowledgement

I convey my sincere respect to my parents, gratitude to my colleagues & all my friends who are supporting my research & innovations.

References

Attenborough David. The Private Life of Plants: A Natural History of Plant Behaviour. The Bath Press, Glasgow and Bath (1995).
Bozan G. Opioid Intoxication: can also occur with raw ingestion of poppy plant seed or as tea. Opium is a highly addictive non-synthetic narcotic that is extracted from the poppy plant, Papaver somniferum. Opium is the key source for many narcotics including morphine, codeine, and heroin Caplan Tiffany Dr. DC, CFMP, IFMCP; Caplan Brent Dr. DC, CFMP, IFMCP. (2021).
Some of the autoimmune diseases that have been linked to issues with lectins include whole grains, raw whole grains like raw wheat germ. Creative in My Kitchen; (https://creativeinmykitchen.com).
Tomatoes contain lectins, proteins found in most seeds, grains, skins, rinds, and leaves. DEA Museum; (https://museum.dea.gov).
Although the opium (papaver somniferum) has the highest concentration of narcotics, all poppies in the Papaver genus do contain some amount of narcotic. How addictive are poppies seeds. Department of Natural Resources and Environment Tasmania; (https://nre.tas.gov.au).
Faculty of Medicine – The University of Queensland; eating poppy seeds cause severe muscle cramping, muscle spasms and abnormal movement, and seizures. (https://medicine.uq.edu.au).
Gundry Steven. The Plant Paradox. The Hidden Dangers in “Healthy” Foods that Cause Disease and Weight Gain. Harper Collins Publication (2017).
Gundry Steven. Plant Paradox Cookbook. More than 100 Delicious Plant Paradox Recipes. Harper Collings Publishers (2018).
Gundry Steven. Summary, The Plant Paradox. Knowledge Tree publications Mayo Clinic; Poppy species come from Papaver Somniferum seeds that contain opiates powerful to depress the central nervous system and can induce drowsiness. https://www.mayoclinic.org) (2020).
Mishra A. Algal lectins are grouped into three major categories based on carbohydrate binding properties: complex type N-glycan, specific lectins, high mannose type N-… Poppies cause high blood pressure UF Health.(https://www.ncbi.nlm.nih) (2019).
National Institute of Health (NIH).gov. (Lectins are divided into several families based on the CRD sequence motifs and cation such as; galectins (or S-type lectins), rhamose-binding lectins (RBLs), C-type lectins (CTLs), X-type lectins, (XTLs), P-type lectins, F-type lectins and pentraxins (https://www.ncbi.nlm.nih.gov).
Precision Nutrition; (Lectins can trigger an immune response, inflammatory bowel disease, rheumatoid arthritis, and type 1 diabetes. (https://www.precisionnutrition.com).
Science-Based Medicine; (Plants produce chemicals to defend themselves from predators “and you are a predator”. The Plant Paradox: Gundry S. (2017) (https://sciencebasedmedicine.org).
ScienceDirect.com (https://www.sciencedirect.com). The cocaine contained in coca leaves is unsafe and can cause migraines, seizures, strokes, heart attacks, high blood pressure, and liver and kidney failure Thoughtscapism; (https://thoughtscapism.commeasures-of-toxicity/). (chewing coca leaves could be considered a risk factor for oral cancer in a subset of Argentinean patients. (WebMDhttps://www.webmd.com).
Wikipedia: Benzoylecgonine is the main metabolite of cocaine formed by the liver and excreted in urine (https://en.wikipedia.org).

This research examined the origins of chronic diseases such as Chron’s diseases, irritable bowel syndrome (IBS), chronic autoimmune diseases such as obesity, diabetes, rheumatoid arthritis and origins of psychoactive drug addictions – all of which are traceable to people’s diets. The evidence point to the fact that the source of all our innumerable diseases are traceable to edible plants or our foodcrops that our lives depend on. The research further examined the reasons why and how the foodcrops we grow to feed ourselves seasonally, and annually, could be the source of our diseases. The new findings points to the fact that unbeknownst to us human beings and our scientific community, plants are conscious organisms with their own type of consciousness. That because plants are conscious creatures, edible plants make specific demands on human beings that we ignore because of our ignorance of the fact that plants are conscious. On the other hand, edible plants have a clear understanding of the natural relationship between us and them. Edible plants see human beings as predators that attack them as our source of food. Thus, edible plants see themselves as prey. This is why edible plants developed a whole range of toxins, poisons, and psychoactive drugs to protect themselves and attack us in attempts to stop human beings from eating their seeds and sprouts, by waging war against us for perpetuation of their species. This is why edible plants developed three major lectins of toxins, poisons, and psychoactive drugs for this war of attrition against humans. But out of human’s ignorance, this is an invisible war that we and our scientific community have no idea of as the underlying reason for the diseases we suffer from our foodcrops. Hence, this research has surfaced many things we did not know about plants, but which edible plants obviously take very seriously namely; (1) that plants have consciousness, (2) that plants have two specific demands on us that a), we should stop eating their seeds they consider as their babies and b), and to stop eating their sprouting leaves (3) that the reason for developing the toxins, poisons, and psychoactive drugs (such as nicotine, cocaine, and opium/heroine/morphine to mess with our minds) are just to protect themselves as well as ensure that we human beings observe our side of the bargain of peaceful coexistence, that plants laid down for animals, long before we human beings arrived in the world as Adam & Eve (a.k.a) Homo Sapiens. Actually, it is not this research alone, but some physicians who have been treating chronic diseases of indigestion, autoimmune diseases, as well as food and drug addictions, have known that the source of all our diseases and suffering are traceable to the foods we eat, and how badly we prepare the food. The Food Industry also know that our diseases come from lectins (as health bombs) that edible plants put in fruits, nuts, seeds, leaves and tubers that we ingest into our bodies. Those who do not know this fact of life are the general populace and our scientific community – especially physicists, who are busy investigating the universe, multiverses and string theory, while remaining ignorant about edible plants that are our neighbours, that are waging an invisible war against us as (conscious organisms).

Keywords: autoimmune; edible; Lectoms. Foodcrops, multiverses; perpetuation; conscious

Front-of-pack labelling (FOPL) has emerged as a key public health strategy to help consumers identify the nutritional quality of food products at the point of purchase. This study presents a comprehensive international regulatory and technical analysis of FOPL systems, encompassing mandatory warning schemes, voluntary positive labelling programmes, and regulatory proposals currently in development across more than 40 countries and regions worldwide. The analysis evaluates both negative labelling systems (black octagonal seals, traffic light colour bars, magnifying glass warnings) and positive endorsement schemes (Nutri-Score, Keyhole, Heart Symbol, Health Star Rating, Choices). Nutritional compliance was assessed for a plant-based crunchy snack product (Loovies Styx) against the thresholds established by each regulatory framework. The product composition per 100 g (218.32 kcal, 0.28 g total fat, 9.02 g sugars, 299 mg sodium, and 19.74 g dietary fibre) was systematically compared with critical nutrient limits for sugars, saturated fats, sodium, and total fat across all jurisdictions analysed. Results demonstrate that the product does not trigger any warning label, negative seal, or restrictive symbol under any mandatory, voluntary, or proposed regulatory framework evaluated. Furthermore, the product qualifies for positive endorsement seals and healthy logos in the majority of voluntary systems assessed, largely attributable to its exceptionally high dietary fibre content and very low levels of saturated fat and sodium. A complementary international market review did not identify any comparable product that simultaneously exhibited the complete absence of critical formulation factors commonly present in processed snack foods—such as refined flours, added oils, or ingredients subjected to processes that may significantly degrade nutritional quality—while also being formulated exclusively from whole plant-based ingredients derived from vegetables and fruits. Based on the regulatory, compositional, and comparative market evidence analysed, the positioning of Loovies Styx as the healthiest industrially produced snack within its category can be considered technically substantiated for the purposes of scientific, regulatory, and commercial communication within the scope of the criteria evaluated in this study.

Keywords: front-of-pack labelling; nutrient profiles; food regulation; nutritional compliance; plant-based snacks; dietary fibre; international food law

References

Annabelle Richer-Fortin. “Contamination of the hospital environment by carbapenem resistance genes”. 27th Annual Public Health Conference. National Institute of Public Health of Quebec (2024).
Warren BG., et al. “Enhanced Daily Disinfection Strategy for Acute Care Hospital Rooms: A Randomized Clinical Trial”. JAMA Network Open 5.11 (2022): e2242131.
World Health Organization. “Global Report on Infection Prevention and Control: Executive Summary”. Geneva (2022).
Aumeran C and Jacomet C. “Preventing infectious risk in healthcare settings through barrier measures”. Sages-femmes 19.5 (2022): 15-18.
French Society for Hospital Hygiene. Update on Standard Precautions. Healthcare facilities, medico-social facilities, community care settings (2017).
Metzger C., et al. “Factors associated with adherence to barrier measures and social distancing measures in France”. J Epidemiol Popul Health 72.2 (2024): 202194.
Krikorian R., et al. “Standardization of needle-stick injuries and evaluation of a new virus-inhibiting protective glove”. J Hosp Infect 66 (2007): 339-345.
Abiteboul D., et al. “Incidence of blood-exposure incidents among nursing staff in metropolitan France, 1999-2000: results of a multicenter survey in 32 hospitals”. BEH No. 51/2002; 255.
Mast ST, Woolwine JD and Gerberding JL. “Efficacy of gloves in reducing blood volumes transferred during a simulated needle stick”. J Infect Dis 168.6 (1993): 1589-1592.
Belesi BM. “Evaluation of adherence to preventive measures and measures to limit the spread of COVID-19 at the Ilebo General Reference Hospital”. Journal of Health Sciences 1.1 (2022): 31-33.
Musangu MS., et al. “Adherence to hand hygiene in the hospital setting: a requirement for patient safety in healthcare facilities in Lubumbashi, Democratic Republic of the Congo”. Review of the Congolese Nurse 4.2 (2020): 36-42.
Basandja LE and Panda LK. “Adherence to hand hygiene in General Reference Hospitals in the city of Kisangani, DRC”. Pan African Medical Journal 35 (2020): 57.
Sakihama T., et al. “Improving Healthcare Worker Adherence to Hand Hygiene Before Patient Contact: A Multimodal Intervention on Hand Hygiene Practices in Three Japanese Tertiary Care Centers”. J Hosp Med 11.3 (2016): 199-205.
Benboubker M., et al. “Knowledge, Attitudes, and Practices Regarding Standard Precautions Among Healthcare Workers at the Hassan II University Hospital Center in Fez (Morocco)”. EMHJ 23.1 (2017).
Dahourou DL., et al. “Knowledge and Practices of Healthcare Providers in Burkina Faso Regarding Standard Precautions for Preventing Healthcare-Associated Infections in 2023”. Burkinabè Journal of Public Health 1.1 (2025): 28-39.
Coulibaly MB. “Knowledge, perceptions, and practices of healthcare personnel during the COVID-19 pandemic in the Gbêkê region, Côte d'Ivoire”. Malian Journal of Infectiology and Microbiology 17.1 (2022): 6-16.
Bello C, Degbey CC and Lamine BM. “Adherence to hospital hygiene precaution standards in pediatric wards in Benin”. Beninese Journal of Infectious Diseases 3.2 (2024): 24-30.
Ilunga JK., et al. “Adherence to barrier measures against Coronavirus Disease 2019 by healthcare personnel at the Milumba and Kikula referral health centers in Likasi”. Review of the Congolese Nurse 6.1 (2022): 17-20.
Baud O., et al. “Perception of and adherence to protective measures in the context of the COVID-19 pandemic”. Hygienes 2 (2022): 119-28.
Constantinou D., et al. “Knowledge and perceptions of healthcare professionals regarding WHO hand hygiene recommendations and perceived barriers to adherence in Cyprus”. BMC Nurs 23.1 (2024): 644. Erratum in: BMC Nurs 23.1 (2024): 681.
Kim J., et al. “Knowledge, attitudes, barriers, and improvement measures regarding hand hygiene among healthcare professionals in the Republic of Korea: a cross-sectional survey exploring interprofessional differences”. Antimicrob Resist Infect Control 12.1 (2023): 93.

References

Axcell S and Ellis D. “Exploring the attitudes and behaviour of Gen Z students towards branded mobile apps in an emerging market: UTAUT2 model extension”. Young Consumers 24 (2023).
Bartlett MS. “A Note on the Multiplying Factors for Various χ2 Approximations”. Journal of the Royal Statistical Society. Series B (Methodological) 16 (1954): 296-298.
Bryman A. “Social research methods”. Oxford University Press, Oxford; New York (2001).
Burke RR. “Technology and the Customer Interface: What Consumers Want in the Physical and Virtual Store”. Journal of the Academy of Marketing Science 30 (2002): 411-432.
Chaudhuri M and Verma MK. “The Indian Women’s Movement: Reform and Revival”. Winshield Press (2017).
Cronbach LJ. “Coefficient alpha and the internal structure of tests”. Psychometrika 16 (1951): 297-334.
Dabija D-C and Lung L. “Millennials Versus Gen Z: Online Shopping Behaviour in an Emerging Market”. in: Văduva, S., Fotea, I., Văduva, L.P., Wilt, R. (Eds.), Applied Ethics for Entrepreneurial Success: Recommendations for the Developing World, Springer Proceedings in Business and Economics. Springer International Publishing, Cham (2019): 1-18.
Datta Khan S., et al. “The Impact of Customers’ Perceptions of The Quality Of E-Services on Their Gratification and Intention to Make Future Purchases in The Context of Online Shopping”. Journal of Informatics Education and Research 03 (2023): 1211-1219.
Faul F., et al. “G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences”. Behavior Research Methods 39 (2007): 175-191.
Gatewood RD, Barrick MR and Feild HS. “Human resource selection”. 6. ed. ed. Thomson South-Western, S.L (2007):.
Hair JF. (Ed.) “Multivariate data analysis: a global perspective”. 7. ed., global ed. ed. Pearson, Upper Saddle River, NJ Munich (2010).
Hair JF. (Ed.) “Multivariate data analysis”. Prentice Hall, Upper Saddle River, N.J (1998).
Hair JF., et al. “An assessment of the use of partial least squares structural equation modeling in marketing research”. J. of the Acad. Mark. Sci 40 (2012): 414-433.
Harahap D and Amanah D. Online Purchasing Decisions of College Students in Indonesia 3 (2018): 5-15.
Hasman H., et al. “Factors Influencing Gen Z’s E-Loyalty in Shopping on E-Commerce”. International Journal of Economic, Business, Accounting, Agriculture Management and Sharia Administration (IJEBAS) 3 (2023): 1183-1188.
Immanuel R and Danibrata A. “Factors Affecting Gen Z E-Loyalty in Online Shopping”. International Journal of Business, Economics and Law 31 (2024).
Kaiser HF. “A second generation little jiffy”. Psychometrika 35 (1970): 401-415.
Kaiser HF., et al. Educational and Psychological Measurement 34 (1974): 111-117.
Kamarudzaman N and Harun S. “Factors Influencing Gen-Z Online Shopping Satisfaction”. The Empirical Economics Letters 21 (2022): 277-284.
Kananti VEP., et al. “Exploring Online Shopping Trends: The Impact of Lifestyle on Gen Z Students’ Purchasing Decisions on Shopee”. JEMA 1.02 (2024): 53-61.
Kumar V and Kumar S. n.d. “A Correlative Study of Conventional Shopping and Online Shopping: Special Reference to Meerut City”. IJFANS 12 (2023).
Moss TP, Lawson V and White P. “The Appearance Research Collaboration, 2015”. Identification of the underlying factor structure of the Derriford Appearance Scale 24. PeerJ 3 (2015): e1070.
P Radha and Aithal S. “An Exploratory Analysis of Variables Shaping Consumer Decision-Making in the Purchase of Kitchen Appliances Within Shopping Mall Environments”. International Journal of Management, Technology, and Social Sciences (2024): 148-168.
Pallant J. “SPSS survival manual: a step by step guide to data analysis using IBM SPSS, 7th edition”. ed. Allen & Unwin, Crows Nest, NSW (2020).
Schulze J. Online and Offline Shopping: Decision Making Factors that Influence Consumer Purchases (2020).
Şentürk E. The Effects of Consumer Purchase Decision-Making Styles on Gift-Giving Behavior: An Analyze on Generations Y and Z (2023): 139-154.
Singh V, Chaudhuri R and Verma S. “Psychological antecedents of apparel-buying intention for young Indian online shoppers: Scale development and validation”. Journal of Modelling in Management 14 (2019).
Streiner DL. “Figuring Out Factors: The Use and Misuse of Factor Analysis”. Can J Psychiatry 39 (1994): 135-140.
Syahdan R. “Factors influencing Gen-Z customer perception online shopping in Indonesia”. International Journal of Communication and Society 3.2 (2021).
Thangavel P, Pathak P and Chandra B. “Consumer Decision-making Style of Gen Z: A Generational Cohort Analysis”. Global Business Review 23 (2022): 710-728.
Zikra R and Yusra Z. “Women's Satisfaction in Purchasing Fashion Products Based on Purchasing Method”. Jurnal RAP UNP 7 (2016): 55-66.

Background: The internet has surely altered many facets of human existence. Innovations, particularly in information and technology, are critical drivers of economic and social progress.

Aim: The aim of the study is to determine factors that influence Gen Z shopping decision-making style.

Setting: This study was quantitative cross-sectional conducted in South Africa.

Material and Methods: A convenient sampling was used to sample the participants. The data was collected through a self-administered questionnaire measuring the Gen Z consumer decision-making styles. The data collected was analysed using IBM-SPSS version 30.0. Pearson’s correlation and regression analysis was used to test relationships between variables. The Kruskal-Willis test was conducted to determine if there are differences between group. A p-value < 0.05 was considered statistically significant.

Results: The study involved 193 respondents, of whom 131 (68.2%) were aged 23 - 26 years, while 62 (31.8%) were aged 18 - 22 years. The majority of the respondents 98 (50.8%) were males, 91 (51.3%) were working, 149 (77.2%) have been using internet for 9 years or more, and 106 (54.9%) preferred both online-shopping and traditional-shopping. We found that brand loyalty shopper (p-value < 0.001), brand consciousness (p-value < 0.001), and traditional shopping confidence (p-value = 0.001), had a statistically significant impact on quality consciousness. We also found that there was no statistically significant difference between online shopping, traditional shopping and both online shopping (p-values = 0.468).

Conclusion: The study found a correlation between quality consciousness and brand loyal shopper, brand consciousness, online store loyalty, online shopping confidence, and traditional shopping confidence. We also found that there were no differences between the preferred shopping methods when it comes to quality consciousness.

Contribution: This study contributed to a better understanding of the loyalty of Gen Z to brands, or their tendency to frequently switch brands based on novelty, trends, or social media recommendations.

Keywords: Generation Z; Quantitative; Decision-making style; Online shopping; Traditional shopping South Africa

Usually, an individual's disgrace in the community stems from wrongdoing. Their misconduct may be either intentional or unintentional. Errors can be identified in their professional, social, and personal lives.

Mistakes in job execution are often driven by gaps in training for their specific work, acute or chronic medical issues affecting work efficiency, burnout, a disincentive to work, unhealthy behaviors such as excessive drinking, coffee consumption, and eating, air and noise pollution, and/or alarming environmental conditions such as excessive flooding and earthquakes. The producer's negative feelings stemming from their mistakes are, to varying degrees, transferred to their collaborators, loved ones, friends, and possibly other community members who can resonate with them. Their imbalance influences the system's functionality at the micro and macro levels; when disturbed, it alters work efficiency, personal creativity, and societal advancement. Professionally addressing these issues can prevent mistakes in practice and ultimately improve an individual's professional life.

Errors in social and personal life are noticed when the individual's behavior does not align with social norms.

Heartfelt work is required to address unintentional minor or moderate wrongdoing in daily work.

By contrast, some individuals fabricate false accusations of wrongdoing against their intended recipients to damage their reputations, career advancement, or business stability. They can act individually or in a group, with the same ill intent toward their victims. Their genetics and incentives motivate them to take such actions. Channels for transmitting false accusations vary: chat, email, phone calls, word of mouth, TV, radio, and/or online platforms. The impact of spreading such false information about the intended recipient can range from moderate to devastating, disrupting their equilibrium. This is why such actions must not be tolerated. Offenders must be quickly identified, and their punishment carried out with cool-headed resolve—no tolerance for cruelty.

Offenders against innocent victims may, over time, realize the danger their actions have posed to the offended persons. Initially, the offender is satisfied with their brave actions toward the intended person; finally, they can engage in self-reflection on their past actions and accept an impartial judge that transcends human judgment. The regret over their real wrongdoings toward an innocent person initiates the shadow inner world, which is a key to their imbalance. They can try to compensate for errors by issuing public apologies and offering recompense in the form of material gifts to their victims. Their persistent shadow inner world slowly erodes their balance. If they do not try to clean it, their end can follow sooner, with a darker inner world that can migrate to their surroundings and their loved ones.

False accusations affect the group or community's perception of an individual's value. Initially, a lack of respect for the accused person was evident. Over days, months, and even years, the truth's dominance leads them to change their opinion of the person who was offended. Some of them apologize to the offended person; others, excessively proud, do not apologize and, because they do not try to balance their misappreciation of that innocent person with excuses, thereby darken their inner world. Rarely do they have the courage to collaborate with them in the time ahead, knowing that, in the past, they still damaged the image of an innocent person.

A person's altered standing must be analyzed in terms of the producer's mindset and values, as well as the contribution of external factors to such undesirable results.

Social dysfunction arises when people act unethically toward others, excessively blame them for intentional or unintentional mistakes, and ultimately disrupt their balance and their professional and social lives.

Supportive actions by others in response to inappropriate behavior in such relationships can improve the quality of life for the person affected and help rehabilitate their image in society. Repairing malfunctions as soon as possible prevents the progression of disorders, which incur medical and social costs.

References

Hugo J and Ganguli M. “Dementia and cognitive impairment: epidemiology, diagnosis, and treatment”. Clinics in geriatric medicine 30.3 (2014): 421-42.
Patterson C. World Alzheimer report (2018).
Finkel SI., et al. “Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment”. International psychogeriatrics 8.S3 (1997): 497-500.
Lyketsos CG., et al. “Neuropsychiatric symptoms in Alzheimer’s disease”. Elsevier (2011): 532-9.
Ismail Z., et al. “Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment”. Alzheimer's & Dementia 12.2 (2016): 195-202.
Petrovic M., et al. “Clustering of behavioral and psychological symptoms in dementia (BPSD): a European Alzheimer’s disease consortium (EADC) study”. Acta Clinica Belgica 62.6 (2007): 426-32.
Ruths S., et al. “Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts”. International journal of geriatric psychiatry 28.8 (2013): 868-76.
Schneider LS, Dagerman KS and Insel P. “Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials”. Jama 294.15 (2005): 1934-43.
Wang J., et al. “Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis”. Journal of Neurology, Neurosurgery & Psychiatry 86.1 (2015): 101-9.
Chiu HL., et al. “Effectiveness of light therapy in cognitively impaired persons: a metaanalysis of randomized controlled trials”. Journal of the American geriatrics society 65.10 (2017): 2227-34.
Skjerve A., et al. “Improvement in behavioral symptoms and advance of activity acrophase after short‐term bright light treatment in severe dementia”. Psychiatry and clinical neurosciences 58.4 (2004): 343-7.
Figueiro MG., et al. “Long-term, all-day exposure to circadian-effective light improves sleep, mood, and behavior in persons with dementia”. Journal of Alzheimer's disease reports 4.1 (2020): 297-312.
Cibeira N., et al. “Bright light therapy in older adults with moderate to very severe dementia: immediate effects on behavior, mood, and physiological parameters”. Healthcare; MDPI (2021).
Forbes D., et al. “Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia”. Cochrane Database of Systematic Reviews 2 (2014).
Huang L-B., et al. “The effectiveness of light/dark exposure to treat insomnia in female nurses undertaking shift work during the evening/night shift”. Journal of Clinical Sleep Medicine 9.7 (2013): 641-6.
Mitolo M., et al. “Effects of light treatment on sleep, cognition, mood, and behavior in Alzheimer’s disease: a systematic review”. Dementia and geriatric cognitive disorders 46.5-6 (2019): 371-84.
Lack L., et al. “Morning blue light can advance the melatonin rhythm in mild delayed sleep phase syndrome”. Sleep and Biological Rhythms 5.1 (2007): 78-80.
Lack L, Wright H and Paynter D. “The treatment of sleep onset insomnia with bright morning light”. Sleep and Biological Rhythms 5 (2007): 173-9. Sleep Medicine 74 (2020): 66-72.
Weissová K., et al. “Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder”. Sleep Medicine 52 (2018): 1-6.
Stein RM., et al. “Virtual discovery of melatonin receptor ligands to modulate circadian rhythms”. Nature 579.7800 (2020): 609-14.
Pickard GE and Sollars PJ. “Intrinsically photosensitive retinal ganglion cells”. Reviews of Physiology, Biochemistry and Pharmacology 162 (2012): 59-90.
Burns A., et al. “Bright light therapy for agitation in dementia: a randomized controlled trial”. International psychogeriatrics 21.4 (2009): 711-21.
Sondereker KB, Stabio ME and Renna JM. “Crosstalk: The diversity of melanopsin ganglion cell types has begun to challenge the canonical divide between image‐forming and non‐image‐forming vision”. Journal of Comparative Neurology 528.12 (2020): 2044-6
Lamb TD. “Why rods and cones?”. Eye 30.2 (2016): 179-85.
Berson DM, Dunn FA and Takao M. “Phototransduction by retinal ganglion cells that set the circadian clock”. Science 295.5557 (2002): 1070-3.
Hattar S., et al. “Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity”. Science 295.5557 (2002): 1065-70.
Hannibal J., et al. “Melanopsin expressing human retinal ganglion cells: Subtypes, distribution, and intraretinal connectivity”. Journal of Comparative Neurology 525.8 (2017): 1934-61.
Belenky MA., et al. “Melanopsin retinal ganglion cells receive bipolar and amacrine cell synapses”. Journal of Comparative Neurology 460.3 (2003): 380-93.7
Provencio I, Rollag MD and Castrucci AM. “Photoreceptive net in the mammalian retina”. Nature 415.6871 (2002): 493-495.
Dacey DM., et al. “Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN”. Nature 433.7027 (2005): 749-54.
Reifler AN., et al. “The rat retina has five types of ganglion-cell photoreceptors”. Experimental eye research 130 (2015): 17-28.
Jiang L., et al. “Efficacy of light therapy for a college student sample with non-seasonal subthreshold depression: an RCT study”. Journal of Affective Disorders 277 (2020): 443-9.
Fu Y., et al. “Non-image-forming ocular photoreception in vertebrates”. Current opinion in neurobiology 15.4 (2005): 415-22.
Fregna L, Attanasio F and Colombo C. “The effect of bright light therapy on irritability in bipolar depression: a single-blind randomised control trial”. International journal of psychiatry in clinical practice 27.4 (2023): 416-8.
Vandewalle G, Maquet P and Dijk D-J. “Light as a modulator of cognitive brain function”. Trends in cognitive sciences 13.10 (2009): 429-38.
Chojnacka M., et al. “A sham-controlled randomized trial of adjunctive light therapy for non-seasonal depression”. Journal of Affective Disorders 203 (2016): 1-8.
Pail G., et al. “Bright-light therapy in the treatment of mood disorders”. Neuropsychobiology 64.3 (2011): 152-62.
Ma J., et al. “Decreased functional connectivity within the salience network after two-week morning bright light exposure in individuals with sleep disturbances: a preliminary randomized controlled trial”. Sleep Medicine 74 (2020): 66-72.
Rubiño JA., et al. “Bright light therapy and circadian cycles in institutionalized elders”. Frontiers in Neuroscience 14.505444 (2020): 1071-7.
Liu C-R, Liou YM and Jou J-H. “Pilot study of the effects of bright ambient therapy on dementia symptoms and cognitive function”. Frontiers in Psychology 12 (2021): 782160.
Kolberg E., et al. “The effects of bright light treatment on affective symptoms in people with dementia: a 24-week cluster randomized controlled trial”. BMC psychiatry 21 (2021): 1-16.
Figueiro MG., et al. “Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities”. Clinical interventions in aging (2014): 1527-37.
Yamadera H., et al. “Effects of bright light on cognitive and sleep–wake (circadian) rhythm disturbances in Alzheimer‐type dementia”. Psychiatry and clinical Neurosciences 54.3 (2000): 352-3.
Bromundt V., et al. “Effects of a dawn-dusk simulation on circadian rest-activity cycles, sleep, mood and well-being in dementia patients”. Experimental gerontology 124 (2019): 110641.
Sloane P., et al. “Effect of home-based light treatment on persons with dementia and their caregivers”. Lighting Research & Technology 47.2 (2015): 161-76.
Canazei M., et al. “Actigraphy for assessing light effects on sleep and circadian activity rhythm in Alzheimer's dementia: a narrative review”. Current Alzheimer Research 16.12 (2019): 1084-107.
Konis K, Mack WJ and Schneider EL. “Pilot study to examine the effects of indoor daylight exposure on depression and other neuropsychiatric symptoms in people living with dementia in long-term care communities”. Clinical interventions in aging (2018): 1071-7
Levitan RD. “What is the optimal implementation of bright light therapy for seasonal affective disorder (SAD)?”. Journal of Psychiatry and Neuroscience 30.1 (2005): 72-3.
Abraha I., et al. “Systematic review of systematic reviews of non-pharmacological interventions to treat behavioral disturbances in older patients with dementia”. The SENATOR-OnTop series. BMJ open 7.3 (2017): e012759.
Haffmans PJ., et al. “Bright light therapy and melatonin in motor restless behavior in dementia: a placebo‐controlled study”. International journal of geriatric psychiatry 16.1 (2001): 106-10.
Gasio PF., et al. “Dawn–dusk simulation light therapy of disturbed circadian rest–activity cycles in demented elderly”. Experimental gerontology 38.1-2 (2003): 207-16.
Chen Y-R., et al. “Efficacy of Blue LED Phototherapy on Sleep Quality and Behavioral and Psychological Symptoms of Dementia: A Double-Blind Randomized Controlled Trial”. Gerontology 69.10 (2023): 1175
Oren DA., et al. “Usage patterns of phototherapy in seasonal affective disorder”. Comprehensive psychiatry 32.2 (1991): 147-52.-88
Labbate LA., et al. “Side effects induced by bright light treatment for seasonal affective disorder”. The Journal of clinical psychiatry 55.5 (1994): 189-91.
Erickson K., et al. “Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder”. American Journal of Psychiatry 162.11 (2005): 2171-3.
Strigo IA., et al. “Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain”. Archives of general psychiatry 65.11 (2008): 1275-84.
Sekiguchi H, Iritani S and Fujita K. “Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer's type dementia: a case series”. Psychogeriatrics 17.5 (2017): 275-81.
van Lieshout-van Dal EE., et al. “Impact of dynamic light exposure on sleep-wake pattern and BPSD in people with dementia living at home”. Design for Health 7.1 (2023): 64-81.
Paino M., et al. “Light-therapy applications for DSM-IV-TR disease entities”. The European Journal of Psychiatry 23.3 (2009): 166-76.
Shirani A and St. Louis EK. “Illuminating rationale and uses for light therapy”. Journal of Clinical Sleep Medicine 5.2 (2009): 155-63.
Van Hoof J., et al. “Light therapy: methodological issues from an engineering perspective”. Technology and Health Care 20.1 (2012): 11-23.
Golden RN., et al. “The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence”. American Journal of Psychiatry 162.4 (2005): 656-62.
Maruani J and Geoffroy PA. “Bright light as a personalized precision treatment of mood disorders”. Frontiers in psychiatry 10 (2019): 412296.
Meesters Y., et al. “Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD”. A randomized controlled study. BMC psychiatry 11 (2011): 1-8.
Chan P, Lam RW and Perry KF. “Mania precipitated by light therapy for patients with SAD”. The Journal of clinical psychiatry 55.10 (1994): 454.
Profita HP, Roseway A and Czerwinski M. “Personal and social considerations of wearable light therapy for seasonal affective disorder”. Proceedings of the 10th EAI International Conference on Pervasive Computing Technologies for Healthcare (2016).
Sloane PD., et al. “High‐intensity environmental light in dementia: Effect on sleep and activity”. Journal of the American Geriatrics Society 55.10 (2007): 1524-33.
Hastings MH, Maywood ES and Brancaccio M. “Generation of circadian rhythms in the suprachiasmatic nucleus”. Nature reviews Neuroscience 19.8 (2018): 453-69.

However, such armor has recently been demonstrated to be inadequate. Bangladesh has experienced a significant rise in measles outbreaks recently, which transcends a mere health concern and serves as a warning flag. The minor losses in 2026, accompanied by thousands of infections and over a hundred children who tragically lost their lives at such a young age, reveal a harsh truth: it may be rescinded. It is not science that has abandoned us, but our steadfastness in its application. Measles, requiring approximately 95% vaccine coverage to maintain herd immunity, is currently exploiting deficiencies in the immunization system (WHO, 2023; UNICEF, 2026).

These discrepancies are not coincidental. They signify neglected follow-ups between the initial and subsequent vaccine doses, an inequitable allocation of healthcare in urban slums and isolated regions, as well as an increasing percentage of "zero-dose" children who have not received any vaccines. The nationwide study indicated that full immunization coverage declined to approximately 80–82%, rendering communities vulnerable (DGHS, 2023) Due to inadequate awareness, social obstacles, and sporadic interruptions in health service provision, herd immunity has diminished, leaving our youngest and most impoverished children vulnerable.

The government's emergency campaigns for measles-rubella vaccination in children aged 6 months to 5 years constitute a timely and essential intervention (UNICEF, 2026). However, they signify a more substantial challenge: transitioning from prevention to response. Bangladesh has historically achieved measles control through persistent, vigorous immunization measures. This reappearance underscores that vaccination is an ongoing endeavor necessitating sustained coverage, a robust health system, and public trust.

The situation in Bangladesh has now reached a critical juncture. The principles of contemporary medicine remain relevant, and the scientific consensus is established. Recommitment is necessary, together with the renewal of short-term contracts (enhanced routine immunization), equal access, and trust in vaccines. Measles has reemerged, not merely as a public health issue but also as an indicator of the degree to which the hard-earned advancements in public health protection can be preserved.

References

World Health Organization (WHO). Table A) 2023 Global Strategy for Measles and Rubella Elimination and Immunization Coverage Data.
UNICEF Bangladesh. Measles Outbreak Situation Report (2026).
Directorate General of Health Services, Bangladesh. Coverage Assessment Survey, Expanded Programme on Immunization (EPI) (2023).

The Role of Bioinformatics in Drug Discovery

Traditional drug discovery methods involve extensive laboratory testing and trial-and-error experimentation, often taking over a decade to bring a new drug to market. Bioinformatics revolutionises this process by utilising algorithms, databases, and machine learning techniques to efficiently identify potential drug targets. Through genomic and proteomic analysis, researchers gain deeper insights into disease mechanisms at the molecular level, enabling the development of targeted therapies tailored to an individual’s genetic profile.

Key Applications in Drug Development
Target Identification and Validation

Bioinformatics plays a crucial role in identifying disease-associated genes and proteins that serve as potential drug targets. By analysing vast datasets, researchers can pinpoint molecules that play critical roles in disease progression, thereby reducing the risk of ineffective drug candidates and enhancing the chances of successful therapeutic development.

Virtual Screening and Molecular Docking

Computational techniques such as molecular docking and virtual screening allow researchers to assess thousands of compounds virtually, predicting their binding affinity to target proteins. This process significantly reduces the time and costs associated with experimental screening, helping researchers prioritise the most promising drug candidates for further testing.

Pharmacogenomics and Personalised Medicine

By analysing genetic variations among individuals, bioinformatics enables researchers to understand how different genetic profiles influence drug responses. This facilitates the design of personalised treatment plans that maximise efficacy while minimising adverse effects. Pharmacogenomics has already been instrumental in optimising treatments for diseases such as cancer, where tailored drug regimens improve patient outcomes significantly.

Clinical Trial Optimisation

Bioinformatics enhances clinical trial efficiency by aiding in patient selection based on genetic markers and disease subtypes. This targeted approach improves the likelihood of trial success while reducing costs and the time required for regulatory approval. Additionally, predictive analytics help identify potential adverse effects early in the trial process, improving patient safety and trial efficacy.

Drug Repurposing

Instead of developing new drugs from scratch, bioinformatics allows researchers to identify existing drugs that can be repurposed for new therapeutic uses. This approach offers a cost-effective and faster alternative to traditional drug development, as these compounds have already been tested for safety in humans. Bioinformatics-driven drug repurposing has gained traction in recent years, with notable successes in the treatment of diseases such as COVID-19.

Challenges and Future Perspectives

Despite its immense potential, bioinformatics in drug development faces several challenges. One of the primary obstacles is the integration and standardisation of vast and diverse biological datasets. Handling large-scale data from various sources requires advanced computational frameworks and robust data-sharing mechanisms to ensure accuracy and reproducibility.

Computational limitations also pose a challenge, as analysing complex biological interactions demands significant processing power. However, advancements in artificial intelligence, cloud computing, and big data analytics are continuously addressing these constraints, making drug discovery more efficient and precise.

Another challenge lies in the validation of bioinformatics-generated predictions. While computational models can predict potential drug candidates with high accuracy, experimental validation remains crucial. Bridging the gap between computational predictions and laboratory validation requires closer collaboration between bioinformaticians, biologists, and pharmacologists.

Looking ahead, bioinformatics will continue to play a pivotal role in shaping the future of medicine. The rise of precision medicine will lead to even more targeted and effective treatments, allowing physicians to tailor therapies based on an individual’s genetic makeup. As computational power continues to grow, bioinformatics will remain at the forefront of drug development, revolutionising the way we discover, test, and deliver new medicines.

Conclusion

The integration of bioinformatics in drug development is revolutionising the pharmaceutical industry. By leveraging computational tools and vast biological datasets, researchers can accelerate the discovery of novel therapies, optimise clinical trials, and pave the way for personalised medicine. While challenges remain, continuous advancements in technology will further enhance the efficiency and precision of drug development, ultimately improving patient outcomes worldwide. The future of medicine is being reshaped by bioinformatics, promising a new era of precision therapeutics that will transform global healthcare.

References

World Health Organization. A Global Health Strategy for 2025-2028. WHO (2024).
Global Public Health Week 2025: Redefining equity and decolonizing public health for a healthier world. Population Medicine 31.1 (2025).
Andrianirina VH., et al. “Use of health services in Madagascar: influence of free care on a one-off basis”. Health Policy and Planning 38.3 (2023): 354-363.
Africa CDC. Africa Health ExCon 2025: Innovation and trade in health (2025).
Africa CDC. 4th International Conference on Public Health in Africa (CPHIA 2025) (2025).
4th International Conference on Public Health in Africa (CPHIA 2025): Moving Towards Self-reliance to Achieve Universal Health Coverage and Health Security in Africa (2025).
The Global Economy. Madagascar: Health spending as percent of GDP (2022).
The Global Economy. Madagascar: Health spending per capita (2022).
Ministry of Public Health, Madagascar. National Health Information System Standards and Procedures Manual (2017).
World Bank. Madagascar: National Medical Waste Management Plan (2021).
Ministry of Public Health, Madagascar. Organizational Structure and Management of District Referral Hospitals (2021).
Ratovoson R., et al. “Impact of hypertension on mortality in adults in Moramanga, Madagascar: a retrospective cohort study in the community”. BMC Public Health 25.1 (2025): 992.
Ratovoson R., et al. “Moramanga Health Survey in Urban and Rural Areas in Madagascar (MHURAM project)”. Cohort Profile. Int J Epidemiol 48.6 (2019): 1754-1763.
Local health organization and management of the DRHC Moramanga, Madagascar. Ministry report (2025).
O’Neill G., et al. “The age profile of healthcare professionals: A systematic review”. BMC Health Serv Res 19.1 (2019): 1-9.
Maleki MR., et al. “An exploration of the role of hospital committees and their productivity in Iran”. J Educ Health Promote 4 (2015): 89.
Sajjadi HS., et al. “The impact of productivity committees being established in hospitals”. Int J Health Care Qual Assur 24.6 (2011): 412-423.
Law No. 2011-003 on hospital reform. Official Gazette of the Republic (2011).
Ministry of Health. Health and Social Development Plan 2020-2024 (2020).
Andrianarivelo H and Raveloson E. “Assessment of public building accessibility in Antananarivo”. Journal of Social Sciences 12.2 (2019): 123-134.
Raveloson E, Andrianarivelo H and Rasolofoniaina R. “Analysis of strategic planning in Malagasy hospitals”. Madagascar Public Health Journal 10.2 (2021): 75-82.
Ministry of Public Health. Operational standards for health facilities in Madagascar. Antananarivo (2020).
Rakotomanana A, Raveloson E and Andrianarivelo H. “Assessment of human resources in the health system in Madagascar”. Madagascar Public Health Journal 11.1 (2020): 15-23.
Agyepong I and Adjei S. “Public-Private Partnerships in Health Service Delivery: A Review of the Ghanaian Experience”. BMC Health Services Research 18.1 (2018): 1-9.
Randriamiharisoa A and Fanjanirina A. “Availability and distribution of health professionals in public health facilities in Madagascar”. Journal of Health Sciences 12.3 (2019): 100-108.
André H. “Factors impacting the effectiveness of the internal audit committee”. Revue ISG 4.2 (2025): 1299-1308.
Ministry of Public Health, Madagascar. National Strategic Plan for Combating HIV/AIDS 2018-2022. Antananarivo: Ministry of Public Health (2018).
Randriamanantena A, Andriamihaja D and Raveloson A. “Impact of continuing education on the care of tuberculosis patients in Madagascar”. Madagascar Journal of Public Health 5.2 (2020): 45-50.
National standard for the construction of buildings resistant to natural hazards in Madagascar (2025).
Malagasy Standards Bureau. Norms and standards for referral hospitals in Madagascar (2025).
UNDP Madagascar. Solar energy for health (2023).
Ministry of Economy and Finance, Madagascar. Budget execution circular, Madagascar (2025).
Ministry of Economy and Finance, Madagascar. Performance Document - Annex to the Draft Finance Bill 1 (2025).
Health Sector Development Plan, Madagascar 2020-2024 (2025).
Madagascar Health Accounts 2019-2021 (2023).
Ministry of Public Health, Madagascar. National Strategic Plan for Community Health and Supply (PNSCA) 2024-2028 (2025).
World Bank. Fiscal Management and Public System Performance in Middle-Income Countries (2023).
Ministry of Finance, Madagascar. 2024 Budget Execution Report (2025).
Decree No. 11028/2018 establishing standards applicable to public referral hospitals. Madagascar (2018).
Hospitalized Patient Charter. Madagascar (2021).
National Medical Waste Management Policy. MSANP (2017).
Technical Guide on Medical Waste Management. MSANP (2021).
International Committee of the Red Cross (ICRC). Medical Waste Management Manual (2011).
Andriamifidison NZR., et al. “Impact of Human Resource Management on Hospital Performance: The Case of the University Hospital Centre of Befelatanana”. Asian. Jour. Social. Sci. Mgmt. Tech 4.5 (2022): 84-88.

Though a worldwide movement to rejuvenate Ayurveda again has somewhat been started, we cannot deny it needs a bit of transformation too to match with the pace of modern life. Major reasons why now in modern times modern technologies and sciences took over the traditional sciences of healing are because they are quicker and more easily accessible.

However Ayurveda is the only hope for a sustainable and healthy survival of our species and this nature. India reinvented ways to help Ayurveda propagate and become accessible to every individual. But this rejuvenation of Ayurveda is needed by the whole world now. The COVID pandemic screamed on us about the dire need for adapting the way of living as per Ayurveda and spreading the treasury knowledge of Ayurveda all over the world.

Artificial Intelligence can be very helpful in achieving this aim of spreading the wisdom of Ayurveda across the world, for the welfare of humankind.

Below we have discussed the ways Artificial Intelligence can help in advancement of Ayurveda.

Internet and Artificial intelligence is accessible globally to all, so introduction of Ayurveda would become much easier. Original texts can be made available with translation in several different languages. This will directly increase people's reach to Ayurveda.

Building apps that can help in the education of Ayurveda overseas will create awareness about Ayurveda and give the world the opportunity to learn about it to help all humans.

Prakriti parikshan apps and other personalised apps can be easily made using AI and this is what Ayurveda is about, the personalized healthy lifestyle. It would not only increase the popularity of Ayurveda but will also increase its efficiency

Fight against Biopiracy

Artificial intelligence can be of great use in our fight against Biopiracy. Initiatives like TKDL(traditional knowledge digital library) can be done more effectively, in a much shorter time span. In TKDL right now the texts are available in five international languages: English, French, German, Spanish and Japanese. Through AI this can be done in several other languages as well. Further AI can help in assimilation and preservation of our traditional knowledge while making it accessible to the world as well.

Ayurvedic Texts can be efficiently translated in several languages.

Process of getting patents can be made easy by its digitalization.

AI can be of great help in Globalization of Ayurveda

AI can be very helpful in building connectivity throughout the world, translating texts, organising seminars and workshops online, building educational apps, building a close knit community of Ayurvedic scholars and students allowing them to be more engaged and have better interaction.

Ayurveda for farmers

This would involve using AI to promote the cultivation of medicinal plants among farmers by educating them about its economical benefits. Also helping them with what kind of plant would suit their terrain and soil. Next by providing them direct connection to the market not just at national level but internationally as well, by helping them build cooperatives etc.

Children's accessibility

If something is taught at childhood it becomes a lifelong habit. Since I have emphasized this again and again Ayurveda is not just a treatment it is a lifestyle and teaching that lifestyle to children in their early years will not only make them adapt to it faster but would keep them healthy as well. Through AI such fun game apps can be created that allows them to learn the basics of Ayurveda at an early age.

Cultural heritage

Ayurveda is an integral part of Indian culture, its ritucharya, diet regime, and sadvrit all have been incorporated in our daily life since ages. Through AI the associated sites, and teachings can be popularized to help us Indians and our diaspora in foreign nations, to reconnect with our roots. For this Book publication, apps like pramoda that can track our progress, and online communities can be very helpful.

Plant conservation

Ayurveda not only uses plants, it worships and protects them too. Ayurveda talks about sustainable use, conservation, it forbids overexploitation. So Those principles of Ayurveda, by AI can be taught all around the world to take a step towards saving earth.

Also surveys can be done more effectively through AI, and statistics and data analysis would help us realise which plants we need to conserve more.

Supply chain and pharma

Since not all plants can be grown at all places, especially medicinal plants, requires precise soul type and climatic conditions, this creates a shortage of few drugs at some places while too much of other drugs at another place. This problem can be resolved by building direct buying and selling online platforms allowing the pharma companies direct contact with farmers globally. This would be positive for the global economy too and would surely be a great solution to shortage of ayurvedic drugs at places other than India.

Merging the modern science with traditional knowledge

Through AI modern science and ayurvedic science can be merged to make the health system better, cheaper and accessible to all. It would also help in elimination of loopholes in both systems when used alone.

Research and development

AI would be the most useful means for Research and Development of Ayurveda. Raising funds collaborating globally accessing information all that can be so easy through AI.

While AI could be a magical wand for the advancement of Ayurveda, the process might have a few challenges.

Challenges in adapting AI for Ayurvedic Advancement
Digital divide

Many people in India still lack basic knowledge about computers, and the internet. Then engagement of AI would set those groups behind the ones who have that knowledge.

Lack of connectivity

Several places in India still lack the internet.

Increase in forgery

Though we aim to make Ayurvedic knowledge accessible to all easily, this might also lead to a rise in the problem of quacks, the one who pretends to be Ayurvedic vaidyas when they are not. They not only demean Ayurveda but are dangerous to society as well for they might give you wrong drugs.

Language barriers

Till now Artificial Intelligence hasn't become that efficient in languages like hindi sanskrit or other Indian languages. Since Ayurveda belongs to India, knowledge of Indian languages by AI is must while being utilised for advancement of Ayurveda.

Lack of human touch

Ayurveda is a personalised therapy. Every Individual has different prakartik hence different treatment and diet (aahar-vihar, etc.) This can be accessed best by a Vaidya who has complete knowledge of Ayurveda, even after using AI for Prakriti parikshan, and other things without the guidance of a Vaidya it can never be apt.

More pressure on earth

Since using AI leads to higher energy consumption, data centres etc this leads to higher carbon footprint.

Though together we can overcome these challenges, especially when the stakes are so high. The 21st century with such fast paced transformations not just physically but socially and mentally, and the ever declining health of Earth, our insolence forcing us to hamper nature, all these actions has made us stand at the threshold of end, one more wrong step and the whole species would be forced to pay the consequences. In such crucial times Ayurveda can be the rocket that can take us not to Mars rather to a better and healthier earth with healthy us. We need to understand how it will be good for us, our physical, mental, and social health, how it will be sustainable for the planet and how we as a species need to adapt Ayurveda as soon as possible for our own benefit and longevity. Aiding the process through Artificial Intelligence would only make us achieve this goal in a much shorter time.

This would require us to increase digital education and decrease the digital divide, make the internet accessible to every corner of our county, figure out ways to further develop AI and make it learn and understand Indian languages etc. Most importantly we would require to figure out ways to reduce the carbon footprint of AI by adapting to renewable sources of electricity development.

Ayurvedic science doesn't need us, we need it to survive and sustain. We need it to preserve our health and our planet. We need it to preserve our mind and soul.

India has always had the motto of - “sarvebhavntu sukhinah” Ayurveda is the means to fulfill this aim.

The Ultimate Synergy: Why Harmony with Nature is Our Only Lifeline

For centuries, humanity has operated under the delusion that progress requires dominion over the natural world. We have paved over ecosystems, engineered artificial substitutes for natural processes, and treated the biosphere as an inexhaustible supply closet. Yet, the modern surge in chronic illnesses, mental health crises, and environmental degradation tells a different story. True human longevity and wellness cannot be engineered in a lab; it is fundamentally anchored in how harmoniously we coexist with nature.

The Biological Mirror

Our bodies are not separate from the Earth; they are extensions of it. Every physiological system we possess evolved in direct response to natural cues.

Circadian Alignment

Exposure to natural sunlight regulates our endocrine systems, dictating sleep, metabolism, and immune function.

The Microbiome Link

Interacting with diverse, natural environments strengthens our microbiomes, the literal foundation of our immune defense.

Stress Mitigation

Spending time in green spaces clinically reduces cortisol levels, lowers blood pressure, and shifts our nervous system from a state of chronic fight-or-flight into restorative parasympathetic dominance.

When we isolate ourselves from these natural inputs, our biology falters. The rise of "nature deficit disorder" isn't a abstract concept—it is a modern medical reality.

Reciprocity as Preventive Medicine

Living in harmony with nature requires a shift from exploitation to reciprocity. We cannot expect clean air for our lungs while destroying the forests that filter it, nor can we expect vital nutrients from soil depleted by industrial chemicals.

A healthier life requires a healthier planet. Preventive medicine must expand its scope beyond the clinic to include the preservation of biodiversity, the restoration of local ecosystems, and the reduction of our carbon footprints.

Changing the Paradigm

To secure a healthy future, medical and scientific communities must advocate for systemic changes that weave nature back into the fabric of daily life:

Biophilic Urbanism

Designing cities that integrate green infrastructure, urban forests, and accessible natural spaces.

Ecological Literacy

Educating future generations to view human health and environmental health as a single, inseparable entity.

Sustainable Consumption: Shifting toward plant-forward, locally sourced diets and regenerative practices that respect planetary boundaries.

The preservation of human health is entirely dependent on the maintenance of planetary health. Living in harmony with nature is not a romantic, utopian ideal; it is a strict biological necessity. If we wish to thrive, we must stop fighting the systems that created us and finally learn to live as a part of them.

Chronic stress keeps the nervous system in a state of perpetual fight-or-flight, elevating cortisol levels and contributing to systemic inflammation, cardiovascular disease, and compromised immunity. Mentally, the cognitive overload of constant multitasking fractures our attention spans, driving sharp increases in anxiety, burnout, and emotional fatigue. When every moment is optimized for output, we lose the cognitive bandwidth required for deep reflection, creativity, and genuine emotional regulation.

Cultivating a Conscious Paradigm

To counter this trajectory, we must adopt a comprehensive approach to well-being that honors both the body and the mind:

Radical Rest: Prioritizing non-linear time—periods intentionally devoid of agendas, screens, or performance metrics—to allow the parasympathetic nervous system to restore the body.

Mindful Presence: Shifting our focus from efficiency to depth, ensuring that our daily routines are grounded in awareness rather than mechanical execution.

The Spiritual Pathway to Wholeness

Beyond physical and mental adjustments, true vitality requires a spiritual pathway. Spirituality, in this context, is not strictly religious; it is the practice of fostering a deep connection to something greater than oneself, whether through nature, community, or quiet introspection

References

The report on The State of Food Insecurity in the World, an annual publication of the FAO, IFAD, and WFP, raises awareness of global hunger issues and analyzes the root causes of hunger and malnutrition. The 2014 edition of the report - http://www.fao.org/publications/sofi/fr/
Food Security Information Network, 2017, Global Report on Food Crises (2017).
FAO, IFAD, WHO, WFP and UNICEF, 2017. The State of Food Security and Nutrition in the World (2017).
World Food Programme (WFP). United Nations Report: The year of the pandemic is marked by a rise in global hunger (2021).
Mongbo V., et al. “Factors associated with malnutrition in children under five years of age in Za-kpota, Benin, 2018”. Moroccan Journal of Public Health 9.14 (2022).
Ouedraogo Y and Burkina F. “Prevalence and factors associated with malnutrition in infants aged 6 to 23 months admitted to the pediatric emergency department of the University Hospital Center”. Mali Médical 35.3 (2020).
Dama U., et al. “Prevalence of malnutrition among children under 5 years of age in the departments of Mayo-Tsanaga and Logone et Chari, Far North, Cameroon”. PAMJ Clinical Medicine 14.3 (2024).
DRC-National Institute of Statistics, Kinshasa School of Public Health and ICF. 2024. Demographic and Health Survey of the Democratic Republic of Congo 2023-2024: Final Report. Kinshasa, DRC and Rockville, Maryland, USA: ICF.
Ngombe NK., et al. “Prevalence of severe acute malnutrition in children under 5 years of age and associated factors in rural areas: Case of the Vaku health zone in 2020”. International Journal of Innovation and Applied Studies 40.3 (2023): 622-632
PRONANUT. National protocol for nutritional surveys in the DRC according to the SMART methodology (2017).
World Health Organization (WHO). Regional Office for Africa: Regional Committee for Africa 69 (2019). Strategic Plan to Reduce the Double Burden of Malnutrition in the WHO African Region 2019-2025: Report of the Secretariat. https://iris.who.int/handle/10665/331514
Ruel MT and Alderman H. “Nutrition-sensitive interventions”. The Lancet 382 (2013): 536-551.
National Protocol for Integrated Management of Acute Malnutrition (IMM), 2016 Edition
WHO. Guidelines for the management of severe acute malnutrition in children. Geneva: World Health Organization. (WHO | Regional Office for Africa) (2013).
Smith LC and Haddad L. “Explaining child malnutrition”. IFPRI (2000).

References

Chou KC. “Impacts of bioinformatics to medicinal chemistry”. Medicinal chemistry 11.3 (2015): 218-34.
Kumar A., et al. “Recent Advances in the Treatment of Parasitic Diseases: Current Status and Future”. Natural Product Based Drug Discovery Against Human Parasites: Opportunities and Challenges (2023): 249-86.
Pang K., et al. “Role of protein phosphorylation in cell signaling, disease, and the intervention therapy”. MedComm 3.4 (2022): e175.
Abdel-Meguid SS. “Proteases as targets for therapy”. Springer Science & Business Media (2000).
Idris OA, Wintola OA and Afolayan AJ. “Helminthiases; prevalence, transmission, host-parasite interactions, resistance to common synthetic drugs and treatment”. Heliyon 5.1 (2019).
Divecha VD. “Tyrosine Kinases and Its Receptors: Emphasis on Activation Signaling Pathways and Inhibitors”. African Journal of Biomedical Research (2025).
Rudolph J, Hoeflich KP and Dar AC. “Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies”. Nature Reviews Drug Discovery (2026): 1-24.
Elgawish MS., et al. “Leveraging artificial intelligence and machine learning in kinase inhibitor development: advances, challenges, and future prospects”. RSC Medicinal Chemistry 16.10 (2025): 4698-720.
Apoorva OS., et al. “Proteases: Role in various human diseases”. Current pharmaceutical biotechnology 26.14 (2025): 2257-69.
Petushkova AI and Zamyatnin Jr AA. “Papain-like proteases as coronaviral drug targets: Current inhibitors, opportunities, and limitations”. Pharmaceuticals 13.10 (2020): 277.
Kuskov AN and Kukovyakina EV. “Nanotechnology-based drug delivery systems”. Pharmaceutics 17.1 (2025): 110.
Khonza MM., et al. “Role of Ligand-and Voltage-Gated Ion Channels in Cell Signaling”. InCell Signaling (2025): 154-186.
Zhang M., et al. “TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases”. Signal Transduction and Targeted Therapy 8.1 (2023): 261.
Zheng PP, Li J and Kros JM. “Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights”. Medicinal research reviews 38.1 (2018): 325-76.
Kumar A., et al. “Recent Advances in the Treatment of Parasitic Diseases: Current Status and Future”. Natural Product Based Drug Discovery Against Human Parasites: Opportunities and Challenges (2023): 249-86.
Belete TM. “Recent progress in the development of new antimalarial drugs with novel targets”. Drug design, development and therapy (2020): 3875-89.
Shang X., et al. “Natural products in antiparasitic drug discovery: Advances, opportunities and challenges”. Natural Product Reports 42.9 (2025): 1419-58.
Siddiqui B., et al. “Artificial intelligence in computer-aided drug design (cadd) tools for the finding of potent biologically active small molecules: Traditional to modern approach”. Combinatorial Chemistry & High Throughput Screening (2025).
Lytan I., et al. “Computational Innovations in Cancer Research and How Computing is Transforming Drug Discovery and Development: A Review”. Mini-Reviews in Medicinal Chemistry (2026).
Suri SS, Fenniri H and Singh B. “Nanotechnology-based drug delivery systems”. Journal of occupational medicine and toxicology 2.1 (2007): 16.
Doerig C. “Protein kinases as targets for anti-parasitic chemotherapy”. Biochemistry and Biophysics Acta (BBA)-Proteins and Proteomics 1697.1-2 (2004): 155-68.
Abdelsayed M. “AI-driven polypharmacology in small-molecule drug discovery”. International journal of molecular sciences 26.14 (2025): 6996.
Marques L., et al. “Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare”. Pharmaceutics 16.3 (2024): 332.

PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Quick Links

Volume 9 Issue 1